{"meta":{"query_hash":"a0bb49e076ec","filters":{"venue":"The Lancet Diabetes & Endocrinology"},"cohort_total":247,"direct_labels_cover":3,"predictions_cover":247,"exported":247,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a0bb49e076ec","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Lancet+Diabetes+%26+Endocrinology"},"results":[{"id":"W1858444929","doi":"10.1016/s2213-8587(15)00076-5","title":"Prevalence of behavioural risk factors for cardiovascular disease in adolescents in low-income and middle-income countries: an individual participant data meta-analysis","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Environmental health; Meta-analysis; Disease; Obesity; Demography; Gerontology; Internal medicine","score_opus":0.2893329745542987,"score_gpt":0.3796146050471501,"score_spread":0.09028163049285143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858444929","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42015576,0.572912,7.336074e-7,0.000021458134,0.00004967247,0.0013512253,0.0054868404,0.000021773974,5.2815386e-7],"genre_scores_gemma":[0.616612,0.38246402,0.000026409098,0.0000148800455,0.00009046195,0.0002956504,0.00045367534,0.000038801114,0.000004088031],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99415827,0.001593548,0.0010491415,0.001122402,0.0006495884,0.0014270539],"domain_scores_gemma":[0.9948632,0.0007646705,0.0006160158,0.0033312482,0.00011669352,0.0003081728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020694744,0.0006641059,0.008695653,0.0004582485,0.00005239098,0.000031005493,0.0014481595,0.00019304405,0.000014404051],"category_scores_gemma":[0.0006513655,0.00041716645,0.0017818385,0.00061632966,0.0005128295,0.00022925275,0.0010569796,0.0008348179,0.000004106108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004026192,0.0010614292,0.89521855,0.027215026,0.074806996,0.00003326002,0.00010712381,0.000029575709,2.2618975e-8,0.00002897298,0.000001613731,0.001457191],"study_design_scores_gemma":[0.00088609534,0.00016126479,0.49326593,0.0017141581,0.5027197,0.0000014730131,0.000015814783,0.00011485396,0.0000013458812,0.00013752554,0.0006914704,0.00029034942],"about_ca_topic_score_codex":0.0006830406,"about_ca_topic_score_gemma":0.00026794657,"teacher_disagreement_score":0.4279127,"about_ca_system_score_codex":0.000090041634,"about_ca_system_score_gemma":0.00020517857,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W1955483128","doi":"10.1016/s2213-8587(15)00329-0","title":"Heart failure: fatal, forgotten, and frequent in type 1 diabetes too","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Population; Disease; Macrovascular disease; Ageing; Cohort; Internal medicine; Pediatrics; Endocrinology","score_opus":0.034930682609626285,"score_gpt":0.27431237131636005,"score_spread":0.23938168870673376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955483128","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33126742,0.00922433,2.3530349e-7,0.6557211,0.00065542135,0.0010487328,0.000051550025,0.00017409158,0.0018570686],"genre_scores_gemma":[0.070927665,0.0011628815,0.00067448686,0.916363,0.004652312,0.0005509148,0.0013951334,0.00017909578,0.004094497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957028,0.00022084762,0.0004672428,0.0007477334,0.00037807768,0.002483267],"domain_scores_gemma":[0.9980928,0.00032770255,0.00016625698,0.0011823886,0.000113024566,0.00011784328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040727342,0.0006290365,0.0017098725,0.0003424657,0.00007625519,0.000072655,0.00044935994,0.00043465005,0.0001128812],"category_scores_gemma":[0.00015650147,0.00043589386,0.00014398339,0.0003019393,0.0004108171,0.00010290549,0.00044696746,0.0016138111,0.00027819996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022742806,0.00006267819,0.091207534,0.00032827567,0.0005343737,0.00019808453,0.00005314849,8.443457e-7,0.00016701437,0.00018579321,0.9045511,0.002688454],"study_design_scores_gemma":[0.002414936,0.0007023494,0.011644,0.00018777579,0.0005508534,0.000014698856,0.000032568933,0.00002121057,0.00052672403,0.001960191,0.98153275,0.00041195017],"about_ca_topic_score_codex":0.000044687415,"about_ca_topic_score_gemma":0.00003783928,"teacher_disagreement_score":0.26064187,"about_ca_system_score_codex":0.00020234252,"about_ca_system_score_gemma":0.00009377844,"threshold_uncertainty_score":0.99980927},"labels":[],"label_agreement":null},{"id":"W1960273689","doi":"10.1016/s2213-8587(15)00319-8","title":"Global health metrics and non-communicable diseases: the case of hypertension","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Global health; Population; Non-communicable disease; Gerontology; Disease; Scopus; Health care; Diabetes mellitus; Environmental health; Public health; MEDLINE; Economic growth; Nursing; Internal medicine","score_opus":0.07062258934294062,"score_gpt":0.3199145073091296,"score_spread":0.249291917966189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960273689","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034402974,0.010022512,0.0000056084796,0.95058095,0.0009255196,0.00051558943,0.00017638823,0.00008450916,0.0032859333],"genre_scores_gemma":[0.07593301,0.0012341329,0.000041001746,0.91642725,0.0060624415,0.000050435774,0.00017832995,0.00003006584,0.00004329953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961663,0.00037954238,0.0006750794,0.0003859429,0.0001814693,0.0022116944],"domain_scores_gemma":[0.99651223,0.0009952062,0.00080083514,0.0013965133,0.0002538223,0.000041382245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016076572,0.00037550332,0.0016184081,0.00016173375,0.00042609635,0.000089748806,0.0011817031,0.00029562088,0.00002129776],"category_scores_gemma":[0.0011089253,0.00020839172,0.00012906203,0.0006775199,0.00066274987,0.0001607593,0.0014284909,0.001076373,0.00004603316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009025907,0.000018553093,0.0052223224,0.0004764094,0.00009073833,0.0001607317,0.000010003609,0.000026924221,1.4531311e-7,0.003787393,0.986603,0.0035947245],"study_design_scores_gemma":[0.0005361748,0.000046372174,0.002589265,0.00003622378,0.00014517327,0.00019469926,0.00013196752,0.0019736148,5.6806773e-8,0.009819503,0.98434263,0.00018432263],"about_ca_topic_score_codex":0.032660775,"about_ca_topic_score_gemma":0.00050818216,"teacher_disagreement_score":0.041530035,"about_ca_system_score_codex":0.000110923495,"about_ca_system_score_gemma":0.00014742398,"threshold_uncertainty_score":0.9737808},"labels":[],"label_agreement":null},{"id":"W1968938093","doi":"10.1016/s2213-8587(14)70226-8","title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"Canadian Diabetes Association; Juvenile Diabetes Research Foundation International","keywords":"Medicine; Artificial pancreas; Insulin; Diabetes mellitus; Crossover study; Glucagon; Internal medicine; Insulin pump; Endocrinology; Pancreas; Type 2 diabetes; Type 1 diabetes; Hormone; Gastroenterology; Pathology; Placebo","score_opus":0.06536605166457726,"score_gpt":0.3404041475937732,"score_spread":0.2750380959291959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968938093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880475,0.0015296002,0.000054205717,0.0010127621,0.00028302957,0.008646564,0.00008468744,0.000061100596,0.0002805454],"genre_scores_gemma":[0.9968286,0.00009206316,0.00016019659,0.00079297216,0.00067289494,0.0009533861,0.00034955062,0.000062992534,0.0000873218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99552804,0.000755356,0.0010801387,0.0006284127,0.0004975881,0.0015104344],"domain_scores_gemma":[0.99654645,0.001697921,0.0005423507,0.0006378082,0.0004056348,0.00016981541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019383766,0.00041927453,0.002613371,0.0002486803,0.00020168215,0.00013945362,0.0004838717,0.00017770493,0.0000585467],"category_scores_gemma":[0.0008872159,0.00027239523,0.00011105344,0.00031297526,0.00070669997,0.00021150314,0.00015570817,0.0004388539,0.000012646058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8202197,0.005819357,0.10948281,0.0000726211,0.0013018348,0.0000023549278,0.00010726063,0.000011511632,0.037760407,0.0018428562,0.0009731131,0.022406198],"study_design_scores_gemma":[0.8526684,0.021042047,0.11271466,0.00007218862,0.0004753137,3.0160402e-7,0.000048362443,0.006101419,0.0031557758,0.0019925528,0.0013541521,0.00037479485],"about_ca_topic_score_codex":0.000028691815,"about_ca_topic_score_gemma":0.000026851738,"teacher_disagreement_score":0.034604628,"about_ca_system_score_codex":0.000056372868,"about_ca_system_score_gemma":0.000097264216,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W1984346612","doi":"10.1016/s2213-8587(14)70026-9","title":"Inducing thyrotoxicosis in the liver to treat raised cholesterol","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; Internal medicine; Statin; Familial hypercholesterolemia; Population; Endocrinology; Pediatrics","score_opus":0.047250953375664276,"score_gpt":0.2867011758288138,"score_spread":0.23945022245314956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984346612","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29518652,0.0017964182,0.000012602237,0.6970925,0.00026422378,0.0023361915,0.000024928808,0.000093829636,0.0031928162],"genre_scores_gemma":[0.19153814,0.0004999028,0.00006156738,0.7956814,0.010653144,0.0011232285,0.00009272142,0.00007628025,0.00027358593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950231,0.0011570901,0.0004417572,0.00065935915,0.0005616449,0.0021570732],"domain_scores_gemma":[0.99673253,0.0004801727,0.00014620615,0.0025030763,0.000058299123,0.00007973429],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012555833,0.0004817012,0.0015961796,0.00025014082,0.0001403601,0.000056500365,0.0009543651,0.0004956804,0.000087285436],"category_scores_gemma":[0.00016990943,0.000257868,0.00040103582,0.0003212398,0.00016292755,0.000035806446,0.00018360329,0.0031199483,0.00025559418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061248335,0.00006236214,0.0063168383,0.0007571114,0.00035541577,0.0006628183,0.0009831727,0.0000056437616,0.0004332852,0.00006276384,0.95022786,0.040071476],"study_design_scores_gemma":[0.002374736,0.00042972527,0.033067424,0.00028339066,0.0003259713,0.0002532161,0.000041911662,0.0000105318795,0.0011523815,0.00008938506,0.96166414,0.00030719722],"about_ca_topic_score_codex":0.0003912654,"about_ca_topic_score_gemma":0.00004327804,"teacher_disagreement_score":0.103648394,"about_ca_system_score_codex":0.00014022675,"about_ca_system_score_gemma":0.000082869294,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W1991607561","doi":"10.1016/s2213-8587(14)70095-6","title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cancer; Vitamin D and neurology; Internal medicine; MEDLINE; Oncology; Intensive care medicine; Biochemistry","score_opus":0.03202633226101352,"score_gpt":0.353065617794784,"score_spread":0.3210392855337705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991607561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17805406,0.0018317576,0.000002225074,0.81642663,0.00081958045,0.0018438523,0.00014219232,0.000090609174,0.0007891074],"genre_scores_gemma":[0.27966157,0.014145765,0.000078121964,0.6741141,0.011550124,0.0055852453,0.00077089446,0.00029001458,0.013804143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950937,0.001161774,0.0004905556,0.00048475852,0.0007720382,0.0019971835],"domain_scores_gemma":[0.9913303,0.0067763533,0.0003167543,0.001406458,0.00012405499,0.000046067104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094553665,0.00052366534,0.0018194811,0.00016580484,0.0002945603,0.000029291,0.00080813916,0.00025409056,0.00022551662],"category_scores_gemma":[0.0011251312,0.00021182842,0.0003912186,0.00018357056,0.00092565635,0.000025730373,0.00030344867,0.0019538708,0.00009793876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012634101,0.000018511375,0.07459962,0.0010031752,0.0024077555,0.00007771298,0.0000515919,0.00000243288,0.00026458732,0.000038734383,0.91017467,0.011234897],"study_design_scores_gemma":[0.004650146,0.0028927354,0.062385082,0.0002934073,0.0009210424,0.000011053208,0.000024970626,0.000014470071,0.0071091903,0.000054767457,0.92138386,0.0002592814],"about_ca_topic_score_codex":0.000109155866,"about_ca_topic_score_gemma":0.000083353836,"teacher_disagreement_score":0.1423125,"about_ca_system_score_codex":0.00015066011,"about_ca_system_score_gemma":0.000073146184,"threshold_uncertainty_score":0.8638112},"labels":[],"label_agreement":null},{"id":"W1993971782","doi":"10.1016/s2213-8587(15)00049-2","title":"Diagnostic criteria for osteoporosis should be expanded","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Peter's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; FRAX; Osteoporosis; Bone mineral; Hip fracture; Bone density; Physical therapy; Osteoporotic fracture; Internal medicine","score_opus":0.18162541963200432,"score_gpt":0.41285192205753746,"score_spread":0.23122650242553314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993971782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8991775,0.0027609589,0.000021290807,0.09333594,0.0006235943,0.0014326394,0.00008891045,0.0001879026,0.0023712742],"genre_scores_gemma":[0.97592056,0.00044714016,0.00095396896,0.019212319,0.0014258857,0.0010497035,0.00012750266,0.000050378123,0.0008125584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966531,0.00019378755,0.0003625634,0.00037379525,0.00031182682,0.0021049648],"domain_scores_gemma":[0.9967493,0.0017247619,0.000084372994,0.0007644324,0.00026290113,0.0004142363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008751866,0.00022349221,0.0007693351,0.000108831635,0.00015787026,0.00003374278,0.0003413468,0.0001305141,0.00017456892],"category_scores_gemma":[0.0030772253,0.00014957545,0.00012060616,0.00019146039,0.00029030486,0.0000667262,0.00015866087,0.00041866562,0.00010895141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015725106,0.0004281574,0.32346877,0.000805575,0.0002631488,0.00008446242,0.0015658329,0.000003995446,0.01182813,0.003007391,0.6210257,0.03594633],"study_design_scores_gemma":[0.019184496,0.004871866,0.155421,0.00017740224,0.00041257124,0.0001943909,0.0014108375,0.0005172648,0.039891765,0.0072947377,0.77000874,0.0006149507],"about_ca_topic_score_codex":0.000086145104,"about_ca_topic_score_gemma":0.000060337927,"teacher_disagreement_score":0.16804779,"about_ca_system_score_codex":0.00009296453,"about_ca_system_score_gemma":0.00023402493,"threshold_uncertainty_score":0.609951},"labels":[],"label_agreement":null},{"id":"W1995388358","doi":"10.1016/s2213-8587(14)70054-3","title":"Treatment of severe hypertriglyceridaemia – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine","score_opus":0.03521302912128351,"score_gpt":0.2850295492805223,"score_spread":0.2498165201592388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995388358","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23754062,0.0051519186,0.0000032068212,0.7421326,0.00079271436,0.00092003966,0.00021159675,0.00022133054,0.013025995],"genre_scores_gemma":[0.23574159,0.0031235619,0.0008408411,0.7352745,0.010384778,0.00069241563,0.0013578852,0.00015682995,0.012427582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965609,0.00044600092,0.0005111743,0.0006400542,0.00022232816,0.0016195963],"domain_scores_gemma":[0.9970049,0.0007186701,0.0003668711,0.0017521896,0.00008707829,0.000070294314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013607109,0.0005674766,0.0023031603,0.00016662256,0.00012618813,0.000008864304,0.0003284214,0.0006377513,0.0002186212],"category_scores_gemma":[0.000105602405,0.00034101863,0.00038865497,0.00012538629,0.00059037737,0.000022862232,0.00007649007,0.0010055793,0.00025569217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023515798,0.00021292569,0.118656956,0.00033398252,0.0023499883,0.0041395943,0.00017834196,0.0000021713045,0.0005411678,0.00033465563,0.862954,0.010061012],"study_design_scores_gemma":[0.003887196,0.002347408,0.017586777,0.000121599216,0.0017627878,0.0021870816,0.000006501049,0.000008329779,0.003045952,0.00068036147,0.9680779,0.00028807967],"about_ca_topic_score_codex":0.00008982944,"about_ca_topic_score_gemma":0.0000042285833,"teacher_disagreement_score":0.10512388,"about_ca_system_score_codex":0.00019972371,"about_ca_system_score_gemma":0.00012135084,"threshold_uncertainty_score":0.99990416},"labels":[],"label_agreement":null},{"id":"W2007374852","doi":"10.1016/s2213-8587(15)00044-3","title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Women's College Hospital; University of Toronto; University Health Network","funders":"Women's College Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Type 2 diabetes; Internal medicine; Heart failure; Diabetes mellitus; Relative risk; Meta-analysis; Randomized controlled trial; Clinical endpoint; Cochrane Library; Endocrinology; Confidence interval","score_opus":0.1464167848642998,"score_gpt":0.3674972547904398,"score_spread":0.22108046992614003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007374852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057530545,0.9302715,0.0000032223666,0.000059665428,0.00013577701,0.011435123,0.00035181807,0.00005595564,0.0001563784],"genre_scores_gemma":[0.009515215,0.9833732,0.00024345051,0.00011705014,0.00009366067,0.0055065565,0.00052189815,0.00009632706,0.000532623],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943879,0.0014752263,0.0017471783,0.00071805186,0.0004765513,0.0011950457],"domain_scores_gemma":[0.9905394,0.0064194477,0.0013597632,0.0013269545,0.00024447887,0.000109981054],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0043739546,0.00085930695,0.033797625,0.0007505936,0.00007299516,0.000057776142,0.0003675785,0.00018565018,0.00013389072],"category_scores_gemma":[0.0016584292,0.00032689373,0.00492751,0.00073540583,0.0002230392,0.00009556963,0.00021484627,0.0002618509,0.0000046313867],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009982369,0.00024809426,0.008296592,0.0040454553,0.87407625,0.000010500112,0.000102629994,0.000031585267,1.6619428e-7,0.000034141052,0.00013108771,0.10304112],"study_design_scores_gemma":[0.09880085,0.0012226704,0.00055168197,0.00027452112,0.8024713,2.633163e-7,0.00007134441,0.000018395249,0.000004544254,0.000028017472,0.09622752,0.00032890151],"about_ca_topic_score_codex":0.00002455365,"about_ca_topic_score_gemma":0.00007104918,"teacher_disagreement_score":0.10271222,"about_ca_system_score_codex":0.00013245325,"about_ca_system_score_gemma":0.00020730283,"threshold_uncertainty_score":0.9999183},"labels":[],"label_agreement":null},{"id":"W2019951267","doi":"10.1016/s2213-8587(14)70172-x","title":"The US diabetes epidemic: tip of the iceberg","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Scopus; Diabetes mellitus; Epidemiology; Type 2 diabetes; Obesity; MEDLINE; Gerontology; Demography; Internal medicine; Political science","score_opus":0.024894071144664888,"score_gpt":0.2574979926696367,"score_spread":0.2326039215249718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019951267","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23818284,0.023219718,0.0000050800113,0.7261958,0.002887461,0.0019105708,0.00011573767,0.00023411645,0.0072486303],"genre_scores_gemma":[0.154552,0.003002802,0.000104078244,0.8125357,0.023441175,0.0008098609,0.00019876802,0.0002994472,0.0050561503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99185896,0.0018562009,0.0010092529,0.00083452207,0.00092493626,0.003516114],"domain_scores_gemma":[0.99086934,0.0029899245,0.00082290056,0.004949997,0.00026351408,0.00010430275],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021693867,0.00083453965,0.0029759153,0.00014089864,0.0005215281,0.00006802801,0.0026583774,0.00080024364,0.000093181516],"category_scores_gemma":[0.0014790854,0.00039238945,0.0016748324,0.00038958053,0.0021620102,0.000054971857,0.00071861467,0.004347918,0.0002392086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028731969,0.00003280713,0.02734416,0.0005694559,0.0029064321,0.000032616117,0.00006246886,0.000010884358,0.0002222128,0.00026308515,0.9096434,0.058883745],"study_design_scores_gemma":[0.0013383162,0.000204972,0.033640627,0.0003454769,0.0016049495,0.0000446599,0.000013142809,0.0000480656,0.0047712578,0.0021547829,0.95541304,0.0004206977],"about_ca_topic_score_codex":0.0006857063,"about_ca_topic_score_gemma":0.00016107348,"teacher_disagreement_score":0.08633988,"about_ca_system_score_codex":0.00011385035,"about_ca_system_score_gemma":0.00017645581,"threshold_uncertainty_score":0.9998528},"labels":[],"label_agreement":null},{"id":"W2039571658","doi":"10.1016/s2213-8587(13)70027-5","title":"Intensive insulin for type 2 diabetes: the risk of causing harm","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Type 2 diabetes; Scopus; Diabetes mellitus; Internal medicine; Insulin; Hazard ratio; Post-hoc analysis; MEDLINE; Endocrinology","score_opus":0.10492927098788356,"score_gpt":0.3586264788800713,"score_spread":0.25369720789218775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039571658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005842721,0.9862368,0.000004646576,0.0014403361,0.00095353567,0.0044442387,0.00015817131,0.00010585438,0.0008136925],"genre_scores_gemma":[0.0007485782,0.99375254,0.00028912784,0.0015934095,0.00090785726,0.0013517782,0.00030800272,0.000107340566,0.0009413922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653476,0.00036168608,0.0007589546,0.0005171901,0.0002008673,0.0016265607],"domain_scores_gemma":[0.9954017,0.0018247826,0.0008370385,0.0014335823,0.00042374016,0.00007920331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005334735,0.00062546064,0.0034324948,0.00020229635,0.00016663902,0.000036914935,0.0006014713,0.00020311194,0.00010747391],"category_scores_gemma":[0.00087347836,0.00029857896,0.0007247854,0.00037927582,0.00049146864,0.000050547773,0.00041013042,0.00066924107,0.00019657308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002540819,0.000101565565,0.0009538594,0.008528018,0.0058428235,0.0000072226812,0.00012550925,0.0000012327715,0.0000092964465,0.00096061686,0.027340768,0.9561037],"study_design_scores_gemma":[0.0011457509,0.00063315284,0.00020760922,0.0029161691,0.011155783,0.0000051250004,0.00008862174,0.00003924536,0.00010179866,0.00062542205,0.9828043,0.00027700924],"about_ca_topic_score_codex":0.000023995783,"about_ca_topic_score_gemma":0.0000049937635,"teacher_disagreement_score":0.9558267,"about_ca_system_score_codex":0.000116784366,"about_ca_system_score_gemma":0.00012402519,"threshold_uncertainty_score":0.99994665},"labels":[],"label_agreement":null},{"id":"W2067176839","doi":"10.1016/s2213-8587(14)70071-3","title":"Subconjunctival bevacizumab for iris neovascularisation – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Herzig Eye Institute","funders":"","keywords":"Medicine; Bevacizumab; IRIS (biosensor); Ophthalmology; Optometry; Surgery; Artificial intelligence; Biometrics; Chemotherapy; Computer science","score_opus":0.04234987265080108,"score_gpt":0.30238818158025627,"score_spread":0.2600383089294552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067176839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07686007,0.0017992902,0.0001579984,0.9164998,0.0009251665,0.0018811973,0.00015157946,0.00025914004,0.0014657597],"genre_scores_gemma":[0.06980985,0.00029158322,0.0007166296,0.9054749,0.015041616,0.0010625813,0.0031592413,0.0001689731,0.004274628],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965529,0.00028418284,0.00041489123,0.0007086695,0.00033079894,0.0017085746],"domain_scores_gemma":[0.9974529,0.0005769879,0.00028781904,0.0014316947,0.0001594061,0.0000911794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027862028,0.00048645618,0.0013385832,0.00013620476,0.0002001143,0.00004345907,0.0003814899,0.00041921638,0.0001268936],"category_scores_gemma":[0.0003300515,0.00031734558,0.0006529564,0.00010369254,0.0002427421,0.000039033574,0.00009848296,0.0011461829,0.000205112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028389064,0.000054541277,0.009010708,0.0004880574,0.0014528675,0.00018256833,0.00004137639,0.0000016466455,0.000054359705,0.00021943115,0.98090076,0.007309774],"study_design_scores_gemma":[0.0035617843,0.00078662095,0.016345434,0.00011235948,0.002208886,0.00010060177,0.000007201818,0.00009795513,0.00021233827,0.003759852,0.97250724,0.0002997101],"about_ca_topic_score_codex":0.00007187432,"about_ca_topic_score_gemma":0.0000018281479,"teacher_disagreement_score":0.014116449,"about_ca_system_score_codex":0.00013798787,"about_ca_system_score_gemma":0.00009460552,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W2067533175","doi":"10.1016/s2213-8587(14)70174-3","title":"Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Liraglutide; Medicine; Metformin; Type 2 diabetes; Insulin; Pioglitazone; Clinical endpoint; Internal medicine; Diabetes mellitus; Urology; Endocrinology; Insulin glargine; Randomized controlled trial","score_opus":0.03207177693034416,"score_gpt":0.28331800456135975,"score_spread":0.25124622763101556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067533175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936795,0.00055223616,0.00001139351,0.0006143927,0.000064483094,0.0044412953,0.00012424515,0.000025994748,0.0004864282],"genre_scores_gemma":[0.9981672,0.00018822329,0.00089596177,0.00016280964,0.00003401402,0.00015777718,0.00032739813,0.000033450953,0.00003312737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99746805,0.00039731635,0.0007940444,0.00043764518,0.00028576254,0.00061717466],"domain_scores_gemma":[0.99761635,0.0009194239,0.0005829977,0.00049588917,0.0002739571,0.00011136933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053737086,0.0003238427,0.001709548,0.0002730615,0.00006415637,0.000017820124,0.0002955484,0.00006726158,0.000006522226],"category_scores_gemma":[0.0004471123,0.00021252858,0.000031105268,0.0003943834,0.00034046036,0.00012866553,0.00025471367,0.0001664201,0.0000025030545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68996876,0.01294223,0.2613479,0.0005736623,0.0018017755,0.000013129063,0.0015489401,0.00013925384,0.008409169,0.0006467275,0.0002877985,0.022320626],"study_design_scores_gemma":[0.6994163,0.018966265,0.2672073,0.0005034466,0.00053159485,7.4962105e-7,0.000036509555,0.0008199645,0.011821119,0.00009239751,0.00039524076,0.00020915344],"about_ca_topic_score_codex":0.000071544455,"about_ca_topic_score_gemma":0.000039826766,"teacher_disagreement_score":0.022111474,"about_ca_system_score_codex":0.000043449712,"about_ca_system_score_gemma":0.000045525,"threshold_uncertainty_score":0.8666664},"labels":[],"label_agreement":null},{"id":"W2068638936","doi":"10.1016/s2213-8587(13)70150-5","title":"Regression of iris neovascularisation secondary to diabetic retinopathy with subconjunctival anti-VEGF therapy","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Herzig Eye Institute","funders":"","keywords":"Medicine; Ophthalmology; Diabetic retinopathy; IRIS (biosensor); VEGF receptors; Retinopathy; Optometry; Diabetes mellitus; Internal medicine; Artificial intelligence; Endocrinology","score_opus":0.016948612111963315,"score_gpt":0.26530421005034466,"score_spread":0.24835559793838136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068638936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934553,0.001094122,0.000057836776,0.0032993483,0.00012317061,0.0005238184,0.000011049533,0.00006559966,0.0013697883],"genre_scores_gemma":[0.9972245,0.00027314786,0.00041269453,0.0016083103,0.00023139881,0.00006990135,0.00004193735,0.00003057779,0.00010754912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833727,0.00021658768,0.00022513655,0.00031430196,0.00022924985,0.0006774721],"domain_scores_gemma":[0.9987952,0.00016108797,0.0001317166,0.00070381165,0.000098087505,0.00011010912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019995181,0.00022017494,0.0006828337,0.00008911845,0.00008063696,0.000010880309,0.00017551058,0.00005485733,0.00009636053],"category_scores_gemma":[0.000082172075,0.000112969174,0.00012221783,0.00017558991,0.00017309094,0.000041703148,0.00005985275,0.00019654728,0.000042393884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091775286,0.00024428286,0.89964944,0.000118143966,0.00041170808,0.000033619926,0.00029167876,0.000014189706,0.020531457,0.00041340513,0.00061329035,0.07676102],"study_design_scores_gemma":[0.003782674,0.0020623172,0.9559992,0.00016334247,0.00020273414,0.000026352702,0.000046003766,0.00005501933,0.032088455,0.00050684786,0.004930093,0.00013699042],"about_ca_topic_score_codex":0.000039646737,"about_ca_topic_score_gemma":0.0000026116834,"teacher_disagreement_score":0.076624036,"about_ca_system_score_codex":0.000028322593,"about_ca_system_score_gemma":0.000042019044,"threshold_uncertainty_score":0.46067494},"labels":[],"label_agreement":null},{"id":"W2073789256","doi":"10.1016/s2213-8587(13)70090-1","title":"Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Medicine; Insulin aspart; Post-prandial; Bolus (digestion); Clinical trial; Anesthesia; Randomized controlled trial; Insulin; Internal medicine; Diabetes mellitus; Endocrinology; Postprandial","score_opus":0.09021902719333778,"score_gpt":0.35477167714156554,"score_spread":0.26455264994822775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073789256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824896,0.00036444856,0.000039809733,0.005391724,0.00019504226,0.009915207,0.000032463868,0.00011834405,0.001453369],"genre_scores_gemma":[0.99408567,0.0003178371,0.00054671493,0.00062320667,0.00077642873,0.0027602597,0.00016588489,0.000049190556,0.0006747931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963752,0.00083228206,0.00068122405,0.00057619106,0.0004503246,0.0010847716],"domain_scores_gemma":[0.9971718,0.00096407573,0.00032888394,0.00097541045,0.00037007392,0.00018973819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065063883,0.00037327848,0.001585401,0.00024467136,0.00012207097,0.000053149728,0.0003445362,0.000083020284,0.000430611],"category_scores_gemma":[0.0002021796,0.0001872253,0.0001675866,0.00037505908,0.00046190954,0.00011187397,0.00008395938,0.00031300637,0.00018866075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7064951,0.008343714,0.17836648,0.00010303144,0.00403541,0.000099347664,0.0010622491,0.00007835855,0.0014338207,0.00010181267,0.013530865,0.086349785],"study_design_scores_gemma":[0.7143065,0.065061055,0.20477496,0.00012026642,0.00080335053,0.000010557441,0.0009990179,0.00074922806,0.0023383067,0.00012472848,0.010306452,0.0004055878],"about_ca_topic_score_codex":0.00009258537,"about_ca_topic_score_gemma":0.00004716756,"teacher_disagreement_score":0.0859442,"about_ca_system_score_codex":0.00007503979,"about_ca_system_score_gemma":0.00012583956,"threshold_uncertainty_score":0.76348263},"labels":[],"label_agreement":null},{"id":"W2093912425","doi":"10.1016/s2213-8587(14)70187-1","title":"Fetal growth and ethnic variation – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Birth, Development, and Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Scopus; Medicine; Fetal growth; Ethnic group; Pooling; MEDLINE; Pregnancy; Fetus; Political science; Computer science; Artificial intelligence","score_opus":0.04578181969140841,"score_gpt":0.3041631926899599,"score_spread":0.25838137299855146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093912425","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030944893,0.0019648564,0.000047275946,0.95790476,0.0011000155,0.00060372386,0.00002328941,0.00024966712,0.007161548],"genre_scores_gemma":[0.034970026,0.022006974,0.00074254465,0.9313705,0.009971107,0.00011488762,0.000330424,0.000077595614,0.00041592267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648774,0.00041986606,0.0004549077,0.0006187776,0.00027337437,0.0017453668],"domain_scores_gemma":[0.99827266,0.00044792224,0.00030794428,0.0007867762,0.00008364781,0.00010103585],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006122453,0.00038776852,0.0011992968,0.00018356754,0.00018748987,0.000026270187,0.0002615849,0.00058407057,0.00008956193],"category_scores_gemma":[0.00026196477,0.00027057208,0.000098791745,0.00015102501,0.00029943846,0.000040573304,0.0001490566,0.0028633317,0.00013454328],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004483683,0.000021480068,0.013704672,0.0011416246,0.00034726123,0.00017641658,0.00046221743,5.6444417e-8,0.00041485843,0.014042349,0.96660066,0.0030435515],"study_design_scores_gemma":[0.0024528408,0.00048632512,0.1939431,0.00022546969,0.00050276995,0.00047155042,0.00001390842,0.000050180297,0.0003992545,0.04983878,0.75108737,0.0005284469],"about_ca_topic_score_codex":0.00009076704,"about_ca_topic_score_gemma":0.000009964382,"teacher_disagreement_score":0.2155133,"about_ca_system_score_codex":0.00007098109,"about_ca_system_score_gemma":0.0001645862,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W2101382476","doi":"10.1016/s2213-8587(14)70031-2","title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"University of Oxford; Medtronic; Teva Pharmaceutical Industries; Novartis; Roche; Novo Nordisk; Merck; Bayer; Servier; British Microcirculation Society; Amgen","keywords":"Medicine; Heart failure; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Internal medicine; Cardiology; Randomized controlled trial; Surrogate endpoint; Endocrinology","score_opus":0.030508690995126726,"score_gpt":0.2589968043897658,"score_spread":0.22848811339463906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101382476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663969,0.0016615647,0.00000464139,0.026789995,0.00044897333,0.00088349,0.000015940555,0.00023559814,0.0035628446],"genre_scores_gemma":[0.986567,0.000091751535,0.00050739787,0.011084629,0.0005763478,0.0004038537,0.00008123043,0.000059209135,0.00062858034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962162,0.0003153482,0.00037929817,0.0005830694,0.0003690426,0.002137035],"domain_scores_gemma":[0.9979927,0.0002581024,0.000087522414,0.0014619274,0.0000601188,0.00013964776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007514232,0.00041054198,0.0015298511,0.00022578845,0.00009899056,0.000044307322,0.00041348548,0.000111619935,0.00014103386],"category_scores_gemma":[0.00020912793,0.00028274878,0.00043471134,0.0002692707,0.000267955,0.000081741186,0.0002669389,0.00040776716,0.00027100055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021716007,0.00014375549,0.977091,0.0001546821,0.0011965882,0.000026753693,0.000108510714,0.000029368412,0.0007119666,0.0009752269,0.012450952,0.007089441],"study_design_scores_gemma":[0.006065715,0.000545435,0.55448705,0.00009478605,0.0009083655,0.000006212266,0.000121678466,0.0002721788,0.00481057,0.0006882822,0.43153602,0.0004636974],"about_ca_topic_score_codex":0.00011530553,"about_ca_topic_score_gemma":0.0001771,"teacher_disagreement_score":0.422604,"about_ca_system_score_codex":0.00012098329,"about_ca_system_score_gemma":0.000023331573,"threshold_uncertainty_score":0.99996245},"labels":[],"label_agreement":null},{"id":"W2105575861","doi":"10.1016/s2213-8587(13)70006-8","title":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Insulin resistance; Internal medicine; Insulin; Diabetes mellitus; Meta-analysis; Type 2 diabetes; Type 2 Diabetes Mellitus; Homeostatic model assessment; Endocrinology","score_opus":0.11718134704544426,"score_gpt":0.35498969325980406,"score_spread":0.2378083462143598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105575861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052247726,0.9890678,2.988921e-7,0.0017568358,0.00009618229,0.008166811,0.00004876639,0.000106794876,0.00023404235],"genre_scores_gemma":[0.00036405693,0.98802394,0.00007128285,0.005532958,0.00008834773,0.0049536023,0.0003415059,0.00008464713,0.00053964165],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99491847,0.00090029347,0.0014448167,0.0008717479,0.0002785592,0.001586128],"domain_scores_gemma":[0.9962407,0.0008938279,0.0005774444,0.0019023751,0.0002509832,0.00013468886],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00082290865,0.0010062723,0.017903863,0.00065582833,0.000063123334,0.00006997354,0.0006683196,0.00021731983,0.00037143895],"category_scores_gemma":[0.00030911935,0.00049775996,0.001895245,0.0012672673,0.00026259874,0.00008622735,0.00035628988,0.00067203003,0.000258704],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000484751,0.00013611662,0.00034889622,0.54194814,0.37131584,0.000047837144,0.00005797989,1.2830998e-7,5.265169e-7,0.00023255045,0.001211664,0.08469545],"study_design_scores_gemma":[0.00044211195,0.00033225148,0.000119574426,0.019175056,0.8980303,0.000008609704,0.000021926633,0.0000040815194,0.000003382554,0.00007817127,0.08130646,0.0004781075],"about_ca_topic_score_codex":0.000011808103,"about_ca_topic_score_gemma":0.000011229979,"teacher_disagreement_score":0.52671444,"about_ca_system_score_codex":0.00011997147,"about_ca_system_score_gemma":0.000049445975,"threshold_uncertainty_score":0.9997474},"labels":[],"label_agreement":null},{"id":"W2117986945","doi":"10.1016/s2213-8587(15)00042-x","title":"Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Science Council; Wellcome Trust","keywords":"Medicine; Tuberculosis; Diabetes mellitus; Incidence (geometry); Epidemiology; Transmission (telecommunications); Environmental health; Internal medicine; Pathology; Endocrinology","score_opus":0.02763255295077844,"score_gpt":0.3062447165250641,"score_spread":0.27861216357428564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117986945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816179,0.0014814256,0.000011841784,0.01435447,0.00012703762,0.0017608764,0.000039406703,0.000104710765,0.00050229416],"genre_scores_gemma":[0.9956998,0.00018618326,0.000055065582,0.0029745388,0.000282086,0.00070591294,0.000021691487,0.000051287847,0.000023394428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941499,0.00197011,0.00061854644,0.0005919195,0.00051335595,0.002156145],"domain_scores_gemma":[0.99510103,0.0033087938,0.00016574995,0.0009874834,0.00019681158,0.00024010404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002871626,0.0004413129,0.0021942419,0.00035548527,0.00007999176,0.000018683362,0.0004416964,0.00014623144,0.000032378237],"category_scores_gemma":[0.0008533832,0.00024613144,0.00013218439,0.00041541707,0.0005302937,0.000092964416,0.000118772135,0.00083515304,0.00006312854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028574734,0.00045760584,0.9846003,0.00020252062,0.0010529025,0.00006005763,0.0003770982,0.0072239256,0.0005402033,0.00056379434,0.0011102809,0.0009538555],"study_design_scores_gemma":[0.08258204,0.09338137,0.72952306,0.0009870296,0.0028009275,0.00006829029,0.0011997712,0.046992246,0.03614713,0.0018933219,0.0030195094,0.0014052745],"about_ca_topic_score_codex":0.00064673997,"about_ca_topic_score_gemma":0.00023102493,"teacher_disagreement_score":0.25507718,"about_ca_system_score_codex":0.00015492373,"about_ca_system_score_gemma":0.00009610481,"threshold_uncertainty_score":0.9999991},"labels":[],"label_agreement":null},{"id":"W2122104474","doi":"10.1016/s2213-8587(13)70089-5","title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Libin Cardiovascular Institute of Alberta; University of Ottawa; University of Toronto; University Health Network; Trillium Health Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Diabetes mellitus; Internal medicine; Coronary artery disease; Randomized controlled trial; Coronary artery bypass surgery; Meta-analysis; Cardiology; Stent; Surgery; Artery; Myocardial infarction","score_opus":0.1395131283791794,"score_gpt":0.3776054172370421,"score_spread":0.2380922888578627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122104474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30463025,0.69174707,0.000003230615,0.000080529375,0.000109866975,0.0030064317,0.00037264364,0.000020438347,0.000029568628],"genre_scores_gemma":[0.44903684,0.5482228,0.00008210833,0.000090687696,0.000058861417,0.0010832503,0.0012730194,0.000059067395,0.00009341158],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9912686,0.0031089482,0.003915099,0.0005252553,0.00036428816,0.00081780716],"domain_scores_gemma":[0.9765416,0.019153617,0.0030244456,0.000901336,0.00028638283,0.00009266834],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0022574407,0.00065765687,0.028033955,0.0011180157,0.000042967415,0.0000194099,0.00031014654,0.00024571744,0.00087860087],"category_scores_gemma":[0.0019344806,0.00034393318,0.005882388,0.00057378534,0.00043285685,0.00006720068,0.00016286138,0.0005235743,0.0000063890398],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050937915,0.002248533,0.2911664,0.008143849,0.43886974,0.000062952626,0.000077036755,0.000016145534,0.000004061642,0.00003570635,0.0005170123,0.25376475],"study_design_scores_gemma":[0.040833265,0.0020830412,0.053609967,0.003144417,0.89470774,0.000034605404,0.0000772859,0.00016577925,0.000006328089,0.000032275802,0.004826106,0.0004792017],"about_ca_topic_score_codex":0.000030785533,"about_ca_topic_score_gemma":0.00004657098,"teacher_disagreement_score":0.45583797,"about_ca_system_score_codex":0.00007239784,"about_ca_system_score_gemma":0.00009633222,"threshold_uncertainty_score":0.9999013},"labels":[],"label_agreement":null},{"id":"W2123384152","doi":"10.1016/s2213-8587(15)00141-2","title":"Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Diabetes Association","keywords":"Medicine; Artificial pancreas; Insulin; Diabetes mellitus; Type 2 diabetes; Internal medicine; Pancreas; Type 1 diabetes; Endocrinology; Hormone; Glucagon; Crossover study; Randomized controlled trial; Pediatrics; Placebo; Pathology","score_opus":0.057192812232807394,"score_gpt":0.29983249857646044,"score_spread":0.24263968634365304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123384152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835884,0.0032340947,0.0000108111735,0.0015039197,0.00023763976,0.010973672,0.000061877174,0.00012608201,0.0002635068],"genre_scores_gemma":[0.9952747,0.0005280392,0.00009810668,0.0013404412,0.0010478939,0.0011624809,0.00027040346,0.00009297986,0.00018492466],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941873,0.0011944221,0.00090979115,0.0008761732,0.0008560452,0.0019762616],"domain_scores_gemma":[0.99751675,0.00040722685,0.00044260576,0.0008243291,0.00038174976,0.0004273586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019513951,0.00060849864,0.0023069428,0.00030380918,0.00021063954,0.0002541201,0.000604788,0.00019571965,0.00006867279],"category_scores_gemma":[0.0005503107,0.00033361348,0.000076505465,0.0005323654,0.0007420997,0.00033158413,0.00024490297,0.00075807766,0.000048170477],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8964783,0.0057971836,0.07662539,0.00003274749,0.0016780429,0.00008623899,0.00015077408,0.000015050524,0.0078039807,0.00028831878,0.00072722154,0.0103167845],"study_design_scores_gemma":[0.85597354,0.031813152,0.107625276,0.00017703742,0.0005667318,0.000011220977,0.00010030334,0.0010531322,0.0012072069,0.00043052208,0.00050919066,0.00053269096],"about_ca_topic_score_codex":0.00009481303,"about_ca_topic_score_gemma":0.000110790395,"teacher_disagreement_score":0.040504728,"about_ca_system_score_codex":0.00013605146,"about_ca_system_score_gemma":0.000333671,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2125012558","doi":"10.1016/s2213-8587(13)70191-8","title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":634,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Novo Nordisk Fonden; Western University; British Heart Foundation; Valeant Pharmaceuticals International; Canadian Institutes of Health Research; Danone; F. Hoffmann-La Roche; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; Kowa Company; Sanofi; Regeneron Pharmaceuticals; Novartis; Amgen; European Atherosclerosis Society; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; MEDLINE; Intensive care medicine","score_opus":0.06561073376839394,"score_gpt":0.3450392408922733,"score_spread":0.27942850712387934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125012558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037591008,0.9890464,0.0000040680065,0.0060741613,0.0003433036,0.002674906,0.00018387413,0.000043745295,0.0012536091],"genre_scores_gemma":[0.00028362,0.99181354,0.00040196677,0.0010827018,0.00051647495,0.0055400184,0.00017567088,0.000041616884,0.00014437576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822843,0.00011274801,0.00045040713,0.00031650427,0.00008401172,0.0008079178],"domain_scores_gemma":[0.9973749,0.0012984768,0.00028362818,0.00090127526,0.000083589985,0.000058133537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002081099,0.0002904909,0.0014555985,0.00009587096,0.00021394895,0.000022857093,0.0004204552,0.000223846,0.000014166277],"category_scores_gemma":[0.00017909458,0.00014331803,0.0002911611,0.00019087824,0.00033478707,0.000028442613,0.00018363488,0.00045880204,0.00001659146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009616458,0.000041101317,0.0010115328,0.006891973,0.0007030642,4.2421686e-7,0.000010180689,2.5781135e-8,0.0000016732216,0.093178555,0.022906894,0.875245],"study_design_scores_gemma":[0.00070347113,0.000058245343,0.0027731215,0.0006809854,0.0026332492,0.0000237603,0.00002239407,2.9898587e-7,0.000007848651,0.0049755834,0.98798615,0.0001348773],"about_ca_topic_score_codex":0.000005926856,"about_ca_topic_score_gemma":0.0000044070694,"teacher_disagreement_score":0.96507925,"about_ca_system_score_codex":0.000021517504,"about_ca_system_score_gemma":0.00006377279,"threshold_uncertainty_score":0.584434},"labels":[],"label_agreement":null},{"id":"W2129884578","doi":"10.1016/s2213-8587(13)70013-5","title":"Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials","year":2013,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Insulin degludec; Insulin glargine; Insulin; Internal medicine; Diabetes mellitus; Type 2 diabetes; Metformin; Hypoglycemia; Endocrinology","score_opus":0.06192950866681248,"score_gpt":0.350071599731984,"score_spread":0.2881420910651715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129884578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866762,0.0019413545,0.000018398536,0.0017206998,0.00023343891,0.006867765,0.00018243988,0.00006363104,0.0022960529],"genre_scores_gemma":[0.9964335,0.0007098255,0.0015107514,0.00030590873,0.00020377574,0.00039179128,0.00019180906,0.000069249276,0.0001833659],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99476534,0.0008789923,0.0014743849,0.0007545805,0.00052049576,0.0016062035],"domain_scores_gemma":[0.9937825,0.0036791158,0.0006620522,0.0011172832,0.0004969233,0.000262082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026314107,0.0005168182,0.0029313955,0.00047783152,0.0001201047,0.000061243285,0.0009530659,0.0001398572,0.00015451145],"category_scores_gemma":[0.0038249665,0.00032922497,0.000096057396,0.0010717746,0.0006365146,0.0002732706,0.0008779303,0.0006102242,0.000090077505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36797377,0.013883457,0.2885411,0.0009006518,0.0036354878,0.000073167736,0.001601954,0.00017106422,0.013645634,0.00042703236,0.0035854937,0.30556116],"study_design_scores_gemma":[0.6904043,0.015690885,0.27837235,0.0007742122,0.0006047262,5.3388544e-7,0.00007663353,0.0015026603,0.009058895,0.00039646885,0.0025892502,0.0005291074],"about_ca_topic_score_codex":0.00028484446,"about_ca_topic_score_gemma":0.000086307016,"teacher_disagreement_score":0.3224305,"about_ca_system_score_codex":0.00009565616,"about_ca_system_score_gemma":0.00019250685,"threshold_uncertainty_score":0.99991596},"labels":[],"label_agreement":null},{"id":"W2133596089","doi":"10.1016/s2213-8587(14)70062-2","title":"Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Insulin glargine; Diabetes mellitus; Placebo; Digit symbol substitution test; Type 2 diabetes; Insulin; Cognitive decline; Randomized controlled trial; Endocrinology; Disease; Dementia","score_opus":0.015669779618474978,"score_gpt":0.2877979056001723,"score_spread":0.27212812598169733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133596089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937095,0.0007119139,0.000016948561,0.002926819,0.0001345954,0.002365771,0.000036516896,0.000019019912,0.00007888816],"genre_scores_gemma":[0.99853665,0.00021366285,0.0000922205,0.0007741709,0.00012522921,0.00022655174,0.0000085179,0.000019145466,0.000003846032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730104,0.0008655448,0.000305172,0.00032026,0.00025621886,0.0009517381],"domain_scores_gemma":[0.9969749,0.0024300546,0.00019429122,0.00022136426,0.000102778926,0.00007661175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007398877,0.00020894506,0.00075312064,0.00011689,0.00012019649,0.000013857757,0.00021060302,0.00007365243,0.000003878351],"category_scores_gemma":[0.00075780577,0.000115467235,0.000037033537,0.00031225325,0.0005673697,0.000053289656,0.00018512848,0.00054901047,0.0000021017352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061003085,0.0008410475,0.9212898,0.00087050773,0.00014024969,0.000007772672,0.0016364761,0.000004713133,0.00749014,0.00041672477,0.000049017304,0.0062504685],"study_design_scores_gemma":[0.062682755,0.007832679,0.7125839,0.0004651915,0.000083238425,0.0000050943927,0.00026556064,0.00013477975,0.21508294,0.0007248955,0.000018306882,0.00012064456],"about_ca_topic_score_codex":0.00020372034,"about_ca_topic_score_gemma":0.0014065503,"teacher_disagreement_score":0.20870589,"about_ca_system_score_codex":0.00004169597,"about_ca_system_score_gemma":0.00006105446,"threshold_uncertainty_score":0.4708617},"labels":[],"label_agreement":null},{"id":"W2147391073","doi":"10.1016/s2213-8587(14)70137-8","title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; University of Melbourne","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Cohort; Cross-sectional study; Young adult; Population; Prospective cohort study; Pediatrics; JADE (particle detector); Age of onset; Cohort study; Internal medicine; Disease; Environmental health; Endocrinology; Pathology","score_opus":0.019454963442666968,"score_gpt":0.28496569375733155,"score_spread":0.2655107303146646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147391073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157953,0.0038685114,3.5857553e-7,0.00031433062,0.00018085481,0.0034752728,0.00001724958,0.00006349677,0.00050036376],"genre_scores_gemma":[0.99704385,0.0003602407,0.0000631687,0.00009029734,0.00033621016,0.0019726215,0.0000289329,0.0000345485,0.00007014552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969103,0.0005923725,0.00049255864,0.00053241313,0.0003111155,0.0011612421],"domain_scores_gemma":[0.99859375,0.00029770005,0.00015098824,0.00077316834,0.000114447466,0.000069962545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867227,0.0003111134,0.0012835995,0.00020674885,0.00010191844,0.00004169695,0.00024892043,0.00009764958,0.000020111474],"category_scores_gemma":[0.00038992177,0.00018411007,0.00014676632,0.0004829546,0.00052236876,0.0000659054,0.00012323848,0.00040082153,0.000010665746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017362312,0.0007802923,0.9754516,0.000048156337,0.000956206,0.000008147147,0.00078793505,0.000015440068,0.00019266142,0.00024251759,0.000015452137,0.021327965],"study_design_scores_gemma":[0.0058004283,0.0018540858,0.9855722,0.000034576024,0.00030445016,0.000020043002,0.0003017233,0.00011023918,0.003981886,0.00055586005,0.0012967109,0.00016780783],"about_ca_topic_score_codex":0.0034732288,"about_ca_topic_score_gemma":0.004783756,"teacher_disagreement_score":0.021160157,"about_ca_system_score_codex":0.00009665232,"about_ca_system_score_gemma":0.0000689156,"threshold_uncertainty_score":0.7507791},"labels":[],"label_agreement":null},{"id":"W2151947272","doi":"10.1016/s2213-8587(14)70213-x","title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","year":2014,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Killam Trusts; Canadian Diabetes Association","keywords":"Medicine; Gliclazide; Glibenclamide; Glimepiride; Glipizide; Tolbutamide; Internal medicine; Chlorpropamide; Relative risk; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Myocardial infarction; Stroke (engine); Confidence interval; Cardiology; Endocrinology; Insulin","score_opus":0.09578919385841846,"score_gpt":0.3540050939430012,"score_spread":0.2582159000845828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151947272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000418693,0.99223757,0.000009400888,0.00046912406,0.00009668397,0.005717266,0.00009202205,0.00017364441,0.0011624361],"genre_scores_gemma":[0.0001540286,0.99190456,0.000091259404,0.0022360897,0.00033488518,0.0037356552,0.00034733978,0.00007081525,0.0011253484],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99343044,0.002240225,0.0014496213,0.00087194936,0.00032394708,0.0016838418],"domain_scores_gemma":[0.9942246,0.0011999569,0.0015269076,0.0027969847,0.000077958866,0.00017358833],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002514048,0.00093597383,0.023405876,0.00023765,0.00015842616,0.000060351307,0.000631167,0.00019608582,0.00022791463],"category_scores_gemma":[0.00039296536,0.0004594862,0.0039647394,0.00092742563,0.00032623,0.000049298425,0.00040735633,0.000688583,0.0001443323],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.8525826e-7,0.000036741563,0.0016953535,0.53587687,0.45521176,0.000017874803,0.0000048254337,9.2622713e-7,1.4123492e-9,0.00051588356,0.0023898885,0.0042490037],"study_design_scores_gemma":[0.00020732515,0.00007807248,0.00034486325,0.021976452,0.7905114,0.0000067158317,0.0000017316279,0.0000071016957,3.9174626e-8,0.00015771358,0.18641493,0.00029361297],"about_ca_topic_score_codex":0.000056450375,"about_ca_topic_score_gemma":0.000072983974,"teacher_disagreement_score":0.5139004,"about_ca_system_score_codex":0.00007354311,"about_ca_system_score_gemma":0.0000363018,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W2156174833","doi":"10.1016/s2213-8587(13)70025-1","title":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"Association pour la Recherche sur le Diabète; Diabetes Canada; McMaster University; Canadian Diabetes Association","keywords":"Medicine; Retina; Diabetes mellitus; Diabetic retinopathy; Retinopathy; Internal medicine; Vasa vasorum; Endocrinology; Ophthalmology; Biology; Neuroscience","score_opus":0.04586101067304761,"score_gpt":0.33023359097107585,"score_spread":0.28437258029802825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156174833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020653248,0.97429156,1.5194e-7,0.0015172967,0.00016846649,0.0019571087,0.00007700499,0.00004347862,0.0012916583],"genre_scores_gemma":[0.0079171695,0.98984414,0.00003352408,0.00035794085,0.00042595563,0.0008719159,0.00008099673,0.00004413145,0.000424242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708337,0.00055218907,0.0005886643,0.00042213284,0.00020804287,0.0011456187],"domain_scores_gemma":[0.997028,0.001329444,0.0004723124,0.000996776,0.00007027625,0.00010322147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030568,0.0004830786,0.0035057184,0.00008560404,0.00012146083,0.00003329056,0.0005404166,0.00015619646,0.0001976314],"category_scores_gemma":[0.00018232486,0.00020226857,0.00058757886,0.00018064152,0.0024934155,0.000039179522,0.0002781776,0.00049784814,0.00013028142],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025686144,0.000059920465,0.0062592714,0.013022711,0.0030118246,0.000021883292,0.000028402434,1.221525e-7,0.000010292999,0.0034961505,0.0012869786,0.9727768],"study_design_scores_gemma":[0.004123283,0.0005509933,0.0025021408,0.0070077754,0.010082656,0.000093610004,0.000031769105,0.000008153495,0.00007835745,0.0020852664,0.9730815,0.0003544395],"about_ca_topic_score_codex":0.000067992216,"about_ca_topic_score_gemma":0.000005333236,"teacher_disagreement_score":0.9724223,"about_ca_system_score_codex":0.00007212093,"about_ca_system_score_gemma":0.0002480145,"threshold_uncertainty_score":0.91870934},"labels":[],"label_agreement":null},{"id":"W2157724073","doi":"10.1016/s2213-8587(13)70028-7","title":"Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Wellcome Trust","keywords":"Medicine; Observational study; Drug; Diabetes mellitus; Epidemiology; Risk assessment; Intensive care medicine; MEDLINE; Cancer; Pharmacology; Internal medicine","score_opus":0.02911998042535419,"score_gpt":0.2965901894858524,"score_spread":0.26747020906049823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157724073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25314066,0.74541026,2.826059e-7,0.00004213687,0.00028851774,0.0006327148,0.00026248352,0.000011850719,0.00021105859],"genre_scores_gemma":[0.017617267,0.98052794,0.00004275492,0.00023025012,0.0006365516,0.00070628856,0.000074330565,0.00006586775,0.000098780416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692774,0.00053688086,0.00072427763,0.00057183456,0.00016559509,0.001073681],"domain_scores_gemma":[0.9971857,0.00030683546,0.0011028792,0.0012287649,0.00010689823,0.00006893237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003702435,0.00054643594,0.0021923855,0.00006529218,0.00011538264,0.000020589849,0.00075484114,0.00022258717,0.00007903401],"category_scores_gemma":[0.00015492321,0.00030352618,0.00035784327,0.00014919013,0.0007487724,0.0000073470874,0.00038046058,0.0003824599,0.000005327486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073344554,0.00004471726,0.032386746,0.0029738522,0.0021106245,0.0000013093055,0.000082319755,0.000003865849,0.0005522867,0.0003568049,0.0020815372,0.9593986],"study_design_scores_gemma":[0.0006968191,0.00014302049,0.0013138776,0.00087864866,0.0018252172,0.0000043506893,0.000042343625,0.000002686432,0.012647012,0.00066506705,0.98139507,0.00038587226],"about_ca_topic_score_codex":0.00007091146,"about_ca_topic_score_gemma":0.000100158,"teacher_disagreement_score":0.97931355,"about_ca_system_score_codex":0.000022111522,"about_ca_system_score_gemma":0.00017952394,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W2161569030","doi":"10.1016/s2213-8587(15)00040-6","title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":897,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institutes of Health; National Center for Advancing Translational Sciences; Mitsubishi Tanabe Pharma Corporation; Kyowa Hakko Kirin; Servier; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; National Eye Institute; National Institute on Aging; Astellas Pharma; Alexion Pharmaceuticals; National Kidney Foundation; Sanofi; MSD","keywords":"Medicine; Albuminuria; Renal function; Proteinuria; Internal medicine; Kidney disease; Creatinine; Stroke (engine); Dipstick; Cardiology; Meta-analysis; Framingham Risk Score; Disease; Kidney; Urine","score_opus":0.4483719534108682,"score_gpt":0.4318365600653313,"score_spread":0.01653539334553694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161569030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017776259,0.9668261,0.000017382632,0.00019126838,0.00008554885,0.0019756614,0.029068088,0.00003907499,0.00001928754],"genre_scores_gemma":[0.003203877,0.9790694,0.0004190129,0.00013801116,0.0001343066,0.0008754253,0.016090013,0.000046568806,0.000023368595],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99652344,0.0007461661,0.0010362198,0.00061225775,0.00037959,0.00070231355],"domain_scores_gemma":[0.9955745,0.0011108457,0.0007322089,0.002076201,0.00036374977,0.00014252948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021161607,0.00043415965,0.009286725,0.00033101247,0.000050276987,0.000019443854,0.0005186602,0.00018861974,0.000043546745],"category_scores_gemma":[0.001310162,0.0002529584,0.0015616285,0.0008667932,0.0003656276,0.0000954169,0.00027482363,0.0002065568,0.0000021979872],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049467086,0.00015479677,0.00082849275,0.008586878,0.9495661,0.0000056646945,0.00018913427,0.000058976842,0.000008872665,0.0001550826,0.002564771,0.03783172],"study_design_scores_gemma":[0.0012466775,0.00022642652,0.00064520794,0.00023691484,0.8037141,0.000002065884,0.000054145326,0.00043282227,0.000043404303,0.000072336654,0.19317909,0.00014679445],"about_ca_topic_score_codex":0.000021952279,"about_ca_topic_score_gemma":0.000007146377,"teacher_disagreement_score":0.19061431,"about_ca_system_score_codex":0.00003418031,"about_ca_system_score_gemma":0.0006725318,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W2168023382","doi":"10.1016/s2213-8587(14)70221-9","title":"Risks and benefits of childhood physical activity","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Scopus; Physical activity; Childhood obesity; Sports medicine; Health professionals; Health benefits; Position statement; MEDLINE; Family medicine; Gerontology; Physical therapy; Health care; Obesity; Pathology","score_opus":0.04670530495986426,"score_gpt":0.2941253053526578,"score_spread":0.24742000039279355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168023382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74882597,0.0002833348,6.029992e-7,0.24874082,0.00016288883,0.00039897088,0.00009376739,0.00009899306,0.0013946409],"genre_scores_gemma":[0.871187,0.000153082,0.000025970028,0.1192102,0.00911889,0.000059376463,0.00006254929,0.00007240754,0.0001105662],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99689674,0.00034675546,0.00021468711,0.00064501585,0.00037642947,0.0015203545],"domain_scores_gemma":[0.99709016,0.0011993938,0.00033159292,0.0012077786,0.00008871369,0.0000823834],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00015910059,0.00051435846,0.002216369,0.00010953476,0.00008851164,0.000017416254,0.00046900715,0.00039516418,0.000023396393],"category_scores_gemma":[0.00015764017,0.0003537789,0.00027436967,0.00014181415,0.0007468268,0.00006081449,0.00046476958,0.003018771,0.00006537894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014666763,0.00875623,0.3230137,0.0030133147,0.003151456,0.0001529613,0.00041110162,0.000013382271,0.0027394406,0.003971999,0.5861211,0.06850864],"study_design_scores_gemma":[0.0016339894,0.0008214396,0.91268444,0.0001743599,0.00089151884,0.00005020741,0.0000034104207,0.0000640665,0.012520607,0.004521342,0.0662285,0.00040611858],"about_ca_topic_score_codex":0.000073155614,"about_ca_topic_score_gemma":0.0000048832358,"teacher_disagreement_score":0.5896707,"about_ca_system_score_codex":0.0000401676,"about_ca_system_score_gemma":0.000040307885,"threshold_uncertainty_score":0.9998914},"labels":[],"label_agreement":null},{"id":"W2168937840","doi":"10.1016/s2213-8587(14)70121-4","title":"The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Bill and Melinda Gates Foundation","keywords":"Medicine; Fetus; Intrauterine growth restriction; Population; Fetal growth; Gestation; Pregnancy; Obstetrics; Longitudinal study; Gestational age; Demography; Pediatrics; Environmental health; Biology; Pathology","score_opus":0.05272309607930561,"score_gpt":0.3470317788286238,"score_spread":0.2943086827493182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168937840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924499,0.0012551538,0.000036913738,0.0032267715,0.00032382406,0.0020132868,0.00003266806,0.00005080478,0.0006106857],"genre_scores_gemma":[0.9985921,0.00023474167,0.00006143807,0.0002805734,0.0003501879,0.00040471068,0.000008367929,0.000025673291,0.00004223853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666876,0.00086234603,0.0006108164,0.0005020015,0.00033763843,0.0010184186],"domain_scores_gemma":[0.9964238,0.0024396577,0.00023863713,0.0007091056,0.00014740626,0.00004140261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015414389,0.00035084086,0.0007318076,0.00006571261,0.0011284143,0.00013805996,0.00066729414,0.000083171864,0.0000036015547],"category_scores_gemma":[0.0007254845,0.00016136967,0.00009633733,0.00044812678,0.0012386788,0.00013788487,0.0006096319,0.00077387586,0.0000022375004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040361885,0.00040703904,0.9876558,0.00005408711,0.00041344686,0.000012085267,0.00701613,0.0000020285645,0.00011936091,0.0014038496,0.00004650227,0.0024660386],"study_design_scores_gemma":[0.003986336,0.001374487,0.9870235,0.00004172646,0.00019474991,0.00009558483,0.004536069,0.00018257443,0.000066838606,0.002204408,0.0001373158,0.00015646103],"about_ca_topic_score_codex":0.0009045932,"about_ca_topic_score_gemma":0.0032138245,"teacher_disagreement_score":0.006142177,"about_ca_system_score_codex":0.000028223176,"about_ca_system_score_gemma":0.000041850595,"threshold_uncertainty_score":0.86789644},"labels":[],"label_agreement":null},{"id":"W2169497693","doi":"10.1016/s2213-8587(14)70229-3","title":"Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; University of Calgary; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Overweight; Diabetes mellitus; Obesity; Type 2 diabetes; Years of potential life lost; Disease; National Health and Nutrition Examination Survey; Risk factor; Gerontology; Demography; Internal medicine; Population; Endocrinology; Environmental health; Life expectancy","score_opus":0.01844392281592022,"score_gpt":0.23514660279209618,"score_spread":0.21670267997617595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169497693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392182,0.05875172,0.000023196315,0.0007268662,0.00012207335,0.0009803127,0.00006410028,0.000041131072,0.00007239353],"genre_scores_gemma":[0.99375814,0.0046579232,0.00017719,0.0007713613,0.0004787246,0.000077112265,0.000020573312,0.000048577756,0.0000104036235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679565,0.00058643846,0.00045872465,0.0007103281,0.00039552207,0.0010533512],"domain_scores_gemma":[0.9977411,0.0005444671,0.00011370589,0.001128751,0.000055894732,0.00041606583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009992897,0.00031651754,0.0018668565,0.00019897836,0.000068421155,0.000039342318,0.00020634639,0.00010163123,0.000019073184],"category_scores_gemma":[0.00050694024,0.00027065576,0.00021236193,0.00023138408,0.00039244647,0.00010312599,0.0003006382,0.00043663548,0.000010150746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024165733,0.00024294094,0.9480354,0.00033464553,0.0019045244,0.00004037815,0.00122246,0.00045773882,0.000040714487,0.00013382039,0.000060414615,0.04728527],"study_design_scores_gemma":[0.0064814584,0.00055919396,0.9830025,0.00013323412,0.0010256355,0.0000029531623,0.00035390526,0.0048229294,0.00004721,0.0007178593,0.0025608717,0.00029224137],"about_ca_topic_score_codex":0.003108189,"about_ca_topic_score_gemma":0.0003574302,"teacher_disagreement_score":0.054539926,"about_ca_system_score_codex":0.000022241187,"about_ca_system_score_gemma":0.00007680548,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W2174912211","doi":"10.1016/s2213-8587(15)00368-x","title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; St. Michael's Hospital; University of Calgary; Vancouver General Hospital; University of Alberta; Dalhousie University; Western University; Queen's University; McMaster University; University of Ottawa; McGill University; Centre Hospitalier de l’Université de Montréal; University Health Network; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Proteinuria; Placebo; Ramipril; Renal function; Population; Internal medicine; Kidney disease; Clinical endpoint; Creatinine; Randomized controlled trial; Clinical trial; Urology; Surgery; Kidney; Blood pressure","score_opus":0.04848031869414648,"score_gpt":0.30316669990349776,"score_spread":0.2546863812093513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174912211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835421,0.0001690615,0.00001063348,0.0017025431,0.00058421254,0.011447848,0.000034810968,0.00008113153,0.0024276995],"genre_scores_gemma":[0.99633735,0.00008528802,0.00020915052,0.00059098296,0.0002300366,0.0020894436,0.00022067511,0.000030777337,0.00020626216],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997593,0.0002747508,0.0004677056,0.00032944212,0.0003448194,0.0009902864],"domain_scores_gemma":[0.99857336,0.0005248227,0.0001701332,0.00038078768,0.00010504967,0.0002458177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031478071,0.00030461792,0.0012147705,0.00012588054,0.000055198452,0.000022331198,0.00019011096,0.00009353995,0.00004935653],"category_scores_gemma":[0.00013402173,0.00016153735,0.00014189468,0.00017156416,0.00012325899,0.00007556151,0.000015798974,0.00031998166,0.000053984404],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90588844,0.00063336414,0.09146426,0.00006723617,0.0009151508,0.00010246979,0.000418383,0.000030214855,0.00002252267,0.00013052301,0.000046825873,0.00028061162],"study_design_scores_gemma":[0.9896108,0.0019181446,0.0062513244,0.0001906978,0.00076721783,0.0000060271996,0.00004144919,0.000087815206,0.0005097241,0.000026547166,0.00041765952,0.00017258342],"about_ca_topic_score_codex":0.000059667174,"about_ca_topic_score_gemma":0.00007143779,"teacher_disagreement_score":0.08521293,"about_ca_system_score_codex":0.00009406155,"about_ca_system_score_gemma":0.00016786128,"threshold_uncertainty_score":0.6587302},"labels":[],"label_agreement":null},{"id":"W2196806522","doi":"10.1016/s2213-8587(15)00427-1","title":"Understanding EMPA-REG OUTCOME","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Asymptomatic; Diabetes mellitus; Diastole; Type 2 diabetes; Subclinical infection; Diabetic cardiomyopathy; Cardiomyopathy; Blood pressure; Endocrinology","score_opus":0.20224509148441888,"score_gpt":0.32123961387028116,"score_spread":0.11899452238586228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196806522","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016991217,0.0023653836,0.00008967245,0.9594423,0.003745982,0.0006626226,0.0000751069,0.0005250192,0.016102681],"genre_scores_gemma":[0.068369575,0.00055515824,0.00005076822,0.89975405,0.017814599,0.00007203877,0.0005420709,0.00015478293,0.012686946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964124,0.00030608734,0.00041625457,0.0005097227,0.000547771,0.0018077977],"domain_scores_gemma":[0.9980009,0.00028828005,0.00017223245,0.0013291835,0.00009978378,0.00010960269],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005124361,0.00045950073,0.0016971302,0.00024542314,0.00013744178,0.000036624653,0.0004005884,0.00059327105,0.00034688448],"category_scores_gemma":[0.00021592573,0.00028171268,0.00067317754,0.00020880873,0.00037373436,0.000038201248,0.00018204797,0.003123355,0.00061976723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027438009,0.000011236996,0.080564946,0.00012937574,0.0010825626,0.00046084964,0.00005972264,0.0000034039456,0.000023660685,0.00016217175,0.91705674,0.00041790176],"study_design_scores_gemma":[0.0017290969,0.00012492058,0.0056355265,0.000055573197,0.0009378905,0.00028754692,0.00009193089,0.000010139685,0.000082210165,0.0008720165,0.98985946,0.00031371217],"about_ca_topic_score_codex":0.000040279116,"about_ca_topic_score_gemma":0.00001074163,"teacher_disagreement_score":0.07492942,"about_ca_system_score_codex":0.0005564816,"about_ca_system_score_gemma":0.00012840581,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W2202092430","doi":"10.1016/s2213-8587(15)00369-1","title":"Is the artificial pancreas coming to a home near you?","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University","funders":"","keywords":"Medicine; Diabetes mellitus; Scopus; Type 2 diabetes; Evening; Artificial pancreas; MEDLINE; Type 1 diabetes; Randomized controlled trial; Intensive care medicine; Family medicine; Internal medicine; Endocrinology","score_opus":0.08551281787050605,"score_gpt":0.33004498534740645,"score_spread":0.2445321674769004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202092430","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1097868,0.0013537739,0.000003550109,0.8762382,0.0010101784,0.0013638007,0.00008270566,0.00018828492,0.009972671],"genre_scores_gemma":[0.015847772,0.00011290741,0.00013864221,0.9400287,0.01629975,0.00040085576,0.00023757703,0.00013775188,0.026796032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429125,0.00046348813,0.0004562854,0.0006915363,0.0008500022,0.0032474552],"domain_scores_gemma":[0.99679106,0.0006570025,0.00016816452,0.0020128577,0.00021359703,0.0001573328],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011579053,0.0005124309,0.0013789885,0.00023493184,0.00033988137,0.00021032931,0.0015205985,0.00037746693,0.00059458904],"category_scores_gemma":[0.00034729586,0.00027706966,0.0002877453,0.00048009292,0.0007506066,0.000048697402,0.0009580306,0.0032045033,0.0036865615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008610844,0.00003450076,0.0051703765,0.0002030372,0.0006490057,0.0002559097,0.0002692937,0.0000026591683,0.000141304,0.00017709834,0.980772,0.012238685],"study_design_scores_gemma":[0.00079896516,0.00036207424,0.0024865475,0.00012997228,0.0004628354,0.000011810886,0.00006582598,0.00015189759,0.00026883296,0.0024575053,0.99247,0.00033369733],"about_ca_topic_score_codex":0.000064757354,"about_ca_topic_score_gemma":0.000009506923,"teacher_disagreement_score":0.09393903,"about_ca_system_score_codex":0.00012740654,"about_ca_system_score_gemma":0.0001659014,"threshold_uncertainty_score":0.9999682},"labels":[],"label_agreement":null},{"id":"W2206181613","doi":"10.1016/s2213-8587(15)00324-1","title":"Myostatin inhibition for treatment of sarcopenia","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Myostatin; Medicine; Sarcopenia; Muscle hypertrophy; Skeletal muscle; Endocrinology; Internal medicine","score_opus":0.03898680223898934,"score_gpt":0.2902058703422169,"score_spread":0.2512190681032276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206181613","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6468648,0.00778151,0.00006471545,0.3396294,0.00075931544,0.0014794489,0.0011970545,0.000045230663,0.0021785444],"genre_scores_gemma":[0.3511457,0.0027535264,0.00085202977,0.60854465,0.014010916,0.0018938847,0.017498512,0.00018790996,0.003112894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982605,0.00019605529,0.00024428888,0.00037765675,0.00007312734,0.0008483814],"domain_scores_gemma":[0.99891305,0.00011566587,0.00020812232,0.00063215644,0.000106410575,0.000024566665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011344322,0.00027191814,0.00060417154,0.00004361679,0.000061024373,0.0000063078132,0.0002667189,0.00040288735,0.000024170311],"category_scores_gemma":[0.00007431365,0.00019245733,0.00017344032,0.000039282175,0.00031154958,0.0000018499188,0.00008071132,0.00015626494,0.0000153315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020583563,0.00005140477,0.00033686357,0.000087987406,0.00027162497,0.0000041745484,0.000044437023,0.000009850248,0.052642122,0.00007263722,0.9429727,0.003300363],"study_design_scores_gemma":[0.0017225957,0.0017163097,0.00016091223,0.000011544473,0.00010203998,0.0000037705818,0.000016831647,0.0000053080234,0.07624498,0.0029855606,0.9168303,0.00019985465],"about_ca_topic_score_codex":0.000020627234,"about_ca_topic_score_gemma":0.000020619591,"teacher_disagreement_score":0.29571906,"about_ca_system_score_codex":0.000020476555,"about_ca_system_score_gemma":0.0000963123,"threshold_uncertainty_score":0.7848182},"labels":[],"label_agreement":null},{"id":"W2219637998","doi":"10.1016/s2213-8587(15)00488-x","title":"Beyond the opportunities of SDG 3: the risk for the NCDs agenda","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Sustainable development; Vision; Politics; Medicine; Process (computing); Millennium Development Goals; Sustainability; Construct (python library); Economic growth; Environmental resource management; Political science; Developing country; Economics; Sociology; Ecology; Computer science","score_opus":0.15875164997272867,"score_gpt":0.32708746865243793,"score_spread":0.16833581867970926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219637998","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30577773,0.0038612816,0.0000790531,0.6584775,0.0019934808,0.0009074285,0.000079322876,0.00010835072,0.028715894],"genre_scores_gemma":[0.81646556,0.0009028493,0.000032079548,0.17697461,0.0048188213,0.0003077336,0.000023944784,0.000027780794,0.00044660614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760383,0.00022423467,0.00042750686,0.00018629369,0.00015457642,0.0014035612],"domain_scores_gemma":[0.99615633,0.0022739973,0.00047469026,0.00086371385,0.00021207971,0.000019165362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003454753,0.0001960344,0.00046590736,0.000048834307,0.00064175844,0.000079128906,0.0014628728,0.00006567018,0.000048702623],"category_scores_gemma":[0.0015828253,0.00007374884,0.00014058284,0.00021166947,0.00087643403,0.00014988071,0.0005052016,0.00034592242,0.00005830555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025283229,0.00001200431,0.0083428165,0.000037527265,0.00010991451,5.3564264e-7,0.00014926906,0.00032359076,0.000004137952,0.3015299,0.6812601,0.008204905],"study_design_scores_gemma":[0.00043825398,0.000032516036,0.009062398,0.0000042240927,0.00012384371,0.0000026313594,0.002088679,0.0036580563,0.0000072569596,0.05514851,0.92934614,0.000087482236],"about_ca_topic_score_codex":0.00392055,"about_ca_topic_score_gemma":0.00028605928,"teacher_disagreement_score":0.5106879,"about_ca_system_score_codex":0.000020497853,"about_ca_system_score_gemma":0.000059747654,"threshold_uncertainty_score":0.59267247},"labels":[],"label_agreement":null},{"id":"W2233447513","doi":"10.1016/s2213-8587(15)00495-7","title":"INDEPTH Network: contributing to the data revolution","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of Toronto","funders":"Wellcome Trust","keywords":"Medicine; MEDLINE; Data science","score_opus":0.08392349605258684,"score_gpt":0.3130773507607169,"score_spread":0.22915385470813007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233447513","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007577317,0.0013212388,0.00017787547,0.9825229,0.0037849552,0.00077024114,0.0002221811,0.00025658787,0.010186302],"genre_scores_gemma":[0.003071285,0.00019214132,0.000031701555,0.8546866,0.1406262,0.00011544651,0.00079588906,0.00004986208,0.00043086015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99063224,0.00037376993,0.00072534755,0.00078387116,0.00026568217,0.0072190776],"domain_scores_gemma":[0.99486756,0.0013890091,0.00068602106,0.0028469756,0.00018551608,0.000024915942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048941723,0.00045779342,0.0011270125,0.00012443264,0.00094576186,0.00017939943,0.004358213,0.00047321964,0.00016298864],"category_scores_gemma":[0.0023497716,0.00023021811,0.00011200945,0.00044163893,0.0002915182,0.0003123153,0.005304418,0.0019166196,0.0022102976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000088392135,0.0000028494885,0.005017125,0.00009269128,0.000098681616,0.0000119188,0.000003408253,0.000060884307,9.690411e-7,0.011096656,0.9776841,0.0059218984],"study_design_scores_gemma":[0.00032850532,0.000013219104,0.0037601124,0.000088946705,0.0001017315,0.000006795023,0.000009980325,0.000709561,1.662294e-7,0.006236385,0.9884541,0.0002905071],"about_ca_topic_score_codex":0.002141162,"about_ca_topic_score_gemma":0.00029787343,"teacher_disagreement_score":0.13684125,"about_ca_system_score_codex":0.000098884135,"about_ca_system_score_gemma":0.000063795276,"threshold_uncertainty_score":0.99856657},"labels":[],"label_agreement":null},{"id":"W2257765661","doi":"10.1016/s2213-8587(15)00480-5","title":"Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"U.S. Public Health Service","keywords":"Medicine; Acute coronary syndrome; Randomized controlled trial; Physical therapy; Clinical trial; Blood pressure; Community health; Intervention (counseling); Internal medicine; Myocardial infarction; Public health; Nursing","score_opus":0.0758911750230868,"score_gpt":0.3667132912328758,"score_spread":0.29082211620978904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257765661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560085,0.00092224573,0.00041206315,0.031002952,0.00034249318,0.011109688,0.0000528122,0.00006955754,0.00007969232],"genre_scores_gemma":[0.96907634,0.00020483785,0.0005909266,0.014755491,0.00015902462,0.013966033,0.000028592338,0.00001911771,0.0011996652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975433,0.0007591718,0.00046919606,0.0002864611,0.00013665455,0.0008052393],"domain_scores_gemma":[0.99748284,0.0012825315,0.000265814,0.0006683938,0.00009801064,0.00020241094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011362038,0.0001992029,0.0010566574,0.00006716213,0.00017680787,0.000028137185,0.00047269356,0.00005758852,0.0003139409],"category_scores_gemma":[0.00046915637,0.000112193135,0.00012942222,0.00010549572,0.0001840249,0.00009269942,0.00019863376,0.00023428755,0.00011766286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8062384,0.0010018855,0.03286466,0.00025932086,0.0006853326,0.000019837556,0.00081949553,1.5919596e-7,0.0005973484,0.00016906453,0.008993001,0.14835148],"study_design_scores_gemma":[0.9250105,0.00528565,0.06304756,0.000981765,0.00023707097,0.000020600506,0.00017659315,0.00011979876,0.00023339252,0.00028462915,0.0044238805,0.00017852662],"about_ca_topic_score_codex":0.0000895874,"about_ca_topic_score_gemma":0.000059854057,"teacher_disagreement_score":0.14817294,"about_ca_system_score_codex":0.00006338551,"about_ca_system_score_gemma":0.00009389494,"threshold_uncertainty_score":0.45751032},"labels":[],"label_agreement":null},{"id":"W2289823333","doi":"10.1016/s2213-8587(14)70102-0","title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","year":2014,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":813,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"British Heart Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Kidney disease; Diabetes mellitus; Disease; Type 2 diabetes; Intensive care medicine; Risk assessment; Internal medicine; Environmental health; Endocrinology","score_opus":0.05224403673869319,"score_gpt":0.3421681128012508,"score_spread":0.2899240760625576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289823333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22767967,0.7554359,0.000010017001,0.00021522783,0.00058000983,0.002545072,0.013238884,0.0001487716,0.00014646623],"genre_scores_gemma":[0.11030831,0.8826244,0.00006348055,0.00025990678,0.0026808043,0.0010006089,0.0028789118,0.0001366865,0.000046891153],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99128234,0.0023397866,0.0013252018,0.0016929461,0.0009341524,0.0024255961],"domain_scores_gemma":[0.99102,0.0016450544,0.0009690131,0.0040036617,0.00021248755,0.00214976],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009541677,0.0014061836,0.009830652,0.00046651938,0.00029406048,0.00008528732,0.0010118206,0.00027948595,0.00014636196],"category_scores_gemma":[0.0013029155,0.00093767926,0.0027543637,0.0006809282,0.0009197718,0.00011729086,0.00087580085,0.0013476801,0.00008690707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010272361,0.00040226776,0.65110093,0.028546082,0.078247406,0.000055353255,0.0002787368,0.00026823272,0.000016255291,0.00034279886,0.012606072,0.22803313],"study_design_scores_gemma":[0.0019848922,0.00022395198,0.24344678,0.004398051,0.064879395,7.53259e-7,0.00003199799,0.00025902895,0.000018300905,0.00043912584,0.68346006,0.00085763633],"about_ca_topic_score_codex":0.0013764314,"about_ca_topic_score_gemma":0.000014871666,"teacher_disagreement_score":0.67085403,"about_ca_system_score_codex":0.0004071433,"about_ca_system_score_gemma":0.0018214766,"threshold_uncertainty_score":0.99986887},"labels":[],"label_agreement":null},{"id":"W2311523609","doi":"10.1016/s2213-8587(16)00049-8","title":"Heart failure event definitions in drug trials in patients with type 2 diabetes","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Saxagliptin; Heart failure; Diabetes mellitus; Myocardial infarction; Type 2 diabetes; Type 2 Diabetes Mellitus; Internal medicine; Intensive care medicine; Stroke (engine); Sitagliptin; Endocrinology","score_opus":0.03372443033758165,"score_gpt":0.2737029513498433,"score_spread":0.23997852101226164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311523609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97954553,0.0004188093,9.552474e-7,0.017842947,0.00016629315,0.00095707143,0.00002621919,0.0000750754,0.0009670873],"genre_scores_gemma":[0.99702895,0.00013843922,0.00026691883,0.0018327493,0.00012606978,0.00028206847,0.000059688202,0.000027605414,0.00023748641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974423,0.0003825204,0.000459877,0.00032695621,0.00018547791,0.0012028464],"domain_scores_gemma":[0.9984199,0.0008089371,0.00012366314,0.00052638043,0.000056288878,0.000064863554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007208455,0.00023368663,0.0010588248,0.00025009,0.00004325206,0.0000145033355,0.00018332204,0.000049504015,0.00018850503],"category_scores_gemma":[0.0003674168,0.000115069946,0.00009178325,0.0003212243,0.00014935594,0.00009147091,0.00010343656,0.00017331098,0.00018605845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014160719,0.00038185448,0.9843984,0.000034042216,0.00019775766,0.0000069296393,0.00005350268,0.0000039817055,0.0003062168,0.0019296724,0.007404915,0.0051410687],"study_design_scores_gemma":[0.01065674,0.0006947689,0.9569046,0.000326211,0.00018706579,3.7898758e-7,0.00003908513,0.0000041146263,0.0017735495,0.0021037967,0.027117632,0.00019204263],"about_ca_topic_score_codex":0.000018015075,"about_ca_topic_score_gemma":0.00018174133,"teacher_disagreement_score":0.027493836,"about_ca_system_score_codex":0.000116021874,"about_ca_system_score_gemma":0.00003511875,"threshold_uncertainty_score":0.46924162},"labels":[],"label_agreement":null},{"id":"W2326373086","doi":"10.1016/s2213-8587(16)00080-2","title":"Diagnosis of diabetes type in children and young people: challenges and recommendations","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Diabetes mellitus; Scopus; Type 2 diabetes; Type 1 diabetes; MEDLINE; Childhood obesity; Pediatrics; Maturity onset diabetes of the young; Obesity; Family medicine; Gerontology; Internal medicine; Endocrinology; Overweight","score_opus":0.04784792248632218,"score_gpt":0.31863235979368926,"score_spread":0.27078443730736707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326373086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06881448,0.9257824,5.667735e-8,0.0035681908,0.00023337988,0.0006829437,0.00009776256,0.00004977754,0.0007710063],"genre_scores_gemma":[0.01107297,0.9878417,0.000056121233,0.00017838237,0.00028745818,0.00032711454,0.00009916222,0.000041565578,0.000095475334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780536,0.0003201545,0.0005194269,0.00043240588,0.00010426565,0.0008183914],"domain_scores_gemma":[0.99759686,0.0014386975,0.0002748035,0.0005476744,0.000053428404,0.000088545756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035719003,0.0003638832,0.0025136347,0.0002874268,0.000050569153,0.0000109083585,0.00018728702,0.00019548276,0.00010444555],"category_scores_gemma":[0.0005472012,0.00021459874,0.000116041054,0.00021339873,0.00031375454,0.000052960102,0.00019822546,0.0003700532,0.000025892772],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004650062,0.00005033942,0.22626479,0.0024927529,0.0004318694,6.2359237e-7,0.00007308738,5.350335e-9,0.000003747203,0.00087138556,0.0008328004,0.76897395],"study_design_scores_gemma":[0.0024911135,0.0005257022,0.37932432,0.015163086,0.0021725735,0.00006814113,0.0000596397,0.0000025370196,0.0000626532,0.0012187037,0.5983394,0.0005721655],"about_ca_topic_score_codex":0.000013615703,"about_ca_topic_score_gemma":0.00002911122,"teacher_disagreement_score":0.7684018,"about_ca_system_score_codex":0.000039596656,"about_ca_system_score_gemma":0.00006536125,"threshold_uncertainty_score":0.87510824},"labels":[],"label_agreement":null},{"id":"W2342715909","doi":"10.1016/s2213-8587(16)30006-7","title":"The role of glucagon in the artificial pancreas","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"","keywords":"Artificial pancreas; Medicine; Glucagon; Pancreas; Continuous glucose monitoring; Dosing; Diabetes mellitus; Blood Glucose Self-Monitoring; Type 1 diabetes; Intensive care medicine; Insulin; Internal medicine; Endocrinology","score_opus":0.06274600878356476,"score_gpt":0.3647426691679581,"score_spread":0.3019966603843933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342715909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017402723,0.9744265,2.9642308e-7,0.0040092072,0.0002746916,0.0014620986,0.000026094474,0.00003573747,0.018025119],"genre_scores_gemma":[0.0021135088,0.9944944,0.000005892444,0.00029274894,0.0012922342,0.00046966813,0.000032068645,0.000042218096,0.0012572872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957776,0.0010525624,0.0006518562,0.000346413,0.0004086164,0.0017629544],"domain_scores_gemma":[0.9954906,0.0026398257,0.0003072463,0.0014592524,0.00005848655,0.000044572425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001940297,0.00034447276,0.0018254622,0.00018212259,0.00016291803,0.000043670123,0.0015805376,0.00015557818,0.00009788378],"category_scores_gemma":[0.00041631478,0.00011740643,0.00040724652,0.00043729343,0.0007544991,0.000030098652,0.00039069256,0.0009048552,0.00043418581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002944142,0.00006665003,0.0006439762,0.0014581477,0.00036332654,0.000013754112,0.000036280948,3.7086462e-8,0.000016833737,0.018218318,0.002349796,0.9768034],"study_design_scores_gemma":[0.00033381913,0.00015543288,0.00039656716,0.0021621652,0.00047375355,0.000005853606,0.00008212537,0.0000038741828,0.000056528243,0.0063298442,0.9898677,0.0001323439],"about_ca_topic_score_codex":0.000014871635,"about_ca_topic_score_gemma":0.00001911956,"teacher_disagreement_score":0.9875179,"about_ca_system_score_codex":0.000054237295,"about_ca_system_score_gemma":0.00013023801,"threshold_uncertainty_score":0.5580725},"labels":[],"label_agreement":null},{"id":"W2346770749","doi":"10.1016/s2213-8587(16)00112-1","title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Ontario; Physicians' Services Incorporated Foundation; Institute for Clinical Evaluative Sciences; Johns Hopkins University","keywords":"Medicine; Testosterone replacement; Database; Prostate cancer; Androgen deprivation therapy; Testosterone (patch); Comorbidity; Cohort; Population; Hormone replacement therapy (female-to-male); Cohort study; Internal medicine; Cancer; Androgen","score_opus":0.05578504886145688,"score_gpt":0.2914114295745438,"score_spread":0.23562638071308692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346770749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928023,0.0007996531,0.000004599343,0.004475615,0.000041184765,0.0013015642,0.00000807518,0.00004498853,0.00052200106],"genre_scores_gemma":[0.9984939,0.00034869055,0.00003448318,0.00013606797,0.00013564424,0.00035753663,0.000011263765,0.000016694185,0.0004656957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830943,0.0002588866,0.00019102175,0.00048551,0.00024433984,0.0005108248],"domain_scores_gemma":[0.9991276,0.0001044578,0.00003839231,0.00055659073,0.00011746352,0.00005546144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058203394,0.00017838084,0.00065409724,0.00007414703,0.00007806278,0.0000040805944,0.00010557275,0.000022351293,0.000016894743],"category_scores_gemma":[0.000073168674,0.00007838076,0.000041877996,0.00014756218,0.00014058551,0.000057003686,0.000094145,0.000095775526,0.000007903905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007788099,0.00030538844,0.9882267,0.000008037374,0.0011672358,0.000016531803,0.00023286199,0.0000018318707,0.0033855636,0.00006298709,0.00003800433,0.005776021],"study_design_scores_gemma":[0.005438222,0.002243701,0.9897183,0.000032128555,0.00015618103,0.000011305552,0.0005769839,0.0000017054404,0.0011341876,0.00008618924,0.0004897889,0.000111281246],"about_ca_topic_score_codex":0.00020790412,"about_ca_topic_score_gemma":0.00011740318,"teacher_disagreement_score":0.0056916047,"about_ca_system_score_codex":0.000052759133,"about_ca_system_score_gemma":0.0000166767,"threshold_uncertainty_score":0.31962746},"labels":[],"label_agreement":null},{"id":"W2403716937","doi":"10.1016/s2213-8587(16)30096-1","title":"Supporting research leadership in Africa","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Health and Surgery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Capacity building; General partnership; Scopus; Medicine; Health care; Public relations; Medical education; Multidisciplinary approach; Political science; MEDLINE; Social science; Sociology","score_opus":0.3142364555807402,"score_gpt":0.40539834102066996,"score_spread":0.09116188543992976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403716937","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021932743,0.004601851,4.3717068e-7,0.9496589,0.0006672333,0.0005975072,0.000040786956,0.000115773895,0.022384824],"genre_scores_gemma":[0.080683574,0.0005055965,0.00004207116,0.89508015,0.012822512,0.00024839517,0.00009985915,0.000072885916,0.010444931],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98632705,0.0010312534,0.0006070906,0.0005910078,0.00056033046,0.010883272],"domain_scores_gemma":[0.9955362,0.002924166,0.00016554267,0.0010916175,0.0001476491,0.0001348437],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004137798,0.00031410213,0.001287478,0.0004906658,0.00014600837,0.000019183506,0.00058721384,0.0006314756,0.00038179563],"category_scores_gemma":[0.0012334503,0.00018782912,0.00015523865,0.00040273697,0.000589623,0.000035763078,0.00020848821,0.005223143,0.0009385424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006825217,0.000015517595,0.036611963,0.0007018251,0.000048033675,0.0017263668,0.00010386792,2.862062e-8,0.00011196121,0.00021652297,0.9502998,0.010095885],"study_design_scores_gemma":[0.0008834586,0.00016133495,0.0049008233,0.00050169084,0.000027745125,0.000072710885,0.00008979053,0.0000026437924,0.0001779893,0.0032435784,0.9897552,0.00018299575],"about_ca_topic_score_codex":0.00005807572,"about_ca_topic_score_gemma":0.000015627109,"teacher_disagreement_score":0.058750834,"about_ca_system_score_codex":0.0002501274,"about_ca_system_score_gemma":0.0003520793,"threshold_uncertainty_score":0.99983937},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"incentives","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2405171365","doi":"10.1016/s2213-8587(16)30041-9","title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University","funders":"British Heart Foundation","keywords":"Medicine; Familial hypercholesterolemia; Subclinical infection; Disease; Internal medicine; Cholesterol; Myocardial infarction; Risk stratification; Ldl cholesterol","score_opus":0.12123139253369282,"score_gpt":0.3749064451119221,"score_spread":0.2536750525782293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405171365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029264566,0.9325047,0.00008618946,0.026955172,0.0011534394,0.0056382446,0.0037968946,0.00013349716,0.00046725644],"genre_scores_gemma":[0.0021662035,0.98263997,0.0008336543,0.008877452,0.0024736202,0.0022991286,0.00043368316,0.00009361417,0.00018266893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529904,0.001005243,0.0012249,0.0008934287,0.0003696384,0.001207747],"domain_scores_gemma":[0.9937622,0.0036149556,0.0005279166,0.0018344903,0.00013415574,0.00012627647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027215402,0.0005724888,0.0024271181,0.000039092807,0.00050287944,0.00010807504,0.0011386691,0.0003313883,0.000019754361],"category_scores_gemma":[0.00024186065,0.00025266572,0.0014416781,0.00011622429,0.0009970954,0.00004278132,0.000770358,0.0010807225,0.00003954917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001697389,0.000052379393,0.005023073,0.0011468199,0.0048369584,0.0000022835632,0.00018889955,3.446598e-7,0.0000029950572,0.0022500267,0.009730905,0.9765956],"study_design_scores_gemma":[0.009026679,0.00010492951,0.02225571,0.0024755292,0.0036125875,0.000114973125,0.00021743437,0.000012333786,6.49814e-7,0.0009552224,0.96091264,0.00031131876],"about_ca_topic_score_codex":0.00009490832,"about_ca_topic_score_gemma":0.000026415219,"teacher_disagreement_score":0.97628427,"about_ca_system_score_codex":0.0002152701,"about_ca_system_score_gemma":0.0002325665,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2490307463","doi":"10.1016/s2213-8587(16)30145-0","title":"De-evolution of diagnostic testing for adrenal insufficiency","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia, Okanagan Campus; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Adrenal insufficiency; Diagnostic test; Intensive care medicine; MEDLINE; Internal medicine; Pediatrics","score_opus":0.03170536410616449,"score_gpt":0.2827121624994056,"score_spread":0.25100679839324114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490307463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892368,0.0019826135,0.0029645686,0.0041759177,0.000081372506,0.0003033399,0.000024523555,0.0000617598,0.0011691139],"genre_scores_gemma":[0.99809223,0.00006929283,0.0009880605,0.00041166498,0.00026041697,0.00007814672,0.0000031628597,0.00001291215,0.0000841354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987579,0.000037935915,0.00019276064,0.00015076558,0.00008126408,0.00077937037],"domain_scores_gemma":[0.9970453,0.0024768459,0.00009694992,0.00024384698,0.00008998981,0.00004707939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019688495,0.00009852932,0.0003040334,0.000054222968,0.00006293435,0.000002802323,0.00015097317,0.00004156541,0.000025173274],"category_scores_gemma":[0.0034535376,0.00005204836,0.00006660124,0.00012492282,0.00023983195,0.00002930571,0.000051224182,0.00007567689,0.000012119199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017092572,0.00024346051,0.7901534,0.00012231023,0.00008450461,0.000007537124,0.00008459568,0.000012615583,0.070908375,0.027556144,0.0022120103,0.108444154],"study_design_scores_gemma":[0.0041998313,0.0024925456,0.9583126,0.00021813886,0.00020818108,0.000066817396,0.00012517137,0.00037057043,0.0106537305,0.017690152,0.0054821987,0.00018010012],"about_ca_topic_score_codex":0.000027291675,"about_ca_topic_score_gemma":0.0000046955415,"teacher_disagreement_score":0.16815919,"about_ca_system_score_codex":0.000050104445,"about_ca_system_score_gemma":0.00008054977,"threshold_uncertainty_score":0.41344568},"labels":[],"label_agreement":null},{"id":"W2523634442","doi":"10.1016/s2213-8587(16)30237-6","title":"SGLT2 inhibitors: β blockers for the kidney?","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Medicine; Renal function; Nephron; Kidney disease; Tubuloglomerular feedback; Diabetes mellitus; Kidney; Type 2 diabetes; Urology; Internal medicine; Endocrinology","score_opus":0.028122738169641774,"score_gpt":0.2737894242405104,"score_spread":0.2456666860708686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523634442","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012772202,0.003293178,0.000015960664,0.9854675,0.0022687558,0.0024883118,0.00023997274,0.00027968464,0.0046694246],"genre_scores_gemma":[0.001641181,0.0012049518,0.00021860871,0.93629825,0.029853223,0.0021015361,0.00048884377,0.00014050514,0.028052919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995784,0.00012889088,0.0004097857,0.0006297057,0.0003244048,0.0027232552],"domain_scores_gemma":[0.99640983,0.0014469709,0.0002602719,0.0016906303,0.0000983712,0.00009390096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035668176,0.0005855207,0.0011602172,0.00015432914,0.00025210012,0.00005665502,0.000859484,0.00036006892,0.0002733402],"category_scores_gemma":[0.00022778062,0.0002625774,0.0004794368,0.00013246742,0.00054568914,0.000046886296,0.00032251983,0.0010438286,0.0004260866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004915409,0.00002859555,0.0018800322,0.00029894066,0.0022394902,0.000074178264,0.00003663422,1.2541616e-7,0.00012636665,0.0004991214,0.96739554,0.027371837],"study_design_scores_gemma":[0.0030312168,0.00040623528,0.00025849917,0.0002600198,0.0020704414,0.000010855556,0.000016801961,0.00001090852,0.0014213368,0.0015816883,0.9906225,0.0003094638],"about_ca_topic_score_codex":0.000012376874,"about_ca_topic_score_gemma":0.000002955424,"teacher_disagreement_score":0.04916926,"about_ca_system_score_codex":0.00014299274,"about_ca_system_score_gemma":0.00010006009,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W2550203760","doi":"10.1016/s2213-8587(16)30373-4","title":"Cardiovascular effects of incretin-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Incretin; Type 2 diabetes; Metformin; Placebo; Internal medicine; Meta-analysis; Alogliptin; Diabetes mellitus; Stroke (engine); Cochrane Library; Myocardial infarction; Linagliptin; Saxagliptin; Exenatide; Adverse effect; Odds ratio; Sitagliptin; Insulin; Endocrinology","score_opus":0.030809290791371076,"score_gpt":0.27701789372438546,"score_spread":0.2462086029330144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550203760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006793174,0.9925873,0.0000021041874,0.0001662781,0.000057395395,0.006351265,0.00002809501,0.000048946742,0.00007924341],"genre_scores_gemma":[0.0015327964,0.9950432,0.00009089992,0.00092277245,0.000058542882,0.0020698786,0.00014343509,0.00006569787,0.00007275993],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99551225,0.0014997025,0.0009014519,0.00058401335,0.00036986987,0.0011327259],"domain_scores_gemma":[0.9957146,0.0015540792,0.0006922645,0.0018394303,0.00012820533,0.00007140658],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0010279422,0.00069919176,0.016826447,0.00035529162,0.000043031854,0.000015572481,0.00040396958,0.00012644407,0.000047933652],"category_scores_gemma":[0.00022086705,0.00029524454,0.0021404212,0.0010798723,0.00023314309,0.000034170058,0.00015542084,0.00026696644,0.000020246209],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008688021,0.00007775313,0.0048943493,0.58259463,0.4035855,0.000009313407,0.0000074230957,0.0000016468173,2.0464741e-8,0.000046125766,0.00010702291,0.008667505],"study_design_scores_gemma":[0.0013126591,0.0005290022,0.0008172651,0.09421347,0.87015665,3.5239268e-7,9.916598e-7,0.0000011462674,0.0000011508606,0.000019488143,0.032656863,0.00029094936],"about_ca_topic_score_codex":0.0000054247357,"about_ca_topic_score_gemma":0.000003725209,"teacher_disagreement_score":0.48838118,"about_ca_system_score_codex":0.00007481937,"about_ca_system_score_gemma":0.000053153697,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W2553740625","doi":"10.1016/s2213-8587(16)30316-3","title":"Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Metformin; Insulin; Type 2 diabetes; Confounding; Proportional hazards model; Diabetes mellitus; Internal medicine; Stroke (engine); Cohort study; Cohort; Retrospective cohort study; Adverse effect; Hazard ratio; Myocardial infarction; Marginal structural model; Observational study; Endocrinology; Confidence interval","score_opus":0.016920589904538277,"score_gpt":0.2589785261817467,"score_spread":0.24205793627720845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553740625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943972,0.0009984166,0.0000605144,0.0009572092,0.00022315573,0.0023249714,0.00009163741,0.00014558563,0.00080130994],"genre_scores_gemma":[0.9975637,0.00043034976,0.000106658474,0.00020136657,0.00051100994,0.0004702066,0.000013792455,0.000047034242,0.00065585837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623245,0.0006724769,0.00045169657,0.0005855636,0.0009357629,0.0011220756],"domain_scores_gemma":[0.9973227,0.00023287097,0.00029861956,0.0017221496,0.00032763026,0.00009603471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021775342,0.00031100432,0.001937897,0.00011295249,0.00009734964,0.0000070908154,0.00032919896,0.00011779077,0.00015466596],"category_scores_gemma":[0.00078716385,0.00015356304,0.0005501067,0.00036627846,0.00020665143,0.00011645481,0.00014087211,0.00032546226,0.00004696479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032867194,0.00034179728,0.9655025,0.00006061132,0.017838372,0.000075648626,0.00016372827,0.0000045477464,0.00016310302,0.00004811332,0.0002606973,0.015212217],"study_design_scores_gemma":[0.009241306,0.0011441488,0.97778094,0.0000935645,0.0040407944,0.000014631412,0.00016392209,0.0000023259722,0.002584561,0.00016761382,0.004549586,0.000216618],"about_ca_topic_score_codex":0.0016060205,"about_ca_topic_score_gemma":0.001034971,"teacher_disagreement_score":0.014995599,"about_ca_system_score_codex":0.0003690986,"about_ca_system_score_gemma":0.000105864165,"threshold_uncertainty_score":0.6262119},"labels":[],"label_agreement":null},{"id":"W2554342207","doi":"10.1016/s2213-8587(16)30366-7","title":"1 year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: a randomised trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Gestational diabetes; Randomized controlled trial; Diabetes mellitus; Weight loss; Clinical trial; Physical therapy; Intervention (counseling); Pediatrics; Family medicine; Pregnancy; Gerontology; Obesity; Gestation; Nursing; Surgery; Internal medicine","score_opus":0.0377457741755283,"score_gpt":0.33075668103972894,"score_spread":0.2930109068642006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554342207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96011895,0.00089728873,0.000026012125,0.03287365,0.00019605088,0.003281071,0.000031669413,0.00009000267,0.0024853025],"genre_scores_gemma":[0.9930152,0.0007527502,0.0005422934,0.0013307377,0.00073247106,0.0025024773,0.00011170636,0.000022495617,0.0009898298],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99693125,0.0006318779,0.00037581267,0.0003208477,0.00047108546,0.0012691226],"domain_scores_gemma":[0.99769276,0.001541029,0.000114069895,0.0004807014,0.00009740747,0.000074027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011183695,0.00019169571,0.0004544565,0.00015852344,0.00009610851,0.000045707842,0.00040606633,0.00005718433,0.00035190128],"category_scores_gemma":[0.0007355043,0.00008928406,0.0001464021,0.0002636045,0.00032002365,0.00010373977,0.0000905168,0.00024609457,0.00019820945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05933744,0.0037329157,0.21755083,0.0007263733,0.0017843479,0.0001212482,0.00082929316,0.000015454994,0.00917643,0.06714049,0.0670599,0.57252526],"study_design_scores_gemma":[0.361732,0.0034134346,0.422869,0.00031243596,0.00031270177,0.0000070451883,0.00020796678,0.00014852031,0.004260259,0.040950477,0.16538045,0.0004056848],"about_ca_topic_score_codex":0.0000071561826,"about_ca_topic_score_gemma":0.000020071295,"teacher_disagreement_score":0.5721196,"about_ca_system_score_codex":0.00006544224,"about_ca_system_score_gemma":0.00009812653,"threshold_uncertainty_score":0.38530725},"labels":[],"label_agreement":null},{"id":"W2555589501","doi":"10.1016/s2213-8587(16)30370-9","title":"Stroke risk in treatment of type 2 diabetes in China: a 7 year retrospective cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Metformin; Diabetes mellitus; Stroke (engine); Type 2 diabetes; Internal medicine; Retrospective cohort study; Logistic regression; Cohort; Cohort study; Risk factor; Insulin; Endocrinology","score_opus":0.013517256126619,"score_gpt":0.2680827595210014,"score_spread":0.2545655033943824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555589501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261016,0.00042272834,8.6811707e-7,0.0016212416,0.00015814019,0.0012838992,0.000044880057,0.000048213948,0.0038098537],"genre_scores_gemma":[0.99808353,0.0007816673,0.00007790386,0.00007409397,0.00015311454,0.0002139873,0.0000053950093,0.000023924344,0.00058638863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979911,0.00019426292,0.00034427104,0.00038228263,0.00019211824,0.0008959976],"domain_scores_gemma":[0.9988126,0.00021469824,0.00014983665,0.0007447394,0.000040137886,0.000037943428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034486438,0.00021071412,0.0009631323,0.0002031817,0.00002145121,0.0000034649336,0.00021919255,0.000051919735,0.00011150274],"category_scores_gemma":[0.00023437322,0.000115660834,0.000068968635,0.00026460775,0.0002148053,0.00003470805,0.00013311957,0.00017355857,0.000039639104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015047232,0.0005733456,0.99068063,0.000010152357,0.0004698387,0.000032306023,0.0003651392,0.0000017381277,0.003226282,0.00013023817,0.0006132711,0.0037465524],"study_design_scores_gemma":[0.0059794527,0.0019985489,0.9837852,0.00003832941,0.0001940986,0.0000010363694,0.0002366591,0.000018992012,0.006215586,0.00013454752,0.0012911095,0.00010640182],"about_ca_topic_score_codex":0.00021413824,"about_ca_topic_score_gemma":0.00017104343,"teacher_disagreement_score":0.0068954257,"about_ca_system_score_codex":0.0003749868,"about_ca_system_score_gemma":0.000026903126,"threshold_uncertainty_score":0.4716512},"labels":[],"label_agreement":null},{"id":"W2559592043","doi":"10.1016/s2213-8587(16)30396-5","title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Sanofi; University College London Hospitals NHS Foundation Trust; Economic and Social Research Council; Lundbeckfonden; National Cancer Institute; British Heart Foundation; University College London; AstraZeneca; Amgen; National Institute for Health and Care Research; Medical Research Council; Foundation for the National Institutes of Health","keywords":"Medicine; Mendelian randomization; Type 2 diabetes; PCSK9; Mendelian inheritance; Diabetes mellitus; MEDLINE; Internal medicine; Bioinformatics; Genetic variants; Genetics; Endocrinology; Cholesterol; Genotype; Gene","score_opus":0.02064260349654017,"score_gpt":0.2663447683854673,"score_spread":0.2457021648889271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559592043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942585,0.002764021,0.000037524132,0.0015523047,0.00017936411,0.0009434042,0.000019261053,0.000046443245,0.00019913363],"genre_scores_gemma":[0.99663264,0.0023627703,0.00020442069,0.00027510972,0.0003634145,0.00008112961,0.0000025499617,0.000020170735,0.00005777917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980809,0.00048018765,0.0002927953,0.0002705521,0.00020365753,0.00067189644],"domain_scores_gemma":[0.9987062,0.000244566,0.00013574197,0.00074452464,0.00009293449,0.00007602146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008803418,0.00014850985,0.00073802954,0.00007544214,0.00007447719,0.0000064622986,0.00013459868,0.0000521542,0.00005936473],"category_scores_gemma":[0.00033682564,0.0000751191,0.00008848004,0.00013801754,0.00015561313,0.00003251949,0.0000830903,0.00014182809,0.000015804306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002661131,0.00011595454,0.87196374,0.00007301824,0.0010666085,0.000008544344,0.0002617174,0.0000014637894,0.007042896,0.00012024016,0.00014155704,0.118938126],"study_design_scores_gemma":[0.014152714,0.001177457,0.9764975,0.00005765571,0.000769416,0.000013356479,0.00011949537,0.000054533066,0.0037441496,0.00075908314,0.0025379306,0.000116741794],"about_ca_topic_score_codex":0.0000848142,"about_ca_topic_score_gemma":0.000023319904,"teacher_disagreement_score":0.11882138,"about_ca_system_score_codex":0.000026282964,"about_ca_system_score_gemma":0.000050238457,"threshold_uncertainty_score":0.30632678},"labels":[],"label_agreement":null},{"id":"W2560403714","doi":"10.1016/s2213-8587(16)30398-9","title":"PCSK9 inhibition and diabetes: turning to Mendel for clues","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Diabetes mellitus; MEDLINE; Bioinformatics; Endocrinology","score_opus":0.030734306734960692,"score_gpt":0.2845203620672843,"score_spread":0.2537860553323236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560403714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1698939,0.004116478,0.00009776287,0.82180256,0.0005984594,0.0020863134,0.0002767156,0.00019753692,0.00093029765],"genre_scores_gemma":[0.038092896,0.00078916945,0.0008330263,0.92857933,0.028500617,0.0015892386,0.0003755532,0.0001483116,0.0010918536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611175,0.00023371294,0.0003919901,0.000675971,0.0003246958,0.0022618598],"domain_scores_gemma":[0.9980349,0.00047404823,0.00016449449,0.0010650825,0.00013608995,0.00012536373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075392757,0.0004301938,0.0014836735,0.00019620969,0.00019390933,0.000039592796,0.00022368382,0.0004341575,0.000042073043],"category_scores_gemma":[0.00024582774,0.00025901844,0.00031783088,0.00010737322,0.00019627913,0.000053983294,0.00020591919,0.0010896259,0.000052366075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064372834,0.000014713229,0.0031340749,0.0014784618,0.00094837457,0.00007443791,0.00013245238,6.024572e-7,0.0032761437,0.0002690252,0.91244,0.07816732],"study_design_scores_gemma":[0.0020919223,0.0005612052,0.001737209,0.0005547167,0.00045631023,0.000044344863,0.000017674096,0.000011769961,0.0047976472,0.001930414,0.9874652,0.00033160218],"about_ca_topic_score_codex":0.000016585913,"about_ca_topic_score_gemma":0.000004956407,"teacher_disagreement_score":0.13180101,"about_ca_system_score_codex":0.00011648825,"about_ca_system_score_gemma":0.00008475798,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2572398654","doi":"10.1016/s2213-8587(17)30013-x","title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":707,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Semaglutide; Medicine; Placebo; Tolerability; Type 2 diabetes; Randomized controlled trial; Diabetes mellitus; Dulaglutide; Internal medicine; Clinical trial; Adverse effect; Physical therapy; Exenatide; Liraglutide; Endocrinology; Alternative medicine","score_opus":0.03132321637257893,"score_gpt":0.3149938320151195,"score_spread":0.2836706156425406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572398654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858009,0.0007097809,0.0000039807114,0.0020842263,0.00033592072,0.009780827,0.000022635704,0.00006503685,0.0011966537],"genre_scores_gemma":[0.99728686,0.00037506997,0.0005177815,0.0002203607,0.00024060496,0.00086213334,0.0001367599,0.000047651956,0.00031280745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970189,0.00025717137,0.00063064793,0.0005262088,0.000346841,0.001220246],"domain_scores_gemma":[0.99682045,0.0013820691,0.0005982825,0.000917996,0.00015648332,0.00012469052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006263967,0.000441895,0.0015882629,0.00021476603,0.00025812464,0.00006645465,0.00043423942,0.00010985866,0.000055836255],"category_scores_gemma":[0.00045086688,0.0002848584,0.00013938312,0.00012557254,0.0004689309,0.00015240254,0.00017702868,0.00030699678,0.0000121706935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8965141,0.0019302273,0.08367867,0.00008319526,0.0019137866,0.000014539278,0.00022550469,0.00009544276,0.0000839971,0.00052106817,0.00019988939,0.014739579],"study_design_scores_gemma":[0.9532591,0.0044803335,0.038266316,0.00012352256,0.00081520475,2.3512413e-7,0.000091899194,0.00073472457,0.00024509872,0.00005016307,0.0016640167,0.0002693881],"about_ca_topic_score_codex":0.000038074228,"about_ca_topic_score_gemma":0.00007629458,"teacher_disagreement_score":0.056744996,"about_ca_system_score_codex":0.00012181588,"about_ca_system_score_gemma":0.00006588145,"threshold_uncertainty_score":0.99996036},"labels":[],"label_agreement":null},{"id":"W2580463185","doi":"10.1016/s2213-8587(17)30014-1","title":"Exercise management in type 1 diabetes: a consensus statement","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":890,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; York University","funders":"","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Aerobic exercise; Diabetes management; Population; Physical therapy; Endocrinology; Environmental health","score_opus":0.17890817576619625,"score_gpt":0.4277048627118327,"score_spread":0.24879668694563647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580463185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008944835,0.9692274,1.4073329e-7,0.0017816526,0.00088166614,0.003901868,0.000037753125,0.0001442985,0.02313074],"genre_scores_gemma":[0.00018246716,0.98419476,0.00015633604,0.00045258758,0.00046174385,0.0010557268,0.00022735071,0.00011802988,0.013150983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938319,0.00042650336,0.0010210043,0.00088961044,0.00050550536,0.0033254758],"domain_scores_gemma":[0.9962015,0.000391402,0.0005226046,0.0026187983,0.00009305868,0.00017260267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014796818,0.0007477916,0.004130874,0.00073591195,0.00020630557,0.00012610534,0.0015449325,0.00024608805,0.00034288922],"category_scores_gemma":[0.00016427843,0.00047256117,0.0004559662,0.00047903636,0.00060301763,0.00004783419,0.0012608888,0.0012503783,0.0016979182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039777264,0.00018236779,0.0007467175,0.02267669,0.0014516483,0.00042837506,0.00001977165,7.2033896e-7,5.0866595e-7,0.0006340719,0.030653711,0.94316566],"study_design_scores_gemma":[0.0016818932,0.00023577234,0.00045908135,0.014149533,0.0021676933,0.0000031793672,0.000026229927,0.000023156537,0.0000039729925,0.00041023226,0.9803976,0.00044168349],"about_ca_topic_score_codex":0.000008763121,"about_ca_topic_score_gemma":0.00000882106,"teacher_disagreement_score":0.94974387,"about_ca_system_score_codex":0.00025918466,"about_ca_system_score_gemma":0.00016575713,"threshold_uncertainty_score":0.9997726},"labels":[],"label_agreement":null},{"id":"W2585220979","doi":"10.1016/s2213-8587(17)30034-7","title":"Elimination of iodine deficiency disorders from the Americas: a public health triumph","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network","funders":"","keywords":"Iodine deficiency; Medicine; Micronutrient; Latin Americans; Public health; Micronutrient deficiency; Environmental health; Iodine; Gerontology; Economic growth; Development economics; Political science; Endocrinology; Pathology; Law; Thyroid","score_opus":0.06094045561239831,"score_gpt":0.32944888159444596,"score_spread":0.26850842598204766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585220979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8408157,0.0055271545,0.0000360203,0.15090816,0.00016623472,0.00036819486,0.000057643065,0.00004198568,0.0020789148],"genre_scores_gemma":[0.9946892,0.0022679132,0.00014560958,0.0025484264,0.00014088803,0.00006137349,0.00005777297,0.000015013001,0.000073788986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839324,0.0001361302,0.0002459609,0.0002339818,0.0001668347,0.0008238624],"domain_scores_gemma":[0.99812245,0.000278856,0.0003686524,0.001119695,0.00004982239,0.000060502865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024587775,0.0001505818,0.00050532154,0.000043674347,0.00043027528,0.00003299443,0.00053382554,0.00003491047,0.00005224524],"category_scores_gemma":[0.00042067326,0.00008051241,0.00009959852,0.00009184045,0.0005535266,0.00007175055,0.0001411966,0.00018035827,0.00003199379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000847752,0.00046290387,0.76941395,0.000026983296,0.00022758888,0.0000035612663,0.0008902256,0.0000015117017,0.0005424005,0.005525722,0.003607791,0.21921258],"study_design_scores_gemma":[0.0032991865,0.0005104578,0.97948337,0.00001963231,0.000087850865,0.0000035034232,0.00040844595,0.00006932742,0.0002705824,0.0029535058,0.012811649,0.000082479346],"about_ca_topic_score_codex":0.0009787193,"about_ca_topic_score_gemma":0.0002474262,"teacher_disagreement_score":0.21913008,"about_ca_system_score_codex":0.000038239883,"about_ca_system_score_gemma":0.00008520355,"threshold_uncertainty_score":0.3309373},"labels":[],"label_agreement":null},{"id":"W2588614813","doi":"10.1016/s2213-8587(17)30044-x","title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Medicine; Evolocumab; Interim analysis; Ezetimibe; Internal medicine; Adverse effect; PCSK9; LDL apheresis; Familial hypercholesterolemia; Cholesterol; Clinical trial; Lipoprotein","score_opus":0.05832711720972705,"score_gpt":0.34472170470917196,"score_spread":0.2863945874994449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588614813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950431,0.00013754018,0.000006603011,0.0007006558,0.000064517924,0.0038585518,0.000093088434,0.000025966694,0.00006996208],"genre_scores_gemma":[0.9982739,0.000051953557,0.0001608985,0.00049802626,0.000089320005,0.0006789353,0.000067105335,0.000042850508,0.0001369932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972109,0.00050908554,0.00035245495,0.000590511,0.0005277208,0.0008092927],"domain_scores_gemma":[0.99668115,0.000053807555,0.00030834757,0.0026399577,0.00018825877,0.00012847813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261148,0.00035822796,0.0015497865,0.00015479988,0.00029272313,0.000092865244,0.0010672493,0.000055793007,0.000042115975],"category_scores_gemma":[0.000021859394,0.00014264084,0.00009903229,0.00036479588,0.00039214478,0.00016478832,0.0002628511,0.00029324918,0.0000017853666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093296645,0.0029129093,0.96368146,0.000027055596,0.004792547,0.00006139293,0.0008782236,0.00001205655,0.000050924442,0.000010236503,0.000011115566,0.018232416],"study_design_scores_gemma":[0.03468366,0.012936521,0.94961,0.00012309662,0.001674844,0.000016329112,0.00036368327,0.000019797573,0.0003100595,0.0000028139075,0.00006799546,0.00019118375],"about_ca_topic_score_codex":0.0019550214,"about_ca_topic_score_gemma":0.021181872,"teacher_disagreement_score":0.025353996,"about_ca_system_score_codex":0.00015328829,"about_ca_system_score_gemma":0.00022986264,"threshold_uncertainty_score":0.996679},"labels":[],"label_agreement":null},{"id":"W2591631347","doi":"10.1016/s2213-8587(17)30067-0","title":"Does fetal exposure to vitamin D programme childhood bone mass?","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Calcitriol; Calcitriol receptor; Vitamin D and neurology; Endocrinology; Rickets; Calcium metabolism; Internal medicine; Medicine; Osteomalacia; Bone remodeling; Calcium; vitamin D deficiency","score_opus":0.028359246283053745,"score_gpt":0.2959302140544903,"score_spread":0.2675709677714366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591631347","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099998444,0.0023771608,0.0000033474757,0.89017993,0.0014597694,0.0022708115,0.00024472646,0.00038356145,0.0030822677],"genre_scores_gemma":[0.22965816,0.0015311417,0.0017944595,0.68196595,0.043814976,0.003284235,0.0007564987,0.0003778064,0.036816783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99196523,0.00038125928,0.0005515537,0.0011147328,0.00084810203,0.0051391046],"domain_scores_gemma":[0.9953639,0.0006163479,0.00033387405,0.0032118314,0.000245843,0.0002282395],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00061514165,0.00084417657,0.002477819,0.0003454983,0.00055086956,0.00016054371,0.001675254,0.0006414064,0.00016362792],"category_scores_gemma":[0.0016532385,0.00041394145,0.00041881314,0.0001792962,0.001103623,0.000080781596,0.0011116419,0.0044907453,0.00074932224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038825845,0.00011370869,0.02559174,0.00062270026,0.001481523,0.0033071793,0.00029329842,3.2393868e-7,0.0011937431,0.000028140605,0.94180524,0.025523545],"study_design_scores_gemma":[0.00241366,0.0013275973,0.0851004,0.00040878906,0.00047337112,0.00016968018,0.000087186374,0.0000015671852,0.0014561466,0.00061887444,0.90736866,0.00057405065],"about_ca_topic_score_codex":0.000041321913,"about_ca_topic_score_gemma":0.000033597782,"teacher_disagreement_score":0.20821397,"about_ca_system_score_codex":0.00017846822,"about_ca_system_score_gemma":0.00017388024,"threshold_uncertainty_score":0.99983126},"labels":[],"label_agreement":null},{"id":"W2595010755","doi":"10.1016/s2213-8587(17)30087-6","title":"Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Enalapril; Sacubitril, Valsartan; Sacubitril; Medicine; Valsartan; Internal medicine; Diabetes mellitus; Type 2 diabetes; Heart failure; Post-hoc analysis; Endocrinology; Ejection fraction; ACE inhibitor; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.01004263881300927,"score_gpt":0.261315251005856,"score_spread":0.25127261219284674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595010755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902784,0.00056779437,5.081441e-7,0.006841592,0.0002079747,0.0017696251,0.000120009776,0.000037189973,0.00017688735],"genre_scores_gemma":[0.99815786,0.000049462134,0.000023987015,0.0011532682,0.00022391664,0.00023177112,0.0001130161,0.000024947522,0.000021794776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975603,0.00043016832,0.00032356672,0.00044209877,0.00029584963,0.0009479751],"domain_scores_gemma":[0.99614763,0.0020497944,0.00030298243,0.0013753197,0.000047016692,0.00007723471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046972727,0.00034316588,0.0017566311,0.00015746173,0.0001924635,0.000060288647,0.00044374057,0.00008161497,0.000039162882],"category_scores_gemma":[0.00028754107,0.00017104653,0.00020263913,0.00017566427,0.00043460852,0.00008490878,0.0001310629,0.00030270763,0.000015673568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04860182,0.00020803293,0.9439948,0.000034448913,0.0032560136,0.000006370903,0.000056437722,0.0000092925775,0.00015497916,0.00013496575,0.00049380265,0.0030490411],"study_design_scores_gemma":[0.15883753,0.016302789,0.81637055,0.00010744611,0.005188469,1.08779034e-7,0.000024019719,0.00009577925,0.001027087,0.00006573517,0.001787992,0.0001925192],"about_ca_topic_score_codex":0.00010323736,"about_ca_topic_score_gemma":0.00020127543,"teacher_disagreement_score":0.12762426,"about_ca_system_score_codex":0.000058786805,"about_ca_system_score_gemma":0.000023951998,"threshold_uncertainty_score":0.6975075},"labels":[],"label_agreement":null},{"id":"W2597545061","doi":"10.1016/s2213-8587(17)30104-3","title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":528,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Cilag; Medical Research Council; National Health and Medical Research Council; Michigan Diabetes Research Center, University of Michigan; Servier; AstraZeneca Australia; Monash University; Novartis Australia; Novo Nordisk; National Institute for Health and Care Research; Intarcia Therapeutics; Amgen Australia; Office of Research and Development; Sanofi; GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; McMaster University; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Diabetic retinopathy; Diabetes mellitus; Meta-analysis; Randomized controlled trial; Retinopathy; Nephropathy; Type 1 diabetes; Internal medicine; Type 2 diabetes; Kidney disease; Endocrinology","score_opus":0.2610826419163918,"score_gpt":0.41161466678297365,"score_spread":0.15053202486658185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597545061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17377639,0.8164927,4.1872823e-7,0.00009906685,0.000110416506,0.0066540106,0.0028444773,0.000013229281,0.00000929152],"genre_scores_gemma":[0.2263962,0.7667596,0.000033764336,0.00076523214,0.00008981309,0.0016011681,0.004258986,0.00007340035,0.000021846865],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99230504,0.0034497587,0.0020223414,0.00073976774,0.00054511,0.000937954],"domain_scores_gemma":[0.97851604,0.014933685,0.0031283868,0.0028865295,0.0004216816,0.00011370322],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0018013843,0.00074707525,0.03579466,0.0005017676,0.000046125762,0.000026586533,0.0011833617,0.00018504611,0.00008391591],"category_scores_gemma":[0.013632656,0.0003109096,0.0043652323,0.00029101837,0.00033373828,0.00004750635,0.00026691591,0.00038745668,0.000013403465],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01048592,0.0010350496,0.032083638,0.0020509807,0.9349487,0.00006404546,0.000036951707,0.0000028919794,0.0000038306207,0.0000071107484,0.000077401004,0.019203486],"study_design_scores_gemma":[0.120536916,0.0009972953,0.040345296,0.0010817022,0.83485395,1.7020949e-7,0.0000063178695,0.000009690116,0.000033866017,0.0000146294715,0.0019110313,0.00020915526],"about_ca_topic_score_codex":0.00009076464,"about_ca_topic_score_gemma":0.000018846924,"teacher_disagreement_score":0.110051,"about_ca_system_score_codex":0.00003104279,"about_ca_system_score_gemma":0.00016837698,"threshold_uncertainty_score":0.9999343},"labels":[],"label_agreement":null},{"id":"W2604761574","doi":"10.1016/s2213-8587(17)30102-x","title":"Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Guideline; Statement (logic); Heart failure; MEDLINE; Intensive care medicine; Cardiology; Epistemology; Pathology; Law","score_opus":0.034596081187273496,"score_gpt":0.30894695214025825,"score_spread":0.27435087095298477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604761574","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050283846,0.00063134276,0.00000700686,0.94175047,0.0020378954,0.001569929,0.00012405717,0.00020719628,0.003388268],"genre_scores_gemma":[0.008718145,0.00016567709,0.0011414982,0.93072736,0.0051366105,0.00048808986,0.0010999768,0.00008885285,0.052433763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963071,0.00013395188,0.0004793735,0.00084908993,0.00037969003,0.0018508431],"domain_scores_gemma":[0.99738187,0.00018582559,0.00023284095,0.0019180216,0.00014370384,0.0001377379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044915755,0.0005196804,0.0011478739,0.00041726494,0.0005428788,0.00026312526,0.0005174288,0.00021434863,0.00020160191],"category_scores_gemma":[0.00014129856,0.00034437948,0.000162838,0.00013869155,0.00038186964,0.0000679646,0.0003435099,0.0009743825,0.00073033327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036732647,0.00007842614,0.00100056,0.00008073366,0.0004807368,0.00009693574,0.000053263517,0.000003569148,0.00042435594,0.00010452741,0.98932403,0.00831612],"study_design_scores_gemma":[0.0015638927,0.00095345546,0.0011388821,0.00026049,0.00056547014,0.000009469481,0.000045595458,0.000016892145,0.0010666364,0.00039216212,0.9936784,0.00030863823],"about_ca_topic_score_codex":0.000078968056,"about_ca_topic_score_gemma":0.000045413402,"teacher_disagreement_score":0.049045492,"about_ca_system_score_codex":0.00016271207,"about_ca_system_score_gemma":0.000088506116,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W2607067254","doi":"10.1016/s2213-8587(17)30114-6","title":"Analysis of the MAVIDOS trial","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Placebo; Vitamin D and neurology; Pediatrics; Pregnancy; Gestational diabetes; Clinical trial; Randomized controlled trial; Offspring; Gestation; Cholecalciferol; Gestational age; Internal medicine; Alternative medicine","score_opus":0.048576371339355016,"score_gpt":0.3237987000983701,"score_spread":0.2752223287590151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607067254","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.428582,0.005058165,6.539365e-7,0.5566812,0.00089623185,0.00092416734,0.00023561617,0.000040682156,0.007581273],"genre_scores_gemma":[0.5382608,0.000714882,0.000023928877,0.44334167,0.005693094,0.0003461813,0.00056053157,0.00006688828,0.010991981],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767846,0.00023396914,0.00034674982,0.0003766464,0.0002968381,0.0010673298],"domain_scores_gemma":[0.9965924,0.00028971012,0.0005263618,0.002501195,0.00006207822,0.000028256633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000146825,0.00031680026,0.0017458644,0.00018243346,0.00017836977,0.000021345788,0.0009717292,0.0003249261,0.00008398822],"category_scores_gemma":[0.00016935005,0.00015453016,0.00078382046,0.00023638166,0.0005501657,0.000021050078,0.00022668067,0.0011398393,0.00005668646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079787144,0.000095508774,0.07504298,0.000026204814,0.009731076,0.0001316245,0.000046242312,0.0000020182167,0.000057442776,0.000053844826,0.91338587,0.0006293219],"study_design_scores_gemma":[0.029497145,0.00038708554,0.07527119,0.000027915306,0.018311087,0.00001308046,0.0000072986136,0.00003694469,0.0003464775,0.00052694394,0.87535757,0.00021723477],"about_ca_topic_score_codex":0.00010210563,"about_ca_topic_score_gemma":0.000025865456,"teacher_disagreement_score":0.113339536,"about_ca_system_score_codex":0.000041407027,"about_ca_system_score_gemma":0.00009192529,"threshold_uncertainty_score":0.6301557},"labels":[],"label_agreement":null},{"id":"W2610389201","doi":"10.1016/s2213-8587(17)30150-x","title":"PCSK9 inhibitors: smooth sailing or a little turbulence ahead?","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Scopus; Web of science; Internal medicine; MEDLINE; Meta-analysis","score_opus":0.04458113329424931,"score_gpt":0.313264644494611,"score_spread":0.2686835112003617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610389201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741386,0.0037141028,0.000021084275,0.015841331,0.0006919744,0.0005776674,0.000016067357,0.00016351261,0.0048356233],"genre_scores_gemma":[0.991188,0.000895253,0.0005265754,0.0028475518,0.0035087764,0.0001141508,0.00000920919,0.000035632,0.0008748597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974972,0.0001398838,0.0002762953,0.00039090248,0.00028659814,0.0014090913],"domain_scores_gemma":[0.9972239,0.00012247694,0.00016540725,0.0022732264,0.0000789761,0.00013602241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075232226,0.00021703134,0.0007865012,0.000054808945,0.0005248227,0.00007447924,0.00057736895,0.0001011034,0.00013775768],"category_scores_gemma":[0.0005789065,0.00012590481,0.00021466755,0.00007395255,0.00038371602,0.00010299866,0.00027676325,0.0005179714,0.00014790893],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007209186,0.00029781566,0.21619901,0.0010261455,0.001166644,0.00071102055,0.00078331085,0.000013515921,0.0091939345,0.004053282,0.014171284,0.7516631],"study_design_scores_gemma":[0.006600157,0.0010041612,0.28707367,0.0006288139,0.0004583548,0.0003540118,0.00021532648,0.00026405742,0.03928078,0.0022739645,0.6612858,0.0005608964],"about_ca_topic_score_codex":0.00028909405,"about_ca_topic_score_gemma":0.00006540016,"teacher_disagreement_score":0.7511022,"about_ca_system_score_codex":0.000063059386,"about_ca_system_score_gemma":0.00014293233,"threshold_uncertainty_score":0.51342493},"labels":[],"label_agreement":null},{"id":"W2614965600","doi":"10.1016/s2213-8587(17)30168-7","title":"Exercise and physical activity in patients with type 1 diabetes – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; York University; LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Glycemic; Type 2 diabetes; Diabetes mellitus; Population; Scopus; MEDLINE; Type 1 diabetes; Diabetes management; Physical therapy; Gerontology; Internal medicine; Endocrinology","score_opus":0.027936576885833907,"score_gpt":0.2957409080603756,"score_spread":0.2678043311745417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614965600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78531367,0.00045844133,6.350448e-8,0.21099554,0.00029212647,0.0009639139,0.000025554653,0.00008024308,0.0018704373],"genre_scores_gemma":[0.8684974,0.0003896279,0.000060715476,0.1154286,0.004429472,0.00032241124,0.0004078471,0.0001826962,0.010281271],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99609214,0.00023015281,0.00018775935,0.0007578098,0.00049478206,0.002237346],"domain_scores_gemma":[0.9975842,0.0003402779,0.00022877996,0.0016276403,0.00012854247,0.0000905434],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034178694,0.0004801858,0.0015185758,0.00027960102,0.00019338778,0.0001049339,0.00068310846,0.00028180127,0.000047424608],"category_scores_gemma":[0.00020370647,0.00028862065,0.000097092256,0.00018549945,0.00087335124,0.00013150668,0.0005790501,0.0027616837,0.00011448973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023634959,0.00022203197,0.45324847,0.0006911572,0.00035307984,0.00014679803,0.000055544853,3.6649757e-7,0.00004347563,0.000015689287,0.50967264,0.035314374],"study_design_scores_gemma":[0.0034710548,0.0010211441,0.6380596,0.00076960295,0.0004549816,5.597072e-7,0.000004661206,0.00008551471,0.00036753432,0.00045297798,0.35486686,0.0004454707],"about_ca_topic_score_codex":0.000019031486,"about_ca_topic_score_gemma":0.0000033247532,"teacher_disagreement_score":0.18481116,"about_ca_system_score_codex":0.00006408263,"about_ca_system_score_gemma":0.00005909858,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W2615150331","doi":"10.1016/s2213-8587(17)30167-5","title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":457,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Artificial pancreas; Meta-analysis; Randomized controlled trial; Insulin; Diabetes mellitus; Internal medicine; Crossover study; Type 1 diabetes; Glucagon; MEDLINE; Hypoglycemia; Clinical trial; Endocrinology; Placebo; Pathology","score_opus":0.12174633569873759,"score_gpt":0.39376914580437467,"score_spread":0.27202281010563706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615150331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060013025,0.96140355,5.366187e-7,0.000092573086,0.000119731834,0.03196749,0.00023487434,0.000022092914,0.00015782287],"genre_scores_gemma":[0.035082746,0.95738477,0.0000025976715,0.00020644657,0.00007492233,0.006689835,0.00025158274,0.0000695627,0.00023755946],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.982442,0.011595924,0.0034924638,0.00061362324,0.00073820597,0.0011177739],"domain_scores_gemma":[0.9773786,0.015559897,0.004703655,0.0019172376,0.00033692483,0.000103695944],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.014478781,0.00080947217,0.059086777,0.0010657267,0.00006620842,0.000043646687,0.00070739794,0.0002244094,0.00006447771],"category_scores_gemma":[0.010852277,0.00031958526,0.0033180073,0.0006745253,0.00038152063,0.000041851148,0.0001287555,0.0006020301,0.000016045044],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044033085,0.00022251563,0.0010566522,0.6226419,0.3677686,0.000005138849,0.0000084462745,0.0000043770815,5.9545874e-7,0.000051391984,0.0000850994,0.0037519578],"study_design_scores_gemma":[0.0362229,0.0034265434,0.000068092006,0.052708376,0.9063017,2.280759e-7,0.0000022175664,0.00007243265,0.0000023107834,0.0000029092437,0.0009480068,0.0002443294],"about_ca_topic_score_codex":0.000012046621,"about_ca_topic_score_gemma":0.0000028582476,"teacher_disagreement_score":0.56993353,"about_ca_system_score_codex":0.00007655095,"about_ca_system_score_gemma":0.000091045295,"threshold_uncertainty_score":0.9999256},"labels":[],"label_agreement":null},{"id":"W2618542302","doi":"10.1016/s2213-8587(17)30096-7","title":"Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université Laval; Université de Montréal; Western University; University of Ottawa","funders":"National Institute of General Medical Sciences; British Heart Foundation; National Institute of Nursing Research; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Hazard ratio; Diabetes mellitus; Single-nucleotide polymorphism; Proportional hazards model; Population; Cardiology; Lipoprotein; Blood pressure; Lipoprotein(a); Coronary artery disease; Cholesterol; Endocrinology; Genotype; Genetics; Confidence interval; Biology","score_opus":0.011135084700190754,"score_gpt":0.25313532937448807,"score_spread":0.24200024467429732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618542302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931251,0.0020284327,0.000028740546,0.0024203483,0.00003348246,0.0022400757,0.00007524969,0.000014171708,0.00003443631],"genre_scores_gemma":[0.9991511,0.00018744415,0.00019544586,0.00016084345,0.00008647586,0.00017798481,0.000018898052,0.000013393979,0.0000084150515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799055,0.0007248623,0.0002859684,0.00025986062,0.00031156765,0.0004271777],"domain_scores_gemma":[0.99841124,0.00018541809,0.00028699203,0.00094707846,0.00009517608,0.000074085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070600415,0.0001318451,0.0005780152,0.00003510356,0.00028824143,0.000039178925,0.00014650915,0.000046069654,0.000005192089],"category_scores_gemma":[0.000532723,0.00007779934,0.00004916758,0.00006852469,0.0003092184,0.000065369815,0.00010796684,0.00026827527,7.180927e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014174939,0.00010094657,0.9968803,0.00003486563,0.0004901334,0.000009679382,0.0001336286,0.000014364787,0.00000911111,0.00013709565,0.000012420038,0.002035732],"study_design_scores_gemma":[0.00814386,0.0002928014,0.9895805,0.000032286593,0.0009606485,0.000001378866,0.000037127633,0.000057969723,0.000018977678,0.0007564311,0.00003925279,0.000078775614],"about_ca_topic_score_codex":0.0009305955,"about_ca_topic_score_gemma":0.00015009803,"teacher_disagreement_score":0.008002111,"about_ca_system_score_codex":0.000045116907,"about_ca_system_score_gemma":0.000077013676,"threshold_uncertainty_score":0.3172565},"labels":[],"label_agreement":null},{"id":"W2619448414","doi":"10.1016/s2213-8587(17)30138-9","title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"","keywords":"Denosumab; Medicine; Placebo; Osteoporosis; Adverse effect; Incidence (geometry); Femoral neck; Randomized controlled trial; Bristol-Myers; Clinical endpoint; Physical therapy; Internal medicine; Surgery; Alternative medicine","score_opus":0.07123181860959384,"score_gpt":0.3673927548464625,"score_spread":0.2961609362368687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619448414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866119,0.0017921462,9.932026e-8,0.007887684,0.0001029982,0.0028835866,0.00020035631,0.000018442628,0.00050277164],"genre_scores_gemma":[0.9968911,0.0011547871,0.00015427746,0.0005259043,0.00029132716,0.0005409337,0.00005995588,0.000024219502,0.0003574883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743176,0.0003678624,0.0004704402,0.00042203002,0.00023803128,0.001069857],"domain_scores_gemma":[0.9966684,0.0013405943,0.00032297816,0.0014378115,0.000081299775,0.00014890662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009505388,0.00020057225,0.0010461342,0.000060460807,0.0002615179,0.00007455894,0.0006127743,0.00008490757,0.00008895264],"category_scores_gemma":[0.0009142271,0.000103707054,0.000023974639,0.00007715978,0.00064653065,0.000092643844,0.00030789833,0.00030213775,0.000023130102],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8322208,0.0014330941,0.0050210403,0.00003074934,0.00029692808,0.00013716244,0.0020849507,0.000001050919,0.0086992895,0.000029450943,0.0017106015,0.14833488],"study_design_scores_gemma":[0.85780513,0.018832114,0.114256434,0.00012874014,0.0001411428,0.000014972893,0.0005290114,0.000066949295,0.0020115627,0.00016593648,0.0059102084,0.00013779958],"about_ca_topic_score_codex":0.0027460384,"about_ca_topic_score_gemma":0.00062155083,"teacher_disagreement_score":0.14819707,"about_ca_system_score_codex":0.00010244823,"about_ca_system_score_gemma":0.00024604003,"threshold_uncertainty_score":0.4229051},"labels":[],"label_agreement":null},{"id":"W2624031057","doi":"10.1016/s2213-8587(17)30194-8","title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Joseph's Health Care","funders":"British Heart Foundation; Steno Diabetes Center Copenhagen","keywords":"Medicine; Metformin; Type 2 diabetes; Placebo; Diabetes mellitus; Internal medicine; Randomized controlled trial; MEDLINE; Endocrinology; Alternative medicine","score_opus":0.02280929518301,"score_gpt":0.28236733182863816,"score_spread":0.25955803664562815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624031057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98082495,0.008705706,9.827331e-7,0.00035815072,0.00035281814,0.0073483894,0.0000023862324,0.000034297966,0.0023723424],"genre_scores_gemma":[0.997683,0.00056182913,0.00009927111,0.00011788054,0.0002877388,0.0008045593,0.000015059638,0.000035383666,0.00039529282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972082,0.00030778107,0.00039331938,0.00039257374,0.00045496435,0.0012431896],"domain_scores_gemma":[0.9975941,0.0006325956,0.00025342248,0.0012830086,0.00014051927,0.00009636529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013827033,0.0002921737,0.0022544547,0.00028094748,0.00016696213,0.000055536548,0.0005144975,0.000095194424,0.000022700813],"category_scores_gemma":[0.0007101814,0.00016261624,0.00026837498,0.00017235665,0.00051773345,0.00013955466,0.00031019887,0.0003736958,0.000015539654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.747666,0.00036078284,0.22238734,0.00045275423,0.00518563,0.000043557306,0.00006703002,0.00000861095,0.00021401729,0.00044717282,0.00012344589,0.02304367],"study_design_scores_gemma":[0.9151029,0.0012752253,0.076439545,0.00011509311,0.0015235659,6.6016827e-7,0.000008355021,0.0000686449,0.0032690265,0.00015105163,0.0018692648,0.00017669387],"about_ca_topic_score_codex":0.00002583857,"about_ca_topic_score_gemma":0.000008892324,"teacher_disagreement_score":0.16743688,"about_ca_system_score_codex":0.000020247391,"about_ca_system_score_gemma":0.000049004644,"threshold_uncertainty_score":0.6631298},"labels":[],"label_agreement":null},{"id":"W2733849831","doi":"10.1016/s2213-8587(17)30182-1","title":"Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital","funders":"Sanofi","keywords":"Empagliflozin; Medicine; Albuminuria; Microalbuminuria; Type 2 diabetes; Placebo; Internal medicine; Diabetes mellitus; Creatinine; Renal function; Endocrinology","score_opus":0.016893468684284544,"score_gpt":0.25567587485054005,"score_spread":0.2387824061662555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733849831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906919,0.0013281488,0.0000034266595,0.0014928343,0.00020543886,0.006031941,0.00002500873,0.000040267976,0.00018101367],"genre_scores_gemma":[0.9972658,0.000103432496,0.000034997556,0.00093857525,0.0002714014,0.0011764339,0.000093267045,0.00003365734,0.00008242691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697125,0.0008226014,0.00045386393,0.00050381554,0.00044279272,0.0008056889],"domain_scores_gemma":[0.9948871,0.0024491798,0.00030106067,0.0021179672,0.000100881465,0.0001437729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011809157,0.0003770037,0.0018570697,0.00020214339,0.0002776385,0.00008532364,0.00060810597,0.00005619669,0.000029284345],"category_scores_gemma":[0.0012699617,0.00016815691,0.00033009527,0.00027626895,0.0003526722,0.0001425078,0.00023936987,0.00025255638,0.000008609802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18119979,0.0006039678,0.80548525,0.000044668956,0.00997489,0.000028787294,0.00038266156,0.000088034416,0.000045353412,0.00007877057,0.00018205818,0.0018857481],"study_design_scores_gemma":[0.31206465,0.0018885648,0.6768412,0.000066893765,0.008106375,3.716352e-8,0.00007889896,0.00013895945,0.00040399667,0.000049252598,0.00020206854,0.00015909655],"about_ca_topic_score_codex":0.000049107424,"about_ca_topic_score_gemma":0.00004849812,"teacher_disagreement_score":0.13086487,"about_ca_system_score_codex":0.00004487362,"about_ca_system_score_gemma":0.00003588038,"threshold_uncertainty_score":0.68572396},"labels":[],"label_agreement":null},{"id":"W2736904519","doi":"10.1016/s2213-8587(17)30185-7","title":"Microvascular outcomes in type 2 diabetes – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Albuminuria; Type 2 diabetes; Nephropathy; Intensive care medicine; Kidney disease; Surrogate endpoint; Diabetic retinopathy; Retinopathy; Clinical endpoint; Diabetes mellitus; Internal medicine; Clinical trial; MEDLINE; Disease; Endocrinology","score_opus":0.031162459331585412,"score_gpt":0.29277410673987814,"score_spread":0.26161164740829274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736904519","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3518066,0.0027370595,2.6375042e-7,0.64103866,0.0012525193,0.0007597127,0.000036527246,0.0001859631,0.002182658],"genre_scores_gemma":[0.05168298,0.0005348426,0.00015291863,0.9321527,0.004948488,0.0003578955,0.00052628014,0.00014796802,0.009495944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501204,0.0003895615,0.00056020904,0.0009009269,0.0004062424,0.002731029],"domain_scores_gemma":[0.99584836,0.00025343293,0.00032556208,0.0033863292,0.00009012225,0.000096223135],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048916123,0.000654702,0.0021456538,0.0002910773,0.00018369663,0.0001007544,0.0013687967,0.00038693662,0.00035069327],"category_scores_gemma":[0.00043246552,0.00044675794,0.00041425234,0.00014453725,0.00051085197,0.00008619408,0.000619143,0.0024179574,0.00062737934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024887708,0.000063443935,0.22014819,0.00038263027,0.000959461,0.0015698982,0.00004274061,0.0000012231415,0.00025269116,0.000026262998,0.77393824,0.0025903375],"study_design_scores_gemma":[0.0014180595,0.0001717286,0.15466803,0.00019722938,0.0005158505,0.000016667756,0.0000066220337,0.000022571876,0.00027060756,0.00070940837,0.84160376,0.00039947458],"about_ca_topic_score_codex":0.00006891714,"about_ca_topic_score_gemma":0.000019857098,"teacher_disagreement_score":0.30012363,"about_ca_system_score_codex":0.00018041994,"about_ca_system_score_gemma":0.00009005472,"threshold_uncertainty_score":0.99988353},"labels":[],"label_agreement":null},{"id":"W2744253559","doi":"10.1016/s2213-8587(17)30259-0","title":"SGLT2 inhibitors in the real world: too good to be true?","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Empagliflozin; Medicine; Type 2 diabetes; Diabetes mellitus; Disease; Internal medicine; Incidence (geometry); Endocrinology","score_opus":0.04354202120162847,"score_gpt":0.307080378171915,"score_spread":0.26353835697028655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744253559","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08855051,0.0006250155,1.9453446e-7,0.80636567,0.0010861743,0.0016913433,0.000056339042,0.00013864292,0.10148613],"genre_scores_gemma":[0.06082345,0.00046336162,0.000110192464,0.89324963,0.010106417,0.0011668279,0.00051056955,0.00010742593,0.033462122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953441,0.00035307877,0.00048406303,0.00073402084,0.00049693894,0.0025877745],"domain_scores_gemma":[0.9962971,0.0005829563,0.0002709163,0.0027267167,0.00004703594,0.000075252894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005766922,0.00062487694,0.0014616225,0.00049286574,0.00021901191,0.00013558575,0.0016211368,0.00028281278,0.00012583694],"category_scores_gemma":[0.0001301668,0.00035343654,0.00028005108,0.00030216758,0.00033141422,0.000075086864,0.00050478044,0.0019848994,0.0003857417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039058872,0.00009329036,0.030527832,0.00014503306,0.0005075146,0.0011167296,0.00033995984,8.2879154e-7,0.000035935886,0.0011955632,0.95445675,0.0115414895],"study_design_scores_gemma":[0.0018110032,0.00041848153,0.030263383,0.00016737191,0.0006148755,0.000009864751,0.000055941047,0.0000020703037,0.00022316512,0.0007096956,0.9653848,0.00033934115],"about_ca_topic_score_codex":0.000266665,"about_ca_topic_score_gemma":0.00047768615,"teacher_disagreement_score":0.086883985,"about_ca_system_score_codex":0.00019578334,"about_ca_system_score_gemma":0.000067252004,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W2747783283","doi":"10.1016/s2213-8587(17)30237-1","title":"Meta-analysis of artificial pancreas trials: methodological considerations – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Diabetes Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Scopus; Meta-analysis; Glycemic; Jadad scale; MEDLINE; Internal medicine; Insulin","score_opus":0.49641959484225107,"score_gpt":0.44354854570963775,"score_spread":0.05287104913261331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747783283","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01608574,0.0055603473,0.00013208156,0.9716429,0.0010143333,0.0010911649,0.0012048119,0.00013326255,0.003135369],"genre_scores_gemma":[0.11320795,0.00044697168,0.0035613375,0.8695509,0.00795807,0.0007830545,0.0014214986,0.000083239436,0.0029869878],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99142015,0.0038059985,0.0018227027,0.0008450602,0.00054516713,0.0015609],"domain_scores_gemma":[0.98212534,0.013702376,0.0011371389,0.0024691266,0.0004477989,0.000118197175],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004145933,0.0005739182,0.010504444,0.00042373844,0.00036340466,0.0000780259,0.0006085932,0.00084697705,0.0030656033],"category_scores_gemma":[0.015053438,0.00031864733,0.0042498256,0.00022448921,0.0011623505,0.000047457946,0.00020454527,0.0024557626,0.000043265412],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000385379,0.00013189173,0.0011875425,0.00015304108,0.39766362,0.00072788855,0.00013343472,0.0000070950846,0.0006656523,0.0044751177,0.5934641,0.0010052954],"study_design_scores_gemma":[0.0011131143,0.0004263813,0.000597988,0.000016834578,0.5989671,0.00004958916,0.000014518278,0.00010859616,0.00043290606,0.014093511,0.3838643,0.00031518633],"about_ca_topic_score_codex":0.00014486237,"about_ca_topic_score_gemma":0.000017364395,"teacher_disagreement_score":0.20959973,"about_ca_system_score_codex":0.000036147925,"about_ca_system_score_gemma":0.00017464302,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2752623014","doi":"10.1016/s2213-8587(17)30283-8","title":"Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Ottawa; Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; Impact; McMaster University; Université Laval; Population Health Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Cholesterol; Polyunsaturated fatty acid; Nutrient; Saturated fat; Polyunsaturated fat; Blood pressure; Blood lipids; Internal medicine; Saturated fatty acid; Apolipoprotein B; Food science; Endocrinology; Environmental health; Physiology; Fatty acid; Biology; Biochemistry","score_opus":0.024481405792437447,"score_gpt":0.2982653175784135,"score_spread":0.27378391178597605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752623014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104995,0.0031499986,3.8254095e-7,0.0047570746,0.00008387342,0.00041600765,0.0003011621,0.000016167542,0.00022540007],"genre_scores_gemma":[0.9981964,0.00068863406,0.000031849275,0.00037025576,0.00043263705,0.0000891531,0.000041780924,0.000008256024,0.0001410141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986233,0.000109434586,0.00024535327,0.00027051964,0.00030101993,0.00045033777],"domain_scores_gemma":[0.9984488,0.00057152874,0.0002800898,0.00051420485,0.00015603339,0.000029357245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034719592,0.00013870743,0.00060620165,0.00004827874,0.00039885737,0.0000538468,0.00026269507,0.00006240589,0.00006463658],"category_scores_gemma":[0.0002044137,0.000076705815,0.00007337956,0.0001319416,0.00031842457,0.000056708646,0.00017255108,0.00025717585,0.0000014952117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035140716,0.00057849183,0.9882009,0.000028932876,0.009975655,0.000012531302,0.00022754003,0.000009372102,0.00007057781,0.000110716246,0.00040580996,0.000028046545],"study_design_scores_gemma":[0.006394588,0.00054988504,0.9848047,0.00002331584,0.005744519,0.000002587596,0.00017596029,0.000015043288,0.00012213468,0.00042173563,0.0016689763,0.00007657557],"about_ca_topic_score_codex":0.0005337068,"about_ca_topic_score_gemma":0.0011115158,"teacher_disagreement_score":0.0071464865,"about_ca_system_score_codex":0.000014012182,"about_ca_system_score_gemma":0.000020717565,"threshold_uncertainty_score":0.31279725},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2754562397","doi":"10.1016/s2213-8587(17)30313-3","title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Amgen","keywords":"Medicine; Evolocumab; PCSK9; Internal medicine; Diabetes mellitus; Type 2 diabetes; Clinical endpoint; Myocardial infarction; Stroke (engine); Cardiology; Endocrinology; Clinical trial; Cholesterol; Lipoprotein","score_opus":0.007369601405536356,"score_gpt":0.23838794260371504,"score_spread":0.23101834119817868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754562397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867901,0.0064415857,0.0000015437739,0.0003826096,0.00010410178,0.00613515,0.00007696363,0.0000075761986,0.00006034244],"genre_scores_gemma":[0.9987324,0.00087888533,0.000019356447,0.000046575995,0.00011312716,0.00017085961,0.0000042191405,0.000022681423,0.000011915483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952999,0.002329172,0.0007350509,0.00041545197,0.00065090484,0.0005695506],"domain_scores_gemma":[0.99410635,0.0023511548,0.00094573153,0.002397271,0.00012273189,0.00007673099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036212448,0.00033346566,0.0038056846,0.00014344661,0.00023537513,0.000020345742,0.00038913524,0.00013087358,0.0000032784062],"category_scores_gemma":[0.0032222413,0.00012910014,0.0007185828,0.00025250603,0.002091504,0.000050425984,0.00031505522,0.0004327233,5.4040196e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17866972,0.000064714564,0.80035913,0.00019172968,0.011772489,2.7499843e-7,0.00035626013,0.000041119027,0.00006154458,0.000031934287,0.0000080884865,0.008442989],"study_design_scores_gemma":[0.39841646,0.001150967,0.5894805,0.0001755014,0.008054108,5.8408585e-7,0.000019506637,0.00022923526,0.0023194398,0.00004555184,0.000028258226,0.000079847865],"about_ca_topic_score_codex":0.0003504481,"about_ca_topic_score_gemma":0.0000678331,"teacher_disagreement_score":0.21974674,"about_ca_system_score_codex":0.000025460098,"about_ca_system_score_gemma":0.00007711291,"threshold_uncertainty_score":0.7706233},"labels":[],"label_agreement":null},{"id":"W2756152366","doi":"10.1016/s2213-8587(17)30309-1","title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"National Institute for Health and Care Research; Bayer","keywords":"Acarbose; Medicine; Diabetes mellitus; Placebo; Impaired glucose tolerance; Internal medicine; Coronary heart disease; Double blind; Type 2 diabetes; Cardiology; Impaired fasting glucose; Randomized controlled trial; Clinical trial; Endocrinology; Alternative medicine","score_opus":0.013756135652715646,"score_gpt":0.25266708870099563,"score_spread":0.23891095304828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756152366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853075,0.0037115165,2.1615354e-7,0.0013789788,0.00020328774,0.00920263,0.000011033507,0.000046388213,0.0001384154],"genre_scores_gemma":[0.99696124,0.00029699365,0.000033753702,0.0005012715,0.00011139144,0.001966745,0.000017711776,0.000032074906,0.00007881575],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99777937,0.00022770894,0.00034209914,0.00046788104,0.00029736728,0.00088556437],"domain_scores_gemma":[0.9979148,0.0006887176,0.00021189735,0.000989172,0.00004487167,0.00015056373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039601658,0.00037193974,0.0020934592,0.00014071072,0.00015615589,0.000044679993,0.00022868555,0.00006335925,0.0000043330674],"category_scores_gemma":[0.00023712458,0.00021714489,0.00023916589,0.000051253868,0.00040582105,0.00011724264,0.00019445272,0.00020418847,0.00000312318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44643757,0.00049395417,0.5486923,0.00019021558,0.0018560127,0.000027615915,0.00003794864,0.000007581889,0.000038832204,0.00005554641,0.000029039951,0.002133437],"study_design_scores_gemma":[0.5138395,0.0013929307,0.48278117,0.000119453056,0.0011972833,1.8156092e-7,0.0000037804946,0.000029409086,0.00040906842,0.00005564919,0.00005463288,0.0001169482],"about_ca_topic_score_codex":0.000018587118,"about_ca_topic_score_gemma":0.00000513058,"teacher_disagreement_score":0.06740192,"about_ca_system_score_codex":0.00003760421,"about_ca_system_score_gemma":0.000028947563,"threshold_uncertainty_score":0.88549113},"labels":[],"label_agreement":null},{"id":"W2761192596","doi":"10.1016/s2213-8587(17)30307-8","title":"Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":289,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Medical Research Council; National Institutes of Health; Högskolan Dalarna; Institut National de la Santé et de la Recherche Médicale; Karolinska Institutet; University of New South Wales; Cancer Research UK; University of South Dakota; National Institute for Health and Care Research; University of Washington; AstraZeneca","keywords":"Pooled analysis; Prospective cohort study; Meta-analysis; Cohort study; Cohort; MEDLINE","score_opus":0.10343932015572402,"score_gpt":0.3745042622548038,"score_spread":0.27106494209907983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761192596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97846437,0.009120237,0.000020227732,0.0060871555,0.00052918954,0.0011513414,0.004502938,0.000057820012,0.000066754605],"genre_scores_gemma":[0.9946597,0.001477944,0.0017955052,0.00064754416,0.0003070655,0.00016932655,0.0009038885,0.000030291587,0.000008689767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965506,0.00030125972,0.00047069605,0.00077870995,0.00037054453,0.0015281799],"domain_scores_gemma":[0.99545974,0.0012444312,0.00050412863,0.0023386085,0.00032231532,0.00013078967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012379405,0.0002954532,0.001381571,0.00028434355,0.0007142565,0.00011433328,0.0019428802,0.000110544504,0.000021397074],"category_scores_gemma":[0.0027836463,0.0002122868,0.000111355635,0.0003030178,0.0011214418,0.00028004462,0.0014343502,0.00035414583,0.000009051279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080378365,0.000081079685,0.9606416,0.00017035098,0.01394569,0.0000033156834,0.0008606136,0.0000020437924,0.00791376,0.000067262845,0.0038707564,0.011639723],"study_design_scores_gemma":[0.002326511,0.0004897092,0.95858985,0.000096666474,0.0029992608,4.2840486e-7,0.0005250471,0.00084897503,0.031622306,0.0019135593,0.00036524644,0.00022246012],"about_ca_topic_score_codex":0.0004175586,"about_ca_topic_score_gemma":0.0021373467,"teacher_disagreement_score":0.023708545,"about_ca_system_score_codex":0.000095213225,"about_ca_system_score_gemma":0.000060526447,"threshold_uncertainty_score":0.86568046},"labels":[],"label_agreement":null},{"id":"W2763024200","doi":"10.1016/s2213-8587(17)30326-1","title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pasireotide; Cushing's disease; Clinical endpoint; Mitotane; Internal medicine; Clinical trial; Surgery; Acromegaly; Urology; Gastroenterology; Pediatrics; Disease; Chemotherapy; Hormone; Growth hormone","score_opus":0.06566783101234006,"score_gpt":0.361381509051894,"score_spread":0.29571367803955395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763024200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679465,0.0022382382,7.6882213e-7,0.006111642,0.00026862454,0.0007267098,0.00004622766,0.000027204194,0.003785933],"genre_scores_gemma":[0.99765325,0.0013593774,0.00006457229,0.0003811191,0.00034523438,0.000046511126,0.0000296332,0.000012824434,0.00010746966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983643,0.00015535111,0.00041346654,0.00029470678,0.000118545846,0.0006535712],"domain_scores_gemma":[0.99833786,0.00044820434,0.00020177315,0.0008656229,0.000019542866,0.00012696293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003382192,0.00016249549,0.0008118572,0.00004484608,0.00014083466,0.000016745314,0.00028030973,0.000057344383,0.000019035295],"category_scores_gemma":[0.00079296646,0.00010121199,0.000105635,0.000027922033,0.00047084875,0.00006938948,0.0001702365,0.0002563592,0.000007844159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028599568,0.00056287047,0.938985,0.000033429074,0.00019156898,0.000125341,0.00006163917,0.0000024355804,0.000011502525,0.00070608355,0.0003586369,0.030361943],"study_design_scores_gemma":[0.09898076,0.0008489903,0.8945188,0.0000832824,0.00018670724,0.0000021439116,0.000014369498,0.000092408525,0.00002664559,0.0015600616,0.0036002514,0.000085602594],"about_ca_topic_score_codex":0.00017883745,"about_ca_topic_score_gemma":0.00020516188,"teacher_disagreement_score":0.070381194,"about_ca_system_score_codex":0.00001647007,"about_ca_system_score_gemma":0.0000590742,"threshold_uncertainty_score":0.41273052},"labels":[],"label_agreement":null},{"id":"W2773969925","doi":"10.1016/s2213-8587(17)30412-6","title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"AstraZeneca; National Heart, Lung, and Blood Institute; Amylin Pharmaceuticals","keywords":"Medicine; Semaglutide; Liraglutide; Lixisenatide; Exenatide; Glucagon-like peptide 1 receptor; Internal medicine; Type 2 diabetes; Placebo; Myocardial infarction; Dulaglutide; Meta-analysis; Adverse effect; Odds ratio; Stroke (engine); Hazard ratio; Diabetes mellitus; Agonist; Endocrinology; Receptor; Confidence interval","score_opus":0.09996280311863774,"score_gpt":0.32910575817358245,"score_spread":0.2291429550549447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773969925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009185346,0.9849399,0.0000011536468,0.0003984383,0.00028305073,0.003407278,0.00014089675,0.00015485699,0.0014891132],"genre_scores_gemma":[0.0034904212,0.9874777,0.00047692005,0.00081692595,0.0002222298,0.0021381082,0.0017693733,0.00021821311,0.0033901085],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941767,0.0005680486,0.0008390433,0.0012782553,0.0007786137,0.0023593665],"domain_scores_gemma":[0.9940426,0.00037125478,0.0007800676,0.004420499,0.00020835472,0.00017724858],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007120169,0.0012829925,0.014118143,0.0007729171,0.00020780711,0.00012897258,0.0011531537,0.00025166955,0.00023377221],"category_scores_gemma":[0.00011027114,0.000605634,0.0035931387,0.0009584652,0.0004623303,0.0001360484,0.00040821862,0.00079095125,0.00027189488],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006294604,0.00039169833,0.14898717,0.0031592443,0.6926251,0.00006996507,0.00003652316,0.000011076072,2.7117878e-8,0.000053985677,0.0011241052,0.15347818],"study_design_scores_gemma":[0.0017909735,0.000556257,0.011175849,0.00038436765,0.40110138,7.259871e-7,0.0000049331425,8.570919e-7,8.1713324e-7,0.0000063251327,0.584545,0.00043253612],"about_ca_topic_score_codex":0.000056287954,"about_ca_topic_score_gemma":0.00010198876,"teacher_disagreement_score":0.5834209,"about_ca_system_score_codex":0.00026026982,"about_ca_system_score_gemma":0.00017320873,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W2778968960","doi":"10.1016/s2213-8587(17)30403-5","title":"Questioning the safety and benefits of evolocumab – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Evolocumab; Intensive care medicine; Internal medicine","score_opus":0.24156564224394025,"score_gpt":0.38626011474150096,"score_spread":0.1446944724975607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778968960","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028334662,0.018847186,0.00003683756,0.9454879,0.0015478015,0.0006908546,0.00080140634,0.000068175854,0.0041851783],"genre_scores_gemma":[0.045726713,0.0032225056,0.0004730447,0.93679327,0.009733729,0.00025550587,0.0002101104,0.0001106399,0.0034744854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936918,0.0009789222,0.0030179212,0.000769524,0.00012561458,0.0014161952],"domain_scores_gemma":[0.989075,0.0036901585,0.004566729,0.0025190557,0.0000912,0.00005783798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01338297,0.0003738721,0.0023189513,0.00021076089,0.0007497707,0.00012898842,0.0014949361,0.00044753845,0.00014746153],"category_scores_gemma":[0.0059685055,0.00030449263,0.00017153897,0.00007827749,0.00078955985,0.0001936947,0.0003568433,0.0016396767,0.00035802193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013221683,0.000010017094,0.029860348,0.0004481597,0.00029581966,0.0000037653876,0.000601405,0.000054445925,4.517003e-7,0.0661864,0.9016774,0.00084851123],"study_design_scores_gemma":[0.0005311845,0.00007123806,0.038602903,0.00018887363,0.000044068205,0.000022135375,0.000051047376,0.00024258184,0.0000062193703,0.024267703,0.9356538,0.0003182339],"about_ca_topic_score_codex":0.00085511775,"about_ca_topic_score_gemma":0.0000655555,"teacher_disagreement_score":0.041918695,"about_ca_system_score_codex":0.00019388631,"about_ca_system_score_gemma":0.000104728606,"threshold_uncertainty_score":0.9999407},"labels":[],"label_agreement":null},{"id":"W2789044349","doi":"10.1016/s2213-8587(18)30025-1","title":"Do sulphonylureas still have a place in clinical practice?","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Collaboration for Leadership in Applied Health Research and Care - Greater Manchester; Merck Sharp and Dohme; National Institutes of Health; University of Leicester; Novo Nordisk; National Institute for Health and Care Research; Amgen; Boehringer Ingelheim; Merck; Sanofi; Loughborough University; AstraZeneca; Eli Lilly and Company; University Hospitals of Leicester NHS Trust","keywords":"Medicine; Observational study; Diabetes mellitus; Incidence (geometry); Internal medicine; Linagliptin; Clinical trial; Hypoglycemia; Type 2 diabetes; Intensive care medicine; Insulin; Endocrinology","score_opus":0.10339826261121242,"score_gpt":0.42102339555231955,"score_spread":0.3176251329411071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789044349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009128291,0.97250926,8.455746e-7,0.00259995,0.0009855592,0.0022899706,0.00004262771,0.00016489523,0.02049407],"genre_scores_gemma":[0.00017915767,0.99071383,0.0006149423,0.0025536993,0.0023594482,0.00064442854,0.00020817234,0.00010397646,0.0026223515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942459,0.0010178105,0.0013119142,0.00096303236,0.0003260292,0.0021353278],"domain_scores_gemma":[0.9944536,0.0027357393,0.0006977777,0.0018403119,0.00010759406,0.00016496118],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001784994,0.0007171341,0.0043464242,0.00032330654,0.00006000585,0.00005919095,0.0007711885,0.00040241648,0.00020312925],"category_scores_gemma":[0.0015170675,0.00043354806,0.00069327146,0.00034758408,0.0005318142,0.000097257005,0.00058036204,0.0013202403,0.0013424827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010076526,0.00059189403,0.003561248,0.0039362176,0.0024783956,0.0004920682,0.000081458114,1.3875719e-7,6.450585e-8,0.0014924626,0.047214966,0.9400503],"study_design_scores_gemma":[0.0023677873,0.00071732764,0.0006737153,0.0042555765,0.004841279,0.00007164378,0.00004644514,0.0000050248777,0.0000010598925,0.00020924237,0.9864488,0.000362064],"about_ca_topic_score_codex":0.000028409413,"about_ca_topic_score_gemma":0.00004062568,"teacher_disagreement_score":0.93968827,"about_ca_system_score_codex":0.00023857366,"about_ca_system_score_gemma":0.00024769243,"threshold_uncertainty_score":0.99981165},"labels":[],"label_agreement":null},{"id":"W2793842039","doi":"10.1016/s2213-8587(18)30070-6","title":"The many faces of diabetes: addressing heterogeneity of a complex disease","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; MEDLINE; Internal medicine; Endocrinology","score_opus":0.0383208575324413,"score_gpt":0.286053675948,"score_spread":0.24773281841555872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793842039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88812757,0.010207596,0.000004920322,0.09916853,0.00047836255,0.00044682238,0.0008999687,0.00003204572,0.000634163],"genre_scores_gemma":[0.86585444,0.0015825048,0.00006886053,0.12716357,0.0033107407,0.0001633416,0.001273474,0.000115694274,0.0004673455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962461,0.0005284168,0.0005870137,0.000556496,0.0002969726,0.0017849908],"domain_scores_gemma":[0.99721724,0.0002948122,0.0007783252,0.0014397192,0.0002057124,0.00006421288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040106793,0.00046379244,0.00092529756,0.00006228955,0.0002594815,0.00004667163,0.001610101,0.00038762923,0.000032234984],"category_scores_gemma":[0.00028338731,0.00029656946,0.00041675818,0.0001323982,0.0016493816,0.0000050591293,0.00062456477,0.0006017489,0.000012778084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005266405,0.000078511315,0.061819606,0.0004281486,0.0014912777,0.0000051776055,0.000033088374,0.0000148740355,0.045259923,0.0000656431,0.88771546,0.0030356343],"study_design_scores_gemma":[0.00089060515,0.0003626031,0.01765902,0.00015098667,0.00035575885,6.4287985e-7,0.000041529653,0.00007901994,0.04538583,0.000843292,0.9337391,0.0004915727],"about_ca_topic_score_codex":0.000012944894,"about_ca_topic_score_gemma":0.00002496219,"teacher_disagreement_score":0.046023685,"about_ca_system_score_codex":0.000017341237,"about_ca_system_score_gemma":0.00009650363,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W2795790792","doi":"10.1016/s2213-8587(18)30075-5","title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Amgen","keywords":"Medicine; Denosumab; Osteoporosis; Placebo; Bone mineral; Femoral neck; Glucocorticoid; Prednisone; Internal medicine; Physical therapy","score_opus":0.07859802049889092,"score_gpt":0.3810249539263167,"score_spread":0.30242693342742577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795790792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97746855,0.00061057153,0.000001416676,0.004404426,0.0013393232,0.01255781,0.000013297593,0.00016883318,0.003435801],"genre_scores_gemma":[0.9947191,0.00024155552,0.00007269116,0.0009465777,0.0010290167,0.002619887,0.000027683112,0.000079288584,0.0002641948],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928901,0.0006451081,0.001168892,0.0010002392,0.0007314597,0.0035642043],"domain_scores_gemma":[0.99586946,0.0013045329,0.0003878465,0.001598455,0.0004208651,0.0004188618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015562417,0.0005984201,0.0025379555,0.00045424732,0.00036118532,0.00008175396,0.00076482067,0.00026983037,0.00033347285],"category_scores_gemma":[0.0004442141,0.00042287848,0.00029981547,0.00075851084,0.00042539957,0.0002067784,0.00042643386,0.0015236649,0.0006824357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7999259,0.0018137543,0.17621498,0.00019124034,0.00085607363,0.0001555815,0.0026045383,0.0000059808654,0.008058518,0.00009621911,0.00024570007,0.009831505],"study_design_scores_gemma":[0.8219014,0.0044858363,0.15545858,0.00007680643,0.00050172926,0.000017806537,0.0022843538,0.0005917738,0.01321729,0.00002782338,0.0010331856,0.00040345217],"about_ca_topic_score_codex":0.0014141834,"about_ca_topic_score_gemma":0.004102399,"teacher_disagreement_score":0.02197546,"about_ca_system_score_codex":0.00041352422,"about_ca_system_score_gemma":0.00058288174,"threshold_uncertainty_score":0.9998223},"labels":[],"label_agreement":null},{"id":"W2797845698","doi":"10.1016/s2213-8587(18)30100-1","title":"Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Novartis","keywords":"Medicine; Enalapril; Renal function; Diabetes mellitus; Valsartan; Sacubitril; Internal medicine; Type 2 diabetes; Neprilysin; Nephropathy; Heart failure; Endocrinology; Urology; Gastroenterology; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.0067479420855913255,"score_gpt":0.22510474663847532,"score_spread":0.218356804552884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797845698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970416,0.00027354166,7.766983e-7,0.0014137524,0.00016191216,0.0010330111,0.000022496928,0.000013636644,0.000039269537],"genre_scores_gemma":[0.9996691,0.000009626372,0.00003368008,0.00007449634,0.00013992403,0.00002749717,0.000021856862,0.0000125144425,0.000011357526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981583,0.0005979357,0.00041529708,0.00022623736,0.00024249722,0.0003597602],"domain_scores_gemma":[0.99856687,0.000323652,0.00044019264,0.00054349814,0.00010282234,0.000022942953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046625233,0.00017730755,0.0010419987,0.00023418573,0.00005747085,0.000004334094,0.00009614863,0.00007071566,0.000016973076],"category_scores_gemma":[0.00012428344,0.00008370138,0.000158347,0.00079342903,0.00040218505,0.000042989963,0.00009258426,0.00018151823,7.4936304e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046902625,0.00011994115,0.9832882,0.00027709725,0.0013382692,4.8620757e-7,0.00017221105,0.00005672327,0.007952297,0.00007913454,0.001125521,0.0008998134],"study_design_scores_gemma":[0.012561032,0.0059701605,0.84798455,0.0010530617,0.0018777887,3.6639477e-7,0.000030360368,0.0000961898,0.12999237,0.000021359752,0.00033683926,0.00007594605],"about_ca_topic_score_codex":0.000048002796,"about_ca_topic_score_gemma":0.00017961756,"teacher_disagreement_score":0.13530372,"about_ca_system_score_codex":0.00006846022,"about_ca_system_score_gemma":0.000044248023,"threshold_uncertainty_score":0.3413243},"labels":[],"label_agreement":null},{"id":"W2800283810","doi":"10.1016/s2213-8587(18)30052-4","title":"Precision medicine in the management of type 2 diabetes","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Wellcome Trust","keywords":"Medicine; Type 2 diabetes; MEDLINE; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.06677750395896741,"score_gpt":0.3539323562698343,"score_spread":0.2871548523108669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800283810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030227469,0.97236294,5.6859926e-7,0.001728769,0.00066632184,0.0024471832,0.000013685756,0.000064528314,0.019693257],"genre_scores_gemma":[0.0011070978,0.9953525,0.00016160106,0.0008842972,0.0007699946,0.00048945687,0.00020660112,0.000058001988,0.0009704144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626553,0.00046107196,0.0008766406,0.0005505956,0.00042854663,0.0014175932],"domain_scores_gemma":[0.99692434,0.00073249073,0.0004372266,0.0017793128,0.00007358128,0.000053062427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012249893,0.00055978016,0.002980343,0.00034385835,0.00007085183,0.000015160622,0.0011890582,0.00016137704,0.00021523739],"category_scores_gemma":[0.00007368938,0.00025264287,0.00031358123,0.00085601374,0.0005830916,0.000039102,0.00044776473,0.00048200553,0.00024189721],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026879648,0.00023263862,0.001130529,0.016544849,0.002457944,0.00006580243,0.00013738,2.3352983e-7,0.000001227847,0.0039948914,0.028158335,0.9472493],"study_design_scores_gemma":[0.0012557334,0.00093921367,0.0012613296,0.013181922,0.005027286,0.000005921689,0.00007274782,0.000004939483,0.000008462194,0.0008872648,0.9771479,0.00020728513],"about_ca_topic_score_codex":0.000007871946,"about_ca_topic_score_gemma":0.000004549363,"teacher_disagreement_score":0.94898957,"about_ca_system_score_codex":0.000096554126,"about_ca_system_score_gemma":0.00003675663,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W2804433462","doi":"10.1016/s2213-8587(18)30107-4","title":"Islet transplantation in type 1 diabetes: moving forward","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Transplantation; Diabetes mellitus; Islet cell transplantation; Type 2 diabetes; Type 1 diabetes; Internal medicine; Hypoglycemia; Islet; Intensive care medicine; Endocrinology","score_opus":0.029577322396437344,"score_gpt":0.2753932574915545,"score_spread":0.24581593509511718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804433462","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58949983,0.0023523718,0.0000075109724,0.39562798,0.0017385241,0.0007011733,0.00008998219,0.00027134412,0.00971126],"genre_scores_gemma":[0.08667332,0.0017297459,0.00033578358,0.89417005,0.012679531,0.00026096797,0.0013857464,0.00014286306,0.0026219704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584925,0.0003313572,0.0005745893,0.00064127374,0.00032972122,0.0022738313],"domain_scores_gemma":[0.997666,0.0009080547,0.0002272721,0.0009842176,0.00013953696,0.00007493187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042952417,0.00051933294,0.001498044,0.00040045066,0.00010647167,0.000040347397,0.0004567959,0.00062065857,0.0007563566],"category_scores_gemma":[0.00036473497,0.00037560987,0.00019910237,0.00042720165,0.000401322,0.00008367479,0.000079056925,0.0019950825,0.000737456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115073526,0.000043476728,0.057547536,0.0008556902,0.00037414843,0.00023961393,0.00021247439,0.0000028185689,0.0022833147,0.00006249113,0.93608665,0.0021766992],"study_design_scores_gemma":[0.0033615418,0.0007508257,0.015840545,0.00067713636,0.00080211536,0.00004706677,0.000038865364,0.00026597278,0.007180309,0.0012986143,0.9691487,0.0005882918],"about_ca_topic_score_codex":0.000030807976,"about_ca_topic_score_gemma":0.000010544678,"teacher_disagreement_score":0.5028265,"about_ca_system_score_codex":0.00014148546,"about_ca_system_score_gemma":0.00012652155,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W2808220657","doi":"10.1016/s2213-8587(18)30125-6","title":"Dulaglutide and renal protection in type 2 diabetes","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Toronto General Hospital","funders":"Canadian Institutes of Health Research; University of Toronto; Juvenile Diabetes Research Foundation Canada","keywords":"Medicine; Dulaglutide; Type 2 diabetes; Insulin glargine; Kidney disease; Internal medicine; Diabetes mellitus; Renal function; Metformin; Insulin; Exenatide; Endocrinology","score_opus":0.030730179965765016,"score_gpt":0.2625737284194719,"score_spread":0.2318435484537069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808220657","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50004214,0.0030619514,9.4501206e-7,0.491327,0.0006870994,0.0013097244,0.000016104506,0.0001789003,0.00337612],"genre_scores_gemma":[0.17639436,0.0021849247,0.0003760642,0.7964851,0.014211326,0.0010610657,0.000671509,0.00020062338,0.008415002],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677515,0.0002091902,0.00034723617,0.0006055421,0.00022918024,0.0018337043],"domain_scores_gemma":[0.99874663,0.00016499982,0.00017000145,0.0007960374,0.00007191168,0.00005043311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030181452,0.0004429295,0.0010662894,0.00032599337,0.00009233776,0.00004428512,0.00027954887,0.0003609813,0.00014099285],"category_scores_gemma":[0.000115261755,0.0003031925,0.00009748173,0.00027293194,0.00042691766,0.00006192589,0.00026908,0.0013112706,0.00021627251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007699617,0.00007601451,0.048234396,0.00057332707,0.0008682201,0.00027113926,0.000077275945,7.358243e-7,0.0010364758,0.00012931738,0.9270428,0.021613337],"study_design_scores_gemma":[0.001894995,0.0009879132,0.029606165,0.00031969306,0.00052222796,0.000011405337,0.000008600531,0.00007491935,0.0020117904,0.0016470911,0.96258885,0.00032633997],"about_ca_topic_score_codex":0.00003318858,"about_ca_topic_score_gemma":0.0000276546,"teacher_disagreement_score":0.3236478,"about_ca_system_score_codex":0.00012265625,"about_ca_system_score_gemma":0.00003984497,"threshold_uncertainty_score":0.999942},"labels":[],"label_agreement":null},{"id":"W2883055530","doi":"10.1016/s2213-8587(18)30205-5","title":"Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Department of Surgery; National Institute of General Medical Sciences; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Department of Medicine, Georgetown University; National Center for Research Resources; Eli Lilly Canada; General Research Fund of Shanghai Normal University; National Institutes of Health; Novo Nordisk; Merck; Diagnostic Services Manitoba; National Center for Advancing Translational Sciences; University of Manitoba; McMaster University; Department of Anesthesiology, Medical College of Wisconsin; Heart and Stroke Foundation of Canada; Manitoba Health Research Council; Hamilton Health Sciences; Universiti Malaya; Manitoba Medical Service Foundation; Amgen; Boehringer Ingelheim; Pfizer; Bristol-Myers Squibb Canada; Institute of Clinical and Translational Sciences; Sanofi; American Heart Association; Abbott Laboratories; AstraZeneca","keywords":"Medicine; Diabetes mellitus; Prospective cohort study; Perioperative; Hazard ratio; Odds ratio; Cardiac surgery; Logistic regression; Internal medicine; Cohort; Surgery; Endocrinology; Confidence interval","score_opus":0.009005445890019372,"score_gpt":0.25978140227684515,"score_spread":0.25077595638682576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883055530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945771,0.00029766583,0.0000062220574,0.001244228,0.0001979933,0.0017491253,0.000024131228,0.000045473687,0.0018580776],"genre_scores_gemma":[0.99798685,0.00021606183,0.00005222362,0.00056267664,0.0005898698,0.00035082406,0.0000150476035,0.000019511552,0.0002069436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791926,0.0004687239,0.00030266633,0.00034683748,0.00033842045,0.0006241121],"domain_scores_gemma":[0.9979883,0.0011316283,0.0001652653,0.00035612783,0.00028792786,0.00007079424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009030421,0.00020871994,0.0014341363,0.000057620902,0.00009502754,0.000024653596,0.000066468565,0.00008084754,0.000035244724],"category_scores_gemma":[0.00029456135,0.00012572609,0.0001724604,0.00018060647,0.00022886774,0.000094207004,0.000055491837,0.00021080102,0.000013290915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011788685,0.00012562086,0.9946725,0.000018461353,0.0013544406,0.000022014714,0.0008366022,2.3015414e-7,0.00045256907,0.00023612767,0.00030329815,0.00079926575],"study_design_scores_gemma":[0.0012090555,0.0011359643,0.988862,0.000028818022,0.00074474746,0.000007945636,0.0001664561,0.000011694354,0.0061525716,0.000029834848,0.0015114399,0.00013947887],"about_ca_topic_score_codex":0.000033198543,"about_ca_topic_score_gemma":0.000012148976,"teacher_disagreement_score":0.005810508,"about_ca_system_score_codex":0.000101928716,"about_ca_system_score_gemma":0.00009009525,"threshold_uncertainty_score":0.51269615},"labels":[],"label_agreement":null},{"id":"W2883578953","doi":"10.1016/s2213-8587(18)30208-0","title":"Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; Mount Sinai Hospital","funders":"Medical Research Council","keywords":"Medicine; Diabetes mellitus; Prospective cohort study; Cohort study; Population; Demography; Incidence (geometry); Scopus; Cohort; Gerontology; Internal medicine; MEDLINE; Environmental health; Endocrinology","score_opus":0.014430781140987139,"score_gpt":0.26124626036074045,"score_spread":0.2468154792197533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883578953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75322574,0.027873605,0.0000011812098,0.21215087,0.00031985127,0.0027453632,0.00011616586,0.000058386395,0.0035088568],"genre_scores_gemma":[0.77287847,0.017361782,0.00011292998,0.19854891,0.005680905,0.0029992503,0.00049108855,0.00020019809,0.0017264318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950741,0.0016924252,0.00039523697,0.00055074703,0.00062131166,0.001666196],"domain_scores_gemma":[0.9949632,0.0033027565,0.00019960503,0.0013974241,0.00008448274,0.00005248081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013451276,0.0004214847,0.0018215915,0.00027428693,0.00010143327,0.000024827636,0.0005705921,0.00025421064,0.00004552814],"category_scores_gemma":[0.0011519182,0.00021161372,0.00041443465,0.00023425855,0.0013661245,0.000031603333,0.00033303234,0.0020064805,0.00006276963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062488666,0.000060887935,0.33183315,0.0049790093,0.007172825,0.00026550062,0.00018216044,0.000051413197,0.00008715419,0.00049745786,0.5890804,0.06516516],"study_design_scores_gemma":[0.022549646,0.004613717,0.19905104,0.0028417802,0.002903434,0.000009411867,0.000020964842,0.0002770777,0.0042864033,0.003344791,0.75950587,0.00059585774],"about_ca_topic_score_codex":0.0000650485,"about_ca_topic_score_gemma":0.0000074704544,"teacher_disagreement_score":0.17042549,"about_ca_system_score_codex":0.000064573265,"about_ca_system_score_gemma":0.000034926616,"threshold_uncertainty_score":0.8717271},"labels":[],"label_agreement":null},{"id":"W2884107160","doi":"10.1016/s2213-8587(18)30155-4","title":"Advances in the medical treatment of Cushing's syndrome","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pasireotide; Medicine; Cabergoline; Aminoglutethimide; Pituitary tumors; Corticotropic cell; Somatostatin receptor; Cushing syndrome; Somatostatin; Pharmacotherapy; Glucocorticoid receptor; Pharmacology; Internal medicine; Mifepristone; Endocrinology; Glucocorticoid; Pituitary gland; Acromegaly; Cancer","score_opus":0.055591455730214345,"score_gpt":0.366876238931577,"score_spread":0.31128478320136266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884107160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059061963,0.98768824,4.042123e-7,0.0010880245,0.00024505536,0.00091407116,0.00005093247,0.00002978395,0.004077303],"genre_scores_gemma":[0.005668137,0.9929612,0.00002081569,0.0003540388,0.00035677425,0.00038460628,0.00015249308,0.000026145795,0.000075758726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974876,0.000381377,0.0005212971,0.0003456308,0.0003064934,0.0009576191],"domain_scores_gemma":[0.9980796,0.00075567013,0.00022389524,0.0008531132,0.000021748923,0.00006594881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027035258,0.00038995803,0.0026165785,0.00013016266,0.00006132514,0.000007638096,0.0005629745,0.0001827259,0.00015498576],"category_scores_gemma":[0.000110051296,0.00015533029,0.0003784417,0.00024939043,0.00041030478,0.00003873971,0.00007096734,0.00029086086,0.000103952836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026667602,0.0006164179,0.0063520367,0.0026128693,0.0005159191,0.0008184192,0.00013543991,4.6492865e-8,3.2171744e-8,0.0005125048,0.00046810575,0.98794156],"study_design_scores_gemma":[0.001856532,0.0014180783,0.00092947506,0.0026654317,0.0011502452,0.0008422663,0.000032394488,0.0000015930485,0.000001007833,0.00072255085,0.9902459,0.00013457598],"about_ca_topic_score_codex":0.000047457655,"about_ca_topic_score_gemma":0.00009214972,"teacher_disagreement_score":0.98977774,"about_ca_system_score_codex":0.000071002,"about_ca_system_score_gemma":0.00017589546,"threshold_uncertainty_score":0.63341856},"labels":[],"label_agreement":null},{"id":"W2889089805","doi":"10.1016/s2213-8587(18)30233-x","title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Simon Fraser University; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Metformin; Pharmacy; Environmental health; Audit; Diabetes mellitus; Glibenclamide; Epidemiology; Family medicine; Business; Internal medicine; Accounting; Endocrinology","score_opus":0.04565561249153537,"score_gpt":0.3240000573649068,"score_spread":0.2783444448733714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071807,0.0011519036,0.000025905316,0.0049902173,0.0004864762,0.0013311798,0.0009994116,0.000054796645,0.00024203086],"genre_scores_gemma":[0.9972119,0.00032689958,0.00019453885,0.0012172756,0.000694541,0.00030022772,0.000007280625,0.000024616553,0.000022765322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645925,0.00015741316,0.0011310296,0.00080332457,0.00004257387,0.0014063969],"domain_scores_gemma":[0.99629647,0.002214541,0.0005322075,0.00069313205,0.00011701542,0.00014664374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002958466,0.00034035605,0.001797273,0.00009165109,0.0002971315,0.000049265378,0.0004982794,0.00014201079,0.00012435307],"category_scores_gemma":[0.0015017182,0.0002586508,0.00011801735,0.00016430911,0.0025415656,0.00014512854,0.0004924671,0.00029312502,0.000026416199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014511308,0.000136088,0.95304334,0.00029052002,0.00023477792,5.5338035e-7,0.00062094774,0.0000015139823,0.000037388574,0.045261696,0.00004418257,0.00018385271],"study_design_scores_gemma":[0.0026886642,0.0010052882,0.8742131,0.00002962061,0.000041381747,0.000001621042,0.00010442052,0.0009638983,0.00089167955,0.11846048,0.0013337869,0.00026608605],"about_ca_topic_score_codex":0.00010344302,"about_ca_topic_score_gemma":0.00015992922,"teacher_disagreement_score":0.078830294,"about_ca_system_score_codex":0.0000803325,"about_ca_system_score_gemma":0.00002262373,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W2898783072","doi":"10.1016/s2213-8587(18)30311-5","title":"The perils of polyvascular disease in type 2 diabetes","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Belvoir Media Group; Regado Biosciences; Bayer Fund; Duke Clinical Research Institute; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Amarin Corporation; Boston Scientific Corporation; Amgen; Boehringer Ingelheim; Biotronik; American College of Cardiology Foundation; Cleveland Clinic; AstraZeneca; Bristol-Myers Squibb; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Merck; Abbott Laboratories","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Coronary artery disease; Scopus; Disease; MEDLINE; Endocrinology","score_opus":0.02155852450604999,"score_gpt":0.2663066225748478,"score_spread":0.24474809806879777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898783072","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43268862,0.02113705,2.6310155e-7,0.5409843,0.0011452492,0.0011766712,0.000048854563,0.00010632596,0.0027126803],"genre_scores_gemma":[0.36314863,0.008797282,0.00011152664,0.6060724,0.011017859,0.0008020591,0.0008671845,0.00023744027,0.0089456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604607,0.00031775166,0.0005040167,0.00052226504,0.0004123004,0.0021975816],"domain_scores_gemma":[0.9970596,0.00061710423,0.00025808896,0.0018596163,0.00012528212,0.000080312435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045128702,0.0004785594,0.0012626841,0.00021565583,0.00013293879,0.000040776995,0.00084725604,0.00022601344,0.00016865412],"category_scores_gemma":[0.00026909914,0.00026360073,0.0003147986,0.00033903623,0.0009218818,0.00004449958,0.00038159557,0.0009910944,0.00020076784],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010793147,0.000106733896,0.15029787,0.0005438906,0.0016157175,0.00020555934,0.00006873838,0.0000017167691,0.00011142641,0.00044597933,0.8388474,0.0076470277],"study_design_scores_gemma":[0.0013817059,0.00044225893,0.052693155,0.00025461626,0.0010106699,0.0000010290235,0.0000156251,0.00004527022,0.0006432961,0.001389676,0.9418593,0.00026337046],"about_ca_topic_score_codex":0.000025783587,"about_ca_topic_score_gemma":0.00001435784,"teacher_disagreement_score":0.10301191,"about_ca_system_score_codex":0.00010096952,"about_ca_system_score_gemma":0.000100096164,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W2900584187","doi":"10.1016/s2213-8587(18)30312-7","title":"Insulin use for type 2 diabetes: the challenges of predicting trends and modelling care","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories; Merck; Amgen","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Scopus; Population; Disease; Gerontology; MEDLINE; Environmental health; Internal medicine; Endocrinology","score_opus":0.08561460110873703,"score_gpt":0.296513251782073,"score_spread":0.21089865067333596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900584187","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38239262,0.06613394,0.000012632605,0.5444791,0.0011797833,0.0018224516,0.00029588345,0.0002463429,0.0034373053],"genre_scores_gemma":[0.65238345,0.026568456,0.0020213341,0.2946245,0.018080784,0.0014060863,0.0015064384,0.00036975485,0.003039207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971956,0.0001504866,0.00040688872,0.00055404747,0.00023294403,0.0014600564],"domain_scores_gemma":[0.99734014,0.0010316543,0.00031161838,0.0010499876,0.00022300286,0.000043581207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026508168,0.00045778241,0.0011833358,0.00022239723,0.00016741574,0.000039789098,0.00043943356,0.00031620456,0.00001831818],"category_scores_gemma":[0.00011364964,0.00026278952,0.00019404091,0.0001602037,0.00049174565,0.00006975744,0.00027765814,0.00073738565,0.000008198644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029069764,0.00015386127,0.03893623,0.0055354564,0.0068838657,0.000051634866,0.0039022944,0.00008997544,0.00011924091,0.002303471,0.79227895,0.14945431],"study_design_scores_gemma":[0.00263169,0.0019269442,0.003856398,0.00056823855,0.0027444304,0.0000034935904,0.00030830858,0.0017445697,0.000574906,0.00093292835,0.984328,0.0003801311],"about_ca_topic_score_codex":0.000013912686,"about_ca_topic_score_gemma":0.000012057564,"teacher_disagreement_score":0.26999083,"about_ca_system_score_codex":0.000056176046,"about_ca_system_score_gemma":0.00003327679,"threshold_uncertainty_score":0.9999824},"labels":[],"label_agreement":null},{"id":"W2902807692","doi":"10.1016/s2213-8587(18)30308-5","title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; McGill University Health Centre; St. Joseph’s Healthcare Hamilton; University of Calgary; Alberta Bone and Joint Health Institute","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Novo Nordisk Fonden","keywords":"Medicine; Femoral neck; FRAX; Osteoporosis; Bone mineral; Hazard ratio; Cohort; Bone density; Quantitative computed tomography; Hip fracture; Internal medicine; Prospective cohort study; Framingham Risk Score; Proportional hazards model; Cohort study; Surgery; Confidence interval; Osteoporotic fracture","score_opus":0.010763672847504431,"score_gpt":0.3055207647281193,"score_spread":0.29475709188061483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902807692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882496,0.0012816753,0.0000032520875,0.0074460795,0.000058958627,0.0022038696,0.000051824198,0.000021742902,0.00010761919],"genre_scores_gemma":[0.99702054,0.00025007196,0.000072516785,0.0020096619,0.00025643842,0.00032567815,0.000014852437,0.000022273978,0.000027987344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966406,0.0008725345,0.0005011229,0.00051083555,0.0004106978,0.0010641934],"domain_scores_gemma":[0.9986627,0.00040360625,0.00016629802,0.0005027833,0.000104418104,0.00016017845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014054545,0.00024126164,0.0007428786,0.00026199935,0.00011741821,0.000031901247,0.000311681,0.00014323324,0.0000765002],"category_scores_gemma":[0.00044330925,0.00014167147,0.000036781184,0.00021672886,0.0009707003,0.00004906812,0.00023514031,0.0015490103,0.000002817918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017205778,0.0007208944,0.9587368,0.00006886426,0.00013297315,0.00012530823,0.027359348,0.0000017388759,0.008402357,0.00007458051,0.00010414143,0.0025524553],"study_design_scores_gemma":[0.007839682,0.0024851998,0.9806597,0.00004276589,0.00005121061,0.00028835455,0.0045895395,0.00008330451,0.0019627209,0.0014876281,0.0003883817,0.000121477],"about_ca_topic_score_codex":0.00070072623,"about_ca_topic_score_gemma":0.0015001897,"teacher_disagreement_score":0.022769809,"about_ca_system_score_codex":0.000121232726,"about_ca_system_score_gemma":0.00012748443,"threshold_uncertainty_score":0.6729765},"labels":[],"label_agreement":null},{"id":"W2909182150","doi":"10.1016/s2213-8587(18)30313-9","title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; Mayo Clinic; Medical Research Council; National Institutes of Health; Kidney Research UK; National Medical Research Council; Emory University; Cleveland Clinic; National Center for Advancing Translational Sciences; Tufts Medical Center; Bristol-Myers Squibb; National Kidney Foundation; National Institute for Health and Care Research; PKD Foundation","keywords":"Albuminuria; Medicine; Kidney disease; Creatinine; Internal medicine; Renal function; Cohort study; Cohort","score_opus":0.621653956587924,"score_gpt":0.46191893850136473,"score_spread":0.15973501808655927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909182150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07874094,0.90327996,1.4445678e-7,0.0006112403,0.00010601864,0.0012315039,0.015990859,0.000023937508,0.00001537864],"genre_scores_gemma":[0.046671215,0.94813234,0.00005600558,0.0010462233,0.00017745023,0.0008657754,0.0029164734,0.000043738386,0.000090757545],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995445,0.0010355967,0.001312889,0.00066929625,0.00043713412,0.0011000461],"domain_scores_gemma":[0.9952872,0.0017975051,0.0011499843,0.0012612593,0.0001655555,0.0003385127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010803291,0.0005653817,0.008624131,0.0005682278,0.00004654524,0.0000121545545,0.00045463096,0.00015853184,0.0005608964],"category_scores_gemma":[0.0012607262,0.0003477639,0.0014227488,0.00071551674,0.000748304,0.00010553733,0.00033163757,0.00045055622,0.0000072329462],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001167215,0.00066983217,0.38744834,0.032239787,0.5404199,0.000051712606,0.00097029255,0.000009340507,0.000008191739,0.0036353278,0.0007802373,0.03365032],"study_design_scores_gemma":[0.0012716376,0.00019730622,0.13140592,0.00081546884,0.78640753,0.0000015182388,0.000098035955,0.00005671887,0.00002396293,0.00016551156,0.079201885,0.0003544974],"about_ca_topic_score_codex":0.00011846589,"about_ca_topic_score_gemma":0.000117161035,"teacher_disagreement_score":0.25604242,"about_ca_system_score_codex":0.00006444702,"about_ca_system_score_gemma":0.0007185012,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W2910611591","doi":"10.1016/s2213-8587(18)30336-x","title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health; Rosetrees Trust","keywords":"Medicine; Natural history; Term (time); Retrospective cohort study; Endocrine system; Intensive care medicine; MEDLINE; Pediatrics; Oncology; Internal medicine; Hormone","score_opus":0.018211743893135394,"score_gpt":0.27046274608711907,"score_spread":0.25225100219398366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910611591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573845,0.0013720578,1.6190761e-7,0.00031909996,0.0009275088,0.0013353076,0.000045462784,0.00005287546,0.00020910542],"genre_scores_gemma":[0.9985993,0.00038354206,0.000048659636,0.000155379,0.00012693375,0.00009905734,0.00013713028,0.000029332545,0.0004206751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858737,0.00007848242,0.00020756284,0.00041208076,0.0001780904,0.000536415],"domain_scores_gemma":[0.99891347,0.00011147473,0.00016564403,0.00056888553,0.00016932555,0.00007119186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040069943,0.0002476213,0.0006442503,0.00008488942,0.00003737952,0.000009990136,0.00017169469,0.000028189568,0.00014456321],"category_scores_gemma":[0.000039027418,0.00014743401,0.000055699813,0.00007390252,0.00011616041,0.00011325933,0.0000731112,0.0001471835,0.000015481353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014894268,0.0014948515,0.99213904,0.000020561083,0.0010882345,0.000024922147,0.00067154405,0.000001985853,0.00033452763,0.000097686534,0.00009235122,0.0025448678],"study_design_scores_gemma":[0.023181168,0.0055884076,0.9687533,0.000027221415,0.00036772343,0.0000069396115,0.00011384577,0.000034800956,0.0008506082,0.0000074345303,0.0009387081,0.00012988198],"about_ca_topic_score_codex":0.00012937201,"about_ca_topic_score_gemma":0.0004896523,"teacher_disagreement_score":0.023385782,"about_ca_system_score_codex":0.00045326015,"about_ca_system_score_gemma":0.000042453954,"threshold_uncertainty_score":0.60121846},"labels":[],"label_agreement":null},{"id":"W2912546704","doi":"10.1016/s2213-8587(18)30369-3","title":"Subspecialty training in adult inherited metabolic diseases: a call to action for unmet needs","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Centre for Advancing Health Outcomes; Providence Health Care","funders":"","keywords":"Medicine; Subspecialty; Call to action; Life expectancy; Pediatrics; Disease; Family medicine; Incidence (geometry); Population; Gerontology; Pathology; Environmental health","score_opus":0.023277281133993674,"score_gpt":0.28401549239677154,"score_spread":0.26073821126277785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912546704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457616,0.0016953767,0.00013156119,0.0015843379,0.0005539895,0.0007072574,0.00009409002,0.00002377164,0.00063347106],"genre_scores_gemma":[0.99350786,0.0005763049,0.0003463994,0.0039603203,0.00074236566,0.00031932723,0.00015167272,0.000030387215,0.00036536806],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823177,0.00013278594,0.00022886039,0.00034696795,0.0000876134,0.0009720129],"domain_scores_gemma":[0.9992287,0.000052920506,0.000067220164,0.0005121844,0.000060890885,0.000078059275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001785303,0.00018928158,0.0004320649,0.00011744618,0.000048861275,0.000020399566,0.00037785977,0.000090557776,0.00003476486],"category_scores_gemma":[0.00018682251,0.00015331805,0.00010057915,0.00024809086,0.000065500826,0.0000048992224,0.00010903741,0.00011134948,0.000034511653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010557313,0.00021227979,0.32717544,0.0001576118,0.00045418623,0.000002807781,0.0022910251,0.0008627124,0.4830608,0.014101115,0.011089301,0.15953699],"study_design_scores_gemma":[0.0046674795,0.00043236284,0.30863985,0.000021830007,0.00012047178,0.0000047914073,0.0015429321,0.00019950277,0.039451167,0.0016465934,0.642693,0.0005800558],"about_ca_topic_score_codex":0.000029234256,"about_ca_topic_score_gemma":0.00027788905,"teacher_disagreement_score":0.63160366,"about_ca_system_score_codex":0.0000048626102,"about_ca_system_score_gemma":0.00005962273,"threshold_uncertainty_score":0.62521285},"labels":[],"label_agreement":null},{"id":"W2917530505","doi":"10.1016/s2213-8587(19)30029-4","title":"Intensive periodontal therapy and type 2 diabetes","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Periodontitis; Chronic periodontitis; Clinical trial; Diabetes mellitus; Randomized controlled trial; Type 2 diabetes; Dentistry; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.05025046696741868,"score_gpt":0.2976884483229122,"score_spread":0.2474379813554935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917530505","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72452235,0.016038029,1.2778038e-7,0.25467858,0.0028041948,0.00048285138,0.00030651278,0.00011761241,0.0010497435],"genre_scores_gemma":[0.15673405,0.0047087483,0.00003207635,0.8179085,0.0074893557,0.000111808076,0.0009688152,0.00014542439,0.011901185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532586,0.00076584396,0.00035321817,0.0007920693,0.00018417992,0.0025788066],"domain_scores_gemma":[0.9973835,0.0009560794,0.0001913635,0.0011379415,0.00028812277,0.00004304636],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003024492,0.0005619626,0.0013964715,0.0001684362,0.00025063136,0.00015989467,0.0011796099,0.00095505256,0.0015989237],"category_scores_gemma":[0.00024398978,0.0003840107,0.00018987409,0.00016710948,0.0012040827,0.00009202266,0.00062994246,0.0038857963,0.002851278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005420271,0.000009889705,0.1417941,0.000111576825,0.00050015847,0.0002717813,0.000092943366,1.7844722e-7,0.0050233277,0.000060014747,0.8487872,0.0032946516],"study_design_scores_gemma":[0.00095425243,0.00037189017,0.04499953,0.000057557936,0.000052114912,0.00013834926,0.00004212479,0.0000073990927,0.0017498494,0.00026292185,0.9509113,0.00045272676],"about_ca_topic_score_codex":0.00006282203,"about_ca_topic_score_gemma":0.00004705377,"teacher_disagreement_score":0.5677883,"about_ca_system_score_codex":0.00005302747,"about_ca_system_score_gemma":0.000080340484,"threshold_uncertainty_score":0.9998612},"labels":[],"label_agreement":null},{"id":"W2918407168","doi":"10.1016/s2213-8587(19)30066-x","title":"Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Mount Sinai Hospital","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Placebo; Dulaglutide; Internal medicine; Diabetes mellitus; Randomized controlled trial; Concomitant; Clinical trial; Exenatide; Liraglutide; Endocrinology","score_opus":0.0164886080544158,"score_gpt":0.2803438125386376,"score_spread":0.2638552044842218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918407168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630746,0.0013413014,4.0845396e-7,0.011454756,0.0011725813,0.01084994,0.0000066872267,0.00019780063,0.0119019],"genre_scores_gemma":[0.97990197,0.00032923103,0.00009725868,0.0104471175,0.0009593444,0.0020841989,0.000031598556,0.00006976811,0.0060795164],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958256,0.00046965084,0.0006064998,0.0006705877,0.0003703593,0.0020573158],"domain_scores_gemma":[0.9969357,0.0015911616,0.00018809573,0.0010335725,0.00008702567,0.00016440554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009386988,0.00049657,0.0019042997,0.00038561947,0.00008385979,0.00005251369,0.0004627237,0.00012440821,0.0005126961],"category_scores_gemma":[0.0006475138,0.0003198491,0.0002783139,0.00046612075,0.00011161976,0.00007002243,0.00018136557,0.00045710878,0.0014168224],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87602067,0.0012005686,0.050915,0.00012192849,0.0017383607,0.0001107223,0.0005276418,0.00015080818,0.009858521,0.0028346928,0.017728532,0.03879254],"study_design_scores_gemma":[0.92367977,0.01015401,0.0048416965,0.00020181407,0.00026082498,0.000001795885,0.0002017285,0.00014690771,0.0095445365,0.00076623145,0.049758945,0.0004417213],"about_ca_topic_score_codex":0.000025963162,"about_ca_topic_score_gemma":0.000020383206,"teacher_disagreement_score":0.047659107,"about_ca_system_score_codex":0.00020308973,"about_ca_system_score_gemma":0.000111176254,"threshold_uncertainty_score":0.9999254},"labels":[],"label_agreement":null},{"id":"W2923297316","doi":"10.1016/s2213-8587(19)30077-4","title":"Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre","funders":"Boehringer Ingelheim; Institute for Clinical Evaluative Sciences; Sanofi","keywords":"Medicine; Gestational diabetes; Pregnancy; Obstetrics; Population; Diabetes mellitus; Type 2 diabetes; Cohort; Gestation; Cohort study; Internal medicine; Endocrinology; Environmental health","score_opus":0.010609446224793593,"score_gpt":0.25746717417728293,"score_spread":0.24685772795248934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923297316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921278,0.0050258087,0.0000056130543,0.0006677056,0.00004703768,0.0019625896,0.00002929611,0.00002021873,0.000113974354],"genre_scores_gemma":[0.99819785,0.0010252767,0.0001020651,0.000120928504,0.00006246041,0.00041024724,0.000032641805,0.000013961592,0.00003456312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806064,0.00032278444,0.00023153388,0.00033388354,0.00034232382,0.0007088336],"domain_scores_gemma":[0.9990842,0.00014712362,0.00006847767,0.00056609296,0.000054873097,0.00007923412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059357315,0.00013212966,0.0006165798,0.00022735435,0.00002896429,0.000010804318,0.00013041662,0.000026845437,0.000022754606],"category_scores_gemma":[0.00016472823,0.000098914206,0.00007004262,0.00030190035,0.000055459237,0.00006658571,0.000089325804,0.00028329127,0.000005373003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002200647,0.00021941279,0.98985714,0.00018295349,0.000521014,0.00003533775,0.00012548121,0.001571642,0.000018186147,0.0003167305,0.0000068311087,0.006925212],"study_design_scores_gemma":[0.0044481177,0.00033181466,0.9927788,0.000116596464,0.00011281978,1.913338e-7,0.00023210484,0.0011581164,0.000019405497,0.00038138477,0.00033411913,0.000086576154],"about_ca_topic_score_codex":0.0005017431,"about_ca_topic_score_gemma":0.000053733547,"teacher_disagreement_score":0.006838636,"about_ca_system_score_codex":0.00009069587,"about_ca_system_score_gemma":0.000031854095,"threshold_uncertainty_score":0.40336046},"labels":[],"label_agreement":null},{"id":"W2949665037","doi":"10.1016/s2213-8587(19)30180-9","title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":675,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Research and Development; St. Jude Medical; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Regado Biosciences; Medicines Company; Bristol-Myers Squibb; Cleveland Clinic; Society for Academic Continuing Medical Education; Biotronik; AstraZeneca; Amarin Corporation; Boston VA Research Institute; Boston Scientific Corporation; MyoKardia; Bayer; Gilead Sciences; Takeda Pharmaceutical Company; American College of Cardiology Foundation; Novartis; Mayo Clinic; Merck; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Boehringer Ingelheim; Amgen; MedImmune; Sanofi; Abbott Laboratories","keywords":"Medicine; Dapagliflozin; Renal function; Type 2 diabetes; Internal medicine; Kidney disease; TIMI; Dialysis; Diabetes mellitus; Creatinine; Albuminuria; Urology; Endocrinology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.00957636408848811,"score_gpt":0.24791610790429294,"score_spread":0.23833974381580483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949665037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632466,0.0004478884,7.291971e-7,0.0004233532,0.000117379364,0.0025336808,0.000017697355,0.000023200322,0.00011138374],"genre_scores_gemma":[0.99842894,0.000042843305,0.00019641791,0.00077978335,0.000047932554,0.00018689856,0.000265391,0.000017542481,0.000034276654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982929,0.00026317476,0.00032116933,0.00032284373,0.0002731766,0.00052672235],"domain_scores_gemma":[0.99841934,0.00060370425,0.00020951625,0.00057697535,0.00005842707,0.00013206017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024148048,0.00021486937,0.0008994177,0.00015718785,0.000036875703,0.000010312334,0.0002127208,0.000041790823,0.000038397164],"category_scores_gemma":[0.00023214392,0.00010551477,0.00007568079,0.00032317056,0.0001367916,0.000048696376,0.00010141615,0.00012895884,0.0000059600266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03553611,0.0008377712,0.94996077,0.00014577723,0.0017668593,0.0000035990438,0.0002504359,0.000023079967,0.0002219425,0.000049018436,0.00008442142,0.011120232],"study_design_scores_gemma":[0.1341856,0.002168505,0.8542124,0.00026710788,0.0018611444,7.3088375e-9,0.00001967794,0.00016299584,0.0063788285,0.000041000927,0.000586167,0.000116549665],"about_ca_topic_score_codex":0.000009967247,"about_ca_topic_score_gemma":0.000009599512,"teacher_disagreement_score":0.09864948,"about_ca_system_score_codex":0.000036392583,"about_ca_system_score_gemma":0.000067568864,"threshold_uncertainty_score":0.43027675},"labels":[],"label_agreement":null},{"id":"W2953324257","doi":"10.1016/s2213-8587(19)30254-2","title":"Opioid-induced endocrinopathies","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Opioid; Discontinuation; Hyperprolactinaemia; Endocrine system; Intensive care medicine; Hormone replacement therapy (female-to-male); Pediatrics; Hormone; Internal medicine; Testosterone (patch); Prolactin","score_opus":0.143493559839508,"score_gpt":0.37468312804634085,"score_spread":0.23118956820683284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953324257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015747386,0.9827271,3.0596814e-7,0.0014914055,0.0014043472,0.0016084526,0.000054670945,0.00022845899,0.010910522],"genre_scores_gemma":[0.001107579,0.9913782,0.000042562984,0.00056570064,0.003752432,0.0004504901,0.0000783338,0.00009749588,0.0025271925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573594,0.0003507384,0.00064838905,0.00089423417,0.00029216084,0.0020785152],"domain_scores_gemma":[0.9972117,0.00059288205,0.0003398147,0.0016331164,0.00012975298,0.00009274122],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032517296,0.0007389241,0.00523184,0.00022698958,0.00018799072,0.000024084731,0.0006632218,0.00021177511,0.00008016249],"category_scores_gemma":[0.00033206778,0.00037982836,0.0007839294,0.00035747577,0.00040810843,0.000042402204,0.0005920709,0.0014487357,0.0016513861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022622124,0.000083424165,0.00053920754,0.015200432,0.0018263068,0.000119361386,0.000106671214,5.5834764e-8,0.00004356129,0.0020893451,0.0034396471,0.97652936],"study_design_scores_gemma":[0.0005471479,0.00038273758,0.0005676176,0.0029290237,0.0027089582,0.00026690803,0.0000540423,3.7734628e-7,0.000105092106,0.000315648,0.9917276,0.00039482833],"about_ca_topic_score_codex":0.000014952834,"about_ca_topic_score_gemma":0.0000031975355,"teacher_disagreement_score":0.988288,"about_ca_system_score_codex":0.00011239811,"about_ca_system_score_gemma":0.0002472234,"threshold_uncertainty_score":0.99986535},"labels":[],"label_agreement":null},{"id":"W2953700634","doi":"10.1016/s2213-8587(19)30119-6","title":"The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Diabetes mellitus; Cardiology; Internal medicine; Blood volume; Cardiac dysfunction; Intensive care medicine; Endocrinology; Heart failure","score_opus":0.011130992723685758,"score_gpt":0.23971951421811408,"score_spread":0.22858852149442832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953700634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38031358,0.6181979,2.370955e-8,0.00003723595,0.00019655122,0.0010885482,0.000026867863,0.000015199775,0.00012407871],"genre_scores_gemma":[0.13404277,0.86514145,0.000008322904,0.00003185943,0.00017588127,0.00040184488,0.00010735525,0.000048360947,0.00004212562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972348,0.00042671937,0.00054856925,0.0005005377,0.00019746837,0.0010918769],"domain_scores_gemma":[0.99819106,0.00034583075,0.00025909388,0.001083082,0.000073911215,0.00004703279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043175917,0.0003988581,0.0041508353,0.00018021069,0.000052965854,0.000012388224,0.00029961416,0.00020120906,0.0000052114187],"category_scores_gemma":[0.00007323431,0.00021564553,0.00038560966,0.00035485104,0.00032424933,0.000044656983,0.00017869586,0.00069604174,0.000018518573],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035244148,0.0001346442,0.103481516,0.004369758,0.0009855528,0.0000038060166,0.00008444938,0.000009178108,0.000039815222,0.00004683746,0.00008967468,0.8904023],"study_design_scores_gemma":[0.01017119,0.0014903639,0.5783662,0.02002016,0.012368334,0.000012171306,0.00013588043,0.000050223967,0.0005065551,0.00047821755,0.3752765,0.0011241945],"about_ca_topic_score_codex":0.000040169303,"about_ca_topic_score_gemma":0.000009688299,"teacher_disagreement_score":0.8892781,"about_ca_system_score_codex":0.000049705675,"about_ca_system_score_gemma":0.00009452582,"threshold_uncertainty_score":0.87937695},"labels":[],"label_agreement":null},{"id":"W2954453953","doi":"10.1016/s2213-8587(19)30158-5","title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Gilead UK and Ireland Corporate Contributions; Seventh Framework Programme; Daiichi Sankyo Europe; St. Jude Medical; Esperion Therapeutics; Idorsia Pharmaceuticals; Biotronik; Ferring Pharmaceuticals; NIHR Imperial Biomedical Research Centre; Eisai; Daiichi-Sankyo; Hartstichting; Actavis; Bayer HealthCare; Ironwood Pharmaceuticals, Incorporated; Medicines Company; Arrien Pharmaceuticals; Tenax Therapeutics; Janssen Pharmaceuticals; Novo Nordisk; MyoKardia; Assistance publique-Hôpitaux de Paris; Luitpold Pharmaceuticals; Regado Biosciences; Merck Sharp and Dohme; Novartis; Belvoir Media Group; Portola Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Cleveland Clinic; Boehringer Ingelheim; American College of Cardiology Foundation; Sanofi; National Lipid Association; GlaxoSmithKline; Mayo Clinic; Merck; Servier; Abbott Laboratories; Bayer; National Institute for Health and Care Research; CSL Behring; Pfizer; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Amarin Corporation; Genentech; AstraZeneca; Roche; Flatiron Health; Duke Clinical Research Institute; Astellas Pharma US; Amgen; Regeneron Pharmaceuticals; American Heart Association","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Diabetes mellitus; Internal medicine; Metabolic syndrome; Randomized controlled trial; MEDLINE; Cardiology; Myocardial infarction; Cholesterol; Endocrinology; Total cholesterol","score_opus":0.00810748051552855,"score_gpt":0.24004475415659474,"score_spread":0.2319372736410662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954453953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764545,0.0024635426,0.0000015958735,0.00026167405,0.00021506312,0.009310899,0.000035236553,0.000024980627,0.000041568936],"genre_scores_gemma":[0.99771786,0.00023133605,0.000029838937,0.0006325618,0.00003463035,0.0012116983,0.000011003931,0.000035535446,0.000095533906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963573,0.0009822876,0.00066497014,0.0004527463,0.0007215094,0.00082114496],"domain_scores_gemma":[0.99689656,0.0010190441,0.00032234777,0.0015857327,0.000102110236,0.00007417314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008391159,0.00037298727,0.0056405454,0.00031247962,0.00004144771,0.00000958146,0.0003105108,0.00011025255,0.000028476323],"category_scores_gemma":[0.00026545723,0.00015490342,0.0013542407,0.0005227339,0.00023161012,0.000053821077,0.00013293365,0.0003214982,0.000002227599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1426944,0.00026943206,0.8144883,0.00020038396,0.041374553,0.00001737138,0.00011941592,0.000032708427,0.000036890342,0.00002895999,0.0000022352087,0.00073535077],"study_design_scores_gemma":[0.37989113,0.0008624042,0.60758626,0.00006867736,0.011097269,0.0000016265794,0.000009875292,0.000025444833,0.0003061689,0.000007753603,0.00003491371,0.00010845186],"about_ca_topic_score_codex":0.000064712585,"about_ca_topic_score_gemma":0.000023754927,"teacher_disagreement_score":0.23719674,"about_ca_system_score_codex":0.000035956964,"about_ca_system_score_gemma":0.00007302244,"threshold_uncertainty_score":0.6316778},"labels":[],"label_agreement":null},{"id":"W2961683851","doi":"10.1016/s2213-8587(19)30084-1","title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":1508,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen's University","funders":"Novo Nordisk; California Walnut Commission; Eli Lilly and Company; Université Laval; International Atherosclerosis Society; AstraZeneca; International Chair on Cardiometabolic Risk; Amgen","keywords":"Medicine; Obesity; Disease; Epidemiology; Diabetes mellitus; Adipose tissue; Metabolic syndrome; Public health; Internal medicine; Intensive care medicine; Pathology; Endocrinology","score_opus":0.05889242315486752,"score_gpt":0.33075468401668245,"score_spread":0.2718622608618149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961683851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026447022,0.9710153,0.0000035761047,0.0006016025,0.00020460758,0.0012918946,0.00022886357,0.000072814066,0.00013437356],"genre_scores_gemma":[0.007323084,0.9905674,0.000019300756,0.0005564995,0.0008037549,0.00021701591,0.0002578074,0.000048930775,0.00020624312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977002,0.0003762919,0.00033105194,0.00053098093,0.00019335626,0.00086811965],"domain_scores_gemma":[0.99869066,0.000116625226,0.00013615735,0.00083223224,0.000024124274,0.00020021168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019037306,0.0004046599,0.0025684293,0.00013463818,0.00010636407,0.00005266208,0.00015372314,0.00011219398,0.000020033543],"category_scores_gemma":[0.000022597433,0.00026070274,0.0005644974,0.00014375319,0.00019429337,0.000043627337,0.00025967343,0.00040882095,0.00003248505],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003884831,0.000077702,0.01372411,0.020504255,0.0051570837,0.00004667096,0.00003836756,4.9067273e-7,0.0000328508,0.0010459366,0.00079475064,0.95853895],"study_design_scores_gemma":[0.0013344828,0.000097434975,0.057080317,0.00256918,0.013768353,0.00008581588,0.000005578044,0.0000049642513,0.000007009971,0.00008566218,0.92465186,0.0003093203],"about_ca_topic_score_codex":0.000010819056,"about_ca_topic_score_gemma":8.799668e-7,"teacher_disagreement_score":0.9582296,"about_ca_system_score_codex":0.000047972226,"about_ca_system_score_gemma":0.00007865612,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W2969734794","doi":"10.1016/s2213-8587(19)30156-1","title":"Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Hypertriglyceridemia; Cholesterol; Triglyceride; Internal medicine; Intensive care medicine; Bioinformatics; Pediatrics","score_opus":0.2661569581946629,"score_gpt":0.4552828823409667,"score_spread":0.1891259241463038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969734794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002665183,0.9839444,0.000014176532,0.0041836225,0.0022841212,0.0021687383,0.00041112758,0.00007719916,0.0042514154],"genre_scores_gemma":[0.00021724358,0.98895085,0.005192351,0.0030496407,0.0018767128,0.0003194766,0.00025613402,0.00007568462,0.000061900384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638,0.00062275707,0.0010515247,0.00061967387,0.0002330888,0.0010929962],"domain_scores_gemma":[0.9860229,0.011808862,0.0006316269,0.0010017952,0.0003883079,0.00014653786],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007351685,0.00045417086,0.003658315,0.00012439542,0.00009198638,0.000023610764,0.00030691904,0.00050512527,0.000019576039],"category_scores_gemma":[0.011731829,0.00029314583,0.00058901584,0.0001795067,0.0005518312,0.00014728724,0.0002362872,0.0012385555,0.000079630816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022682396,0.00048260242,0.0009196176,0.018926786,0.0024836517,0.000026648688,0.00006919445,2.3569322e-7,0.0000054525754,0.02641973,0.022710493,0.9256874],"study_design_scores_gemma":[0.0068115806,0.00076467334,0.00026896052,0.0011482548,0.0102771865,0.00033512677,0.00013965122,0.000005318985,0.000002110951,0.00018382646,0.97978246,0.0002808725],"about_ca_topic_score_codex":0.000016250677,"about_ca_topic_score_gemma":0.000005066672,"teacher_disagreement_score":0.95707196,"about_ca_system_score_codex":0.000038023576,"about_ca_system_score_gemma":0.0006406838,"threshold_uncertainty_score":0.9999521},"labels":[],"label_agreement":null},{"id":"W2971414122","doi":"10.1016/s2213-8587(19)30256-6","title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":870,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca; National Health and Medical Research Council; Verily Life Sciences; Medical Research Council; Bristol-Myers Squibb; Akebia Therapeutics; Gilead Sciences; Servier; Relypsa; Astellas Pharma; University of New South Wales; University of Oxford; MyoKardia; Novo Nordisk; ZOLL Medical Corporation; Janssen Pharmaceuticals; Ablynx; Sanofi; GlaxoSmithKline; Eli Lilly and Company; Boehringer Ingelheim; Amgen; Pfizer; Brigham and Women's Hospital","keywords":"Medicine; Empagliflozin; Albuminuria; Meta-analysis; Kidney disease; Dialysis; Kidney transplantation; Internal medicine; Renal function; Intensive care medicine; Diabetes mellitus; Type 2 diabetes; Transplantation; Endocrinology","score_opus":0.058367977203398036,"score_gpt":0.3210231811762127,"score_spread":0.26265520397281467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971414122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019263376,0.9862279,0.0000016766535,0.0012684594,0.00006483131,0.0120413555,0.00012051221,0.00002587602,0.000056755125],"genre_scores_gemma":[0.0005129876,0.9931445,0.00009734902,0.0014949435,0.0000433324,0.0033420164,0.0005412941,0.0000541837,0.0007693791],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970893,0.00045807404,0.000948095,0.00047247607,0.0002498251,0.00078223285],"domain_scores_gemma":[0.9967399,0.0008092285,0.0009503659,0.0012840035,0.00014280259,0.00007366936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007579093,0.00052183867,0.0091846185,0.0003067122,0.000046503912,0.000020507981,0.00039666187,0.00011139586,0.00006190788],"category_scores_gemma":[0.0003963373,0.00021240076,0.0012418319,0.00084776885,0.00013699928,0.000053747477,0.00016477457,0.0002695412,0.00001617194],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011389909,0.00015075019,0.0019643551,0.7619165,0.22940308,7.407088e-7,0.00001937771,6.417939e-7,5.489358e-8,0.0001459172,0.0022508618,0.0041363323],"study_design_scores_gemma":[0.0009292076,0.0005956668,0.00012270396,0.026782213,0.8899377,3.698372e-7,0.000008287091,0.0000033188608,0.0000010999678,0.000025973819,0.08139663,0.00019683425],"about_ca_topic_score_codex":0.0000035856403,"about_ca_topic_score_gemma":0.000012936726,"teacher_disagreement_score":0.7351343,"about_ca_system_score_codex":0.00006426695,"about_ca_system_score_gemma":0.00008979784,"threshold_uncertainty_score":0.86614513},"labels":[],"label_agreement":null},{"id":"W2972257966","doi":"10.1016/s2213-8587(19)30253-0","title":"Diabetic kidney disease 2.0: the treatment paradigm shifts","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Albuminuria; Renal function; Dialysis; Kidney disease; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Acute kidney injury; Kidney; Kidney transplantation; Disease; Internal medicine; Urology; Diabetic nephropathy; Endocrinology","score_opus":0.02738031076867474,"score_gpt":0.26593630356204073,"score_spread":0.23855599279336598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972257966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03548054,0.0066212765,0.0000014532752,0.9441144,0.00185696,0.0031579956,0.0003074437,0.00033997488,0.008119947],"genre_scores_gemma":[0.028988801,0.0035600085,0.00003040203,0.92741877,0.009308547,0.0017598437,0.002215825,0.00018351008,0.026534323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99439186,0.00041047216,0.00049857626,0.0009581821,0.0005068786,0.0032340589],"domain_scores_gemma":[0.9952666,0.0009192158,0.0002924155,0.0032553533,0.000045078126,0.00022134472],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021822902,0.00096528704,0.0017778499,0.00019827911,0.00025173498,0.00011529904,0.0010347534,0.00031283472,0.00054733525],"category_scores_gemma":[0.000106517175,0.00047870964,0.0006522806,0.00023037092,0.00056794076,0.00006303638,0.00027247934,0.0013758236,0.0023672725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078445446,0.000250458,0.023990873,0.00038476835,0.0028227784,0.00060907175,0.00011016655,0.0000033743413,0.000010607126,0.00088636985,0.9635878,0.007265259],"study_design_scores_gemma":[0.0031811583,0.0008644095,0.013542951,0.00019290307,0.004151201,0.00000524436,0.000009868809,0.000047938887,0.00009357995,0.0022113435,0.9752382,0.00046122112],"about_ca_topic_score_codex":0.00004095037,"about_ca_topic_score_gemma":0.0000058148853,"teacher_disagreement_score":0.018414374,"about_ca_system_score_codex":0.00037214402,"about_ca_system_score_gemma":0.00022516403,"threshold_uncertainty_score":0.99976647},"labels":[],"label_agreement":null},{"id":"W2978430228","doi":"10.1016/s2213-8587(19)30264-5","title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Western University","funders":"Janssen Pharmaceuticals; Silence Therapeutics; Akebia Therapeutics; Eli Lilly and Company; Lundbeckfonden; Novartis; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Ionis Pharmaceuticals; Institut de Cardiologie de Montréal; AstraZeneca; REGENXBIO; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Unilever; European Commission; Meso Scale Diagnostics; European Atherosclerosis Society; Sanofi; MedImmune; HLS Therapeutics; GlaxoSmithKline; Merck; Pfizer","keywords":"Medicine; Task force; Intensive care medicine; Family medicine","score_opus":0.06134634696561439,"score_gpt":0.31501951223427677,"score_spread":0.25367316526866235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978430228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006390234,0.97963655,0.00012006349,0.0018416902,0.0009495853,0.005957597,0.0007548551,0.00026128392,0.0040881196],"genre_scores_gemma":[0.0008445404,0.9821216,0.0024659366,0.009403866,0.0024296287,0.0005700789,0.0005125931,0.00024631713,0.0014054483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945269,0.0008167743,0.000895708,0.0011046659,0.0005130679,0.0021428596],"domain_scores_gemma":[0.9962524,0.00023101196,0.00031869812,0.0027654949,0.00010379336,0.00032856647],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010944156,0.0007454351,0.0035667357,0.00012946632,0.00019018409,0.000059230853,0.0008874668,0.00017671664,0.00015129926],"category_scores_gemma":[0.00006271594,0.0005037569,0.0011122186,0.0004684649,0.000095413976,0.000021094065,0.000923146,0.0007978243,0.00234987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004634291,0.00005884326,0.00012546878,0.010191952,0.0040671327,0.00004774966,0.00034853446,0.000007688916,0.00007189013,0.0002528311,0.030663788,0.9541178],"study_design_scores_gemma":[0.0013169546,0.0003010279,0.000862503,0.0045343395,0.0034388932,0.000008831562,0.00008330772,0.000002668312,0.000024610832,0.000033215496,0.9888954,0.0004982446],"about_ca_topic_score_codex":0.00011431423,"about_ca_topic_score_gemma":0.0000144123815,"teacher_disagreement_score":0.9582316,"about_ca_system_score_codex":0.00039561494,"about_ca_system_score_gemma":0.00015837145,"threshold_uncertainty_score":0.9997414},"labels":[],"label_agreement":null},{"id":"W2989883260","doi":"10.1016/s2213-8587(19)30382-1","title":"Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institutes of Health","keywords":"Medicine; Pharmacovigilance; Anaphylactic reactions; Pharmacology; Glucagon; Anaphylaxis; Allergy; Drug; Internal medicine; Immunology; Insulin","score_opus":0.026838217049605005,"score_gpt":0.28738247348020185,"score_spread":0.26054425643059687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989883260","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14555159,0.007394124,0.000024514404,0.83291036,0.0021384375,0.0025060815,0.0003215497,0.00061421545,0.008539119],"genre_scores_gemma":[0.10445556,0.0036613962,0.0006905898,0.85770184,0.00479854,0.0009497491,0.0033466103,0.00018999017,0.024205752],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99538034,0.00033528608,0.0005672136,0.0010825589,0.0004407129,0.0021938987],"domain_scores_gemma":[0.9966552,0.0009454679,0.0005037447,0.0016853143,0.00010717562,0.0001030988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034766906,0.0007615072,0.0021263012,0.0007923002,0.00020019666,0.00011030401,0.0005245788,0.0003695618,0.0005961437],"category_scores_gemma":[0.0000849015,0.00055716664,0.00054370007,0.00079197076,0.00040588278,0.00010185193,0.00020246168,0.0017442325,0.00049197464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014229637,0.00014013173,0.06050199,0.0010718191,0.010524271,0.00025329218,0.00003937688,0.000023718227,0.00065264397,0.00006201243,0.92250943,0.00407899],"study_design_scores_gemma":[0.0027735345,0.00038761654,0.008072834,0.00015135821,0.008851527,0.000009229933,0.000017534361,0.00032361335,0.00083901733,0.00006825078,0.9779874,0.00051807717],"about_ca_topic_score_codex":0.00007345807,"about_ca_topic_score_gemma":0.000014849232,"teacher_disagreement_score":0.055477947,"about_ca_system_score_codex":0.0002515982,"about_ca_system_score_gemma":0.00010657277,"threshold_uncertainty_score":0.99968797},"labels":[],"label_agreement":null},{"id":"W2990517472","doi":"10.1016/s2213-8587(19)30351-1","title":"Physical activity and skeletal health in adults","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Observational study; Randomized controlled trial; Physical therapy; Hip fracture; Psychological intervention; Bone health; Physical activity; Balance (ability); Physical medicine and rehabilitation; Meta-analysis; Osteoporosis; Bone mineral; Internal medicine; Psychiatry","score_opus":0.07743467410875322,"score_gpt":0.4155452207863193,"score_spread":0.33811054667756607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990517472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044859383,0.9460871,1.2229168e-7,0.006439488,0.00015697455,0.0019055482,0.0000647475,0.00004877793,0.00043784053],"genre_scores_gemma":[0.004398215,0.99329513,0.000016504722,0.001071605,0.00068344874,0.00023124497,0.000069278845,0.000046466917,0.0001880854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961905,0.00063872524,0.0003362603,0.0005433114,0.00019304163,0.0020981499],"domain_scores_gemma":[0.9980563,0.00074939505,0.00021081149,0.0007493823,0.0000284491,0.00020568431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046525899,0.0003541887,0.0037013774,0.00019099654,0.000071333576,0.000012679407,0.00026306117,0.00017674101,0.000019658622],"category_scores_gemma":[0.000138713,0.00021388305,0.00020947386,0.0002800429,0.00026085885,0.000036122754,0.00025584726,0.0018407359,0.00018884419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045907236,0.00013177017,0.00065311475,0.033484343,0.000059386584,0.000013527008,0.0000507558,1.5824918e-8,0.0000010140379,0.00021163054,0.0010021934,0.96434635],"study_design_scores_gemma":[0.0016776755,0.00074759236,0.009097343,0.0071277786,0.0001233836,0.00008044954,0.000010262075,0.000028916053,0.000002677247,0.000058857677,0.9808442,0.00020086378],"about_ca_topic_score_codex":0.00019786399,"about_ca_topic_score_gemma":0.00008971277,"teacher_disagreement_score":0.979842,"about_ca_system_score_codex":0.00017105018,"about_ca_system_score_gemma":0.0006159904,"threshold_uncertainty_score":0.87218976},"labels":[],"label_agreement":null},{"id":"W2995065776","doi":"10.1016/s2213-8587(19)30389-4","title":"LDL cholesterol: lower, faster, younger?","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; PCSK9; Internal medicine; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Clinical trial; Relative risk; Ldl cholesterol; Meta-analysis; Statin; Drug class; Endocrinology; Drug; Pharmacology; Confidence interval; Lipoprotein; LDL receptor","score_opus":0.029746175073489114,"score_gpt":0.27137853520218747,"score_spread":0.24163236012869835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995065776","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090078704,0.008141295,0.000012413774,0.8876674,0.003999648,0.0018126534,0.00014501881,0.00034179477,0.0078010582],"genre_scores_gemma":[0.014689702,0.0017378632,0.00008171524,0.94528276,0.029504262,0.0002758683,0.00047992982,0.00018664532,0.0077612633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944332,0.00044992144,0.0005304268,0.0008620967,0.0006993425,0.003025016],"domain_scores_gemma":[0.9958247,0.00022995849,0.0002670013,0.003461892,0.00012709704,0.00008933596],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005867136,0.00064692984,0.0023329644,0.00018714966,0.00012352981,0.00005884089,0.0008482887,0.0008071958,0.00025862432],"category_scores_gemma":[0.000083219486,0.00042323637,0.00075398176,0.00018440615,0.00030145395,0.000081457845,0.00033411372,0.0041435305,0.0013568107],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054567765,0.000043548764,0.004103983,0.0010413751,0.0012631203,0.0006026356,0.000046384466,0.0000010901175,0.0001594849,0.000050090497,0.9743108,0.018322913],"study_design_scores_gemma":[0.0025290877,0.0004876913,0.008125466,0.0002572837,0.0006633609,0.00041770615,0.000010078446,0.000009083995,0.00030116033,0.00012072885,0.9866781,0.00040021335],"about_ca_topic_score_codex":0.00012703607,"about_ca_topic_score_gemma":0.000007842225,"teacher_disagreement_score":0.075389005,"about_ca_system_score_codex":0.0001485927,"about_ca_system_score_gemma":0.00019799646,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W3000040775","doi":"10.1016/s2213-8587(19)30423-1","title":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"","keywords":"Dulaglutide; Medicine; Placebo; Stroke (engine); Modified Rankin Scale; Randomized controlled trial; Internal medicine; Diabetes mellitus; Clinical trial; Type 2 diabetes; Physical therapy; Exenatide; Ischemic stroke; Endocrinology; Alternative medicine","score_opus":0.029892093681518128,"score_gpt":0.28478468934896,"score_spread":0.2548925956674419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000040775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891767,0.0005695094,0.0000012631266,0.0074543487,0.00023801344,0.0008751657,0.000037397942,0.000039650313,0.0016079734],"genre_scores_gemma":[0.9980205,0.00012060457,0.000009172749,0.0012747735,0.00027973892,0.00010374393,0.000022855964,0.000015610316,0.0001529914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979975,0.00056827354,0.00032227347,0.00024303953,0.00026829966,0.00060061645],"domain_scores_gemma":[0.997891,0.000801585,0.00022804918,0.0009839921,0.00003539492,0.000059983013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048231063,0.00018557403,0.0008766823,0.0000804582,0.000106777516,0.000010641868,0.0005153961,0.000041308853,0.00004342878],"category_scores_gemma":[0.0002791565,0.00007873415,0.00034009205,0.00048507343,0.0003221543,0.00003395161,0.00017765672,0.00021629171,0.00001180364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031250935,0.00055759307,0.83883494,0.00029152984,0.026701199,0.00002732807,0.0016557763,0.00057936285,0.024950825,0.009155882,0.01118853,0.054806076],"study_design_scores_gemma":[0.09779402,0.032041766,0.40102446,0.00013161972,0.0315986,9.957997e-7,0.0008375093,0.0020692935,0.37641916,0.00040996567,0.05716437,0.00050823967],"about_ca_topic_score_codex":0.000009290389,"about_ca_topic_score_gemma":0.000033844557,"teacher_disagreement_score":0.43781048,"about_ca_system_score_codex":0.00002618835,"about_ca_system_score_gemma":0.000020908179,"threshold_uncertainty_score":0.32106853},"labels":[],"label_agreement":null},{"id":"W3010842324","doi":"10.1016/s2213-8587(20)30062-0","title":"Cardiorenal risk reduction guidance in diabetes: can we reach consensus?","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Boehringer Ingelheim","keywords":"Medicine; Guideline; Intensive care medicine; Diabetes mellitus; Consensus conference; MEDLINE; Evidence-based medicine; Alternative medicine; Internal medicine","score_opus":0.031881481092899636,"score_gpt":0.26590802918457024,"score_spread":0.23402654809167062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010842324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92026645,0.004318699,0.000002661556,0.06993252,0.00031743853,0.00068298297,0.000044818244,0.00023032686,0.004204094],"genre_scores_gemma":[0.99295413,0.0010826177,0.0004251389,0.0040417924,0.0008991212,0.00020303515,0.000054895663,0.000039596245,0.0002996395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709404,0.00028209045,0.00039476302,0.00052968145,0.00021845535,0.0014809989],"domain_scores_gemma":[0.99882555,0.00016643868,0.00016537277,0.00063999154,0.000053815424,0.00014885025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032723727,0.00030476466,0.00089349644,0.000118758384,0.00009757375,0.000023990695,0.00028571315,0.000079920595,0.000058113117],"category_scores_gemma":[0.00022689452,0.00022282203,0.00015231458,0.0003417963,0.00029738728,0.00003942498,0.00016831515,0.0005027351,0.00012149429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020622779,0.00018301456,0.8882788,0.00025796224,0.0011036058,0.00013648628,0.0012406562,0.00013051229,0.009339856,0.0015530576,0.034173045,0.06339679],"study_design_scores_gemma":[0.016645927,0.0026587131,0.61366296,0.0004677031,0.0023088036,0.000036178837,0.001181768,0.0021955187,0.05262215,0.0062874113,0.30073822,0.0011946377],"about_ca_topic_score_codex":0.00006787117,"about_ca_topic_score_gemma":0.000025821251,"teacher_disagreement_score":0.27461582,"about_ca_system_score_codex":0.000126166,"about_ca_system_score_gemma":0.00004352806,"threshold_uncertainty_score":0.9086419},"labels":[],"label_agreement":null},{"id":"W3011403229","doi":"10.1016/s2213-8587(20)30105-4","title":"Insulin access and affordability in the USA: anticipating the first interchangeable insulin product","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Arnold Ventures","keywords":"Medicine; Insulin; Diabetic ketoacidosis; Diabetes mellitus; Insulin delivery; Quarter (Canadian coin); Scopus; Ketoacidosis; Intensive care medicine; MEDLINE; Internal medicine; Endocrinology; Type 1 diabetes","score_opus":0.20502484247822503,"score_gpt":0.40062188686824285,"score_spread":0.19559704439001782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011403229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7060845,0.0036528239,0.0000017732013,0.2876822,0.000085135696,0.0005218295,0.000006456494,0.000025238056,0.0019400755],"genre_scores_gemma":[0.96002173,0.002744706,0.000037611768,0.03635679,0.00067720446,0.00014132704,0.0000027583762,0.00001016919,0.000007720203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980971,0.00037160158,0.0002572802,0.00030855235,0.00014778096,0.0008176429],"domain_scores_gemma":[0.9976873,0.0017354628,0.00009967915,0.0003894453,0.000037400412,0.00005073438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010081145,0.00016308196,0.00044827192,0.000019433084,0.00028009302,0.000063384556,0.0005855976,0.000030813095,0.00007923978],"category_scores_gemma":[0.0017644878,0.00007126025,0.000043567543,0.00033190468,0.0004288949,0.00012389953,0.0005960818,0.0007901326,0.000022369793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035233572,0.000118355936,0.9530368,0.0002734279,0.00013782766,0.000026006863,0.0046430607,0.000009047313,0.00032862995,0.0008618064,0.0019400988,0.038272645],"study_design_scores_gemma":[0.0014918915,0.00031445044,0.7424972,0.00004359736,0.00015338062,0.00002416305,0.0006252955,0.00086279784,0.0017323645,0.0007576619,0.25136217,0.0001350417],"about_ca_topic_score_codex":0.00026432532,"about_ca_topic_score_gemma":0.0006045393,"teacher_disagreement_score":0.25393724,"about_ca_system_score_codex":0.000019505036,"about_ca_system_score_gemma":0.000018280962,"threshold_uncertainty_score":0.3432777},"labels":[],"label_agreement":null},{"id":"W3019508129","doi":"10.1016/s2213-8587(20)30038-3","title":"Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Western University; St. Michael's Hospital; Canadian VIGOUR Centre; University of Alberta; University Health Network; University of Toronto; Women's College Hospital","funders":"Women's College Research Institute; University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Medicine; Meta-analysis; Mace; Myocardial infarction; Type 2 diabetes; Heart failure; Internal medicine; Diabetes mellitus; Relative risk; Randomized controlled trial; Clinical trial; Stroke (engine); MEDLINE; Intensive care medicine; Confidence interval; Percutaneous coronary intervention; Endocrinology","score_opus":0.08404563886580996,"score_gpt":0.3274024658709334,"score_spread":0.24335682700512345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019508129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01802575,0.971557,0.0000035757462,0.000146679,0.000035611116,0.009950605,0.00021250294,0.00005525198,0.000013002481],"genre_scores_gemma":[0.009636489,0.9879655,0.00018559543,0.00017493602,0.000035117486,0.0015118129,0.0003418713,0.000090821646,0.000057835747],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914865,0.0038732241,0.002298642,0.0008883541,0.0005429994,0.0009102708],"domain_scores_gemma":[0.99497277,0.0013044062,0.0012894116,0.0021503347,0.00012858158,0.00015451602],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0045557516,0.0008958516,0.037866075,0.00044533573,0.00006543212,0.000030672887,0.00043284037,0.00017827892,0.00015537751],"category_scores_gemma":[0.0006075103,0.0004051947,0.0042185923,0.0015823924,0.00019035269,0.0001067872,0.0002920141,0.00039847032,0.0000048409042],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023144916,0.00008032798,0.0012846845,0.34194624,0.6546321,0.000021181228,0.00009965792,0.00002759689,0.0000017566106,0.000010230232,0.000030387104,0.0016344058],"study_design_scores_gemma":[0.0071805385,0.0005796817,0.00025790918,0.009287932,0.9629593,0.000009665761,0.0001020175,0.000018347335,0.0000104505,0.000003905743,0.01921739,0.00037284428],"about_ca_topic_score_codex":0.00008057783,"about_ca_topic_score_gemma":0.00015449114,"teacher_disagreement_score":0.3326583,"about_ca_system_score_codex":0.00011468358,"about_ca_system_score_gemma":0.00014069886,"threshold_uncertainty_score":0.99984},"labels":[],"label_agreement":null},{"id":"W3028550899","doi":"10.1016/s2213-8587(20)30114-5","title":"Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim; Gilead Sciences; Medtronic; Novo Nordisk; Merck; Janssen Pharmaceuticals; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Insulin pump; Insulin degludec; Insulin; Regimen; Type 1 diabetes; Diabetes mellitus; Type 2 diabetes; Hypoglycemia; Crossover study; Internal medicine; Physical therapy; Endocrinology; Insulin glargine; Placebo","score_opus":0.03800815549740619,"score_gpt":0.28292218559548576,"score_spread":0.24491403009807958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028550899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988084,0.001938681,0.000003917444,0.0019140824,0.00004651006,0.007424104,0.000039096976,0.000074532414,0.0004750343],"genre_scores_gemma":[0.9980201,0.00037850806,0.0003852185,0.00048539735,0.00013776816,0.00023923769,0.000079549165,0.000085154534,0.00018908083],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964934,0.00033722888,0.00061588583,0.0007492212,0.0005347777,0.001269462],"domain_scores_gemma":[0.9976807,0.00050564745,0.0005469575,0.0006445918,0.0004374517,0.00018463864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032775878,0.00049804425,0.002007177,0.00018472572,0.000099218196,0.00006985787,0.0006456095,0.000110566994,0.000068304646],"category_scores_gemma":[0.00023035645,0.00027836591,0.000059925347,0.0008562401,0.0010518103,0.00022282504,0.00043162075,0.00063481834,0.0000055046917],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.800268,0.0028801372,0.011804688,0.0005348327,0.0009017548,0.00025537258,0.003140169,0.00007456487,0.013786516,0.00007161194,0.00017401653,0.16610835],"study_design_scores_gemma":[0.6401219,0.054159537,0.0043386947,0.002701499,0.00043140532,0.000011716564,0.00063341134,0.0012288648,0.29475784,0.00028008936,0.00071793934,0.00061708485],"about_ca_topic_score_codex":0.00006206556,"about_ca_topic_score_gemma":0.00006174808,"teacher_disagreement_score":0.28097135,"about_ca_system_score_codex":0.000058638416,"about_ca_system_score_gemma":0.00022269643,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W3034389083","doi":"10.1016/s2213-8587(20)30153-4","title":"Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"ZonMw; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Retrospective cohort study; Pediatrics; Cohort; Internal medicine; Newborn screening; Cohort study; Underweight; Body mass index","score_opus":0.0262587116503348,"score_gpt":0.2924348689762644,"score_spread":0.26617615732592964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034389083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930997,0.00025312812,0.000004578934,0.004933502,0.00017246844,0.0006766565,0.00010705899,0.00007302501,0.000679916],"genre_scores_gemma":[0.99822396,0.0001545827,0.000056732017,0.0011906401,0.00019108063,0.00004869739,0.000079507256,0.000016766118,0.000038058384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987765,0.00007365691,0.00021961673,0.00029460885,0.00019473076,0.00044087524],"domain_scores_gemma":[0.99919647,0.000044878107,0.00011566661,0.00042531907,0.000090633956,0.00012704753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000697985,0.00013955742,0.00046668772,0.000034468994,0.000052947507,0.000010940601,0.00026530324,0.000020941434,0.00011102633],"category_scores_gemma":[0.00023862535,0.000095992305,0.00005886797,0.00010491055,0.00011592568,0.000058666574,0.00010216995,0.0001486219,0.000029578974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027455942,0.000977471,0.995528,0.000018849896,0.00024752232,0.00006435589,0.0004797173,0.0000017345208,0.00041435193,0.00066308404,0.00015198877,0.0011783757],"study_design_scores_gemma":[0.0026461622,0.00065066223,0.9949186,0.000006347183,0.00032371268,0.0000015467591,0.00024256522,0.0003074816,0.00014424691,0.00009712901,0.00058265304,0.00007893098],"about_ca_topic_score_codex":0.000019965744,"about_ca_topic_score_gemma":0.000006164866,"teacher_disagreement_score":0.005124269,"about_ca_system_score_codex":0.000034281118,"about_ca_system_score_gemma":0.00003121058,"threshold_uncertainty_score":0.39144525},"labels":[],"label_agreement":null},{"id":"W3034480710","doi":"10.1016/s2213-8587(20)30188-1","title":"Walking the path together: incorporating Indigenous knowledge in diabetes research","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Indigenous Health, Education, and Rights","field":"Social Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Assembly of First Nations","funders":"National Health and Medical Research Council","keywords":"Indigenous; Colonisation; Government (linguistics); Poverty; Medicine; Indigenous culture; Economic growth; Socioeconomics; Gender studies; Geography; Sociology; Colonization","score_opus":0.07474282655997846,"score_gpt":0.3658740319269448,"score_spread":0.29113120536696635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034480710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93144125,0.0034512724,0.0000012793346,0.012560355,0.00050994044,0.00088421314,0.000006625087,0.00011615824,0.051028933],"genre_scores_gemma":[0.99283296,0.0025453982,0.000075222604,0.0010547269,0.0030052767,0.00005719894,0.000007631318,0.000026336373,0.0003952603],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926189,0.0034864242,0.00038098273,0.00038822935,0.00036800766,0.0027574303],"domain_scores_gemma":[0.9968914,0.0021777248,0.00015243643,0.00044549035,0.00019300947,0.00013997086],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0049297437,0.00017570399,0.00040984844,0.000120809455,0.0065711834,0.000113740105,0.0013813729,0.00013667706,0.000065221524],"category_scores_gemma":[0.0001441703,0.00010414459,0.000060726674,0.0010367893,0.0011283357,0.00013334437,0.0000343726,0.0011066531,0.00022867227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000090631875,0.00008436215,0.13125685,0.000058488484,0.000031292908,0.0000059253525,0.7106492,0.0000068302797,0.000099141864,0.1514126,0.00041362894,0.005972606],"study_design_scores_gemma":[0.00063080643,0.00030104138,0.027846055,0.00008738539,0.000023641118,0.0000012524138,0.04658926,0.00012063838,0.0013657894,0.03556237,0.88706464,0.00040714734],"about_ca_topic_score_codex":0.013149184,"about_ca_topic_score_gemma":0.26676363,"teacher_disagreement_score":0.886651,"about_ca_system_score_codex":0.00022428874,"about_ca_system_score_gemma":0.0035631617,"threshold_uncertainty_score":0.9947221},"labels":[],"label_agreement":null},{"id":"W3035452648","doi":"10.1016/s2213-8587(20)30187-x","title":"Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials","year":2020,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim; Novo Nordisk; Abbott Laboratories; Sanofi; Merck; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Canagliflozin; Dapagliflozin; Empagliflozin; Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Clinical trial; Internal medicine; Glycemic; Pharmacology; Intensive care medicine; Endocrinology; Drug","score_opus":0.23551056235457685,"score_gpt":0.3721536130965929,"score_spread":0.13664305074201605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035452648","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.073322564,0.0067390157,0.000028693492,0.9063955,0.0035779746,0.0030784167,0.005569712,0.0005127559,0.000775401],"genre_scores_gemma":[0.02188027,0.0025370254,0.0015594579,0.91455257,0.023424238,0.00075702835,0.034087982,0.00018692522,0.0010145162],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98986787,0.0019406837,0.0023298175,0.0018425931,0.0015911087,0.0024279295],"domain_scores_gemma":[0.9875922,0.00702223,0.0011431145,0.0038061452,0.00013973382,0.00029658296],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010611803,0.0010094516,0.0048534567,0.00020176059,0.00020319612,0.00013412698,0.002526986,0.00055204704,0.0062359227],"category_scores_gemma":[0.0054591866,0.00066068745,0.00045436076,0.00037573956,0.000394877,0.00013902201,0.0031637521,0.0028104112,0.0010227694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030652565,0.00015084258,0.03721362,0.00016536628,0.004229768,0.001958004,0.00012571919,2.7384115e-7,0.000099219345,0.000009597534,0.94483835,0.010902742],"study_design_scores_gemma":[0.00539741,0.0009325967,0.009284605,0.0010066647,0.0043198555,0.000005368526,0.000043868462,0.00034516523,0.00041860927,0.0005045291,0.9771157,0.0006256137],"about_ca_topic_score_codex":0.0012494554,"about_ca_topic_score_gemma":0.00026953468,"teacher_disagreement_score":0.05144229,"about_ca_system_score_codex":0.00032595388,"about_ca_system_score_gemma":0.0003154531,"threshold_uncertainty_score":0.999755},"labels":[],"label_agreement":null},{"id":"W3035468154","doi":"10.1016/s2213-8587(20)30162-5","title":"Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto","funders":"Novo Nordisk; Diabetes Australia Research Trust; Rijksuniversiteit Groningen; AstraZeneca","keywords":"Medicine; Dapagliflozin; Kidney disease; Renal function; Proteinuria; Albuminuria; Placebo; Diabetes mellitus; Internal medicine; Crossover study; Type 2 diabetes; Urology; Randomized controlled trial; Kidney; Endocrinology; Pathology","score_opus":0.01359334487993476,"score_gpt":0.24622368326784044,"score_spread":0.23263033838790567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035468154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98054403,0.00039231565,0.0000012364097,0.006631297,0.00041954074,0.011288469,0.000029299032,0.00006159774,0.00063219055],"genre_scores_gemma":[0.9928473,0.000032910044,0.000019084175,0.0038312264,0.00069178734,0.0022882055,0.000052010244,0.00004620259,0.00019124875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99725837,0.00022305617,0.00043562904,0.00050488353,0.00041720812,0.001160836],"domain_scores_gemma":[0.99838823,0.00030318394,0.00025131644,0.00073908514,0.00005778917,0.00026038906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016304314,0.0003906721,0.0010039501,0.00010225975,0.00008688343,0.000030168741,0.0004468114,0.00007385008,0.00005532638],"category_scores_gemma":[0.00029494558,0.0002046784,0.00021363057,0.00041051753,0.00033428703,0.000077391196,0.0002315652,0.0004125995,0.000055078057],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7553741,0.0024690933,0.22575806,0.0018961327,0.0013606877,0.00008294981,0.00041919673,0.000083978324,0.0020803707,0.00079601776,0.005454302,0.0042251153],"study_design_scores_gemma":[0.8612431,0.003913642,0.10474439,0.0005828804,0.00094130804,1.4744268e-7,0.000006591645,0.00009109341,0.024245067,0.000093275026,0.0038660131,0.00027247652],"about_ca_topic_score_codex":0.000015321548,"about_ca_topic_score_gemma":0.000009396596,"teacher_disagreement_score":0.12101366,"about_ca_system_score_codex":0.00013898457,"about_ca_system_score_gemma":0.0001679681,"threshold_uncertainty_score":0.83465433},"labels":[],"label_agreement":null},{"id":"W3035689851","doi":"10.1016/s2213-8587(20)30130-3","title":"Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Vifor Pharma; Amarin Corporation; Novo Nordisk; Steno Diabetes Center Copenhagen; Sanofi; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Cohort study; Cohort; Multinational corporation; Internal medicine; Pharmacology","score_opus":0.02227324117206337,"score_gpt":0.25364194466514184,"score_spread":0.23136870349307848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035689851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766445,0.0003308916,0.000024067751,0.0005304954,0.000025988842,0.001114898,0.0001362375,0.000048730522,0.00012425963],"genre_scores_gemma":[0.9988834,0.000112431706,0.00012638429,0.00014691766,0.00012788238,0.00010348934,0.00047657857,0.000018295177,0.000004621559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800503,0.0004805146,0.00032551656,0.00034637324,0.00046754422,0.0003750196],"domain_scores_gemma":[0.99859846,0.0003664898,0.00033394544,0.00045995982,0.00017638819,0.00006473569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041058444,0.00020668114,0.0010128525,0.00009024337,0.0000887604,0.000010912159,0.00017113776,0.000037307578,0.000013412106],"category_scores_gemma":[0.00011393063,0.00011085503,0.00013578277,0.0004614103,0.00014820443,0.000078530036,0.00009871551,0.00016396574,9.851301e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019176626,0.00045207777,0.9698588,0.000014361765,0.02660374,0.000008440788,0.0010970008,0.0010842673,0.000059701957,0.00004085155,0.000040170875,0.0005488038],"study_design_scores_gemma":[0.0051263645,0.0012866732,0.9762417,0.000032979595,0.014043061,2.6495474e-7,0.00079515536,0.0014473548,0.0008417029,0.000027711334,0.000048731898,0.00010830861],"about_ca_topic_score_codex":0.00081416353,"about_ca_topic_score_gemma":0.00034253908,"teacher_disagreement_score":0.012560679,"about_ca_system_score_codex":0.000044093053,"about_ca_system_score_gemma":0.000027318782,"threshold_uncertainty_score":0.45205367},"labels":[],"label_agreement":null},{"id":"W3044765479","doi":"10.1016/s2213-8587(20)30240-0","title":"Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharma; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Cushing's disease; Internal medicine; Clinical trial; Gastroenterology; Surgery; Disease","score_opus":0.020525549475121814,"score_gpt":0.2898927121754603,"score_spread":0.2693671627003385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044765479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932601,0.00056698924,0.0000080327545,0.0015988442,0.000022419363,0.0043039597,0.00008266875,0.000049074886,0.000107942156],"genre_scores_gemma":[0.9988796,0.000056620247,0.00005674867,0.00058220676,0.000051819396,0.00016459191,0.00017196956,0.000027733991,0.000008681278],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998125,0.00012682678,0.00036047294,0.00042680482,0.0002399137,0.0007209648],"domain_scores_gemma":[0.9989447,0.00018602583,0.000164987,0.00037790884,0.000065546665,0.00026084782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092474154,0.00029903115,0.00097374024,0.000077760385,0.000089238,0.0000143264,0.0001469988,0.000030348081,0.000024686871],"category_scores_gemma":[0.000052082472,0.00016094325,0.00004465534,0.00023226211,0.0002260539,0.00009033157,0.00007808203,0.00024186072,0.0000034302875],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44171003,0.0050830357,0.549315,0.000052490584,0.00047002925,0.00014831638,0.0013095381,0.000015458374,0.00002108819,0.000016071588,0.000017255421,0.001841726],"study_design_scores_gemma":[0.777341,0.0076808906,0.21316935,0.00008392503,0.00081962306,0.0000018441089,0.0004014985,0.0001688287,0.00009791937,0.000010321388,0.00006535422,0.00015943462],"about_ca_topic_score_codex":0.000058533326,"about_ca_topic_score_gemma":0.00007170786,"teacher_disagreement_score":0.3361456,"about_ca_system_score_codex":0.000022728469,"about_ca_system_score_gemma":0.000072759845,"threshold_uncertainty_score":0.6563076},"labels":[],"label_agreement":null},{"id":"W3085210273","doi":"10.1016/s2213-8587(20)30310-7","title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; McMaster University; University of Alberta; Alberta Children's Hospital; Sunnybrook Health Science Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Calgary; University Health Network; Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"Roche Diabetes Care; University of Toronto; Department of Medicine, University of Toronto; Novo Nordisk; Canadian Institutes of Health Research; National Institute for Health and Care Research; Sunnybrook Research Institute; Medtronic","keywords":"Medicine; Metformin; Type 2 diabetes; Pregnancy; Postprandial; Placebo; Regimen; Diabetes mellitus; Insulin; Internal medicine; Obstetrics; Endocrinology","score_opus":0.02742699541447207,"score_gpt":0.2904454808768105,"score_spread":0.2630184854623384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085210273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097575,0.0011514289,0.0000031879858,0.009945029,0.00016719561,0.00460971,0.000008573913,0.00006012763,0.0030789806],"genre_scores_gemma":[0.9925583,0.00090905244,0.00026396106,0.0030434532,0.0002556089,0.002619471,0.00003617282,0.000026199232,0.00028778028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970936,0.0002905348,0.0004516309,0.00037599145,0.00035548917,0.0014327281],"domain_scores_gemma":[0.9984998,0.000829066,0.00012631841,0.00029250648,0.00009363426,0.00015868167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047854436,0.0002288551,0.0009729945,0.00024132716,0.000035560883,0.000031315525,0.00040087098,0.00005291994,0.0002452276],"category_scores_gemma":[0.0014458294,0.00014616956,0.00006778298,0.00042567757,0.00013036291,0.00011698089,0.00016240214,0.00043950044,0.00006028388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8718505,0.0006573321,0.09723472,0.00029426045,0.0011105182,0.0002499146,0.0012890352,0.00031859108,0.0014847707,0.0006687895,0.0011317586,0.023709813],"study_design_scores_gemma":[0.9616396,0.0019008412,0.02284557,0.00021636963,0.00008863385,0.0000013512733,0.00038277835,0.0046382938,0.0006626035,0.00040370188,0.007000135,0.0002201535],"about_ca_topic_score_codex":0.000018792452,"about_ca_topic_score_gemma":0.00006375366,"teacher_disagreement_score":0.08978907,"about_ca_system_score_codex":0.00014972848,"about_ca_system_score_gemma":0.00010175572,"threshold_uncertainty_score":0.5960622},"labels":[],"label_agreement":null},{"id":"W3085703194","doi":"10.1016/s2213-8587(20)30230-8","title":"Diabetes in ageing: pathways for developing the evidence base for clinical guidance","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Aging; National Institutes of Health; MannKind Corporation; Eisai; Insulet Corporation; Amarin Corporation; Novo Nordisk; Dexcom; Intarcia Therapeutics; Bigfoot Biomedical; Sanofi; Merck; GlaxoSmithKline; Takeda Pharmaceuticals U.S.A.; Pfizer; AstraZeneca; Eli Lilly and Company; National Institute of Diabetes and Digestive and Kidney Diseases; Boehringer Ingelheim; Leona M. and Harry B. Helmsley Charitable Trust; U.S. Department of Veterans Affairs","keywords":"Medicine; Life expectancy; Multidisciplinary approach; Comorbidity; Gerontology; MEDLINE; Diabetes mellitus; Health care; Multimorbidity; Geriatrics; Diabetes management; Type 2 diabetes; Psychiatry; Population","score_opus":0.3001917020371686,"score_gpt":0.4297795609243814,"score_spread":0.1295878588872128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085703194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010013041,0.978158,0.00007574676,0.012410332,0.000881456,0.00694542,0.00011188916,0.00017252006,0.00024333863],"genre_scores_gemma":[0.00046711214,0.98085487,0.0023946895,0.005978856,0.0019501217,0.007816489,0.00019178254,0.0001228279,0.00022323977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994588,0.0005662432,0.0013940125,0.0010277472,0.00021851854,0.0022054783],"domain_scores_gemma":[0.9889178,0.008933908,0.000627509,0.0013021905,0.00010896382,0.00010960205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020809886,0.00072481483,0.004099592,0.0001571853,0.00019835973,0.00006933979,0.0012589167,0.0002485118,0.0000121529],"category_scores_gemma":[0.0031961198,0.00039525877,0.001034052,0.00043164918,0.00035150893,0.00008844703,0.00051906175,0.00072140386,0.00005963428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049380058,0.00008711022,0.0046626967,0.016048048,0.0012092888,0.000045439003,0.00004503211,4.2796887e-7,0.0000029343694,0.0065566846,0.014830764,0.9564622],"study_design_scores_gemma":[0.0017984278,0.0006383673,0.0008475885,0.012173117,0.0028247838,0.000002818881,0.000021080845,0.00012283801,0.000030969164,0.0014472607,0.9796845,0.00040827377],"about_ca_topic_score_codex":0.0000036406557,"about_ca_topic_score_gemma":0.000018450079,"teacher_disagreement_score":0.9648537,"about_ca_system_score_codex":0.00023126214,"about_ca_system_score_gemma":0.0003738701,"threshold_uncertainty_score":0.9998499},"labels":[],"label_agreement":null},{"id":"W3087691613","doi":"10.1016/s2213-8587(20)30313-2","title":"Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Medicine; Post-hoc analysis; Type 2 diabetes; Renal function; Diabetes mellitus; Post hoc; MEDLINE; Randomized controlled trial; Internal medicine; Endocrinology; Liraglutide","score_opus":0.010137212375282744,"score_gpt":0.23273598781001736,"score_spread":0.2225987754347346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087691613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049795,0.00067211385,0.000002095356,0.0048495233,0.000104436775,0.003501331,0.00003646022,0.0000333761,0.00030270824],"genre_scores_gemma":[0.99474174,0.00013712472,0.000022644568,0.0047598733,0.0000543243,0.00012900314,0.00006661271,0.000019833748,0.00006883256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724966,0.0008623751,0.00067170284,0.00031495985,0.00027315313,0.0006281501],"domain_scores_gemma":[0.9962616,0.0025698983,0.00051016954,0.00041126195,0.0001520132,0.000095077536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006590743,0.00026671845,0.0028301533,0.00022809528,0.000048656148,0.0000092514765,0.00018371119,0.000060894727,0.00003553797],"category_scores_gemma":[0.0020575959,0.0001277279,0.00031468482,0.0007574645,0.0002015416,0.000027588207,0.000093588584,0.00018623516,0.0000024860647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18086879,0.0007828625,0.7818214,0.0006801103,0.019146167,0.000018502195,0.00043388986,0.00026650887,0.004763468,0.00069709757,0.0006873704,0.00983382],"study_design_scores_gemma":[0.2612187,0.013728099,0.6976696,0.00027031198,0.021719057,2.0397721e-7,0.00012194713,0.00083534216,0.0033989048,0.000109114895,0.0006960994,0.00023263026],"about_ca_topic_score_codex":0.000012968015,"about_ca_topic_score_gemma":0.000011322158,"teacher_disagreement_score":0.08415181,"about_ca_system_score_codex":0.000056207147,"about_ca_system_score_gemma":0.000057362795,"threshold_uncertainty_score":0.52085924},"labels":[],"label_agreement":null},{"id":"W3093341334","doi":"10.1016/s2213-8587(20)30300-4","title":"Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Research and Development; National Health and Medical Research Council; Medical Research Council; University of New South Wales; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Japan Society for the Promotion of Science; Mitsubishi Tanabe Pharma Corporation; Janssen Scientific Affairs","keywords":"Canagliflozin; Medicine; Post-hoc analysis; Placebo; Internal medicine; Kidney disease; Type 2 diabetes; Diabetes mellitus; Erythropoiesis; Anemia; Endocrinology; Pathology","score_opus":0.009670599550727556,"score_gpt":0.23195711636645489,"score_spread":0.22228651681572734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093341334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877586,0.0022794458,4.6180153e-7,0.008472074,0.00009817192,0.0012036839,0.00008018317,0.000040263254,0.000067132794],"genre_scores_gemma":[0.9929681,0.00019807379,0.00002365003,0.0062282714,0.00021825483,0.00011274349,0.00021087522,0.000018890545,0.000021174259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982922,0.00018355422,0.00022459107,0.00037370092,0.00023338293,0.0006925806],"domain_scores_gemma":[0.9984935,0.00067955843,0.00012572262,0.00047445536,0.000053440584,0.00017331354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008970646,0.00023044737,0.0007514702,0.0000995563,0.000054485834,0.000017959721,0.0002676199,0.000036991547,0.00004859735],"category_scores_gemma":[0.00040268793,0.00012287797,0.000086023116,0.00058084016,0.00021206566,0.000043973505,0.00013921226,0.00018362045,0.0000084656585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008047605,0.00022670333,0.98332167,0.00014845027,0.0020161192,0.000019451643,0.0001919795,0.00002490743,0.00022805911,0.00019362483,0.0014102224,0.0041712327],"study_design_scores_gemma":[0.029956209,0.004782343,0.9591633,0.00012783369,0.0030293083,1.3890405e-8,0.000021700003,0.00021712719,0.00079004845,0.00005196324,0.0017200725,0.00014005699],"about_ca_topic_score_codex":0.00015089069,"about_ca_topic_score_gemma":0.00018808628,"teacher_disagreement_score":0.024158321,"about_ca_system_score_codex":0.00006898266,"about_ca_system_score_gemma":0.00008182521,"threshold_uncertainty_score":0.5010818},"labels":[],"label_agreement":null},{"id":"W3096071972","doi":"10.1016/s2213-8587(20)30337-5","title":"Insulin's centenary: the birth of an idea","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Insulin; Classics; Medicine; Biochemist; Human insulin; History; Library science; Internal medicine; Computer science","score_opus":0.07860023709587693,"score_gpt":0.3626415229952919,"score_spread":0.28404128589941496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096071972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008755925,0.9835656,8.7554724e-7,0.0070148213,0.00035199284,0.0016305723,0.000092045346,0.00013518186,0.0063333074],"genre_scores_gemma":[0.0007077787,0.9945162,0.00005851019,0.0014351942,0.0014286585,0.0002180012,0.00020146501,0.000087108536,0.0013470888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996045,0.00072992133,0.0006411501,0.000515354,0.00041847,0.0016501265],"domain_scores_gemma":[0.9971797,0.00062475045,0.00037880766,0.0015816437,0.00009022954,0.00014490925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006762941,0.0004664015,0.0030333253,0.00020469635,0.00012830421,0.000035474903,0.0016442208,0.0001662948,0.00023686931],"category_scores_gemma":[0.00028707372,0.00021104822,0.00052182755,0.0006634829,0.00070957607,0.000053134827,0.0008038224,0.0013363758,0.00042994827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033851084,0.00010963615,0.0003528394,0.010042948,0.0010997619,0.00008623182,0.000038286384,3.2256673e-7,0.0000040969026,0.0031681573,0.0072090756,0.9778548],"study_design_scores_gemma":[0.0007350478,0.00052528904,0.00031277945,0.0015902696,0.0012372147,0.000014039981,0.00004095615,0.00003874907,0.0000147994,0.00053931575,0.9947537,0.0001978248],"about_ca_topic_score_codex":0.0000103434695,"about_ca_topic_score_gemma":0.0000033625363,"teacher_disagreement_score":0.98754466,"about_ca_system_score_codex":0.000050257328,"about_ca_system_score_gemma":0.00018503412,"threshold_uncertainty_score":0.8606296},"labels":[],"label_agreement":null},{"id":"W3101690455","doi":"10.1016/s2213-8587(20)30344-2","title":"Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Abbott Vascular; St. Jude Medical; Boehringer Ingelheim","keywords":"Empagliflozin; Medicine; Internal medicine; Myocardial infarction; Placebo; Diabetes mellitus; Type 2 diabetes; Clinical trial; Adverse effect; Hazard ratio; Cardiology; Confidence interval; Endocrinology","score_opus":0.029464730661604415,"score_gpt":0.2747470569956991,"score_spread":0.24528232633409472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101690455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549454,0.0018838034,3.260962e-7,0.00095087016,0.0001460676,0.0014551649,0.000024119237,0.000016942977,0.000028141072],"genre_scores_gemma":[0.9989109,0.00032576936,0.000014309079,0.0005672851,0.00006554748,0.00006742818,0.000023348886,0.000016459704,0.000008927082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818903,0.00033074786,0.00041379812,0.00035476394,0.000260873,0.00045079485],"domain_scores_gemma":[0.99865496,0.00050227914,0.00017441643,0.00052639167,0.000040037306,0.00010188592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002819083,0.00020676947,0.0013007759,0.00010875054,0.000043083503,0.0000045298298,0.00017944133,0.000043756394,0.000009775606],"category_scores_gemma":[0.00033773942,0.00011029803,0.0002740442,0.0004369147,0.00023955257,0.000029968913,0.00019311572,0.00021938584,0.0000016647601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031897305,0.00042559227,0.984089,0.00038392303,0.0058125556,0.0000026197338,0.0001155526,0.000027991884,0.0000055468417,0.00003066565,0.000039179235,0.0058776042],"study_design_scores_gemma":[0.027886,0.0027348353,0.96181834,0.00014154922,0.0067573097,1.943175e-8,0.000010106016,0.00013078406,0.00009339106,0.000022837823,0.0003082065,0.000096610456],"about_ca_topic_score_codex":0.0000053768727,"about_ca_topic_score_gemma":0.000009431918,"teacher_disagreement_score":0.02469627,"about_ca_system_score_codex":0.000022147786,"about_ca_system_score_gemma":0.000018153536,"threshold_uncertainty_score":0.44978234},"labels":[],"label_agreement":null},{"id":"W3113238274","doi":"10.1016/s2213-8587(20)30374-0","title":"SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond","year":2020,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Providence Health Care","keywords":"Diabetes mellitus; Medicine; Kidney disease; Type 2 diabetes; Disease; Kidney; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.01780741140234083,"score_gpt":0.253928814049395,"score_spread":0.23612140264705417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113238274","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28878224,0.0051759267,3.9797396e-7,0.7035045,0.0002454098,0.001009782,0.0001656158,0.00014497105,0.0009711399],"genre_scores_gemma":[0.14644921,0.002280972,0.000065894455,0.84604883,0.0022128264,0.00053934206,0.0013088456,0.00009302989,0.0010010357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665636,0.00018902076,0.00040277847,0.00077753654,0.00025286348,0.0017214329],"domain_scores_gemma":[0.99855715,0.00033240108,0.00016484402,0.0006718858,0.000027501008,0.00024619512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013420921,0.00058797677,0.001477542,0.00027038,0.00009736443,0.00006809691,0.00019962717,0.00021008015,0.000091389025],"category_scores_gemma":[0.0001798942,0.00041175197,0.0001322738,0.0001729115,0.00048643968,0.00009943911,0.0004430544,0.0012556995,0.0000652877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000365695,0.00008713646,0.35404557,0.0017859912,0.0008075446,0.0010063607,0.00010555882,3.438386e-7,0.00023515908,0.00036842842,0.6359614,0.0055599483],"study_design_scores_gemma":[0.007899657,0.00091521617,0.10787288,0.0006172492,0.0020288294,0.0000063382995,0.00003191765,0.0001498462,0.0004314535,0.0059672957,0.87332046,0.00075887365],"about_ca_topic_score_codex":0.000007470651,"about_ca_topic_score_gemma":0.0000074940613,"teacher_disagreement_score":0.24617268,"about_ca_system_score_codex":0.00015498993,"about_ca_system_score_gemma":0.00009004982,"threshold_uncertainty_score":0.9998334},"labels":[],"label_agreement":null},{"id":"W3130307224","doi":"10.1016/s2213-8587(20)30402-2","title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Toronto","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Medicine; Demography; Incidence (geometry); Diabetes mellitus; Poisson regression; Population; Environmental health; Gerontology","score_opus":0.056064755751702555,"score_gpt":0.32892676483538785,"score_spread":0.2728620090836853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130307224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44126305,0.55665696,6.6129394e-7,0.00017831085,0.00012256879,0.0006024412,0.0011338752,0.00002302873,0.000019123605],"genre_scores_gemma":[0.16307327,0.83290046,0.00020819658,0.00027217827,0.00032617158,0.00041847097,0.0027223974,0.000067468245,0.000011402609],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99246705,0.0021806252,0.0018291306,0.0012742325,0.0007123814,0.0015365661],"domain_scores_gemma":[0.9878291,0.006491714,0.001152153,0.0043008034,0.00012276563,0.00010348979],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024643894,0.00079547137,0.008920587,0.0016860234,0.00006892445,0.00004995306,0.002108515,0.00041670696,0.00010419365],"category_scores_gemma":[0.0020637158,0.0005014868,0.0010176066,0.0037031411,0.00077810604,0.00017158255,0.0011491423,0.0012800269,0.000006472872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024476896,0.00029979894,0.1837848,0.007801257,0.008065904,0.00037011548,0.00048121644,0.000014216384,0.0000055781206,0.00004128362,0.00008747065,0.79902387],"study_design_scores_gemma":[0.0047846036,0.00035015863,0.8185573,0.050260946,0.03738354,0.000022799064,0.00037227286,0.00046767018,0.0001300948,0.00017453446,0.08644153,0.0010545381],"about_ca_topic_score_codex":0.008079725,"about_ca_topic_score_gemma":0.005113393,"teacher_disagreement_score":0.79796934,"about_ca_system_score_codex":0.00011647644,"about_ca_system_score_gemma":0.00015645493,"threshold_uncertainty_score":0.9997437},"labels":[],"label_agreement":null},{"id":"W3134851073","doi":"10.1016/s2213-8587(21)00019-x","title":"Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novo Nordisk Fonden; Novo Nordisk","keywords":"Medicine; Liraglutide; Placebo; Type 2 diabetes; Diabetes mellitus; Internal medicine; Antibody; Endocrinology; Immunology; Alternative medicine; Pathology","score_opus":0.01903826276283652,"score_gpt":0.2832448740454684,"score_spread":0.26420661128263184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134851073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899669,0.0059294486,0.00006223193,0.001295235,0.0003209892,0.0021301236,0.000059032263,0.000014689835,0.00022133399],"genre_scores_gemma":[0.9948662,0.003104385,0.000052686974,0.00055018737,0.00024606788,0.00052924873,0.00048035645,0.000027799742,0.00014307411],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99810773,0.00025211318,0.00039423548,0.00039087326,0.00011267351,0.00074234884],"domain_scores_gemma":[0.9985405,0.0004697838,0.0002818605,0.00044117798,0.00022920492,0.000037472146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005577567,0.00022512244,0.00064985943,0.000052382144,0.00010584925,0.000039788967,0.0002558129,0.00012542603,0.000019093613],"category_scores_gemma":[0.0003782433,0.00014041764,0.00011772529,0.00021082818,0.00016515874,0.000016093818,0.00010730602,0.00017899499,0.0000011174941],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8318501,0.0006564675,0.0248754,0.00015437952,0.0009458724,0.000002642688,0.00013708054,0.00017296245,0.13500793,0.00009789249,0.0013534754,0.004745799],"study_design_scores_gemma":[0.8986936,0.0023390648,0.0010794941,0.00007276067,0.00034826776,0.0000014631624,0.00030429463,0.0007178326,0.08755518,0.0001554437,0.008488156,0.00024441097],"about_ca_topic_score_codex":0.000014960596,"about_ca_topic_score_gemma":0.00012978756,"teacher_disagreement_score":0.06684354,"about_ca_system_score_codex":0.000012712603,"about_ca_system_score_gemma":0.00010546725,"threshold_uncertainty_score":0.5726065},"labels":[],"label_agreement":null},{"id":"W3145956627","doi":"10.1016/s2213-8587(21)00051-6","title":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; St. Michael's Hospital","funders":"Barts Charity","keywords":"Medicine; Meta-analysis; Intensive care medicine; Randomized controlled trial; MEDLINE; Aggregate data; Respiratory tract infections; Respiratory system; Internal medicine; Pathology","score_opus":0.24297030245666074,"score_gpt":0.4648227817449091,"score_spread":0.22185247928824836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145956627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005821994,0.97372997,0.000014885802,0.0021594486,0.00006814338,0.018835805,0.005070076,0.000035576828,0.000027849677],"genre_scores_gemma":[0.00002595959,0.9824322,0.00012516446,0.0014894378,0.00012208412,0.013268061,0.002198163,0.000040148072,0.000298788],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98166573,0.012494904,0.0036172033,0.00086846744,0.00052389165,0.0008298008],"domain_scores_gemma":[0.9769186,0.017114261,0.0024468012,0.0030637127,0.00033139496,0.0001252404],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010563556,0.00063540024,0.047564767,0.0006654898,0.00010856947,0.000042677948,0.00081779016,0.00012692121,0.00060336106],"category_scores_gemma":[0.023413323,0.00030096335,0.0034795282,0.001176588,0.0001948499,0.00006796278,0.0010146808,0.00047943954,0.000021598764],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007788761,0.00011624639,0.0000060423213,0.26439497,0.7284565,0.000025955069,0.000033571083,2.3599655e-7,0.000010414357,0.000018137542,0.0050635003,0.0017965051],"study_design_scores_gemma":[0.010319328,0.00017642826,0.0000066516473,0.028582627,0.9349812,0.000006998239,0.000025679836,0.0000040941363,0.000017723003,0.000009713693,0.025668358,0.00020120015],"about_ca_topic_score_codex":0.000035853438,"about_ca_topic_score_gemma":0.000074656185,"teacher_disagreement_score":0.23581235,"about_ca_system_score_codex":0.00009673206,"about_ca_system_score_gemma":0.0002312095,"threshold_uncertainty_score":0.99994427},"labels":[],"label_agreement":null},{"id":"W3146122039","doi":"10.1016/s2213-8587(21)00046-2","title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; Université de Montréal","funders":"Akebia Therapeutics; Ionis Pharmaceuticals","keywords":"Medicine; Placebo; Clinical trial; Internal medicine; Triglyceride; Dosing; Randomized controlled trial; Surgery; Physical therapy; Cholesterol","score_opus":0.021223623337175528,"score_gpt":0.2868707706200514,"score_spread":0.26564714728287586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146122039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929967,0.0010229616,0.00000440312,0.00059328176,0.00076288194,0.0041777347,0.00004364847,0.00003809647,0.00036027786],"genre_scores_gemma":[0.99811745,0.00022400207,0.00015324999,0.0002600203,0.0007996112,0.00019122832,0.00016363393,0.000028580469,0.00006223933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99748015,0.0003235925,0.0006295725,0.00040807162,0.00023731537,0.0009213217],"domain_scores_gemma":[0.9980113,0.00095442845,0.00025129537,0.0005303965,0.00013690672,0.00011569908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034829925,0.00029294894,0.0017524735,0.00012286908,0.00006460291,0.000017577304,0.00016933105,0.000112293565,0.000112666086],"category_scores_gemma":[0.0004526237,0.0001810445,0.00012322603,0.0001956413,0.00024395496,0.000067014786,0.00010039099,0.0003776021,0.000008613712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92141986,0.0013703806,0.07124279,0.00006399721,0.00045198653,0.000015660167,0.0003696407,0.000017231816,0.0009661269,0.00012339298,0.00013261201,0.0038263167],"study_design_scores_gemma":[0.9626601,0.0005803218,0.0305043,0.000049386585,0.00053289457,0.0000033740391,0.00009656799,0.000071217386,0.0020918217,0.000015144412,0.0032134093,0.00018151061],"about_ca_topic_score_codex":0.00005659366,"about_ca_topic_score_gemma":0.00006896974,"teacher_disagreement_score":0.04124019,"about_ca_system_score_codex":0.000032374868,"about_ca_system_score_gemma":0.00014306819,"threshold_uncertainty_score":0.73827803},"labels":[],"label_agreement":null},{"id":"W3154073035","doi":"10.1016/s2213-8587(21)00054-1","title":"Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Muscle metabolism and nutrition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Athletes; Type 2 diabetes; Diabetes mellitus; Physical therapy; Type 1 diabetes; Diabetes management; Exercise physiology; Endurance training; Physical medicine and rehabilitation; Intensive care medicine; Endocrinology","score_opus":0.0396287813029562,"score_gpt":0.30524530210711115,"score_spread":0.26561652080415493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154073035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053493977,0.9903072,0.000023255916,0.00084594183,0.00081260665,0.0017400419,0.00082519255,0.00002956958,0.000066762004],"genre_scores_gemma":[0.00028370038,0.9937599,0.00036654287,0.0011341849,0.0012166025,0.0014053796,0.0013857068,0.00008571341,0.00036228602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969946,0.0003834218,0.00049985084,0.0006659417,0.00014349492,0.0013126736],"domain_scores_gemma":[0.99756604,0.0004572206,0.00038699497,0.0012809372,0.0002483516,0.000060479622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046988163,0.0005079363,0.0015952977,0.000053238142,0.00021723816,0.00005778119,0.0007293518,0.00022771851,0.000029729877],"category_scores_gemma":[0.00020510645,0.0002759382,0.00039594027,0.00018655723,0.0002982298,0.0000035689384,0.00024211202,0.00034327942,0.000018771374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015633935,0.00006864442,0.000041821262,0.00376481,0.0012293118,0.000009231774,0.000016111913,0.000005473032,0.001466844,0.00016256256,0.019464156,0.9736147],"study_design_scores_gemma":[0.00078307616,0.00037686527,0.000043045617,0.0014789733,0.0012431812,0.000016584356,0.000022422695,0.0000031250972,0.0013750895,0.000051901858,0.9942262,0.00037951747],"about_ca_topic_score_codex":0.000006578261,"about_ca_topic_score_gemma":0.000021059526,"teacher_disagreement_score":0.9747621,"about_ca_system_score_codex":0.000024367819,"about_ca_system_score_gemma":0.00023520028,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W3154717121","doi":"10.1016/s2213-8587(21)00078-4","title":"Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; Division of Research Capacity Development; Bloomberg Family Foundation; South African Medical Research Council; Robert Wood Johnson Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; International Development Research Centre; National Institutes of Health; Bloomberg Philanthropies; Laura and John Arnold Foundation; Arnold Ventures","keywords":"Environmental health; Medicine; Added sugar; Micronutrient; Consumption (sociology); Food processing; Food choice; Food policy; Saturated fat; Obesity; Business; Marketing; Food science; Food security; Agriculture; Geography","score_opus":0.10641426824687417,"score_gpt":0.3895894235756924,"score_spread":0.2831751553288182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154717121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08446,0.91048664,0.0000029991143,0.0034435575,0.00014380147,0.0011216444,0.00006487125,0.000099044686,0.0001774386],"genre_scores_gemma":[0.021417933,0.97595334,0.00045385613,0.0014047512,0.00041412798,0.00017121006,0.00007424299,0.000058686757,0.000051869047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725854,0.00022915707,0.0005398135,0.0005722575,0.0001579991,0.001242241],"domain_scores_gemma":[0.99851537,0.0003647458,0.00023342636,0.00055942335,0.00010080991,0.00022621632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040405508,0.00045258956,0.0024629023,0.00017899495,0.00019086429,0.00009340074,0.00020080426,0.00020035275,0.000027363358],"category_scores_gemma":[0.0004084513,0.0003063567,0.00012866325,0.0002865157,0.00022611498,0.000056922137,0.00020362006,0.00076976337,0.000010164147],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022070546,0.000036783716,0.0012199925,0.022434605,0.001223357,0.000017884566,0.00053615327,1.15877135e-7,0.00028445385,0.000861615,0.00010427735,0.9732587],"study_design_scores_gemma":[0.0017088024,0.001192856,0.0032642365,0.02249963,0.005160612,0.001047988,0.00013346542,0.000007854509,0.00048739614,0.00016854669,0.9635804,0.0007482021],"about_ca_topic_score_codex":0.00006367155,"about_ca_topic_score_gemma":0.000032604632,"teacher_disagreement_score":0.9725105,"about_ca_system_score_codex":0.00007332269,"about_ca_system_score_gemma":0.00029193793,"threshold_uncertainty_score":0.99993885},"labels":[],"label_agreement":null},{"id":"W3176374233","doi":"10.1016/s2213-8587(21)00115-7","title":"Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Université Laval; Population Health Research Institute; McMaster University Medical Centre; University of Toronto; Hamilton Health Sciences; LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Placebo; Medicine; Type 2 diabetes; Exploratory analysis; Erectile function; Internal medicine; Physical therapy; Diabetes mellitus; Erectile dysfunction; Endocrinology; Alternative medicine; Exenatide","score_opus":0.031157304752435853,"score_gpt":0.27215442253790983,"score_spread":0.24099711778547397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176374233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935688,0.00095395825,0.000008145448,0.0010929364,0.00029146037,0.001117432,0.000007538043,0.00008496438,0.0028747576],"genre_scores_gemma":[0.9972074,0.00008105067,0.000022760154,0.00094487215,0.00024394323,0.00038184068,0.000048345097,0.000023936609,0.0010458354],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758637,0.0007069866,0.00042600167,0.00039014383,0.0002765986,0.0006139049],"domain_scores_gemma":[0.9979385,0.0006609454,0.00024364809,0.0007383793,0.00035783576,0.0000607069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004950215,0.0002456442,0.0015418705,0.0003222117,0.00014927726,0.000018192242,0.000125394,0.00007736466,0.0002947239],"category_scores_gemma":[0.00040941956,0.00011700142,0.00015250924,0.0022523568,0.0002448898,0.00008023834,0.0000537507,0.00031005713,0.000007868732],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3886639,0.0003477616,0.59381664,0.000024653493,0.0075205048,0.000015431246,0.00040349338,0.0005258122,0.0069168867,0.00010771023,0.0008546503,0.0008025824],"study_design_scores_gemma":[0.6940173,0.0036390813,0.27206224,0.00007422358,0.00972277,0.00000800787,0.0033684785,0.0011199303,0.013331594,0.00006873509,0.0022871336,0.00030050875],"about_ca_topic_score_codex":0.000021506152,"about_ca_topic_score_gemma":0.0003248927,"teacher_disagreement_score":0.32175437,"about_ca_system_score_codex":0.00005878996,"about_ca_system_score_gemma":0.00014342878,"threshold_uncertainty_score":0.47711796},"labels":[],"label_agreement":null},{"id":"W3183300604","doi":"10.1016/s2213-8587(21)00180-7","title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Bayer Fund; Novartis; Servier; Amgen; Pfizer; Bristol-Myers Squibb; AstraZeneca; Fundação Lemann; Boehringer Ingelheim","keywords":"Medicine; Dapagliflozin; Discontinuation; Placebo; Internal medicine; Adverse effect; Hazard ratio; Population; Kidney disease; Organ dysfunction; Randomized controlled trial; Clinical trial; Diabetes mellitus; Type 2 diabetes; Confidence interval; Sepsis; Endocrinology; Pathology","score_opus":0.030205094319406333,"score_gpt":0.30034683372907833,"score_spread":0.270141739409672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183300604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865455,0.0011085683,0.000028703478,0.002362067,0.00036982825,0.0076581216,0.00011907444,0.0001914468,0.0016166909],"genre_scores_gemma":[0.9942706,0.00028756,0.00013716407,0.0016426063,0.0003614417,0.002163251,0.00057258096,0.0000698439,0.00049494527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957499,0.00058344606,0.00060369296,0.00077649707,0.00054131815,0.0017451416],"domain_scores_gemma":[0.9971622,0.00080271857,0.0003754515,0.001146221,0.00014424116,0.00036915982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059596926,0.0005881362,0.0024902835,0.00041054058,0.00019796475,0.00007646558,0.00034843475,0.000113299466,0.00019315085],"category_scores_gemma":[0.00050217554,0.00032880716,0.0003013848,0.00075703114,0.00031352558,0.00013947749,0.00015609404,0.0004896219,0.000028094044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6154218,0.0013704232,0.3766987,0.00006698819,0.0035417671,0.00017687627,0.0003557319,0.00013632404,0.000017359946,0.00022228052,0.000703974,0.0012878142],"study_design_scores_gemma":[0.96348834,0.0032088426,0.020070918,0.000039964114,0.0030480216,0.0000031085262,0.00030253184,0.000027577704,0.00044017847,0.00008389695,0.00889765,0.00038897042],"about_ca_topic_score_codex":0.0001759652,"about_ca_topic_score_gemma":0.00013022701,"teacher_disagreement_score":0.3566278,"about_ca_system_score_codex":0.00024072902,"about_ca_system_score_gemma":0.00035040922,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W3185437491","doi":"10.1016/s2213-8587(21)00174-1","title":"Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Discontinuation; Type 2 diabetes; Sulfonylurea; Internal medicine; Randomized controlled trial; Diabetes mellitus; Metformin; Physical therapy; Insulin; Endocrinology","score_opus":0.03327913042604658,"score_gpt":0.3050845420511496,"score_spread":0.271805411625103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185437491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175036,0.0013090485,0.0000017631172,0.0015883383,0.00038233775,0.0029116361,0.000024548774,0.00006643141,0.0019655407],"genre_scores_gemma":[0.9980116,0.0003207903,0.00021938115,0.0003626912,0.00022300927,0.0002296625,0.00025147496,0.000040177405,0.00034120004],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972156,0.00020265847,0.000537396,0.0004903161,0.0002874208,0.0012666077],"domain_scores_gemma":[0.99807507,0.000711884,0.00022468736,0.00069907255,0.00017216346,0.00011714856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035827397,0.00034524914,0.0012761789,0.00018244448,0.00008400565,0.000025709614,0.0002099439,0.00008906716,0.00009102848],"category_scores_gemma":[0.00023814419,0.00023312001,0.00010909659,0.00046136492,0.00030279014,0.00007963302,0.00021322437,0.00029466674,0.000011688361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8345184,0.002506715,0.12359735,0.00024339712,0.0020945568,0.000080006714,0.00024478484,0.000022361437,0.0004580983,0.001159192,0.0007158251,0.034359355],"study_design_scores_gemma":[0.9497751,0.005758414,0.03421823,0.00014913677,0.0010724975,7.8757677e-7,0.00013123275,0.000061684754,0.0030433892,0.000105077626,0.0054316707,0.00025276208],"about_ca_topic_score_codex":0.000015123839,"about_ca_topic_score_gemma":0.000039385395,"teacher_disagreement_score":0.11525677,"about_ca_system_score_codex":0.00009971497,"about_ca_system_score_gemma":0.00011814749,"threshold_uncertainty_score":0.95063585},"labels":[],"label_agreement":null},{"id":"W3190876990","doi":"10.1016/s2213-8587(21)00173-x","title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Centre Hospitalier Universitaire Sainte-Justine","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; National Cancer Institute; Medical Research Council; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital","keywords":"Medicine; Childhood cancer; Guideline; Bone mineral; Harmonization; Cancer; Young adult; MEDLINE; Environmental health; Gerontology; Pediatrics; Internal medicine; Pathology; Osteoporosis","score_opus":0.05460489342700565,"score_gpt":0.35299141637266995,"score_spread":0.2983865229456643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190876990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025395704,0.9333143,0.00026509454,0.033039264,0.0030026564,0.0028024123,0.002059933,0.00011247392,0.000008156658],"genre_scores_gemma":[0.0070721293,0.97446114,0.000907245,0.009212225,0.0037923153,0.0011983288,0.0031769038,0.00012409494,0.00005561637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99462605,0.0012017651,0.0015665207,0.0010246419,0.00052419904,0.0010568567],"domain_scores_gemma":[0.99237895,0.0040960577,0.0014052504,0.0012093512,0.0007738958,0.00013647151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011190599,0.0007435172,0.0033203256,0.00015636176,0.0002544146,0.000083435916,0.00084109395,0.0002859346,0.000097874276],"category_scores_gemma":[0.0027505492,0.0005058397,0.0006087526,0.00047065722,0.00033450083,0.00013941036,0.0003859399,0.00091791665,0.0000037220293],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018704878,0.00077086873,0.16526727,0.012331849,0.004948249,0.00002143739,0.0010257371,0.00002844363,0.0001325709,0.0003498485,0.050199565,0.7647371],"study_design_scores_gemma":[0.009670096,0.0004581973,0.18324812,0.09674893,0.0074155377,0.000082296814,0.00014940878,0.0005314868,0.0005998411,0.00028556868,0.6990456,0.0017649282],"about_ca_topic_score_codex":0.006749004,"about_ca_topic_score_gemma":0.01500209,"teacher_disagreement_score":0.7629722,"about_ca_system_score_codex":0.00027599116,"about_ca_system_score_gemma":0.00063356984,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W3195404919","doi":"10.1016/s2213-8587(21)00203-5","title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1502,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Glucagon-like peptide 1 receptor; Diabetes mellitus; MEDLINE; Internal medicine; Intensive care medicine; Bioinformatics; Pharmacology; Receptor; Endocrinology; Agonist","score_opus":0.11400685831002075,"score_gpt":0.35453262479431596,"score_spread":0.24052576648429522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195404919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027507895,0.98754203,5.798544e-7,0.0003191404,0.000053441756,0.009013883,0.00020853512,0.000033249562,0.00007833735],"genre_scores_gemma":[0.00037822677,0.9948336,0.00012871218,0.0011247735,0.000022644212,0.0023895442,0.0008762476,0.000060721864,0.00018555368],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99368566,0.0025404969,0.0016608357,0.0007564456,0.00049327424,0.00086329697],"domain_scores_gemma":[0.9952771,0.0014525902,0.0011668042,0.0017526735,0.00019812831,0.00015272136],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0027030648,0.0007991219,0.03427921,0.00044068,0.000045773948,0.00004184892,0.00029463327,0.00013072594,0.00011467517],"category_scores_gemma":[0.0013247498,0.0003454382,0.0024019901,0.0011010725,0.00025928157,0.0000547156,0.00021982187,0.00029982565,0.0000036885135],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042371754,0.00013199843,0.017306793,0.35277817,0.62790245,0.000012152604,0.00001768603,3.6671625e-7,2.9142909e-8,0.000034388686,0.0001808596,0.0015927415],"study_design_scores_gemma":[0.008046284,0.0003256675,0.001360664,0.024369178,0.94918144,0.0000011160508,0.000006327069,5.974013e-7,8.802857e-7,0.0000026240332,0.016385494,0.00031975054],"about_ca_topic_score_codex":0.000023806399,"about_ca_topic_score_gemma":0.00001753774,"teacher_disagreement_score":0.328409,"about_ca_system_score_codex":0.00007271462,"about_ca_system_score_gemma":0.00012104633,"threshold_uncertainty_score":0.99989974},"labels":[],"label_agreement":null},{"id":"W3204188022","doi":"10.1016/s2213-8587(21)00235-7","title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":846,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Cancer Institute; U.S. Food and Drug Administration; Ipsen Biopharmaceuticals; Pfizer","keywords":"Guideline; MEDLINE; Consensus conference; Disease management; Evidence-based medicine; Disease","score_opus":0.028340897772308072,"score_gpt":0.2987705142329133,"score_spread":0.2704296164606052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204188022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476454,0.012608176,0.0000022894114,0.036729276,0.00009130452,0.00022177455,0.000074209485,0.00003478942,0.0025927478],"genre_scores_gemma":[0.98374265,0.010587307,0.0005986511,0.004623866,0.000070883645,0.000074976444,0.00009591715,0.000011450478,0.00019426896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896914,0.00005713296,0.0001926319,0.00022126285,0.00010346262,0.0004563553],"domain_scores_gemma":[0.99929905,0.000113331684,0.00005277244,0.00041755874,0.00004166396,0.0000756383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070985254,0.00012401222,0.00036638626,0.00003316674,0.000051313138,0.0000061125925,0.00007259971,0.000020335478,0.00010228],"category_scores_gemma":[0.000041624182,0.000079655,0.00005550661,0.00008180927,0.000119696815,0.00001041274,0.00010668302,0.000082940554,0.000020894535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032356742,0.0005333843,0.91780955,0.00029035294,0.0010487495,0.0014373651,0.000038886257,0.000010651421,0.00011105906,0.015153805,0.02638426,0.036858357],"study_design_scores_gemma":[0.008821135,0.00040690016,0.8347292,0.00033185654,0.0011425741,0.00004658078,0.00014542682,0.00012691574,0.004276256,0.009348095,0.14040671,0.00021836243],"about_ca_topic_score_codex":0.000011235345,"about_ca_topic_score_gemma":0.000007708534,"teacher_disagreement_score":0.114022456,"about_ca_system_score_codex":0.000010933599,"about_ca_system_score_gemma":0.000018652996,"threshold_uncertainty_score":0.32482368},"labels":[],"label_agreement":null},{"id":"W3206152482","doi":"10.1016/s2213-8587(21)00236-9","title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Cohort study; Retrospective cohort study; Hyperplasia; Cohort; Prospective cohort study","score_opus":0.009277805141671366,"score_gpt":0.24207861324822527,"score_spread":0.2328008081065539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206152482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957742,0.0013376294,0.0000023877637,0.0009174371,0.00011783083,0.0008773883,0.000046569265,0.00004770698,0.00087885396],"genre_scores_gemma":[0.9987953,0.00020605749,0.00018070028,0.00034516293,0.00004856441,0.000104988874,0.00009191179,0.000027513146,0.00019982764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977608,0.00018080034,0.0003302162,0.00048561182,0.00030940425,0.0009331773],"domain_scores_gemma":[0.9989561,0.000108282555,0.00011209103,0.000657376,0.00009185069,0.000074306685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000173217,0.00025666587,0.0010615938,0.00010066286,0.000062877036,0.000014153479,0.00019164599,0.000056999055,0.0001276392],"category_scores_gemma":[0.000053864165,0.0001619559,0.00007614357,0.00025316983,0.00016107463,0.00007397124,0.00015405736,0.00035615062,0.000016508127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044409095,0.001664317,0.9905094,0.00006664361,0.0009019966,0.0049950383,0.00036068112,0.000023793846,0.00050897343,0.00007723649,0.000035670946,0.00041218597],"study_design_scores_gemma":[0.010916007,0.0009613955,0.9852455,0.00007505877,0.00036771843,0.000590591,0.00022720333,0.000034244757,0.0011863712,0.00016813978,0.000072148265,0.00015558179],"about_ca_topic_score_codex":0.00024352325,"about_ca_topic_score_gemma":0.00047088158,"teacher_disagreement_score":0.010471916,"about_ca_system_score_codex":0.00013567512,"about_ca_system_score_gemma":0.00010087802,"threshold_uncertainty_score":0.660437},"labels":[],"label_agreement":null},{"id":"W3210656179","doi":"10.1016/s2213-8587(21)00286-2","title":"Youth-onset type 2 diabetes among First Nations young people in northern Australia: a retrospective, cross-sectional study","year":2021,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Medicine; Type 2 diabetes; Scopus; Public health; Diabetes mellitus; Gerontology; Disease; Type 1 diabetes; MEDLINE; Family medicine; Pediatrics; Internal medicine; Nursing; Endocrinology","score_opus":0.04725442723727534,"score_gpt":0.3221647942803334,"score_spread":0.27491036704305805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210656179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9187415,0.00029417503,5.9429453e-7,0.07635187,0.000869714,0.001762619,0.00043305024,0.00012045726,0.00142598],"genre_scores_gemma":[0.9722614,0.00021689387,0.00003145751,0.01692957,0.0021174569,0.00086317264,0.003355478,0.00009015124,0.0041343677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99437803,0.00047459602,0.0006990804,0.0009973433,0.0009797964,0.0024711296],"domain_scores_gemma":[0.9970243,0.000878842,0.00025442895,0.0010826128,0.00064537703,0.000114448594],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00062407454,0.000542352,0.0012496806,0.0006872098,0.0004089997,0.00020367703,0.000698586,0.00038125852,0.0005236749],"category_scores_gemma":[0.0013706979,0.00044617968,0.00023924783,0.001157645,0.00042939564,0.00013280363,0.00047342075,0.00302283,0.000171499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003428103,0.00032118312,0.9393612,0.00035530378,0.00084554264,0.00027875605,0.00040261485,0.000060938673,0.000009724678,0.0000481736,0.058266256,0.000015999021],"study_design_scores_gemma":[0.0019636413,0.00056035846,0.982465,0.000112251335,0.0002185073,0.000009409851,0.00025598615,0.000035024517,0.000022686952,0.00023925552,0.013747581,0.00037029426],"about_ca_topic_score_codex":0.0007683806,"about_ca_topic_score_gemma":0.048344105,"teacher_disagreement_score":0.059422307,"about_ca_system_score_codex":0.0005923794,"about_ca_system_score_gemma":0.00018993249,"threshold_uncertainty_score":0.999799},"labels":[],"label_agreement":null},{"id":"W3211322112","doi":"10.1016/s2213-8587(21)00282-5","title":"RETRACTED: Targeting of vitamin D supplementation to individuals with deficiency","year":2021,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":6,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Biogen; GlaxoSmithKline; Eli Lilly and Company","keywords":"Vitamin D and neurology; vitamin D deficiency; Medicine; Vitamin; Epidemiology; Population; Disease; Physiology; Clinical trial; Randomized controlled trial; Environmental health; Internal medicine","score_opus":0.033351529152129425,"score_gpt":0.3131189412683392,"score_spread":0.2797674121162098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211322112","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39100537,0.0012826547,0.00001226056,0.60452,0.00020689929,0.0009094422,0.00029052715,0.00006958065,0.0017032443],"genre_scores_gemma":[0.43809548,0.0012811124,0.006782168,0.5403568,0.006608116,0.00086474663,0.0031716623,0.00018464032,0.0026552759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571943,0.00038576353,0.00050999585,0.000567726,0.0008261298,0.0019909255],"domain_scores_gemma":[0.9975482,0.0009012072,0.0002886751,0.00082928146,0.00036983634,0.0000627535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006103362,0.00037117527,0.001319626,0.00031726106,0.00013995005,0.000027705972,0.0005194225,0.00027551875,0.00031023542],"category_scores_gemma":[0.00086028513,0.00023329617,0.0001144702,0.0005525004,0.00039829023,0.00004628805,0.0004362341,0.0022991209,0.00004120023],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022156053,0.000054413656,0.116950676,0.0008060984,0.0005201486,0.00035120585,0.00048629526,0.000002791178,0.005090076,0.000036083853,0.8743782,0.0013018313],"study_design_scores_gemma":[0.0033038177,0.0021363567,0.16556592,0.0009670991,0.00086376985,0.00011403471,0.0011728598,0.0000050963345,0.042295944,0.000114544324,0.7828488,0.0006117646],"about_ca_topic_score_codex":0.000042006093,"about_ca_topic_score_gemma":0.000015662814,"teacher_disagreement_score":0.09152943,"about_ca_system_score_codex":0.00010895355,"about_ca_system_score_gemma":0.00016833999,"threshold_uncertainty_score":0.99886644},"labels":[],"label_agreement":null},{"id":"W3212157657","doi":"10.1016/s2213-8587(21)00289-8","title":"Opportunities and challenges in closed-loop systems in type 1 diabetes","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Insulin delivery; Insulin; Closed loop; Type 1 diabetes; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Artificial pancreas; Internal medicine; Endocrinology","score_opus":0.1748318750155709,"score_gpt":0.3206666045708026,"score_spread":0.1458347295552317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212157657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8370607,0.12192125,6.454533e-8,0.02909101,0.00036362038,0.00029317185,0.000004170748,0.000051313207,0.011214689],"genre_scores_gemma":[0.9241026,0.07161149,0.000025749849,0.0009131369,0.00028480613,0.00009994259,0.000029382785,0.000026756314,0.0029061593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975329,0.0003288914,0.0002782224,0.00034513694,0.00018823783,0.001326603],"domain_scores_gemma":[0.99890244,0.00040147427,0.00004968882,0.00049447437,0.00007713669,0.00007480622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006628465,0.00017992523,0.00069728034,0.0002539256,0.000043845692,0.0000396367,0.00020543177,0.00008367404,0.00008281722],"category_scores_gemma":[0.0002185358,0.00013074784,0.000036878057,0.00028193876,0.0002511966,0.00007344269,0.00029805838,0.00040444196,0.00004456997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008499462,0.00030980812,0.7657819,0.0020758072,0.0003334592,0.00087757496,0.00040998432,0.000020234444,0.0030096574,0.032231998,0.0038430972,0.1910215],"study_design_scores_gemma":[0.004899414,0.00062208954,0.65491766,0.00078498037,0.00011985051,0.000018663963,0.003952958,0.0014408369,0.0023420686,0.0025998405,0.32783934,0.00046228932],"about_ca_topic_score_codex":0.000015245196,"about_ca_topic_score_gemma":0.000068238805,"teacher_disagreement_score":0.32399625,"about_ca_system_score_codex":0.00004040943,"about_ca_system_score_gemma":0.00006296095,"threshold_uncertainty_score":0.5331742},"labels":[],"label_agreement":null},{"id":"W3214498242","doi":"10.1016/s2213-8587(21)00267-9","title":"Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Horizon 2020; Abbott Diabetes Care; Berlin Institute of Health; Roche Diabetes Care; Stiftung Charité; Novo Nordisk Fonden; Region Hovedstaden; Sanofi; European Commission; International Society for Pediatric and Adolescent Diabetes; Novo Nordisk; Dexcom; Insulet Corporation; Technology Agency of the Czech Republic; Wellcome Trust; Steno Diabetes Center Copenhagen; Stanford Maternal and Child Health Research Institute; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Statement (logic); Consensus conference; Insulin delivery; MEDLINE; Evidence-based medicine; Key (lock)","score_opus":0.06494527321973508,"score_gpt":0.4294518418766844,"score_spread":0.3645065686569493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214498242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5732667,0.005621044,0.000046030298,0.415685,0.00047451275,0.0016352679,0.00010780657,0.00022806691,0.0029355488],"genre_scores_gemma":[0.9350022,0.00088771654,0.015967527,0.038436934,0.0006131451,0.00068771694,0.0005478321,0.000057378667,0.007799559],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977459,0.0003051305,0.00035843096,0.000383796,0.0002490214,0.00095777184],"domain_scores_gemma":[0.9983597,0.0006656566,0.00014920479,0.00037414467,0.00034337823,0.000107922264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007000456,0.0001492665,0.00048716698,0.00006888648,0.00020099162,0.000087848886,0.00027145375,0.000048950773,0.00015710556],"category_scores_gemma":[0.00063905976,0.00010409835,0.000047045425,0.00013006353,0.0002006822,0.000062619685,0.00096234394,0.00026888118,0.000038840586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001063565,0.00068393024,0.037623893,0.0011038819,0.0013499043,0.00019225103,0.0008260344,0.0000146191005,0.0022088413,0.010690248,0.86762017,0.076622635],"study_design_scores_gemma":[0.0077190925,0.0005826734,0.031278387,0.0003076129,0.00009053188,0.00003092996,0.001594966,0.004772786,0.0032997667,0.0005043073,0.9496119,0.00020706271],"about_ca_topic_score_codex":0.000008922264,"about_ca_topic_score_gemma":0.0000137045845,"teacher_disagreement_score":0.37724808,"about_ca_system_score_codex":0.000092927956,"about_ca_system_score_gemma":0.00032056036,"threshold_uncertainty_score":0.42450073},"labels":[],"label_agreement":null},{"id":"W3216543422","doi":"10.1016/s2213-8587(21)00292-8","title":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute for Health and Care Research; Boehringer Ingelheim","keywords":"Empagliflozin; Heart failure; Ejection fraction; Benzhydryl compounds; MEDLINE","score_opus":0.045067551808763276,"score_gpt":0.3194892456944029,"score_spread":0.27442169388563964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216543422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490584,0.0009737677,0.00000399352,0.011877459,0.0000646411,0.0019828794,0.000020738855,0.000017039934,0.00015365191],"genre_scores_gemma":[0.9977275,0.00043120224,0.00015541281,0.00045690744,0.00006574927,0.00091336115,0.00018723654,0.000012295556,0.000050306517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99844563,0.00034928368,0.00035537238,0.00027881024,0.00018122423,0.00038966542],"domain_scores_gemma":[0.99883485,0.0004672045,0.00014068247,0.00042009712,0.000108367036,0.000028779641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027845064,0.00018498264,0.0008529174,0.0004895786,0.00005817742,0.000023841363,0.00008287906,0.000054556072,0.00007423984],"category_scores_gemma":[0.000018122233,0.00010612274,0.00013826988,0.0010907325,0.000113603455,0.00006307842,0.000017944589,0.00011195382,0.000002173681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5960172,0.018378025,0.15461539,0.00029074695,0.028415233,0.00007553648,0.021507954,0.0006571074,0.11887874,0.0067606685,0.0007551291,0.053648278],"study_design_scores_gemma":[0.63646656,0.013883371,0.29930872,0.0001427851,0.0070596053,0.000011031879,0.0116367955,0.00019148945,0.025881063,0.00046390216,0.004653995,0.0003006959],"about_ca_topic_score_codex":0.00013443032,"about_ca_topic_score_gemma":0.0010656279,"teacher_disagreement_score":0.14469334,"about_ca_system_score_codex":0.0001097358,"about_ca_system_score_gemma":0.00005026456,"threshold_uncertainty_score":0.43275595},"labels":[],"label_agreement":null},{"id":"W3217716605","doi":"10.1016/s2213-8587(21)00310-7","title":"SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"","keywords":"Dapagliflozin; Type 2 diabetes; Kidney disease; Diabetes mellitus; Disease; Fluid ounce (US); Population; Incidence (geometry)","score_opus":0.016731972708270423,"score_gpt":0.2671351638708697,"score_spread":0.2504031911625993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217716605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9179845,0.002041819,0.0000011930916,0.057637017,0.0011077356,0.0005262407,0.000017810748,0.00019161806,0.02049209],"genre_scores_gemma":[0.97132546,0.0007074329,0.0003244609,0.016665287,0.0011817088,0.00018823998,0.00013760275,0.000057353765,0.009412427],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970226,0.000196664,0.00036235971,0.00051954563,0.00024994742,0.0016488673],"domain_scores_gemma":[0.9983054,0.00024578779,0.00011764856,0.0010939544,0.00012279209,0.00011444187],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002440417,0.00034557708,0.00079693063,0.00009622036,0.0001292959,0.00006192706,0.00031852224,0.00009001357,0.001893325],"category_scores_gemma":[0.000101721496,0.00020017667,0.00019080123,0.00021626144,0.00017091216,0.00010363125,0.00042259676,0.0003199411,0.0014083363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007223448,0.00086343614,0.7860023,0.0004312063,0.002353804,0.00021592953,0.0005738216,0.0000163394,0.01626462,0.0028779993,0.16858613,0.021742212],"study_design_scores_gemma":[0.004043378,0.0007723146,0.22297832,0.0004142729,0.0015483374,0.000020061589,0.00052222493,0.00007179811,0.14781798,0.0072052665,0.6139118,0.0006942548],"about_ca_topic_score_codex":0.000011717102,"about_ca_topic_score_gemma":0.00003255285,"teacher_disagreement_score":0.5630239,"about_ca_system_score_codex":0.00008767883,"about_ca_system_score_gemma":0.000058442696,"threshold_uncertainty_score":0.9993692},"labels":[],"label_agreement":null},{"id":"W4200125385","doi":"10.1016/s2213-8587(21)00325-9","title":"Nutrition-related health taxes: setting expectations","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Medical Research Council; National Institute of Mental Health; Engineering and Physical Sciences Research Council; National Heart, Lung, and Blood Institute; Wellcome Trust","keywords":"MEDLINE; Health care; Public health; Patient participation","score_opus":0.035324508678129654,"score_gpt":0.3070368767458661,"score_spread":0.27171236806773646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200125385","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29433745,0.0035491216,0.00003013413,0.68011785,0.0011014702,0.0003113339,0.000031408126,0.00034100795,0.02018024],"genre_scores_gemma":[0.7670503,0.00045851985,0.0003724593,0.22816752,0.0032627806,0.00016942513,0.00023913526,0.000028973109,0.0002508537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970626,0.0001634946,0.0005065469,0.0003073642,0.00010345052,0.0018565358],"domain_scores_gemma":[0.99869025,0.00039135714,0.00029583904,0.00044076628,0.00015259942,0.000029219653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005929688,0.00016932041,0.0005237101,0.00010576017,0.0005268625,0.000088303896,0.0003493503,0.00007143329,0.00028956364],"category_scores_gemma":[0.00081149547,0.00013361107,0.00009308781,0.00054251245,0.00014703764,0.0002366678,0.00024639897,0.0003402157,0.0006236129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035362282,0.00007207848,0.0089082485,0.0002132912,0.00006162416,0.0000100891475,0.00009733192,0.00011208363,0.000073766496,0.26308456,0.7224818,0.004881608],"study_design_scores_gemma":[0.00072467566,0.000017097449,0.008834698,0.000044965367,0.0000185212,0.000014268972,0.0013622293,0.0016374589,0.000017948885,0.028295197,0.9588796,0.00015334037],"about_ca_topic_score_codex":0.0011488725,"about_ca_topic_score_gemma":0.00023027346,"teacher_disagreement_score":0.4727129,"about_ca_system_score_codex":0.00005073946,"about_ca_system_score_gemma":0.00007894011,"threshold_uncertainty_score":0.801549},"labels":[],"label_agreement":null},{"id":"W4200360839","doi":"10.1016/s2213-8587(21)00326-0","title":"Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Fundação Lemann; Bayer Fund; Novartis; AstraZeneca; Servier; Amgen; Pfizer; Bristol-Myers Squibb; Novo Nordisk; Merck","keywords":"Acute kidney injury; Dapagliflozin; Clinical endpoint; Renal function; Creatinine; Adverse effect; Renal replacement therapy; Kidney","score_opus":0.02291130481651073,"score_gpt":0.2848254784781782,"score_spread":0.26191417366166747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200360839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491018,0.0012019419,0.000013411423,0.046573684,0.0001975006,0.00042459264,0.0000476705,0.000047940186,0.002391436],"genre_scores_gemma":[0.974971,0.00013220999,0.00038692844,0.023130832,0.00016776344,0.00014443485,0.00014019787,0.000019175088,0.00090745254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978009,0.00045590883,0.0002346251,0.00039595613,0.0001590186,0.00095361396],"domain_scores_gemma":[0.99830765,0.00047155574,0.00009008866,0.0009193595,0.00006452636,0.00014685346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029553418,0.0001994686,0.00055432756,0.00006185722,0.00017538722,0.0000121515395,0.00020581609,0.00007711436,0.00027698383],"category_scores_gemma":[0.0007849281,0.00010309249,0.000060584774,0.00026032486,0.00043225416,0.00003451502,0.000113923394,0.00044543814,0.00010005884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021483008,0.00024484337,0.98956704,0.000023034792,0.00022709074,0.0006888521,0.00039259813,0.000008199854,0.00010615508,0.0012150399,0.004610447,0.002701874],"study_design_scores_gemma":[0.0061065657,0.00042872492,0.9252578,0.000040084604,0.00023941718,0.00011970241,0.000102134145,0.000009203849,0.0020172347,0.00070582994,0.064847805,0.00012547344],"about_ca_topic_score_codex":0.000046140707,"about_ca_topic_score_gemma":0.000110372515,"teacher_disagreement_score":0.06430921,"about_ca_system_score_codex":0.0001034652,"about_ca_system_score_gemma":0.00024861222,"threshold_uncertainty_score":0.42039895},"labels":[],"label_agreement":null},{"id":"W4200548235","doi":"10.1016/s2213-8587(21)00284-9","title":"Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Toronto General Hospital","funders":"","keywords":"Metabolic syndrome; Diabetes mellitus; Hypertriglyceridemia; Context (archaeology); Disease; Residual risk; Atherosclerotic cardiovascular disease; Triglyceride","score_opus":0.08575000769170334,"score_gpt":0.2942208992942478,"score_spread":0.20847089160254445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200548235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873746,0.0019963633,0.00026363146,0.0052312375,0.00040864607,0.001789903,0.00005593397,0.00019004007,0.0013267783],"genre_scores_gemma":[0.9881527,0.000116134506,0.001780663,0.007643342,0.0012209594,0.00067935174,0.00011081584,0.00008037625,0.00021565199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610674,0.000586426,0.00041220972,0.0008910936,0.00038579234,0.0016177101],"domain_scores_gemma":[0.99726933,0.00038482313,0.000088028464,0.0015245306,0.00019320552,0.00054007774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005419109,0.00038539592,0.0014597389,0.00011684991,0.00019090477,0.000060598042,0.0003526434,0.000105443345,0.00004602568],"category_scores_gemma":[0.00067776843,0.0002530242,0.00038271197,0.00043554092,0.00022766585,0.00007131666,0.00032870987,0.00058693375,0.0002664449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013274087,0.00044106817,0.6662994,0.00016006615,0.0014042855,0.000114617585,0.00013016423,0.0001534014,0.000041766638,0.0002954938,0.001848297,0.32778403],"study_design_scores_gemma":[0.0053221197,0.0006502207,0.9484086,0.00015450858,0.00066661055,0.0000093472445,0.000025140538,0.00011338687,0.0020689422,0.00022302658,0.0419975,0.00036061552],"about_ca_topic_score_codex":0.0001148915,"about_ca_topic_score_gemma":0.00009724737,"teacher_disagreement_score":0.32742342,"about_ca_system_score_codex":0.0000794049,"about_ca_system_score_gemma":0.00014198208,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W4205160401","doi":"10.1016/s2213-8587(21)00327-2","title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institutes of Health; Diabetes Australia; Centers for Disease Control and Prevention; Hospital Authority; Steno Diabetes Center Copenhagen; State Government of Victoria; Regione Lombardia; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS","keywords":"Medicine; Diabetes mellitus; Environmental health; Demography; Population; Gerontology; Aggregate data","score_opus":0.03599371790028712,"score_gpt":0.29816351829307397,"score_spread":0.26216980039278687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205160401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949166,0.0023001807,0.0000017543084,0.0011653822,0.00013746538,0.000622891,0.00062705635,0.000101972386,0.00012666486],"genre_scores_gemma":[0.99666226,0.0003209437,0.00013188149,0.00068285747,0.0001452379,0.0005691534,0.0013967884,0.000054604443,0.00003627584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951974,0.0007986316,0.0007402524,0.0008836804,0.0006526627,0.0017273359],"domain_scores_gemma":[0.9958588,0.0005982166,0.00038044783,0.002991828,0.000059883925,0.00011083905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018153035,0.00038936324,0.0024554648,0.0012029668,0.000104561725,0.000026028812,0.0011334805,0.00008899776,0.00025551286],"category_scores_gemma":[0.0002968007,0.00029661154,0.00029337712,0.0030041076,0.0003935385,0.00018523904,0.0009307615,0.0008825679,0.000003913978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101043915,0.00036085362,0.9731728,0.00011808587,0.009684742,0.00022412161,0.00051725574,0.0019050927,0.00012589406,0.000043922457,0.00016594116,0.013580291],"study_design_scores_gemma":[0.004768378,0.00028165014,0.98004836,0.00008380161,0.0057482976,0.0000040847035,0.00035969538,0.0069011664,0.00051143504,0.000058076595,0.00091940723,0.00031565136],"about_ca_topic_score_codex":0.016582822,"about_ca_topic_score_gemma":0.044225987,"teacher_disagreement_score":0.027643166,"about_ca_system_score_codex":0.0001602874,"about_ca_system_score_gemma":0.00006550264,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W4210910136","doi":"10.1016/s2213-8587(22)00036-5","title":"An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settings","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Refugee; Forced migration; Medicine; Scopus; Internally displaced person; Population; Humanitarian aid; Humanitarian crisis; Declaration; Displaced person; Economic growth; Political science; Environmental health; MEDLINE; Law; Economics","score_opus":0.02775117999578486,"score_gpt":0.3073087316220232,"score_spread":0.27955755162623835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210910136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95609206,0.004077296,2.9428833e-7,0.034611426,0.001346233,0.0013862035,0.00045045305,0.000120553064,0.0019154554],"genre_scores_gemma":[0.9137578,0.000070152084,0.000017124845,0.08259037,0.001855259,0.00075566495,0.0007431284,0.000096627205,0.00011384312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99316466,0.0024203006,0.0009282841,0.0010386885,0.00027950646,0.0021685844],"domain_scores_gemma":[0.9968318,0.0007465979,0.0005493192,0.001697011,0.00010307079,0.000072251256],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007360237,0.00055799045,0.001452476,0.00047474797,0.0003444326,0.00004543255,0.0013504606,0.0003590778,0.0013479423],"category_scores_gemma":[0.000074123425,0.0004913483,0.00009752279,0.00029654626,0.00029249652,0.00008968645,0.00028675114,0.0028765362,0.00005540967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048547143,0.00034061662,0.78324217,0.00049919164,0.00029957495,0.0001618679,0.06820203,0.0000026223713,0.000018678718,0.0004558918,0.1412916,0.0054372028],"study_design_scores_gemma":[0.002913214,0.00470976,0.6621615,0.000051821706,0.0001189431,0.000010493352,0.01678217,0.000008435879,0.000007462551,0.0014130342,0.3111304,0.0006927301],"about_ca_topic_score_codex":0.0016041056,"about_ca_topic_score_gemma":0.012767709,"teacher_disagreement_score":0.1698388,"about_ca_system_score_codex":0.00011133932,"about_ca_system_score_gemma":0.00006164607,"threshold_uncertainty_score":0.99975383},"labels":[],"label_agreement":null},{"id":"W4210931643","doi":"10.1016/s2213-8587(21)00349-1","title":"Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stanford Cardiovascular Institute, School of Medicine, Stanford University; Fogarty International Center; Research Management Centre, International Islamic University Malaysia; Centre for Heart Rhythm Disorders, University of Adelaide; Russian Academy of Sciences; National Health and Medical Research Council; Medical Research Council; Sydney Medical School; Manchester Biomedical Research Centre; Samsung; George Institute for Global Health; Universitas Padjadjaran; Jahrom University of Medical Sciences; University of Jeddah; Universiti Sultan Zainal Abidin; National Institute of Diabetes and Digestive and Kidney Diseases; Menzies Institute for Medical Research; Walailak University; Universität Ulm; Xiamen University; Pomorski Uniwersytet Medyczny W Szczecinie; Division of Mathematical Sciences; Universitas Airlangga; Southeast University; Student Research Committee, Tabriz University of Medical Sciences; Shahjalal University of Science and Technology; Madras Diabetes Research Foundation; University of Health and Allied Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Universidad Autónoma del Estado de Morelos; China Medical University; National Taiwan Normal University; University of Toronto; Université de Genève; University of Technology Sydney; Universitas Indonesia; United Arab Emirates University; University Of Nigeria Nsukka; Shahid Beheshti University of Medical Sciences; Directorate for Biological Sciences; Göteborgs Universitet; University Grants Commission; Universitetet i Oslo; I.M. Sechenov First Moscow State Medical University; Bangladesh University of Health Sciences; Shahrekord University of Medical Sciences; Kermanshah University of Medical Sciences; Shahrekord University; National Institutes of Health; Chinese University of Hong Kong; Haramaya University; Curtin University of Technology; Universiti Sains Malaysia; Universiti Kebangsaan Malaysia; Università degli Studi del Piemonte Orientale; Centro de Investigación Biomédica en Red de Salud Mental; University of Gondar; University of Tasmania; University of Waterloo; Tehran University of Medical Sciences and Health Services; Universiti Malaya; Sultan Qaboos University; Seoul National University Hospital; King Abdulaziz University; Università degli Studi di Milano; Arak University of Medical Sciences; Karolinska Institutet; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; National Heart Foundation of Australia; Institució Catalana de Recerca i Estudis Avançats; Uppsala Universitet; University of Calcutta; American University of Sharjah; Universidad Nacional Autónoma de México; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Kuwait University; Department of Social Services, Australian Government; Universiteit Utrecht; National Natural Science Foundation of China; Khalifa University of Science, Technology and Research; Indian Council of Medical Research; University College London; Amity University; Northwell Health; Tribhuvan University; Mashhad University of Medical Sciences; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Anhui Provincial Key Research and Development Plan; Australian Catholic University; Imperial College London; King's College London; Centre Hospitalier Universitaire Vaudois; Seoul National University; University of Oxford; Chandigarh University; Tulane University; Iran University of Medical Sciences; Novo Nordisk Fonden; Department of Health and Social Care; McMaster University; University of Leicester; Akademiska Sjukhuset; Universidade Federal do Rio Grande do Sul; Deutsches Krebsforschungszentrum; Harvard University; University of Wollongong; Babol University of Medical Sciences; York University; Washington University in St. Louis; Monash University; South Eastern Sydney Local Health District; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Social Science Research Council; Trường Đại học Duy Tân; Bill and Melinda Gates Foundation; University of Washington; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Univerzita Karlova v Praze; Imam Abdulrahman Bin Faisal University; University of Georgia; Samara University; Jordan University of Science and Technology; New Mexico State University; U.S. Department of Veterans Affairs; Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Jazan University; University of New South Wales; Department of Biotechnology, Ministry of Science and Technology, India; Hamad Medical Corporation; Universidade Federal de Juiz de Fora; Deakin University; Helsingin Yliopisto; Brigham and Women's Hospital; Department of Anthropology, University of California, Los Angeles; Universidade de São Paulo; Krishna Institute Of Medical Sciences Deemed To Be University; Tufts Medical Center; National Institute for Health and Care Research; Charles Sturt University; Universitatea din București; La Trobe University","keywords":"Burden of disease; Diabetes mellitus; Disease burden; MEDLINE; Disease; Quality-adjusted life year","score_opus":0.0230933414455301,"score_gpt":0.2986359036999356,"score_spread":0.2755425622544055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210931643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995498,0.0025220267,4.882341e-7,0.00041249514,0.00013832454,0.00047103252,0.00076503505,0.000029829718,0.00016274514],"genre_scores_gemma":[0.99940723,0.000047671136,0.00001786123,0.00013297185,0.00013547513,0.000086206404,0.000090840775,0.000016566211,0.00006518273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973544,0.00066776574,0.0004500743,0.00035919214,0.0005454881,0.00062308536],"domain_scores_gemma":[0.99780846,0.00009990776,0.0002920156,0.0016246126,0.000074452975,0.00010053115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007515264,0.0001891294,0.0014332824,0.00019424259,0.0000911728,0.000007255899,0.0005832934,0.00003524614,0.000097332624],"category_scores_gemma":[0.00014041827,0.00013015541,0.0005322485,0.0010818812,0.00058093923,0.000044625354,0.0005352421,0.00024406391,4.9134144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006668933,0.00037460364,0.9410025,0.000072455325,0.0057689613,0.000012049968,0.0007091937,0.00043728304,0.00013917626,0.00025445016,0.0000676858,0.051094957],"study_design_scores_gemma":[0.0015038832,0.0007513987,0.9878899,0.000012834171,0.0075796414,7.997368e-7,0.0006530174,0.0002771678,0.00023172848,0.00042468365,0.000571324,0.000103638704],"about_ca_topic_score_codex":0.004230372,"about_ca_topic_score_gemma":0.0008404527,"teacher_disagreement_score":0.05099132,"about_ca_system_score_codex":0.000048785416,"about_ca_system_score_gemma":0.000051476625,"threshold_uncertainty_score":0.63950855},"labels":[],"label_agreement":null},{"id":"W4221054266","doi":"10.1016/s2213-8587(22)00102-4","title":"Diabetes in Pakistan: addressing the crisis","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Diabetes mellitus; Scopus; Type 2 diabetes; Disease; Population; MEDLINE; Global health","score_opus":0.04572336816902314,"score_gpt":0.31325552120111166,"score_spread":0.26753215303208855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221054266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95736754,0.015399159,0.0000034857246,0.022365967,0.00057927275,0.00076863833,0.000046147543,0.000177602,0.003292197],"genre_scores_gemma":[0.9871736,0.00028487245,0.00008663654,0.0104459245,0.00084623555,0.0008317089,0.00004159738,0.000059074522,0.00023033266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995713,0.00085662975,0.00043497173,0.00049442955,0.0005114628,0.0019895304],"domain_scores_gemma":[0.99779665,0.0004639975,0.00013905377,0.0014650569,0.00005162309,0.00008363861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001587565,0.00029888487,0.0010327083,0.00017732737,0.0005494442,0.00005606251,0.0008001459,0.0000628835,0.00047711362],"category_scores_gemma":[0.00014058025,0.00018868859,0.00036624118,0.0005920156,0.00035700534,0.00007173327,0.00059201336,0.0012093663,0.00005968195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027748095,0.0005501599,0.42375684,0.00032811429,0.0020385871,0.00036032838,0.0024874466,0.00069123966,0.0027424307,0.0034007402,0.06161065,0.501756],"study_design_scores_gemma":[0.0048905048,0.0005647523,0.38814673,0.00008543369,0.0005886333,0.000075387434,0.0031201523,0.0005761263,0.0073579564,0.004314506,0.5897217,0.0005581277],"about_ca_topic_score_codex":0.0009520062,"about_ca_topic_score_gemma":0.00027307923,"teacher_disagreement_score":0.52811104,"about_ca_system_score_codex":0.00015876663,"about_ca_system_score_gemma":0.00008336259,"threshold_uncertainty_score":0.7694498},"labels":[],"label_agreement":null},{"id":"W4223922377","doi":"10.1016/s2213-8587(22)00043-2","title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Seventh Framework Programme; Novo Nordisk; Boston Scientific Corporation; AstraZeneca; Biotronik; Bristol-Myers Squibb; Cleveland Clinic; Sanofi; Cardiological Society of India; Novartis; Merck; Mayo Clinic; Bayer; Abbott Laboratories; CSL Behring; Roche; St. Jude Medical; Astellas Pharma US; Philips; Pfizer; Boehringer Ingelheim; Amgen; National Institutes of Health; Regeneron Pharmaceuticals; Hartstichting; American Heart Association","keywords":"Alirocumab; Randomized controlled trial; MEDLINE; Acute coronary syndrome; Diabetes mellitus; Cardiovascular event","score_opus":0.008161324328906525,"score_gpt":0.24630018301507098,"score_spread":0.23813885868616447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223922377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031335,0.0042624655,4.5392397e-7,0.0004268459,0.0003587405,0.004322225,0.00020796541,0.00003377241,0.00007418436],"genre_scores_gemma":[0.99726737,0.0005194067,0.000006359015,0.0003074777,0.000023796554,0.0016298918,0.00005580992,0.000023615888,0.0001662603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651533,0.0015412391,0.00047462652,0.0003427495,0.00049561163,0.0006304238],"domain_scores_gemma":[0.9972425,0.0012866824,0.00034580406,0.0010357106,0.000038750288,0.00005055789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086929527,0.00032742415,0.0034336366,0.0003102693,0.00013647902,0.0000059563868,0.00033265748,0.000041848416,0.0001334587],"category_scores_gemma":[0.00019432888,0.0001527226,0.0018378891,0.00042513438,0.0001697566,0.000030052639,0.00035141173,0.00025896347,0.0000018874545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17155391,0.00025798831,0.7131703,0.000038561466,0.113023505,0.000033815522,0.00016226516,0.00013181167,0.00010163877,0.000054250333,0.000030964376,0.0014409896],"study_design_scores_gemma":[0.34994164,0.003006998,0.5893088,0.000008042613,0.05681279,0.0000029158734,0.00003335708,0.000042559997,0.00047119244,0.000024521512,0.00025115986,0.00009599658],"about_ca_topic_score_codex":0.00007247746,"about_ca_topic_score_gemma":0.0000062092527,"teacher_disagreement_score":0.17838775,"about_ca_system_score_codex":0.00004470139,"about_ca_system_score_gemma":0.000020746967,"threshold_uncertainty_score":0.6227847},"labels":[],"label_agreement":null},{"id":"W4224992810","doi":"10.1016/s2213-8587(22)00132-2","title":"The uncomfortable truth about kidney disease in type 1 diabetes","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Type 1 diabetes; Kidney disease; Diabetes mellitus; MEDLINE; Disease; Kidney","score_opus":0.02614908274759208,"score_gpt":0.2937284711619155,"score_spread":0.26757938841432344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224992810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94991976,0.0073574083,3.5774036e-7,0.030043794,0.0011268163,0.00073955796,0.000039204948,0.00012731437,0.010645791],"genre_scores_gemma":[0.9842791,0.00072039565,0.000017383865,0.005964487,0.00042913345,0.0005006233,0.00010861239,0.000040793744,0.007939448],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996273,0.0003958887,0.0003051981,0.00037079293,0.00044478793,0.0022103295],"domain_scores_gemma":[0.9979791,0.0006936066,0.00008703467,0.0009820779,0.00004750318,0.00021065777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001091677,0.00021277153,0.0004910932,0.00016529072,0.0006140665,0.00006208512,0.000867233,0.000028776185,0.0009095688],"category_scores_gemma":[0.0006151841,0.00012504266,0.00011151579,0.00069084746,0.00038002178,0.00006210485,0.00086768164,0.00081770174,0.00015365814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031920857,0.00020748872,0.8899138,0.00013235962,0.00025760772,0.000071278766,0.00007134852,0.00018344214,0.0003242305,0.012878134,0.08044712,0.01519401],"study_design_scores_gemma":[0.0023481823,0.00041238288,0.25757506,0.000043820262,0.00012955585,8.920616e-7,0.00014569215,0.0022367747,0.00028354523,0.007251112,0.72935045,0.00022255379],"about_ca_topic_score_codex":0.00001695626,"about_ca_topic_score_gemma":0.000007607466,"teacher_disagreement_score":0.6489033,"about_ca_system_score_codex":0.00011938714,"about_ca_system_score_gemma":0.00016531572,"threshold_uncertainty_score":0.99591404},"labels":[],"label_agreement":null},{"id":"W4245779733","doi":"10.1016/s2213-8587(19)30089-0","title":"Change in albuminuria as a surrogate endpoint in chronic kidney disease","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Impact; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Albuminuria; Observational study; Randomized controlled trial; Surrogate endpoint; Kidney disease; Clinical endpoint; Diabetes mellitus; Internal medicine; Meta-analysis; Type 2 diabetes; Clinical trial; Scopus; Diabetic nephropathy; MEDLINE; Intensive care medicine; Kidney; Endocrinology","score_opus":0.034776815643785486,"score_gpt":0.3002612151051312,"score_spread":0.2654843994613457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245779733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3061072,0.015174802,5.7167618e-8,0.6734831,0.00091577705,0.0020447457,0.0005001419,0.00015742307,0.0016167621],"genre_scores_gemma":[0.18739712,0.0020331256,0.0000080492155,0.7953891,0.0098001575,0.0012356851,0.0023341842,0.0001599447,0.0016425919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933758,0.0005055143,0.0007208216,0.00110604,0.00045571176,0.0038361175],"domain_scores_gemma":[0.9966544,0.00065056735,0.00026650232,0.0020109746,0.000056084846,0.00036145133],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039965753,0.00080431363,0.0021114335,0.00059859664,0.000051513856,0.000042843116,0.0008499795,0.0005724204,0.0016308723],"category_scores_gemma":[0.00067488523,0.000616932,0.0003912083,0.0004405304,0.0003896522,0.0001282988,0.00043105,0.0032546406,0.0016633756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003224509,0.00017199919,0.1662885,0.0027899786,0.0003087229,0.004316368,0.00023662053,0.000002820555,0.00030920305,0.00020410297,0.82304704,0.002002196],"study_design_scores_gemma":[0.0081518665,0.00034218206,0.08754061,0.0016732231,0.00044282826,0.000019502655,0.000014373598,0.00020675275,0.0003831179,0.0012683714,0.8992515,0.0007056373],"about_ca_topic_score_codex":0.0005097064,"about_ca_topic_score_gemma":0.00014136251,"teacher_disagreement_score":0.12190605,"about_ca_system_score_codex":0.0011605534,"about_ca_system_score_gemma":0.0019797166,"threshold_uncertainty_score":0.9996282},"labels":[],"label_agreement":null},{"id":"W4250378947","doi":"10.1016/s2213-8587(17)30115-8","title":"Insulin affordability","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hippocratic Oath; Dilemma; Biography; Oath; Classics; Law; Philosophy; Political science; Psychiatry; History; Epistemology","score_opus":0.10115656115893289,"score_gpt":0.30389343822611214,"score_spread":0.20273687706717924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250378947","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017472174,0.005672391,0.0000056927297,0.880151,0.0020502335,0.00035357295,0.0014921632,0.000105573265,0.092697226],"genre_scores_gemma":[0.061029546,0.0021955324,0.00007332156,0.9192728,0.014096678,0.00018448746,0.00020676824,0.000096426586,0.002844472],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958325,0.00008781541,0.0007963124,0.00080533564,0.00003694337,0.0024410938],"domain_scores_gemma":[0.99624115,0.00041856046,0.00082811323,0.0024045014,0.000026424956,0.000081264334],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00083303236,0.00045414272,0.0016416038,0.00016682467,0.00033395793,0.00020263038,0.0024526084,0.00058116036,0.001119106],"category_scores_gemma":[0.00036960898,0.00040315615,0.0003481358,0.00006377393,0.00067191746,0.00012517079,0.0005353486,0.002749635,0.005043751],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007446292,0.000021441117,0.0084433565,0.00009532728,0.00023299964,0.00003347878,0.000038973314,0.000002430614,0.0000021939536,0.038443968,0.9505958,0.0020826044],"study_design_scores_gemma":[0.0004991651,0.000034531433,0.0027867744,0.000009404788,0.00002124117,0.0000075184885,9.875943e-7,0.00014577457,0.000040744755,0.17715162,0.81892276,0.00037950044],"about_ca_topic_score_codex":0.00015245803,"about_ca_topic_score_gemma":0.000016346963,"teacher_disagreement_score":0.13870765,"about_ca_system_score_codex":0.00015030893,"about_ca_system_score_gemma":0.000045248744,"threshold_uncertainty_score":0.99984205},"labels":[],"label_agreement":null},{"id":"W4280552858","doi":"10.1016/s2213-8587(22)00103-6","title":"Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diabetes Care; National Eye Institute; Roche Diabetes Care; Eli Lilly and Company","keywords":"Medicine; Type 1 diabetes; Diabetes mellitus; Bone mineral; Internal medicine; Cohort; Bone density; Type 2 diabetes; Cross-sectional study; Osteoporosis; Physical therapy; Endocrinology; Pathology","score_opus":0.021152129729333117,"score_gpt":0.29249511719444765,"score_spread":0.27134298746511454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280552858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967106,0.0010917366,0.000001376884,0.00019430419,0.0003311894,0.0014072099,0.00011301635,0.00006303,0.000087552085],"genre_scores_gemma":[0.9983663,0.000022016324,0.000047212867,0.000414229,0.00011841539,0.00060906046,0.00012843715,0.000028894421,0.00026545906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802434,0.00014760527,0.00024387163,0.00041919935,0.0002112451,0.00095370517],"domain_scores_gemma":[0.9990762,0.00026791476,0.00011696904,0.00040920512,0.00007270415,0.000057038444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021124867,0.00022183749,0.00055032864,0.000106898995,0.00027482957,0.000017099263,0.00016177796,0.000037775873,0.00007446356],"category_scores_gemma":[0.000101165235,0.00014377288,0.00008318458,0.0002464731,0.00012065668,0.000043631677,0.0001261413,0.00037470498,0.0000100820325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001466212,0.0015428559,0.9945529,0.000009553794,0.00032859482,0.00005719944,0.0007194329,0.00010116562,0.00012366063,0.000027277792,0.0009677312,0.00010340669],"study_design_scores_gemma":[0.013415056,0.0031697024,0.98174244,0.0000035941898,0.00012271646,0.000011929041,0.00048710319,0.000165129,0.00013641553,0.000109351415,0.0004867053,0.00014986952],"about_ca_topic_score_codex":0.0001229219,"about_ca_topic_score_gemma":0.0001894624,"teacher_disagreement_score":0.012810482,"about_ca_system_score_codex":0.0001033564,"about_ca_system_score_gemma":0.000049605613,"threshold_uncertainty_score":0.5862888},"labels":[],"label_agreement":null},{"id":"W4280558719","doi":"10.1016/s2213-8587(22)00114-0","title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Immune Tolerance Network; Diabetes Canada; Alberta Diabetes Foundation; University of Alberta; Government of Alberta; Canada Research Chairs; Juvenile Diabetes Research Foundation Canada","keywords":"Medicine; Transplantation; Islet; Pancreas transplantation; Cohort; Diabetes mellitus; Internal medicine; Surgery; Type 1 diabetes; Cohort study; Type 2 diabetes; Kidney transplantation; Insulin; Endocrinology","score_opus":0.0204130542818517,"score_gpt":0.23255893114146117,"score_spread":0.21214587685960948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280558719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931447,0.0012621557,8.364768e-7,0.0026522244,0.0004952185,0.00048792476,0.00011799409,0.00005182734,0.001787129],"genre_scores_gemma":[0.994659,0.00016173797,0.00008613181,0.004263067,0.00013346682,0.00024924616,0.00027051225,0.00002337011,0.00015345216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753076,0.00032538522,0.00037901744,0.00038057994,0.0002994419,0.0010848128],"domain_scores_gemma":[0.9987375,0.0006184903,0.00009328838,0.00044112842,0.000031014348,0.000078558944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019885892,0.00020369394,0.0007004077,0.00013052576,0.00008927454,0.000011132318,0.0002516037,0.00003752563,0.0014812463],"category_scores_gemma":[0.00016598467,0.00017139991,0.000042649495,0.00049872254,0.00009095526,0.000053712673,0.0000702764,0.00044199012,0.000025311718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018861993,0.00009878589,0.9841052,0.000037626523,0.000069005124,0.00009748257,0.0008219752,0.00014280634,0.012016869,0.00005924889,0.0016622262,0.0007001124],"study_design_scores_gemma":[0.0052187364,0.00031132286,0.9666011,0.0001286008,0.00018381415,0.00000990326,0.0033311432,0.0018060138,0.011097395,0.00034971905,0.01061282,0.0003494517],"about_ca_topic_score_codex":0.10142116,"about_ca_topic_score_gemma":0.121092334,"teacher_disagreement_score":0.019671168,"about_ca_system_score_codex":0.0006313056,"about_ca_system_score_gemma":0.00034716283,"threshold_uncertainty_score":0.99943155},"labels":[],"label_agreement":null},{"id":"W4280595184","doi":"10.1016/s2213-8587(22)00135-8","title":"Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence – Authors' reply","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Persistence (discontinuity); Cushing's disease; Intensive care medicine; Disease; Internal medicine","score_opus":0.06136103035449662,"score_gpt":0.29458095468939227,"score_spread":0.23321992433489563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280595184","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32964358,0.030964801,0.0000024962858,0.63537484,0.00046631918,0.0020734884,0.001202212,0.000065232416,0.00020701393],"genre_scores_gemma":[0.6140464,0.01593334,0.00017417062,0.35859862,0.0030959386,0.0028002802,0.0025408373,0.00015190887,0.0026584996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757653,0.00020449082,0.0003224323,0.00057331775,0.00025159892,0.0010716373],"domain_scores_gemma":[0.9965847,0.0018530318,0.00019740706,0.0012325618,0.000052475745,0.000079839425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017603426,0.0003854658,0.0010114142,0.00006878521,0.00036335012,0.000021683418,0.00034489878,0.00010269347,0.00020815535],"category_scores_gemma":[0.0001343332,0.00019760996,0.00034513918,0.000096472686,0.00056422246,0.00002715581,0.00013716065,0.00048895093,0.000003685524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025402387,0.0014729921,0.3097775,0.0012287778,0.004373296,0.00053127063,0.0021178175,0.000007457353,0.00007921885,0.00032207262,0.65655726,0.020992113],"study_design_scores_gemma":[0.004626878,0.0027626846,0.03337915,0.000044302924,0.0023654862,0.000025407557,0.0001478501,0.000058702397,0.00013879033,0.0009823524,0.955259,0.00020937753],"about_ca_topic_score_codex":0.000102546655,"about_ca_topic_score_gemma":0.0000128168995,"teacher_disagreement_score":0.29870176,"about_ca_system_score_codex":0.00011619105,"about_ca_system_score_gemma":0.000102180595,"threshold_uncertainty_score":0.80583},"labels":[],"label_agreement":null},{"id":"W4286615932","doi":"10.1016/s2213-8587(22)00172-3","title":"Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"NIHR Oxford Biomedical Research Centre; National Heart, Lung, and Blood Institute; Oxford Martin School, University of Oxford; National Health and Medical Research Council; Medical Research Council; National Institutes of Health; National Heart and Lung Institute; British Heart Foundation; University of Bristol; National Institute for Health and Care Research; UK Research and Innovation","keywords":"Medicine; Blood pressure; Type 2 diabetes; Hazard ratio; Diabetes mellitus; Myocardial infarction; Heart failure; Internal medicine; Cardiology; Stroke (engine); Placebo; Proportional hazards model; Intensive care medicine; Emergency medicine; Confidence interval; Endocrinology","score_opus":0.23440019593656794,"score_gpt":0.3462705530180301,"score_spread":0.11187035708146217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286615932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8485233,0.14891785,0.000009450089,0.0007495741,0.00003406815,0.0007677332,0.0009554856,0.000032303327,0.000010242065],"genre_scores_gemma":[0.99761903,0.00038518332,0.00041022844,0.00031119687,0.00007276225,0.00072143396,0.00038101242,0.000021328293,0.000077814206],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99810576,0.00027983432,0.00027918653,0.00047924914,0.00025352038,0.0006024206],"domain_scores_gemma":[0.99834806,0.00022589185,0.0001204097,0.0011780063,0.00006935899,0.000058268055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044701542,0.0002005859,0.002244921,0.00014382631,0.00014977483,0.000012830408,0.00027800954,0.000026408778,0.000050381474],"category_scores_gemma":[0.00005836049,0.00011972175,0.00029170723,0.00031684866,0.0001136904,0.00007892756,0.00038465878,0.000120724624,2.7496043e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028261848,0.0006320624,0.45394212,0.00013991017,0.5420126,0.000008561468,0.000669212,0.00048713054,0.00031163785,0.00003970326,0.00011980568,0.001354649],"study_design_scores_gemma":[0.0031865544,0.0015521535,0.17069742,0.0000062738322,0.8184943,0.000007987303,0.00032640493,0.00036131966,0.0011010285,0.000067208435,0.0040574116,0.00014190601],"about_ca_topic_score_codex":0.000141808,"about_ca_topic_score_gemma":0.00043438846,"teacher_disagreement_score":0.2832447,"about_ca_system_score_codex":0.0000035000205,"about_ca_system_score_gemma":0.000041371422,"threshold_uncertainty_score":0.48821113},"labels":[],"label_agreement":null},{"id":"W4293123356","doi":"10.1016/s2213-8587(22)00215-7","title":"Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Manchester Biomedical Research Centre; National Institutes of Health; University of Oxford; Department of Health and Social Care; Universidade Federal de Pelotas; National Institute for Health and Care Research; Bill and Melinda Gates Foundation","keywords":"Medicine; Observational study; Fetus; Pregnancy; Fetal growth; Obstetrics; Prospective cohort study; Internal medicine","score_opus":0.01928195400498602,"score_gpt":0.27072988263613584,"score_spread":0.25144792863114984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293123356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925488,0.0013643533,0.0000060371526,0.004033271,0.000107416796,0.0013923272,0.0002831812,0.000046709796,0.00021785457],"genre_scores_gemma":[0.9980182,0.00011030647,0.00029102172,0.00033318793,0.00022621755,0.0006337829,0.00020423859,0.000021102403,0.00016193771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973456,0.00042059607,0.00032641029,0.00043665,0.00064942025,0.0008212812],"domain_scores_gemma":[0.9989363,0.0005176642,0.00016205033,0.00014365205,0.0001513375,0.000089004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005261635,0.00021973981,0.00051675906,0.00024303934,0.00028605765,0.000065879,0.00022342241,0.00004431353,0.000037891867],"category_scores_gemma":[0.00036280608,0.00018244077,0.000053245534,0.00028809597,0.00012859082,0.00018832218,0.00044872012,0.0006960921,0.0000021130654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012742305,0.00034706772,0.9898094,0.00007515912,0.0008692824,0.000025504976,0.0008568529,0.000004879348,0.00050258636,0.005105424,0.000052551623,0.002223872],"study_design_scores_gemma":[0.004493736,0.0008161283,0.9898709,0.000030914125,0.00022147199,0.000007484946,0.00033796259,0.00009403008,0.00057147513,0.0033154872,0.00008270486,0.00015772408],"about_ca_topic_score_codex":0.00022330508,"about_ca_topic_score_gemma":0.00006572368,"teacher_disagreement_score":0.005469356,"about_ca_system_score_codex":0.00020405752,"about_ca_system_score_gemma":0.00006569575,"threshold_uncertainty_score":0.7439719},"labels":[],"label_agreement":null},{"id":"W4294215976","doi":"10.1016/s2213-8587(22)00245-5","title":"Improving HbA1c levels with advanced hybrid closed-loop therapy","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; MEDLINE; Closed loop; Loop (graph theory); Intensive care medicine; Control engineering","score_opus":0.0446649232797819,"score_gpt":0.293441512680277,"score_spread":0.24877658940049513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294215976","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22501442,0.008276618,0.000012248465,0.7486671,0.0010486795,0.002620252,0.00018747133,0.00055739103,0.01361579],"genre_scores_gemma":[0.037103977,0.0015128306,0.00047276812,0.88615435,0.009148016,0.0016512952,0.0012378242,0.00040867596,0.062310282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935166,0.00046306476,0.00044871564,0.0009953034,0.0009244109,0.0036518655],"domain_scores_gemma":[0.9968502,0.0006247377,0.0003382799,0.0019556473,0.0001353378,0.00009578308],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058839435,0.0007001411,0.0016183873,0.00040107293,0.00037633302,0.000092118884,0.0014194562,0.0002090706,0.002984353],"category_scores_gemma":[0.00010280534,0.00042689746,0.00027350264,0.00040051574,0.00060410507,0.00010824093,0.0007354408,0.0048270756,0.00024824188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003852524,0.000102426915,0.0041963304,0.0005893102,0.0014651308,0.0017915185,0.000042715168,0.000010465979,0.0014893245,0.00013144888,0.8099442,0.17985184],"study_design_scores_gemma":[0.004484314,0.002059444,0.0024060244,0.000099200166,0.0002846668,0.000039622766,0.00003618139,0.00007442607,0.0021479796,0.00035414816,0.9874686,0.00054541446],"about_ca_topic_score_codex":0.000023139648,"about_ca_topic_score_gemma":0.0000024018088,"teacher_disagreement_score":0.18791044,"about_ca_system_score_codex":0.00019190945,"about_ca_system_score_gemma":0.0001916856,"threshold_uncertainty_score":0.99981827},"labels":[],"label_agreement":null},{"id":"W4294967762","doi":"10.1016/s2213-8587(22)00254-6","title":"PCSK9 inhibition in children with familial hypercholesterolaemia","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Medicine; MEDLINE; PCSK9; Pediatrics; Internal medicine; Cholesterol; LDL receptor","score_opus":0.01879361050873658,"score_gpt":0.24641889897606134,"score_spread":0.22762528846732477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967762","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6922833,0.0013041465,0.0000016071864,0.3037271,0.00020412327,0.0011708121,0.000106145366,0.00011266026,0.0010901084],"genre_scores_gemma":[0.22283505,0.0005978367,0.00008360041,0.76344496,0.009996355,0.000900095,0.0016744877,0.00012830604,0.00033930692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960581,0.00055573345,0.00035945323,0.000633564,0.00058195356,0.0018111735],"domain_scores_gemma":[0.99828637,0.00008142701,0.00014398873,0.0013899516,0.000042456093,0.000055820547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00052468997,0.00040287545,0.0013408462,0.00023871147,0.00013484171,0.000023709717,0.0002815652,0.00034844506,0.00020368646],"category_scores_gemma":[0.00003623484,0.00026507568,0.00023540182,0.00028416567,0.00023443678,0.000049639242,0.00022765236,0.004565952,0.00004285747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004033307,0.00015981068,0.4192874,0.00063114415,0.0020638185,0.0026951046,0.0002533339,0.000038025744,0.00026541905,0.000103572514,0.54977924,0.024319774],"study_design_scores_gemma":[0.0050273295,0.000903288,0.2529533,0.00015313477,0.0004672996,0.0016985069,0.000028274644,0.0000056751114,0.00030066964,0.00017179211,0.7378874,0.00040333386],"about_ca_topic_score_codex":0.00041517726,"about_ca_topic_score_gemma":0.000044614586,"teacher_disagreement_score":0.46944824,"about_ca_system_score_codex":0.00026985104,"about_ca_system_score_gemma":0.00018356382,"threshold_uncertainty_score":0.99998015},"labels":[],"label_agreement":null},{"id":"W4294967876","doi":"10.1016/s2213-8587(22)00221-2","title":"Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Centre hospitalier universitaire de Québec","funders":"HLS Therapeutics; Amgen; ZonMw; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; F. Hoffmann-La Roche; Abbott Laboratories; Regeneron Pharmaceuticals; Novartis; Pfizer","keywords":"Medicine; Evolocumab; Placebo; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Population; Cholesterol; Lipoprotein; Pathology","score_opus":0.03278071262394313,"score_gpt":0.26891457946732217,"score_spread":0.23613386684337903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307317,0.001456954,0.000034408135,0.00093070796,0.00019273779,0.0038272564,0.00025557636,0.000112869515,0.00011634047],"genre_scores_gemma":[0.9953685,0.00009007955,0.0011347557,0.001722729,0.00029070076,0.00092703215,0.00027150067,0.000095936426,0.00009876626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962911,0.00042772476,0.000481131,0.0007068965,0.00062214053,0.0014710128],"domain_scores_gemma":[0.9974955,0.00022240699,0.00031848013,0.001487455,0.00032116188,0.00015504904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051880704,0.0003905922,0.0013572706,0.0001725368,0.00036117388,0.000031391595,0.0006211244,0.0000887846,0.000033675915],"category_scores_gemma":[0.00010307912,0.00024261519,0.00013603501,0.00043420363,0.00020996286,0.000122060126,0.00045714324,0.0005505197,0.000004798352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020723158,0.00810706,0.80984515,0.0008338824,0.0025554951,0.00023841496,0.00069884775,0.0003316063,0.0053203725,0.00010851827,0.0025521868,0.14868534],"study_design_scores_gemma":[0.20502758,0.072645575,0.6654584,0.0004293692,0.0045253765,0.0004585288,0.00089615793,0.0012661893,0.013325677,0.00015131976,0.034280177,0.0015356833],"about_ca_topic_score_codex":0.00038672038,"about_ca_topic_score_gemma":0.00007398384,"teacher_disagreement_score":0.18430443,"about_ca_system_score_codex":0.00023644093,"about_ca_system_score_gemma":0.00014595666,"threshold_uncertainty_score":0.98935604},"labels":[],"label_agreement":null},{"id":"W4296162804","doi":"10.1016/s2213-8587(22)00218-2","title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1092,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juvenile Diabetes Research Foundation","funders":"Sydney Medical School; Abbott Diabetes Care; Juvenile Diabetes Research Foundation United States of America; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Life expectancy; Incidence (geometry); Demography; Type 2 diabetes; Population; Diabetes mellitus; Mortality rate; Public health; Gerontology; Pediatrics; Environmental health; Internal medicine","score_opus":0.044153837155462526,"score_gpt":0.33003364645539196,"score_spread":0.28587980929992945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296162804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955718,0.00061369926,0.00000578586,0.0009182006,0.00010241704,0.0014731581,0.000014974677,0.00002865869,0.0012713335],"genre_scores_gemma":[0.99878496,0.00007084103,0.000117109616,0.00022499872,0.00007927718,0.00032986837,0.000007296118,0.000011887855,0.00037376996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787563,0.00029462014,0.0002467741,0.0003643099,0.0003894778,0.00082921213],"domain_scores_gemma":[0.9992399,0.000101921796,0.00007682724,0.00044499003,0.00008012687,0.00005618705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087363983,0.00014503376,0.00049710035,0.0001915714,0.00010581361,0.000015428952,0.0002695537,0.000021605587,0.00011170187],"category_scores_gemma":[0.00006299348,0.00009978279,0.000027285496,0.0010399134,0.00014846833,0.00006124959,0.0005288167,0.00028530913,0.0000051219095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020876601,0.0003445806,0.99349153,0.00018975165,0.00018588867,0.000021495749,0.00023574459,0.0024219512,0.0001203798,0.00032164657,0.00024962414,0.002208657],"study_design_scores_gemma":[0.0016884393,0.0031388535,0.9833351,0.000059262984,0.00017296454,0.000002230388,0.00064626505,0.009395325,0.00012198696,0.0005717526,0.0007265616,0.00014127183],"about_ca_topic_score_codex":0.00011413622,"about_ca_topic_score_gemma":0.000116615316,"teacher_disagreement_score":0.0101564275,"about_ca_system_score_codex":0.00008004814,"about_ca_system_score_gemma":0.00006804961,"threshold_uncertainty_score":0.4069024},"labels":[],"label_agreement":null},{"id":"W4296578151","doi":"10.1016/s2213-8587(22)00243-1","title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Eli Lilly and Company","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Post-hoc analysis; Renal function; Internal medicine; Diabetes mellitus; Population; Metformin; Creatinine; Albuminuria; Insulin; Endocrinology","score_opus":0.04109852164761659,"score_gpt":0.3567662093372237,"score_spread":0.3156676876896071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296578151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896935,0.001802674,8.196708e-8,0.003310099,0.0007063244,0.0038472924,0.00035297117,0.000036338453,0.0002506841],"genre_scores_gemma":[0.9935317,0.00024107897,0.000025320685,0.004276639,0.00017561797,0.001064284,0.00062259036,0.000034931665,0.000027843456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99500376,0.0019764102,0.000940545,0.00049372844,0.00050362886,0.0010819078],"domain_scores_gemma":[0.99285406,0.0052938326,0.0004344274,0.0011671544,0.000091560505,0.00015899513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018772478,0.00034482696,0.0024504163,0.00071810896,0.000102456885,0.000023547142,0.0012006015,0.00008113508,0.0002647292],"category_scores_gemma":[0.0038901195,0.00022082833,0.00024729935,0.0017951323,0.00023668198,0.000105632374,0.00037659332,0.0005849735,0.0000060678685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9469606,0.010484277,0.025292518,0.00020582452,0.0031748044,0.00008211004,0.00053878047,0.00009084871,0.0059635146,0.00051636127,0.001157012,0.0055333218],"study_design_scores_gemma":[0.9481327,0.027558113,0.014136406,0.000052571228,0.002916509,4.2077673e-7,0.00018178782,0.00096477894,0.004204117,0.00018097193,0.0014305305,0.00024107094],"about_ca_topic_score_codex":0.0002588567,"about_ca_topic_score_gemma":0.000120377415,"teacher_disagreement_score":0.017073836,"about_ca_system_score_codex":0.00014252965,"about_ca_system_score_gemma":0.00041742707,"threshold_uncertainty_score":0.90051174},"labels":[],"label_agreement":null},{"id":"W4297989537","doi":"10.1016/s2213-8587(22)00252-2","title":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Centers for Disease Control and Prevention; National Institutes of Health; National Health and Medical Research Council; University of Tokyo; National Health Insurance Service; Ministry of Health, Labour and Welfare; Monash University; Diabetes Australia; Steno Diabetes Center Copenhagen","keywords":"Life expectancy; Demography; Type 2 diabetes; Medicine; Population; Jurisdiction; Years of potential life lost; Cohort; Public health; Gerontology; Incidence (geometry); Diabetes mellitus; Environmental health; Political science; Sociology","score_opus":0.014336988114988807,"score_gpt":0.2605917478292352,"score_spread":0.2462547597142464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297989537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927763,0.0032947068,0.000003107487,0.0018575329,0.00036179315,0.0014269656,0.00012575378,0.00009271654,0.00006113195],"genre_scores_gemma":[0.99731946,0.00007212164,0.00033663254,0.001207365,0.00034682153,0.00053326087,0.00008686884,0.0000483753,0.0000490972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996945,0.00072010886,0.0005462201,0.0004757827,0.00049922604,0.0008136091],"domain_scores_gemma":[0.9980436,0.0006848972,0.00021162725,0.0007827603,0.00010870937,0.00016838542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008363737,0.00023568494,0.0010846339,0.00046618006,0.00018797547,0.000018514145,0.00031568197,0.00005689415,0.00020768665],"category_scores_gemma":[0.0014285067,0.00021619393,0.00014323743,0.0007499715,0.00010067315,0.000056467547,0.00028387687,0.00053415267,0.00004053161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016551497,0.00044952903,0.98953474,0.00005487351,0.0004680713,0.000012448682,0.0004955173,0.0015393235,0.00009431143,0.0001061991,0.00030602276,0.0067734816],"study_design_scores_gemma":[0.003973674,0.0010660054,0.99099827,0.00003359601,0.0002322627,0.0000014210373,0.00038240734,0.00055960513,0.00016190583,0.00018862831,0.002194479,0.00020775766],"about_ca_topic_score_codex":0.0023273604,"about_ca_topic_score_gemma":0.0004682547,"teacher_disagreement_score":0.006565724,"about_ca_system_score_codex":0.0001104916,"about_ca_system_score_gemma":0.00014119883,"threshold_uncertainty_score":0.88161325},"labels":[],"label_agreement":null},{"id":"W4302759309","doi":"10.1016/s2213-8587(22)00244-3","title":"Acromegaly: pathogenesis, diagnosis, and management","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"Cedars-Sinai Medical Center; Oregon Health and Science University","keywords":"Acromegaly; Medicine; Pathogenesis; Somatotropic cell; Disease; Epidemiology; Growth hormone; Intensive care medicine; Bioinformatics; Hormone; Internal medicine","score_opus":0.0683543178157663,"score_gpt":0.3328417672675932,"score_spread":0.2644874494518269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302759309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010419968,0.99272573,2.450655e-7,0.0006614174,0.0002669081,0.0013314396,0.0001692655,0.00009921932,0.0037037935],"genre_scores_gemma":[0.0001229908,0.9948518,0.00007491323,0.0009889624,0.00023740045,0.0027454994,0.00047670814,0.000057306377,0.0004444029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760914,0.0002224374,0.00034148069,0.0005243932,0.00016805824,0.0011344932],"domain_scores_gemma":[0.9986333,0.0003020368,0.00015485386,0.0008078368,0.000008154957,0.00009378129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017268196,0.00043939552,0.002110981,0.0001535306,0.00021382676,0.000020893463,0.000324898,0.00009344184,0.000429812],"category_scores_gemma":[0.00002286238,0.0002616515,0.0002969907,0.00021009927,0.00013512708,0.000024794968,0.00051667,0.00037825192,0.00008148721],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000106222915,0.00015823603,0.007881249,0.006427104,0.0015172937,0.00042769962,0.00001579716,4.1599076e-8,5.9567242e-8,0.00082635693,0.0041879276,0.97854763],"study_design_scores_gemma":[0.0011138254,0.00020721734,0.0024674556,0.0007600144,0.0036852274,0.00015551424,0.000018417388,3.969669e-7,5.3093817e-7,0.00030008773,0.9910644,0.0002269097],"about_ca_topic_score_codex":0.000013788333,"about_ca_topic_score_gemma":0.0000063049647,"teacher_disagreement_score":0.9868765,"about_ca_system_score_codex":0.00007665773,"about_ca_system_score_gemma":0.00004129187,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W4308374264","doi":"10.1016/s2213-8587(22)00278-9","title":"The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"NIHR Leicester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Pandemic; Diabetes mellitus; Psychological intervention; Public health; Disease; Type 2 diabetes; Intensive care medicine; Diabetes management; Environmental health; Gerontology; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Psychiatry; Internal medicine; Nursing","score_opus":0.22812929012362465,"score_gpt":0.47789464193180814,"score_spread":0.2497653518081835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308374264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01713472,0.97177505,0.0000018541948,0.0050583566,0.000911864,0.0032633233,0.0013094498,0.00015304104,0.00039233672],"genre_scores_gemma":[0.005163281,0.97998154,0.000009219833,0.012250846,0.001087219,0.0010720518,0.0002274284,0.00008368384,0.00012471077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99470204,0.0010712843,0.00089579483,0.00059620844,0.0003955057,0.002339159],"domain_scores_gemma":[0.9863493,0.01047211,0.0009967741,0.0018561645,0.000062447645,0.00026324144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014484965,0.0006619081,0.0029767444,0.00011647187,0.000769642,0.00004530559,0.0016245614,0.00028397972,0.00009080901],"category_scores_gemma":[0.002160026,0.0002860983,0.0014843914,0.00055119186,0.00036206542,0.00003957199,0.000533533,0.0013485448,0.000014286382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054607197,0.000109296496,0.15202889,0.036122486,0.0029276824,0.000019749203,0.00036205733,0.00014477903,0.0000039646015,0.0006987489,0.015140787,0.7918955],"study_design_scores_gemma":[0.001210027,0.0015134921,0.004186833,0.0026302459,0.00114277,0.00007862388,0.00006551236,0.000022220966,0.0000013443632,0.0018343531,0.9870471,0.0002675124],"about_ca_topic_score_codex":0.0003419745,"about_ca_topic_score_gemma":0.00009012602,"teacher_disagreement_score":0.9719063,"about_ca_system_score_codex":0.0018466138,"about_ca_system_score_gemma":0.0023566603,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W4308426407","doi":"10.1016/s2213-8587(22)00277-7","title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health","keywords":"Medicine; Placebo; Pediatrics; Internal medicine; Clinical endpoint; Randomized controlled trial; Clinical trial","score_opus":0.017803798191251913,"score_gpt":0.2747634658659727,"score_spread":0.2569596676747208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308426407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286205,0.000983572,0.000004081109,0.00030466597,0.00008993998,0.005273035,0.00035704748,0.000016282727,0.00010935182],"genre_scores_gemma":[0.9973458,0.00011390838,0.00031375492,0.00023023375,0.00004719055,0.0012732586,0.0005285571,0.000043323067,0.00010398718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972186,0.00054982054,0.0005079459,0.0006571473,0.00022338158,0.00084310235],"domain_scores_gemma":[0.9986794,0.00012724409,0.00033086675,0.00061217725,0.00006634594,0.00018394283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041554158,0.0003551063,0.0010730441,0.00008939752,0.00025348057,0.000054055316,0.00056183594,0.000067436886,0.00007720749],"category_scores_gemma":[0.0000873849,0.00024219061,0.000041232142,0.00014710562,0.00036795283,0.000015942525,0.0005293191,0.00024483306,0.0000014184618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97316396,0.0018223171,0.020182142,0.000044234,0.0006172063,0.00004185793,0.00014164759,0.000058772515,0.0029994366,0.000021471835,0.000115242816,0.00079171953],"study_design_scores_gemma":[0.9726868,0.0138260005,0.01031874,0.000029936919,0.0003173728,0.00008487748,0.00020508635,0.000047191945,0.000984544,0.000012205075,0.0011270503,0.00036019247],"about_ca_topic_score_codex":0.00003714245,"about_ca_topic_score_gemma":0.00004996185,"teacher_disagreement_score":0.0120036835,"about_ca_system_score_codex":0.000022506223,"about_ca_system_score_gemma":0.00016536884,"threshold_uncertainty_score":0.98762465},"labels":[],"label_agreement":null},{"id":"W4308697810","doi":"10.1016/s2213-8587(22)00313-8","title":"Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Type 2 diabetes; Glycated hemoglobin; Diabetes mellitus; Coronary artery disease; Impaired glucose tolerance; Cardiology; Endocrinology","score_opus":0.01663995489241324,"score_gpt":0.2617943424152707,"score_spread":0.24515438752285748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308697810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5016666,0.0009395626,2.5791414e-7,0.49416664,0.00052115915,0.0011429234,0.00006299739,0.00011132319,0.0013885244],"genre_scores_gemma":[0.6838777,0.000655076,0.00095399783,0.30061674,0.003957928,0.0019980418,0.00169359,0.00027910358,0.0059678066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996594,0.0002675064,0.00043437237,0.00058092584,0.00043053337,0.0016926798],"domain_scores_gemma":[0.9984355,0.00026263014,0.00029533225,0.0009167783,0.000045686855,0.000044100972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018572505,0.00045850308,0.0015566798,0.0005056302,0.00007377232,0.000015211787,0.0002934654,0.00019073988,0.0002976634],"category_scores_gemma":[0.00004820657,0.00029752406,0.00019019414,0.00040946738,0.00035281305,0.000066348584,0.0002444357,0.0018265712,0.000027254566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022468474,0.00015035375,0.2710716,0.00027236636,0.0012019614,0.00021758239,0.00027836658,0.000012918535,0.00028716182,0.00013376452,0.7251129,0.0010363373],"study_design_scores_gemma":[0.0042122095,0.0016537937,0.05026929,0.00019059387,0.00076155196,0.000033308475,0.00045348532,0.0000026105647,0.001692435,0.0005194787,0.9398657,0.00034553322],"about_ca_topic_score_codex":0.00020624441,"about_ca_topic_score_gemma":0.000061971885,"teacher_disagreement_score":0.22080232,"about_ca_system_score_codex":0.00041099865,"about_ca_system_score_gemma":0.00010344246,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W4308702501","doi":"10.1016/s2213-8587(22)00308-4","title":"Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Respicardia; Sanofi Pasteur; National Institutes of Health; Daiichi-Sankyo; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; American Regent; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca Korea; GlaxoSmithKline; Celladon Corporation; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Dapagliflozin; Internal medicine; Atrial fibrillation; Placebo; Cardiology; Prediabetes; Type 2 diabetes; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.01639903670994819,"score_gpt":0.2730839111137107,"score_spread":0.25668487440376253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308702501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927663,0.00016363422,0.000023264965,0.0009909892,0.00013544453,0.0056781843,0.00013075216,0.00005496895,0.000056449182],"genre_scores_gemma":[0.99582195,0.00013047701,0.0003817209,0.00024748212,0.00010904657,0.0011007892,0.0020897964,0.000026152115,0.00009260916],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99739254,0.00058987865,0.00050158345,0.0004984334,0.00040190291,0.000615693],"domain_scores_gemma":[0.99835336,0.0006293476,0.0003490334,0.00049396895,0.00008561998,0.0000886717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004564107,0.0002634469,0.0011720797,0.00036015632,0.000116772,0.000025931393,0.0001925909,0.000047911784,0.00030366698],"category_scores_gemma":[0.00009732905,0.00016164883,0.00009565369,0.00048407144,0.00009148698,0.00018614283,0.00010897601,0.0003084377,0.0000016404925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68382096,0.0012707926,0.30981195,0.000011185464,0.003331149,0.0000039667243,0.0000957383,0.0005361711,0.0003906261,0.0000036684191,0.00026117475,0.00046260032],"study_design_scores_gemma":[0.89498746,0.0031485413,0.093752205,0.000026909409,0.0032915073,3.6114e-7,0.0002861086,0.0022099668,0.00044927892,0.0000036718507,0.001679587,0.00016440627],"about_ca_topic_score_codex":0.00057936047,"about_ca_topic_score_gemma":0.0005179506,"teacher_disagreement_score":0.21605974,"about_ca_system_score_codex":0.00018503658,"about_ca_system_score_gemma":0.000042024447,"threshold_uncertainty_score":0.6591848},"labels":[],"label_agreement":null},{"id":"W4311596863","doi":"10.1016/s2213-8587(22)00319-9","title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":725,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"European Medicines Agency; European Association for the Study of Diabetes; Japan Diabetes Society; Javna Agencija za Raziskovalno Dejavnost RS; American Association of Clinical Endocrinologists; Juvenile Diabetes Research Foundation International; American Diabetes Association","keywords":"Medicine; Statement (logic); Continuous glucose monitoring; MEDLINE; Intensive care medicine; Consensus conference; Medical physics; Internal medicine; Epistemology; Insulin; Law","score_opus":0.5046467869866073,"score_gpt":0.5550496755933165,"score_spread":0.05040288860670927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311596863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028420184,0.9884649,0.00000665762,0.0012981036,0.0029682706,0.0031511865,0.00024076481,0.000105622,0.00092246704],"genre_scores_gemma":[0.00012211331,0.99329305,0.00062554487,0.00020728075,0.0029983192,0.0010951348,0.00036993218,0.00006783296,0.0012208105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934237,0.0026695584,0.0015515704,0.0006601638,0.00041219202,0.0012828127],"domain_scores_gemma":[0.9869069,0.0113529395,0.0007143468,0.00075526873,0.00010735294,0.00016322786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013045436,0.00037850245,0.00383908,0.0004355216,0.00017268787,0.0000953577,0.00074482895,0.00015694577,0.0002345285],"category_scores_gemma":[0.006572058,0.00023688408,0.0005666461,0.0002688547,0.00030939467,0.000042919593,0.00069853215,0.0010365434,0.000023247307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010331268,0.0001827478,0.00407359,0.0029102473,0.0022960352,0.00004313255,0.000013650824,1.8375025e-7,9.90615e-7,0.00060331024,0.0066149547,0.9831579],"study_design_scores_gemma":[0.0025966233,0.00083238963,0.00021729659,0.00053690636,0.0022675844,0.000009077409,0.00007925121,0.00006520644,0.0000052907417,0.00021903901,0.9929517,0.00021962248],"about_ca_topic_score_codex":0.0000041131557,"about_ca_topic_score_gemma":4.745088e-7,"teacher_disagreement_score":0.98633677,"about_ca_system_score_codex":0.00013770377,"about_ca_system_score_gemma":0.00015095586,"threshold_uncertainty_score":0.96598524},"labels":[],"label_agreement":null},{"id":"W4311772176","doi":"10.1016/s2213-8587(22)00342-4","title":"Mendelian randomisation and vitamin D: the importance of model assumptions","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Mendelian randomization; Medicine; Vitamin D and neurology; Confounding; Disease; Population; Observational study; vitamin D deficiency; Internal medicine; Environmental health; Genetics; Genetic variants; Gene; Genotype","score_opus":0.054126002017471815,"score_gpt":0.32068541280479196,"score_spread":0.26655941078732015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311772176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16494477,0.004746921,0.000013680561,0.8271077,0.00018133069,0.0010329915,0.00022132749,0.00006522033,0.0016860327],"genre_scores_gemma":[0.33659422,0.01075999,0.0004577621,0.63861483,0.0037101486,0.0021990926,0.0005993374,0.0001356054,0.0069290395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705416,0.00045014793,0.00042499835,0.00040120917,0.0004923583,0.0011771459],"domain_scores_gemma":[0.99726045,0.0012911211,0.00027818422,0.0010289843,0.00010680172,0.000034454082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007760459,0.0002963627,0.0010823725,0.0001614703,0.00032365267,0.000015634738,0.0005127089,0.00016385257,0.00020157381],"category_scores_gemma":[0.00046983702,0.00016219878,0.00015840087,0.0001806947,0.0009158809,0.000036715985,0.00054597715,0.0022854672,0.000008785729],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010204368,0.000032254888,0.02143261,0.0004043609,0.0008665892,0.0000679097,0.00041204502,0.000049440685,0.0010597836,0.0004110801,0.974123,0.0010388913],"study_design_scores_gemma":[0.012951516,0.0008193501,0.045343384,0.00019867564,0.0018738167,0.00018987461,0.0006055685,0.004901872,0.0011044773,0.0092180325,0.9221296,0.00066387636],"about_ca_topic_score_codex":0.000018933106,"about_ca_topic_score_gemma":0.0000201416,"teacher_disagreement_score":0.18849291,"about_ca_system_score_codex":0.000096976546,"about_ca_system_score_gemma":0.000099869256,"threshold_uncertainty_score":0.9929345},"labels":[],"label_agreement":null},{"id":"W4311781891","doi":"10.1016/s2213-8587(22)00357-6","title":"Predicting the response to GLP-1 receptor agonists: an unexpected role for β-arrestin-1","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Exenatide; Heterotrimeric G protein; G protein-coupled receptor; Gs alpha subunit; Receptor; Medicine; Signal transduction; Intracellular; Adenylyl cyclase; Allosteric regulation; Pharmacology; Cell biology; G protein; Type 2 diabetes; Internal medicine; Endocrinology; Biology; Diabetes mellitus","score_opus":0.029142787363878285,"score_gpt":0.28663356711345067,"score_spread":0.2574907797495724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311781891","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27244064,0.0011890779,0.0000042847028,0.718889,0.0014122534,0.0033299457,0.00046286438,0.0005032412,0.001768704],"genre_scores_gemma":[0.02261273,0.000158717,0.0009533607,0.9334706,0.013413785,0.009185427,0.0033541003,0.00030358668,0.016547715],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99465597,0.00092226797,0.00050850527,0.0008990039,0.000469902,0.002544355],"domain_scores_gemma":[0.9953086,0.0021127674,0.00029408128,0.002047978,0.00011594159,0.00012064668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097505626,0.000607154,0.0012064092,0.000260302,0.0006400876,0.0001039321,0.0012893977,0.00023915032,0.0006291493],"category_scores_gemma":[0.00074160355,0.0003771954,0.00029279586,0.0003739189,0.00025153515,0.00006235032,0.00063135393,0.0016755533,0.00013298568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017230059,0.0001239394,0.0053272415,0.00015919596,0.0012233474,0.00011159904,0.000700197,0.000011597604,0.0025176085,0.00022142818,0.98084867,0.0070321816],"study_design_scores_gemma":[0.0021398133,0.00269552,0.0027510652,0.00007798939,0.0009395529,0.000012912878,0.00041809733,0.000074078176,0.0007076837,0.00038809655,0.9894275,0.00036766613],"about_ca_topic_score_codex":0.000061461215,"about_ca_topic_score_gemma":0.000019999197,"teacher_disagreement_score":0.24982792,"about_ca_system_score_codex":0.00035121347,"about_ca_system_score_gemma":0.00013276502,"threshold_uncertainty_score":0.999868},"labels":[],"label_agreement":null},{"id":"W4313554841","doi":"10.1016/s2213-8587(22)00353-9","title":"Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; Novartis Pharma; National Institute for Health and Care Research; Novartis","keywords":"Medicine; PCSK9; Clinical endpoint; Placebo; Statin; Population; Dosing; Internal medicine; Cholesterol; Adverse effect; Surrogate endpoint; Clinical trial; Lipoprotein; Pathology","score_opus":0.025977539394577646,"score_gpt":0.26660450488717047,"score_spread":0.24062696549259283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313554841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462914,0.0012927512,0.0000025961074,0.0009880787,0.00021348239,0.0025935923,0.00023957557,0.000026584528,0.0000142030485],"genre_scores_gemma":[0.99742717,0.0019192962,0.000031827218,0.00019405808,0.00024319014,0.000048086757,0.00010307644,0.00002568579,0.0000076018064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725807,0.0008356487,0.00049800024,0.00042482626,0.00043406285,0.0005494226],"domain_scores_gemma":[0.9974441,0.00052855746,0.00025565142,0.0016014451,0.000115890165,0.00005434964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015824581,0.00019755027,0.0010598145,0.00006103545,0.00015656256,0.000017181952,0.0004001532,0.00009427122,0.0000026674684],"category_scores_gemma":[0.0004861345,0.000091721384,0.000102193975,0.00041271438,0.00035026652,0.000055487875,0.000521134,0.0004401051,0.0000016745458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030525453,0.00030243502,0.9072991,0.00010562662,0.0016677438,0.000012376325,0.00061897817,0.00005682179,0.00028035117,0.0000642715,0.000099061304,0.058967754],"study_design_scores_gemma":[0.12633753,0.000831778,0.8710552,0.00025681933,0.0004296385,0.0000023215298,0.000035535482,0.000012937003,0.0006098959,0.00007787469,0.00026322438,0.00008726164],"about_ca_topic_score_codex":0.0017069324,"about_ca_topic_score_gemma":0.00013821044,"teacher_disagreement_score":0.09581208,"about_ca_system_score_codex":0.000028895009,"about_ca_system_score_gemma":0.000059970076,"threshold_uncertainty_score":0.37402895},"labels":[],"label_agreement":null},{"id":"W4313621257","doi":"10.1016/s2213-8587(22)00307-2","title":"Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Novo Nordisk","keywords":"Medicine; Insulin detemir; Insulin degludec; Insulin aspart; Insulin; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Internal medicine; Insulin glargine; Endocrinology","score_opus":0.057838707920567244,"score_gpt":0.34275435128427173,"score_spread":0.2849156433637045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313621257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884132,0.0007892754,0.0000045713355,0.00272,0.0001357951,0.0073815617,0.000044090662,0.0000555085,0.00045596794],"genre_scores_gemma":[0.9904053,0.0026089647,0.00024654763,0.00029556765,0.00013262042,0.005973604,0.0002031775,0.00003581303,0.000098375785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960876,0.00083360815,0.0006306417,0.00049360225,0.0005838531,0.0013706587],"domain_scores_gemma":[0.9962165,0.0025029315,0.0002740709,0.00065554003,0.00023370347,0.00011725114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013949098,0.00034146005,0.0012548704,0.00042858082,0.00012503007,0.00006692614,0.0006295635,0.0000808259,0.00004961066],"category_scores_gemma":[0.0006133743,0.00017253011,0.000045326597,0.0010075564,0.0003198477,0.00021748281,0.00012829958,0.00027465116,0.000025887144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8170971,0.009654319,0.08740539,0.00028991123,0.0016508895,0.00020926644,0.0052501974,0.0005418333,0.0046030534,0.0022482122,0.00032888824,0.07072094],"study_design_scores_gemma":[0.74422115,0.02774288,0.22163591,0.00018320559,0.00011426546,0.0000014331031,0.00073344086,0.0021215559,0.001100819,0.0005831216,0.0013243215,0.00023790808],"about_ca_topic_score_codex":0.00011597829,"about_ca_topic_score_gemma":0.00052245316,"teacher_disagreement_score":0.13423052,"about_ca_system_score_codex":0.00031903526,"about_ca_system_score_gemma":0.00029034214,"threshold_uncertainty_score":0.7035574},"labels":[],"label_agreement":null},{"id":"W4319067708","doi":"10.1016/s2213-8587(23)00004-9","title":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital; SickKids Foundation; University of Toronto; University Health Network; Dalhousie University; Sunnybrook Health Science Centre; Women's College Hospital; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Hospital; University of Alberta","funders":"Canadian Institutes of Health Research; University of Guelph","keywords":"Medicine; Metformin; Placebo; Pregnancy; Type 2 diabetes; Anthropometry; Confounding; Diabetes mellitus; Body mass index; Internal medicine; Obstetrics; Endocrinology","score_opus":0.02564788251801934,"score_gpt":0.28473332378248545,"score_spread":0.2590854412644661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319067708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906892,0.000256019,5.2487e-7,0.001313225,0.00034897294,0.0069436315,0.000036700105,0.00006201792,0.00034968296],"genre_scores_gemma":[0.9969996,0.00012705156,0.00006437978,0.000121069854,0.000070240996,0.0019280731,0.000023762279,0.000026665848,0.00063914387],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966173,0.00043367903,0.00055477995,0.00032876286,0.00050759205,0.0015578705],"domain_scores_gemma":[0.99731845,0.0014513595,0.00024242916,0.00071603304,0.00013939172,0.00013232659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078069477,0.0002572716,0.0015267198,0.00029001752,0.000083405605,0.000011688285,0.000528241,0.000058646496,0.0000544651],"category_scores_gemma":[0.0024673531,0.00013848198,0.00018393592,0.00073947577,0.00023183183,0.00006236467,0.00031391066,0.0002933294,0.000014536653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4463839,0.00032067634,0.5392017,0.00027424507,0.00241236,0.000010962244,0.0007431673,0.00012637621,0.0079945605,0.00021726984,0.00023700851,0.0020778165],"study_design_scores_gemma":[0.5324033,0.0015655229,0.45451087,0.00012365676,0.00015843069,4.0450945e-7,0.00015391437,0.000048283917,0.01074292,0.00013822044,0.000038704344,0.000115773764],"about_ca_topic_score_codex":0.000037319798,"about_ca_topic_score_gemma":0.00007454051,"teacher_disagreement_score":0.08601943,"about_ca_system_score_codex":0.00014420498,"about_ca_system_score_gemma":0.00013299064,"threshold_uncertainty_score":0.5647131},"labels":[],"label_agreement":null},{"id":"W4323036455","doi":"10.1016/s2213-8587(23)00009-8","title":"Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Eisai; Janssen Pharmaceuticals; Hebrew University of Jerusalem; University of Liverpool; IFM Therapeutics; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Brigham and Women's Hospital; Novo Nordisk; Daiichi-Sankyo; Zora Biosciences; Intarcia Therapeutics; Sanofi; Esperion Therapeutics; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Dapagliflozin; Type 2 diabetes; Diabetes mellitus; Post-hoc analysis; Internal medicine; TIMI; Placebo; Population; Hazard ratio; Disease; Endocrinology; Myocardial infarction; Confidence interval; Pathology; Environmental health","score_opus":0.030754293599564886,"score_gpt":0.3036016177759771,"score_spread":0.2728473241764122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323036455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353594,0.00056779524,3.830419e-7,0.0030499655,0.0003241873,0.0013610335,0.000018091856,0.000077262746,0.0010653717],"genre_scores_gemma":[0.99819374,0.00024172463,0.00004763348,0.0007819901,0.000120877936,0.00022072825,0.000056694033,0.00002653466,0.00031010516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820143,0.00020090424,0.00031356115,0.0002581773,0.0002603235,0.00076562725],"domain_scores_gemma":[0.99814606,0.0008419753,0.00018456233,0.0007000981,0.000088457906,0.000038852446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022160042,0.00020949933,0.0007880982,0.00025659087,0.000056895766,0.000008473714,0.00033791002,0.000055141947,0.000032836786],"category_scores_gemma":[0.000313863,0.000110131725,0.00013499623,0.0010658458,0.00022302166,0.00004281118,0.0001532854,0.00018530936,0.00003140951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007214636,0.0015931528,0.9344181,0.0009954514,0.0032486208,0.00004061987,0.0012178727,0.00059937313,0.030745704,0.0043419106,0.006940599,0.008644003],"study_design_scores_gemma":[0.03094509,0.0072179204,0.8812958,0.0003727921,0.0012442988,5.177224e-7,0.00022263952,0.0001775918,0.07644244,0.0004159682,0.00145748,0.0002074303],"about_ca_topic_score_codex":0.000045785426,"about_ca_topic_score_gemma":0.00010793675,"teacher_disagreement_score":0.05312223,"about_ca_system_score_codex":0.00004513197,"about_ca_system_score_gemma":0.00005783113,"threshold_uncertainty_score":0.44910416},"labels":[],"label_agreement":null},{"id":"W4328050587","doi":"10.1016/s2213-8587(22)00358-8","title":"Long-term association between homelessness and mortality among people with diabetes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; St. Michael's Hospital","funders":"M.S.I. Foundation","keywords":"Medicine; Scopus; Diabetes mellitus; Glycemic; Socioeconomic status; MEDLINE; Gerontology; Health care; Type 2 diabetes; Family medicine; Environmental health; Population","score_opus":0.050885796901937654,"score_gpt":0.3563564441300071,"score_spread":0.30547064722806944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328050587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9034126,0.0005913468,0.0000021656558,0.09226875,0.0011411101,0.0011579164,0.00046055226,0.00054790097,0.00041766922],"genre_scores_gemma":[0.95258284,0.00070088526,0.0000051029224,0.029358448,0.013357859,0.0012433534,0.0011457738,0.00019339347,0.0014123581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99195826,0.00206121,0.0007512904,0.00079530757,0.00058852776,0.0038453988],"domain_scores_gemma":[0.9930064,0.0046573663,0.0010070627,0.00096352224,0.0002559907,0.00010965548],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012527467,0.0006404269,0.0030309204,0.00018929812,0.001132761,0.0000816418,0.0008591428,0.0014210319,0.0001270879],"category_scores_gemma":[0.00025762542,0.00044406703,0.00014320295,0.00045981014,0.00038786008,0.00015889383,0.0005582999,0.0047534574,0.0002499256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004440439,0.000010823445,0.9726348,0.0012885244,0.0010354167,0.000044072178,0.0035025207,4.1700832e-7,0.0000031116097,0.00006193165,0.02062996,0.000784],"study_design_scores_gemma":[0.00079889444,0.00007509248,0.98743534,0.0003968854,0.0006580304,4.9558118e-8,0.001106545,0.0000033272013,0.00002280184,0.0008798509,0.008089439,0.00053374586],"about_ca_topic_score_codex":0.0008166444,"about_ca_topic_score_gemma":0.013724577,"teacher_disagreement_score":0.0629103,"about_ca_system_score_codex":0.0003123585,"about_ca_system_score_gemma":0.00014168926,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W4362466994","doi":"10.1016/s2213-8587(23)00038-4","title":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Multiple Sclerosis Society of Canada; Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health","keywords":"SDHD; Medicine; Paraganglioma; Guideline; Pheochromocytoma; Watchful waiting; Multiple endocrine neoplasia type 2; Disease; Germline mutation; Internal medicine; Surgery; Pathology; Genetics; Cancer","score_opus":0.10734736985363869,"score_gpt":0.3853101991825035,"score_spread":0.2779628293288648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362466994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32076022,0.67497563,6.6197157e-7,0.0012508183,0.0004936584,0.0018287173,0.00017958299,0.000091759226,0.0004189598],"genre_scores_gemma":[0.031484064,0.965648,0.00021155509,0.0009865988,0.00081561756,0.0002568863,0.0001767633,0.00012315516,0.0002973833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955575,0.0007057577,0.0017005024,0.0006032288,0.0002981711,0.0011348262],"domain_scores_gemma":[0.99673295,0.0013717689,0.00067664834,0.0010494849,0.00007348719,0.000095661526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014122253,0.00048915966,0.0028851547,0.00024326288,0.000079573314,0.00001051483,0.0005186681,0.0002004272,0.000052659612],"category_scores_gemma":[0.00020515983,0.00025790167,0.00037578464,0.00054710964,0.00053398043,0.000012074838,0.00048822205,0.00091958797,0.00011487205],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040400677,0.0006439264,0.0028202995,0.013144657,0.0035209337,0.02805965,0.000068790905,0.0000039888855,5.0096213e-7,0.0047487924,0.003827665,0.9427568],"study_design_scores_gemma":[0.03175833,0.005389948,0.31177655,0.091304705,0.016053552,0.009491733,0.00019721067,0.0003901405,0.000057582027,0.005647866,0.5250633,0.00286909],"about_ca_topic_score_codex":0.000009197043,"about_ca_topic_score_gemma":0.0000054261727,"teacher_disagreement_score":0.9398877,"about_ca_system_score_codex":0.00005227136,"about_ca_system_score_gemma":0.000083225495,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W4362517382","doi":"10.1016/s2213-8587(23)00062-1","title":"Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gestational diabetes; Type 2 diabetes; Hazard ratio; Population; Diabetes mellitus; Cohort; Cohort study; Pregnancy; Proportional hazards model; Internal medicine; Obstetrics; Endocrinology; Gestation; Confidence interval; Environmental health","score_opus":0.025143424648330116,"score_gpt":0.30948270586280235,"score_spread":0.2843392812144722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362517382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611986,0.0011197593,0.0000011790133,0.00096868165,0.000085158325,0.001436654,0.00004100451,0.00008297187,0.00014471552],"genre_scores_gemma":[0.99814135,0.0009715605,0.00007830555,0.00019138196,0.0000397678,0.0003590812,0.00009989205,0.000019767982,0.00009887615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978761,0.0003145862,0.00031135674,0.00031455714,0.00028960416,0.00089379825],"domain_scores_gemma":[0.9986188,0.0006187874,0.00010977411,0.00048369204,0.00009769204,0.000071252914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056939997,0.00015527631,0.0005493249,0.00029329341,0.00006468796,0.000013679876,0.00019276277,0.00003816168,0.000037276717],"category_scores_gemma":[0.0005370481,0.000116176605,0.000042090032,0.0006775829,0.00013113856,0.000048381797,0.0001321174,0.00027716628,0.000029386798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083806626,0.00017627048,0.99203753,0.00019157495,0.00022245674,0.000019195733,0.00015297013,0.00016043674,0.0001418723,0.00010820942,0.00021383305,0.0064918455],"study_design_scores_gemma":[0.002134522,0.00076761714,0.99371654,0.0001542012,0.00010355963,2.5381132e-7,0.00007569388,0.0017073124,0.00034134786,0.0007327935,0.00016714618,0.00009901348],"about_ca_topic_score_codex":0.0002836644,"about_ca_topic_score_gemma":0.00018392119,"teacher_disagreement_score":0.006392832,"about_ca_system_score_codex":0.00003891254,"about_ca_system_score_gemma":0.000042687298,"threshold_uncertainty_score":0.47375444},"labels":[],"label_agreement":null},{"id":"W4365814219","doi":"10.1016/s2213-8587(23)00088-8","title":"BMI versus obesity subtypes in the era of precision medicine","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Institut Universitaire en Santé Mentale de Québec","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research","keywords":"Medicine; Overweight; Scopus; Obesity; Guideline; Task force; Body mass index; Family medicine; MEDLINE; Gerontology; Internal medicine; Pathology","score_opus":0.04082962997764736,"score_gpt":0.3027312542865291,"score_spread":0.26190162430888175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365814219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265433,0.0010988815,0.0000038241847,0.0129469875,0.00081988034,0.00028114702,0.0000049559653,0.000083498046,0.002106476],"genre_scores_gemma":[0.9967663,0.001885659,0.000011854629,0.0006701701,0.00048314294,0.000023806226,0.000027523909,0.000010490103,0.00012100757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853253,0.0002618795,0.0002207765,0.00017885475,0.00026997877,0.00053596153],"domain_scores_gemma":[0.9983803,0.0008834089,0.000058744434,0.0006024194,0.000045946752,0.000029157198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008794553,0.00011384536,0.00052169384,0.000106607724,0.00005879011,0.0000034377097,0.0002441524,0.00005722856,0.00011813854],"category_scores_gemma":[0.00049121,0.000053915006,0.00013725078,0.00053296913,0.00026351312,0.000021768106,0.00007628998,0.00042008323,0.00010586429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000693983,0.000087027714,0.93246984,0.000081148726,0.00039364383,0.00007208286,0.0013455476,0.000054813583,0.003185512,0.002165173,0.025010638,0.034440566],"study_design_scores_gemma":[0.00320017,0.00031957496,0.9547521,0.000054438293,0.00014501445,0.000016559165,0.00055423577,0.000062869774,0.0020451439,0.00043482624,0.03835394,0.000061164035],"about_ca_topic_score_codex":0.0001312435,"about_ca_topic_score_gemma":0.00007609895,"teacher_disagreement_score":0.034379404,"about_ca_system_score_codex":0.00002349634,"about_ca_system_score_gemma":0.000024912906,"threshold_uncertainty_score":0.21985902},"labels":[],"label_agreement":null},{"id":"W4366817786","doi":"10.1016/s2213-8587(23)00090-6","title":"BETA-2 score at 28 days after islet allogeneic transplantation in type 1 diabetes for predicting 5-year outcomes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Islet; Transplantation; Retrospective cohort study; Observational study; Diabetes mellitus; Internal medicine; Type 2 diabetes; Cohort study; Cohort; Intensive care medicine; Pediatrics; Endocrinology","score_opus":0.04436149790616794,"score_gpt":0.2829486983708251,"score_spread":0.23858720046465715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366817786","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7734897,0.0015505743,0.0000022336096,0.22052415,0.0016282923,0.0012620229,0.0005814787,0.00035103134,0.00061052496],"genre_scores_gemma":[0.2690548,0.004183105,0.00045834895,0.6983173,0.00994098,0.0034701736,0.007356164,0.00047143287,0.0067477017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954326,0.00026409057,0.00072233664,0.0008092829,0.0003767017,0.0023949787],"domain_scores_gemma":[0.996307,0.00229031,0.00026617243,0.0009238956,0.0001271105,0.00008549502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004931026,0.0006354428,0.0018643928,0.0006335538,0.00014219749,0.000037407586,0.00042170243,0.00055601937,0.00030558067],"category_scores_gemma":[0.00045103978,0.00045404668,0.00036054244,0.0005102168,0.000276861,0.00007312092,0.0001360614,0.0013429187,0.00038341663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018980341,0.00002903323,0.64850444,0.0010284126,0.00057683577,0.00014907093,0.00011342446,0.000007344081,0.0010698317,0.000021127331,0.34796965,0.00034106622],"study_design_scores_gemma":[0.008114414,0.0010010689,0.5511987,0.00094230287,0.0024636907,0.000028481209,0.000062313164,0.00021946455,0.008111955,0.0009972199,0.42582506,0.0010352834],"about_ca_topic_score_codex":0.000023663677,"about_ca_topic_score_gemma":0.000044847162,"teacher_disagreement_score":0.5044349,"about_ca_system_score_codex":0.00015553142,"about_ca_system_score_gemma":0.00008228216,"threshold_uncertainty_score":0.99979115},"labels":[],"label_agreement":null},{"id":"W4367302347","doi":"10.1016/s2213-8587(23)00094-3","title":"Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Medicine; Thyroid nodules; Pandemic; Retrospective cohort study; Thyroid; Thyroid cancer; Coronavirus disease 2019 (COVID-19); Indeterminate; Thyroidectomy; Cross-sectional study; General surgery; Surgery; Internal medicine; Disease; Pathology; Infectious disease (medical specialty)","score_opus":0.10698540117064269,"score_gpt":0.43483680718135903,"score_spread":0.32785140601071633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367302347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578656,0.00010074788,0.0000048233433,0.010329582,0.0013830938,0.0018821215,0.00021558374,0.00023077865,0.00006672345],"genre_scores_gemma":[0.9927004,0.00014253211,0.000004429048,0.0058282306,0.0006556856,0.0003624752,0.000049362687,0.00003411107,0.0002227479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971304,0.00051044126,0.00047701132,0.0004506368,0.00042149329,0.0010100007],"domain_scores_gemma":[0.99069065,0.008055219,0.00028019375,0.00068988436,0.00015202787,0.00013199882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020949775,0.00024630356,0.00076500914,0.00026884067,0.000282103,0.000029356279,0.00045676823,0.00010921451,0.000044831027],"category_scores_gemma":[0.008194168,0.00014152932,0.00028372547,0.00038780514,0.00030041553,0.000052827254,0.00021372625,0.00048120873,0.000031738815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016092865,0.00013773052,0.9916918,0.00032657202,0.00025902,0.00002074972,0.00032609212,0.000054419263,0.0010240242,0.00014637184,0.0025179673,0.0018859566],"study_design_scores_gemma":[0.0046866313,0.0013895115,0.98540735,0.000036853446,0.00008879975,0.000026575799,0.00004766257,0.0002184138,0.0014595056,0.00037664748,0.006142607,0.00011942894],"about_ca_topic_score_codex":0.00016130174,"about_ca_topic_score_gemma":0.0001871173,"teacher_disagreement_score":0.0075447783,"about_ca_system_score_codex":0.00044280916,"about_ca_system_score_gemma":0.00026565645,"threshold_uncertainty_score":0.98097765},"labels":[],"label_agreement":null},{"id":"W4379380106","doi":"10.1016/s2213-8587(23)00116-x","title":"Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"National Institutes of Health; Javna Agencija za Raziskovalno Dejavnost RS; Fonds Wetenschappelijk Onderzoek; Novo Nordisk; Dexcom; National Institute of Diabetes and Digestive and Kidney Diseases; ZonMw; Insulet Corporation; Diabetes Canada; Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Tandem Diabetes Care; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Pregnancy; Type 2 diabetes; Gestational diabetes; Diabetes mellitus; Type 1 diabetes; Obstetrics; Aspirin; Intensive care medicine; Weight gain; Gestation; Endocrinology; Internal medicine; Body weight","score_opus":0.11602779950696164,"score_gpt":0.3964174148960811,"score_spread":0.2803896153891195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379380106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012590214,0.97985923,0.0000016472369,0.0015263624,0.00031991064,0.0045310105,0.00012325154,0.0003564564,0.0006919115],"genre_scores_gemma":[0.0021159905,0.9939273,0.00028070534,0.00009806141,0.00014949622,0.001994537,0.00019837724,0.00008969719,0.001145843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964293,0.00015326575,0.0006513782,0.00073676766,0.0001877302,0.0018415408],"domain_scores_gemma":[0.99784213,0.0010464686,0.0003122793,0.0006937542,0.00004758337,0.000057756115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046564956,0.0005805065,0.0027882077,0.0006169582,0.000092076894,0.000025843094,0.00067203573,0.00027152553,0.000019411984],"category_scores_gemma":[0.00016399455,0.00033809786,0.00028729727,0.0007248973,0.00045264812,0.00004227083,0.00069190096,0.00059255783,0.00007271057],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087128086,0.00039669676,0.0031244839,0.025780747,0.0030064709,0.00007150945,0.000011922652,0.00000290861,0.00004731606,0.0039970223,0.0009694513,0.9625043],"study_design_scores_gemma":[0.004909466,0.0025772862,0.001097913,0.025512127,0.004071714,0.0000033520762,0.000060927003,0.00014493498,0.00022992697,0.0011372829,0.95966583,0.00058921124],"about_ca_topic_score_codex":0.0000017586083,"about_ca_topic_score_gemma":0.0000021884646,"teacher_disagreement_score":0.96191514,"about_ca_system_score_codex":0.00013895027,"about_ca_system_score_gemma":0.00004988609,"threshold_uncertainty_score":0.9999071},"labels":[],"label_agreement":null},{"id":"W4381848342","doi":"10.1016/s2213-8587(23)00168-7","title":"People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Sydäntutkimussäätiö; Sigrid Juséliuksen Säätiö; Novo Nordisk; KU Leuven; University of Toronto; Pfizer; Insulet Corporation; Astellas Pharma; MannKind Corporation; Diabetes Canada; Wilhelm och Else Stockmanns Stiftelse; Folkhälsanin Tutkimussäätiö; Foundation for Cardiovascular Research; Eli Lilly and Company; AstraZeneca; CSL Behring; Bayer; Gilead Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Diabetestutkimussäätiö; Samfundet Folkhälsan","keywords":"Medicine; Call to action; Type 2 diabetes; Kidney disease; Diabetes mellitus; Disease; Intensive care medicine; Action (physics); MEDLINE; Internal medicine; Endocrinology","score_opus":0.04308128163336083,"score_gpt":0.315554828987163,"score_spread":0.2724735473538022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381848342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555694,0.0023899113,0.0000139369085,0.039829485,0.00029827355,0.0011097093,0.000020807942,0.0003056716,0.0004628443],"genre_scores_gemma":[0.9830781,0.0014727595,0.00009587313,0.002898288,0.0011496727,0.00032072494,0.00023284131,0.00006085314,0.010690894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775976,0.00007080373,0.00015662519,0.00035067485,0.00020242755,0.001459712],"domain_scores_gemma":[0.99872315,0.00034656958,0.000061071325,0.0004786351,0.00007443569,0.00031614344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023961387,0.0002094969,0.00047102207,0.00018594757,0.0001673999,0.00005004076,0.00022068346,0.000048436657,0.00015756897],"category_scores_gemma":[0.00026072262,0.00012790579,0.000070507995,0.00051066914,0.0001868854,0.000081574704,0.00014789266,0.00022178498,0.00013449934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078230764,0.000104325285,0.67120594,0.0012041569,0.0011958763,0.00001786313,0.00040023538,0.000034469584,0.009961448,0.0013239995,0.26102647,0.05274293],"study_design_scores_gemma":[0.008577026,0.0022757393,0.5629616,0.00024579946,0.0007106895,0.0000016886418,0.00026422535,0.0052745976,0.0027886918,0.0031485206,0.41330162,0.00044984405],"about_ca_topic_score_codex":0.000011306132,"about_ca_topic_score_gemma":0.000025473815,"teacher_disagreement_score":0.15227515,"about_ca_system_score_codex":0.00005158078,"about_ca_system_score_gemma":0.00017393175,"threshold_uncertainty_score":0.5215847},"labels":[],"label_agreement":null},{"id":"W4382051681","doi":"10.1016/s2213-8587(23)00128-6","title":"Predicting and preventing heart failure in type 2 diabetes","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Houston Methodist Research Institute","keywords":"Medicine; Heart failure; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Psychological intervention; Incidence (geometry); Internal medicine; Psychiatry; Endocrinology","score_opus":0.056194141244418946,"score_gpt":0.33099809991354023,"score_spread":0.2748039586691213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382051681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03663413,0.9587322,5.4981985e-8,0.0016655389,0.00040149398,0.0016463132,0.000020405607,0.00032137334,0.00057848153],"genre_scores_gemma":[0.0012684606,0.9957493,0.00016244972,0.00038148608,0.0007084429,0.0005091813,0.00018077964,0.00011594897,0.00092396134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643,0.0002827418,0.0006175155,0.00062207115,0.00018422153,0.0018634707],"domain_scores_gemma":[0.99816537,0.0007580834,0.000241732,0.0007130414,0.000032371452,0.00008940863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052394567,0.000520289,0.0028103718,0.00037219774,0.000101442376,0.00005217321,0.00031750416,0.00020156408,0.0000390365],"category_scores_gemma":[0.00028342928,0.00034375113,0.00024418902,0.00062409986,0.00017086299,0.00006431738,0.00055789354,0.00074714585,0.00021644258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009512152,0.00012411462,0.1835895,0.029744817,0.0021631601,0.00009370223,0.00008225153,8.658695e-7,0.000007657964,0.00057266187,0.008649506,0.77496225],"study_design_scores_gemma":[0.00085013226,0.00025867386,0.0037092583,0.010714592,0.0021176068,0.00001356751,0.000034712913,0.000028825423,0.000008709167,0.00027330822,0.9816807,0.00030992684],"about_ca_topic_score_codex":0.000013582901,"about_ca_topic_score_gemma":0.000049804312,"teacher_disagreement_score":0.97303116,"about_ca_system_score_codex":0.0000960757,"about_ca_system_score_gemma":0.00006901498,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W4386024295","doi":"10.1016/s2213-8587(23)00193-6","title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro; Cancer Research UK; Ministère des Affaires Sociales et de la Santé; Deutsche Forschungsgemeinschaft; Agenzia Italiana del Farmaco, Ministero della Salute; Academy of Medical Sciences","keywords":"Mitotane; Medicine; Adrenocortical carcinoma; Clinical endpoint; Observational study; Adjuvant; Internal medicine; Intention-to-treat analysis; Randomized controlled trial; Surgery; Oncology","score_opus":0.18967628582502905,"score_gpt":0.4136935625130954,"score_spread":0.22401727668806637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386024295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915786,0.00028973407,0.0000021744345,0.004286563,0.0010016352,0.0025157866,0.00007470876,0.000105942185,0.00014486899],"genre_scores_gemma":[0.9976559,0.00009846709,0.00006312576,0.0005968714,0.00073555834,0.0003953876,0.0002971697,0.000028214885,0.00012927422],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717045,0.00044849436,0.00056825014,0.00053140504,0.0003092193,0.0009721962],"domain_scores_gemma":[0.9979454,0.0011415209,0.00013806911,0.00051261246,0.000096776785,0.00016557549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006756066,0.00025858008,0.00089011976,0.00015887429,0.00010963747,0.00005559484,0.0005729807,0.00006878607,0.000116685434],"category_scores_gemma":[0.00070492557,0.00018501352,0.0000473881,0.0004276524,0.00023916474,0.00016532057,0.0003087505,0.00039738818,0.00004285836],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43374762,0.0056044087,0.5430115,0.000068274654,0.0006111025,0.0046820114,0.0010493957,0.000087027176,0.0007651809,0.0012374552,0.0015056097,0.007630425],"study_design_scores_gemma":[0.5943812,0.0023640478,0.39335245,0.000027178921,0.000090874775,0.00006158047,0.00038493768,0.008366712,0.00016824903,0.000099175486,0.0005038873,0.00019966572],"about_ca_topic_score_codex":0.00013707335,"about_ca_topic_score_gemma":0.00025651793,"teacher_disagreement_score":0.16063361,"about_ca_system_score_codex":0.0000697933,"about_ca_system_score_gemma":0.000107510845,"threshold_uncertainty_score":0.7544632},"labels":[],"label_agreement":null},{"id":"W4386594957","doi":"10.1016/s2213-8587(23)00223-1","title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norwegian Institute of Public Health; Faculty of Medicine and Health, University of Sydney; Economic and Social Research Council; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Biogen; Agency for Healthcare Research and Quality; National Institutes of Health; National Health and Medical Research Council; Dementias Platform UK; AstraZeneca; Baker Heart and Diabetes Institute; Hjartavernd; Wellcome Trust; Universität Innsbruck; Terveyden ja hyvinvoinnin laitos; Medizinische Universität Innsbruck; Lunds Universitet; Faculty of Health and Medical Sciences, University of Western Australia; Oulun Yliopisto; Hirosaki University; Göteborgs Universitet; Sahlgrenska Universitetssjukhuset; Netherlands Heart Institute; Universitair Medisch Centrum Groningen; Österreichische Forschungsförderungsgesellschaft; Novo Nordisk; Gentofte Hospital; Rijksinstituut voor Volksgezondheid en Milieu; Massachusetts Medical Society; Yonsei University; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Universiteit Utrecht; Rijksuniversiteit Groningen; St. George's, University of London; Institut National de la Santé et de la Recherche Médicale; Fondation Leducq; Istituto Superiore di Sanità; School of Medicine, Duke University; University of Oxford; Medical Research Council; Grifols; Servier; Uppsala Universitet; Amarin Corporation; Tel Aviv University; Novo Nordisk UK Research Foundation; London School of Hygiene and Tropical Medicine; Wake Forest School of Medicine; Department of Health and Social Care; Amsterdam University Medical Centers; Northwell Health; Esperion Therapeutics; Health Services Research and Development; University of Toronto; Kowa Company; Harvard University; Deutsches Krebsforschungszentrum; Queen Mary University of London; Vanderbilt University Medical Center; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Sanofi; Leids Universitair Medisch Centrum; University of Vermont; NIHR Cambridge Biomedical Research Centre; Massachusetts General Hospital; University College London; Diabetes UK; University of Southampton; National Heart, Lung, and Blood Institute; Universiteit Leiden; University of Glasgow; Abbott Laboratories; University of South Carolina; Fiona Stanley Hospital; Háskóli Íslands; British Heart Foundation; University of Pittsburgh; Portland State University; Universitetet i Tromsø; School of Medicine, Boston University; Helsingin Yliopisto; Pfizer; Yale University; University of Bristol; Trakya Üniversitesi; State of Connecticut Department of Public Health; Västra Götalandsregionen; Eli Lilly and Company; University of Tsukuba; Itä-Suomen Yliopisto; Brigham and Women's Hospital; University of California, San Diego; Amgen; Kanazawa Medical University; Mylan; Regeneron Pharmaceuticals; American Heart Association; Universität Heidelberg; Sahlgrenska Akademin; Wake Forest University","keywords":"Medicine; Life expectancy; Gerontology; Demography; Diabetes mellitus; Type 2 diabetes; Environmental health; Population","score_opus":0.029642834997424882,"score_gpt":0.24935513760219197,"score_spread":0.2197123026047671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386594957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200356,0.0049394662,3.3841107e-7,0.0018621229,0.0002704284,0.0006443167,0.000088104716,0.0001452513,0.000046419736],"genre_scores_gemma":[0.9956327,0.0031388295,0.000024758732,0.00034513386,0.00019396924,0.00026735035,0.00024238753,0.00005171682,0.000103132756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735934,0.0002984483,0.00044681996,0.00036133893,0.00047016874,0.0010639072],"domain_scores_gemma":[0.9977609,0.00097070186,0.00030036084,0.00069048366,0.00017953596,0.00009799997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048110457,0.0002669644,0.0015115712,0.0002994702,0.00006194672,0.000009925397,0.00028572106,0.00013824849,0.00006310154],"category_scores_gemma":[0.0012842938,0.00019407606,0.00019377013,0.0008666798,0.00034057297,0.00007213677,0.0001216498,0.0002692521,0.000026963933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012958802,0.00010201076,0.99217594,0.00029270432,0.00090752164,0.000022055256,0.000540171,0.00006384169,0.0005777372,0.00010156624,0.00090076105,0.004186092],"study_design_scores_gemma":[0.0029986256,0.00069642917,0.9797408,0.0005987408,0.00031891573,7.5026065e-7,0.00018336327,0.00013215604,0.014211312,0.00010769972,0.0008177383,0.00019345217],"about_ca_topic_score_codex":0.0005242231,"about_ca_topic_score_gemma":0.0006071941,"teacher_disagreement_score":0.013633574,"about_ca_system_score_codex":0.00013858006,"about_ca_system_score_gemma":0.00006086977,"threshold_uncertainty_score":0.79141915},"labels":[],"label_agreement":null},{"id":"W4386595954","doi":"10.1016/s2213-8587(23)00225-5","title":"Current insights and emerging trends in early-onset type 2 diabetes","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Toronto General Hospital; University of Toronto; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; NIHR Leicester Biomedical Research Centre; NIHR Imperial Biomedical Research Centre; National Institutes of Health; National Institute for Health and Care Research; National Health and Medical Research Council; Wellcome Trust","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Distress; Psychological intervention; Pediatrics; Disease; Type 1 diabetes; Obesity; Age of onset; Psychiatry; Internal medicine; Endocrinology","score_opus":0.10064863402239173,"score_gpt":0.39592956394093487,"score_spread":0.29528092991854316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386595954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052289415,0.9439544,6.014176e-8,0.0006571682,0.0008112025,0.0007455395,0.000025143,0.00020635458,0.0013107073],"genre_scores_gemma":[0.00197266,0.99419725,0.000010288827,0.00015361847,0.0007984386,0.00031015053,0.00031727465,0.000114684095,0.002125648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954567,0.0004826005,0.00066768896,0.0007286174,0.00033835808,0.002326068],"domain_scores_gemma":[0.9979761,0.0006855023,0.0002146552,0.00092125044,0.000055555523,0.00014692359],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006184837,0.00057927147,0.0029398971,0.0014816348,0.000121793804,0.000070260554,0.0006371326,0.00020569189,0.00012297585],"category_scores_gemma":[0.00019951994,0.000358608,0.0002801317,0.0018139586,0.0003876201,0.00007118441,0.0008360232,0.0015082539,0.00050461915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009698561,0.00006594491,0.019710602,0.008921227,0.0005312737,0.000058264955,0.000072331204,2.3082704e-7,6.613862e-7,0.00030689934,0.007894975,0.9624279],"study_design_scores_gemma":[0.0007662338,0.0002311222,0.01218738,0.005869459,0.00079421356,0.0000024892572,0.0000122413685,0.00004017133,0.00000261491,0.0005232103,0.9792094,0.00036145764],"about_ca_topic_score_codex":0.000007899652,"about_ca_topic_score_gemma":0.000016757773,"teacher_disagreement_score":0.97131443,"about_ca_system_score_codex":0.00009226092,"about_ca_system_score_gemma":0.000077990066,"threshold_uncertainty_score":0.9998866},"labels":[],"label_agreement":null},{"id":"W4387328401","doi":"10.1016/s2213-8587(23)00259-0","title":"Faster and faster: meeting the challenges of delayed insulin action during pregnancy","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Pregnancy; Action (physics); Insulin; MEDLINE; Intensive care medicine; Obstetrics; Endocrinology","score_opus":0.07438935433203561,"score_gpt":0.31092401180496554,"score_spread":0.23653465747292993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387328401","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3661301,0.022410784,6.8045824e-7,0.6040785,0.0005454393,0.0009828941,0.000026703117,0.00017764742,0.0056472314],"genre_scores_gemma":[0.7668539,0.0763776,0.00010638039,0.11590894,0.015355611,0.0011031479,0.00026011842,0.0004663719,0.023567922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676454,0.00030714038,0.0004202662,0.00049674505,0.0004153231,0.0015960105],"domain_scores_gemma":[0.99793327,0.0007361907,0.00027880148,0.00092320825,0.00008958178,0.000038950653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037706207,0.0003539082,0.00092543615,0.00027003695,0.00017099398,0.00003508172,0.00056089764,0.00029803318,0.000043272943],"category_scores_gemma":[0.00015253134,0.00019858354,0.00014540175,0.00020628687,0.00046350702,0.000049741768,0.00070103136,0.0018710278,0.000105192434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052172085,0.00017732101,0.032332543,0.023062933,0.010142445,0.0013543885,0.0026458066,0.000017887718,0.00804837,0.001458984,0.56295216,0.35728544],"study_design_scores_gemma":[0.016297769,0.003355148,0.20312509,0.014813035,0.004468607,0.00017482508,0.0029260658,0.00090020435,0.0168982,0.010624281,0.72394186,0.0024749173],"about_ca_topic_score_codex":0.000012764757,"about_ca_topic_score_gemma":0.000014574305,"teacher_disagreement_score":0.48816955,"about_ca_system_score_codex":0.000035780133,"about_ca_system_score_gemma":0.00002365511,"threshold_uncertainty_score":0.81287885},"labels":[],"label_agreement":null},{"id":"W4387749254","doi":"10.1016/s2213-8587(23)00224-3","title":"Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Helse Sør-Øst RHF; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Disease; Depression (economics); Sex characteristics; Gerontology; Biological sex; Psychiatry; Internal medicine; Developmental psychology; Psychology","score_opus":0.09532368868807573,"score_gpt":0.3939945599924252,"score_spread":0.2986708713043495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387749254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06349723,0.9305353,7.749452e-7,0.0038287763,0.0002953651,0.0016223661,0.000103736966,0.000072483206,0.000043923766],"genre_scores_gemma":[0.025679555,0.97128403,0.0000114002,0.0015429357,0.0008267066,0.00042917233,0.000058576246,0.0000620272,0.00010558634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581975,0.0018349221,0.0005905873,0.0005804771,0.0002380824,0.0009362078],"domain_scores_gemma":[0.99279076,0.005123932,0.0004066298,0.0014684919,0.00005541225,0.00015479227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011229396,0.0004200114,0.0021865892,0.00006955271,0.00043749224,0.000033728604,0.0005436803,0.00018782867,0.0000067040596],"category_scores_gemma":[0.0006344097,0.00016678454,0.00023496951,0.0002407995,0.0013621197,0.000030098035,0.0007572071,0.0010162202,0.000015673124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001382954,0.00002314135,0.02377118,0.00790764,0.0014330979,0.000032502703,0.0039955424,5.2907495e-7,0.0000010010535,0.00037553854,0.0012449237,0.9610766],"study_design_scores_gemma":[0.0026726322,0.00019126247,0.016935494,0.0039481795,0.004502655,0.00006730329,0.0012224924,0.000051266485,0.000025127447,0.0037884645,0.9662644,0.0003306825],"about_ca_topic_score_codex":0.00017088656,"about_ca_topic_score_gemma":0.000084858315,"teacher_disagreement_score":0.9650195,"about_ca_system_score_codex":0.000018630255,"about_ca_system_score_gemma":0.00011853795,"threshold_uncertainty_score":0.68012756},"labels":[],"label_agreement":null},{"id":"W4388278575","doi":"10.1016/s2213-8587(23)00267-x","title":"C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; JDRF; Wake Forest School of Medicine; Novo Nordisk; Linköpings Universitet; Harvard University; Diabetes UK; Juvenile Diabetes Research Foundation United States of America; National Institutes of Health; University of Birmingham; University of Florida; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; George Washington University; University of California; Immune Tolerance Network; National Institute of Diabetes and Digestive and Kidney Diseases; University of Exeter; University of Colorado; GlaxoSmithKline","keywords":"Medicine; Type 2 diabetes; Internal medicine; C-peptide; Diabetes mellitus; Insulin; Clinical endpoint; Metabolic control analysis; Randomized controlled trial; Endocrinology","score_opus":0.32101691920626435,"score_gpt":0.4159748924202482,"score_spread":0.09495797321398386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388278575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2715431,0.726885,3.0235617e-7,0.00020895648,0.00007188671,0.00062080595,0.00064389943,0.000018953606,0.0000070902943],"genre_scores_gemma":[0.04419489,0.9536872,0.000036384452,0.0004143326,0.00010466415,0.00037689848,0.0010035397,0.00006993886,0.00011214047],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937761,0.00238334,0.0014514277,0.00074800604,0.000210448,0.0014306785],"domain_scores_gemma":[0.9971546,0.0008478061,0.00082312606,0.0009770747,0.000042522224,0.0001548491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027053843,0.0006011637,0.007518537,0.0005310165,0.000047502526,0.00005141201,0.0008117583,0.00027143687,0.00004154193],"category_scores_gemma":[0.001228057,0.00037458612,0.0015498154,0.0009661866,0.0001925394,0.00001163005,0.00032841615,0.0003762169,0.0000056873673],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016156935,0.0007919563,0.27287975,0.0022109158,0.47942722,0.000016678245,0.0004425983,0.0004890586,0.00016706789,0.00045531738,0.0010827427,0.24187511],"study_design_scores_gemma":[0.005546287,0.0010603727,0.06911732,0.0004997249,0.52169055,7.738131e-7,0.00030009268,0.00008974512,0.0004061342,0.0028934958,0.39588478,0.0025107374],"about_ca_topic_score_codex":0.00013287572,"about_ca_topic_score_gemma":0.0005289986,"teacher_disagreement_score":0.39480203,"about_ca_system_score_codex":0.000010387914,"about_ca_system_score_gemma":0.00025959153,"threshold_uncertainty_score":0.9998706},"labels":[],"label_agreement":null},{"id":"W4389304068","doi":"10.1016/s2213-8587(23)00352-2","title":"New clarity for managing statin intolerance in diabetes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Statin; Diabetes mellitus; Dyslipidemia; Internal medicine; Ezetimibe; Scopus; MEDLINE; Disease; Intensive care medicine; Physical therapy; Endocrinology","score_opus":0.04077186506000876,"score_gpt":0.30051341303082385,"score_spread":0.2597415479708151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389304068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045544848,0.004917103,0.00014197784,0.9443425,0.001342465,0.002431192,0.00017363256,0.00037640665,0.00072988356],"genre_scores_gemma":[0.008874382,0.0021104165,0.0026769175,0.9540109,0.025709817,0.0016034483,0.0010312527,0.00030038835,0.0036824683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496514,0.00033156117,0.00057143107,0.0007595023,0.00041280442,0.0029595937],"domain_scores_gemma":[0.99740505,0.0006902463,0.00020562434,0.0015234856,0.00008021228,0.00009537415],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010210375,0.00047631713,0.002000423,0.00028720897,0.00011903425,0.000042813288,0.0005993056,0.00050777313,0.0000484497],"category_scores_gemma":[0.0002698291,0.00035727854,0.00045301122,0.00037842395,0.00014854639,0.000052029245,0.00021300199,0.0029636617,0.00008862049],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000438833,0.00001758263,0.015629573,0.002164578,0.00062447775,0.00024528595,0.00011975965,0.000010802459,0.000061866354,0.00034223564,0.9013021,0.079437844],"study_design_scores_gemma":[0.0032920358,0.00027181715,0.027336586,0.0005480799,0.00033458165,0.000013100395,0.000028539082,0.00019979084,0.00038719093,0.011905057,0.9552561,0.0004271212],"about_ca_topic_score_codex":0.00053731824,"about_ca_topic_score_gemma":0.00013115963,"teacher_disagreement_score":0.079010725,"about_ca_system_score_codex":0.00018327801,"about_ca_system_score_gemma":0.00024177475,"threshold_uncertainty_score":0.99988794},"labels":[],"label_agreement":null},{"id":"W4389938368","doi":"10.1016/s2213-8587(23)00347-9","title":"Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Diabetes Victoria; Novo Nordisk Fonden; Deakin University; Steno Diabetes Center Copenhagen","keywords":"Medicine; Stigma (botany); Prejudice (legal term); Social stigma; Blame; Psychiatry; Social psychology; Family medicine; Psychology","score_opus":0.36051325391205835,"score_gpt":0.5461487006412896,"score_spread":0.18563544672923127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389938368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07613431,0.8430139,0.0000051425573,0.07163212,0.0031391934,0.0037592016,0.00074711384,0.00044391802,0.0011251259],"genre_scores_gemma":[0.001636128,0.9913098,0.00050002657,0.0034939179,0.0012254207,0.00094349263,0.00024877218,0.00006324812,0.0005791869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374974,0.0028700312,0.0009412924,0.00072838657,0.00024010331,0.0014704352],"domain_scores_gemma":[0.9888034,0.0094453255,0.0006759106,0.00068517786,0.00012629802,0.00026392043],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0026250845,0.00039126747,0.0012896998,0.00036613774,0.0013311941,0.00008736727,0.0006104292,0.00019958014,0.00033614985],"category_scores_gemma":[0.0013828998,0.00029286195,0.00005429225,0.00022497092,0.00019760293,0.0003505179,0.0005983373,0.0013743878,0.00035432482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029931725,0.00009854612,0.0055465354,0.014216011,0.00027732828,0.00001181786,0.0024506154,0.0000021348958,0.000002100096,0.010405316,0.0073314,0.9596283],"study_design_scores_gemma":[0.00031838898,0.00037117905,0.006742812,0.015697083,0.0003312651,0.000003858171,0.0010555814,0.0000787861,0.0000014475949,0.00083891384,0.9742341,0.000326602],"about_ca_topic_score_codex":0.00015984035,"about_ca_topic_score_gemma":0.0012094203,"teacher_disagreement_score":0.9669027,"about_ca_system_score_codex":0.00020702131,"about_ca_system_score_gemma":0.00023473326,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W4391155287","doi":"10.1016/s2213-8587(23)00344-3","title":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Food composition and properties","field":"Nursing","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Public Health Ontario; University of Toronto; Hamilton Health Sciences; McMaster University; University of Saskatchewan; Population Health Research Institute; St. Michael's Hospital","funders":"Temerty Faculty of Medicine, University of Toronto; Obesity Canada; Novo Nordisk; University of Toronto; International Sweeteners Association; Alberta Pulse Growers Commission; Canadian Nutrition Society; Danone; Diabetes Canada; Canadian Cardiovascular Society; Centre International de Recherche sur le Cancer; Loblaw Companies Limited; Canola Council of Canada; United Soybean Board; Soy Nutrition Institute; Dairy Farmers of Canada; McMaster University; National Honey Board; International Nut and Dried Fruit Council; Almond Board of California; Harvard University; General Mills; AstraZeneca; Eli Lilly and Company; Canadian Institutes of Health Research; PepsiCo; Kowa Company; Guangdong Provincial Hospital of Traditional Chinese Medicine; World Health Organization; Sanofi","keywords":"Medicine; Meta-analysis; Type 2 diabetes; Disease; Internal medicine; Diabetes mellitus; Mega-; Cohort study; Oncology; Endocrinology","score_opus":0.14288038811393786,"score_gpt":0.3577246968681067,"score_spread":0.21484430875416885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391155287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23588803,0.76241237,1.4474949e-7,0.000290675,0.00014316359,0.00049152353,0.00071927067,0.00003577029,0.00001902586],"genre_scores_gemma":[0.33921236,0.6602999,0.0000065561367,0.000082796316,0.00005189141,0.00017912497,0.00009291765,0.000039757055,0.000034687306],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965125,0.00072926225,0.00080937875,0.00056875066,0.0005568269,0.0008233203],"domain_scores_gemma":[0.997538,0.00037554823,0.0007720906,0.0009982364,0.0002159812,0.00010016077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006743985,0.00048615804,0.0058294353,0.0003209439,0.000049188104,0.00003029479,0.00034532967,0.00017910238,0.000034058616],"category_scores_gemma":[0.00009905588,0.00028987095,0.0010799853,0.0008111406,0.00041268533,0.00006976574,0.00019046986,0.00040365595,0.0000011207785],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024784866,0.0000652418,0.040577125,0.010952943,0.9195852,0.000013346002,0.00034019593,0.00017097041,0.000028894588,0.000033025102,0.00029869567,0.027686503],"study_design_scores_gemma":[0.00040652635,0.0003136674,0.003289722,0.0009915218,0.9471534,0.0000027311985,0.000023023973,0.00023050178,0.00017630286,0.00008815875,0.04698069,0.00034376432],"about_ca_topic_score_codex":0.00070583035,"about_ca_topic_score_gemma":0.00028812207,"teacher_disagreement_score":0.10332434,"about_ca_system_score_codex":0.00012690903,"about_ca_system_score_gemma":0.00012126206,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W4391544195","doi":"10.1016/s2213-8587(23)00356-x","title":"Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim","keywords":"Medicine; Placebo; Agonist; Glucagon-like peptide 1 receptor; Liraglutide; Glucagon-like peptide-1; Double blind; Internal medicine; Diabetes mellitus; Pharmacology; Endocrinology; Type 2 diabetes; Receptor; Alternative medicine","score_opus":0.05994524410212917,"score_gpt":0.343542484035551,"score_spread":0.28359723993342184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391544195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706236,0.006258501,0.000042053733,0.008982417,0.0020306732,0.008533866,0.00007852584,0.0003816987,0.0030686676],"genre_scores_gemma":[0.9848518,0.0009769081,0.00034266265,0.0009913733,0.002987877,0.0044619935,0.0003229242,0.00008168218,0.0049828114],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968111,0.00019020164,0.0005489176,0.00065825443,0.00022731614,0.0015641991],"domain_scores_gemma":[0.9975756,0.0015373862,0.00013935096,0.00053482567,0.00005621371,0.00015665314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012193007,0.00043396596,0.0015473579,0.00026248125,0.00032414336,0.00027303366,0.00021024067,0.0001205838,0.0001622063],"category_scores_gemma":[0.00019806837,0.0002845785,0.0003714342,0.00021580383,0.00031365984,0.00012720076,0.0001600922,0.00033926632,0.000100457364],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9271325,0.0006501554,0.00077758956,0.00050668867,0.0040597883,0.000102080405,0.00034061135,0.0000024572628,0.004311496,0.010285851,0.014920634,0.03691016],"study_design_scores_gemma":[0.850269,0.0021114226,0.000058185724,0.00012188636,0.002197295,0.0000137169245,0.00008618503,0.0003865813,0.005036033,0.00064243545,0.13880207,0.000275187],"about_ca_topic_score_codex":0.00002316203,"about_ca_topic_score_gemma":0.000023006545,"teacher_disagreement_score":0.12388143,"about_ca_system_score_codex":0.00011602892,"about_ca_system_score_gemma":0.000109028115,"threshold_uncertainty_score":0.99996066},"labels":[],"label_agreement":null},{"id":"W4393238646","doi":"10.1016/s2213-8587(24)00059-7","title":"How clinically relevant is statin-induced diabetes?","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; Blindness; Heart failure; Kidney disease; Statin; Type 2 diabetes; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.04807103858403257,"score_gpt":0.3062347696397802,"score_spread":0.25816373105574764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393238646","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07613976,0.003840027,0.0000024812366,0.90766805,0.0022824404,0.0015851266,0.00023850075,0.0007325397,0.007511036],"genre_scores_gemma":[0.018084146,0.0017169788,0.0005495775,0.9210825,0.01164298,0.000812881,0.0010324708,0.00031580712,0.044762652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926228,0.00034210065,0.0008738207,0.0014494642,0.0007185628,0.0039932807],"domain_scores_gemma":[0.9955794,0.001102734,0.00045738704,0.002543053,0.000155995,0.00016140426],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057723775,0.001063745,0.0025838916,0.00039225392,0.00015459208,0.00031437044,0.0010563256,0.0007876251,0.00040858204],"category_scores_gemma":[0.0002717381,0.00068689766,0.00074783055,0.00033650483,0.00042728367,0.00010507974,0.000753977,0.00414327,0.0023862913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033014927,0.00009366602,0.0067068753,0.0011819694,0.0036822327,0.00089180766,0.00010369376,1.4268589e-7,0.00033561082,0.00033009297,0.9661982,0.020442665],"study_design_scores_gemma":[0.0019794987,0.0014062445,0.0011288275,0.00041759165,0.0032945813,0.000011643918,0.000031327574,0.00006441225,0.001269424,0.00420403,0.98553306,0.00065933564],"about_ca_topic_score_codex":0.000009566315,"about_ca_topic_score_gemma":0.0000025049958,"teacher_disagreement_score":0.05805562,"about_ca_system_score_codex":0.00021744914,"about_ca_system_score_gemma":0.00015080866,"threshold_uncertainty_score":0.9995582},"labels":[],"label_agreement":null},{"id":"W4393999792","doi":"10.1016/s2213-8587(24)00069-x","title":"Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; St. Michael's Hospital; University of Toronto; Queen's University; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Glycaemic index; Prospective cohort study; Type 2 diabetes; Diabetes mellitus; Internal medicine; Cohort; Cohort study; Proportional hazards model; Incidence (geometry); Demography; Glycemic index; Confidence interval; Endocrinology","score_opus":0.009002251241899066,"score_gpt":0.25214847423887865,"score_spread":0.24314622299697958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393999792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98012924,0.011824341,5.2852306e-7,0.005710568,0.00016381973,0.0013316993,0.00039431636,0.000032362477,0.00041311458],"genre_scores_gemma":[0.99782085,0.0014504747,0.000011349145,0.00026583925,0.00016254767,0.00020827455,0.000017063276,0.000016040432,0.00004754609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844456,0.0002275463,0.00030042036,0.0002634777,0.00031014136,0.0004538289],"domain_scores_gemma":[0.9977115,0.001537807,0.00017165672,0.00037563543,0.00018265795,0.000020754269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004547932,0.00016950905,0.0008149386,0.00004634347,0.00013451547,0.000016351529,0.00021254203,0.00005112465,0.00002606543],"category_scores_gemma":[0.00035008107,0.00007778019,0.00006928882,0.0004171078,0.0006657061,0.00003686992,0.00017835318,0.0004352975,0.0000038125397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004469282,0.00013827099,0.993421,0.000049962982,0.0012718035,0.00000307269,0.0013959664,0.0000099981235,0.000115483606,0.0019042509,0.0011836109,0.00005963775],"study_design_scores_gemma":[0.0040033343,0.00039601402,0.98542863,0.00011889742,0.0006891422,0.000002317283,0.0009235249,0.00017062614,0.0002748565,0.007417185,0.00049180735,0.000083686544],"about_ca_topic_score_codex":0.0014347199,"about_ca_topic_score_gemma":0.0048026666,"teacher_disagreement_score":0.017691614,"about_ca_system_score_codex":0.00010375471,"about_ca_system_score_gemma":0.000108693355,"threshold_uncertainty_score":0.31717843},"labels":[],"label_agreement":null},{"id":"W4396990859","doi":"10.1016/s2213-8587(24)00102-5","title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Meta-analysis; Heart failure; Medicine; Disease; Internal medicine; Intensive care medicine; Cardiology","score_opus":0.040512222091693965,"score_gpt":0.34716185231502206,"score_spread":0.3066496302233281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396990859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009548871,0.9886646,3.072182e-7,0.0034204666,0.00009412839,0.0064750435,0.00025042475,0.000083336614,0.00005680235],"genre_scores_gemma":[0.0052039186,0.9904044,0.0000075113817,0.00087677175,0.00012388686,0.0028956716,0.000074011834,0.0000699033,0.00034390463],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99499416,0.0018295065,0.0008698688,0.0007970423,0.00046963428,0.0010397675],"domain_scores_gemma":[0.9959366,0.001145597,0.00031662523,0.0024216075,0.000032787313,0.00014681534],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002231746,0.0009129196,0.019023988,0.00033306913,0.00011839061,0.000075267526,0.00038811867,0.00010102204,0.000018880071],"category_scores_gemma":[0.00028105846,0.00033968635,0.0069070766,0.0008808775,0.00029187405,0.000034988214,0.00047081284,0.00050694647,0.00004470868],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004279705,0.000020257105,0.0005958169,0.5258798,0.46993053,0.000036176243,0.00001582494,6.558457e-7,2.1287528e-8,0.00023773499,0.0005372108,0.0027417194],"study_design_scores_gemma":[0.0003396391,0.00020391983,0.00014958245,0.010792321,0.8744983,0.000016317987,0.000006951072,8.715335e-7,0.0000022441072,0.000026014724,0.11374154,0.00022230881],"about_ca_topic_score_codex":0.00002204927,"about_ca_topic_score_gemma":0.000005376452,"teacher_disagreement_score":0.5150874,"about_ca_system_score_codex":0.000049369784,"about_ca_system_score_gemma":0.0000310045,"threshold_uncertainty_score":0.9999055},"labels":[],"label_agreement":null},{"id":"W4398161950","doi":"10.1016/s2213-8587(24)00100-1","title":"Small Island Developing States: addressing the intersecting challenges of non-communicable diseases, food insecurity, and climate change","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council","keywords":"Food insecurity; Climate change; Environmental health; Non-communicable disease; Developing country; Geography; Food security; Environmental planning; Medicine; Economic growth; Public health; Biology; Ecology; Economics","score_opus":0.27589191933026147,"score_gpt":0.3781368852415118,"score_spread":0.10224496591125032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398161950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001891111,0.97202086,0.00000191544,0.022673951,0.0007330472,0.0007752029,0.00011685705,0.00011753076,0.001669526],"genre_scores_gemma":[0.0047118515,0.9848632,0.00002905426,0.0076268674,0.002289325,0.0003282626,0.00008378471,0.00006467653,0.000002969548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630666,0.00032538123,0.0008615465,0.00045594524,0.00010836109,0.0019420807],"domain_scores_gemma":[0.9971412,0.0011808369,0.00078160566,0.0007917781,0.000078317324,0.00002629945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014815576,0.0005103458,0.002444257,0.00025481515,0.0003849516,0.00018033742,0.0012397573,0.00019275355,0.000009122163],"category_scores_gemma":[0.00034548456,0.00027602617,0.00023013726,0.0003715431,0.0003995124,0.00019970402,0.0029375334,0.00093708694,0.00003887587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010975068,0.00003640827,0.0008219683,0.11544945,0.00071399147,0.00001097513,0.0005812942,0.0000028180636,1.1255381e-7,0.09745466,0.013460873,0.7714565],"study_design_scores_gemma":[0.00018970479,0.000034482782,0.00026027497,0.0078051067,0.00071570615,0.000012219077,0.00047143002,0.00038584965,5.3509815e-8,0.004401243,0.9854369,0.0002870332],"about_ca_topic_score_codex":0.0010363108,"about_ca_topic_score_gemma":0.0013884294,"teacher_disagreement_score":0.97197604,"about_ca_system_score_codex":0.000054974258,"about_ca_system_score_gemma":0.00005630379,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W4399722924","doi":"10.1016/s2213-8587(24)00158-x","title":"Call for effective therapies for preventing dementia in people with type 2 diabetes","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Dementia; Type 2 diabetes; Diabetes mellitus; MEDLINE; Gerontology; Intensive care medicine; Internal medicine; Disease; Endocrinology","score_opus":0.017646837611785687,"score_gpt":0.29206074020070744,"score_spread":0.27441390258892173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399722924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566978,0.03654115,0.00005390158,0.0037877676,0.00058841094,0.0016720402,0.00002242805,0.0001235009,0.00051296205],"genre_scores_gemma":[0.99506825,0.00062484556,0.0008974538,0.00067425764,0.00063189433,0.0016658367,0.000026050211,0.000038462418,0.00037293002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984503,0.000054860662,0.00016717352,0.00027777907,0.00007291422,0.0009770028],"domain_scores_gemma":[0.9987456,0.0009067097,0.00004030076,0.00020670625,0.00007428947,0.000026345233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034970144,0.00017848809,0.000602722,0.000091816226,0.00008432595,0.000025178993,0.00012226854,0.00003943512,0.000010903711],"category_scores_gemma":[0.00015052555,0.00010347759,0.00009199644,0.00019483162,0.00010858981,0.000051005216,0.00005822428,0.0001568997,0.000007821637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047884253,0.0001354401,0.87112194,0.001860913,0.0032039005,0.000007119928,0.0031656313,0.000009162803,0.014727592,0.007323789,0.009404669,0.08856101],"study_design_scores_gemma":[0.004325216,0.0016922712,0.7598639,0.0004577383,0.001472946,0.0000030433528,0.00037273596,0.0006086158,0.012142599,0.005377945,0.21336111,0.000321858],"about_ca_topic_score_codex":0.000009082954,"about_ca_topic_score_gemma":0.00011681309,"teacher_disagreement_score":0.20395645,"about_ca_system_score_codex":0.000022430662,"about_ca_system_score_gemma":0.0000349799,"threshold_uncertainty_score":0.42196938},"labels":[],"label_agreement":null},{"id":"W4399993403","doi":"10.1016/s2213-8587(24)00153-0","title":"The potential role for artificial intelligence in fracture risk prediction","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Manitoba; Alberta Children's Hospital","funders":"","keywords":"Medicine; Osteoporosis; Optimism; Leverage (statistics); Wearable computer; Artificial intelligence; Workload; Machine learning; Risk assessment; Risk analysis (engineering); Intervention (counseling); Physical therapy; Computer science; Computer security; Nursing; Pathology","score_opus":0.13289283565239984,"score_gpt":0.43470291422698765,"score_spread":0.3018100785745878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399993403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041204618,0.98788947,0.00029447326,0.006047552,0.0029781878,0.0020482577,0.00012387005,0.00010748704,0.00009863981],"genre_scores_gemma":[0.0039036633,0.9883299,0.000071698865,0.0004015491,0.0056446837,0.0012653017,0.00018257386,0.0000561744,0.00014448044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674803,0.00033173544,0.0010021303,0.0004852569,0.00017011134,0.0012627478],"domain_scores_gemma":[0.997465,0.0013609325,0.00030477083,0.0006981233,0.00010286264,0.000068321395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010203767,0.0003426758,0.0011932441,0.00017840274,0.00032590228,0.000077947065,0.00044700204,0.00035323593,0.000030214776],"category_scores_gemma":[0.0006807232,0.00017739141,0.00038734116,0.00036840676,0.00025679782,0.000040212493,0.00008592872,0.0016294871,0.0002600446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004305864,0.00003810636,0.000099445795,0.0020616017,0.00015874954,0.000005231482,0.0002094772,0.000016931599,0.0000011816265,0.0017145147,0.002783415,0.9928683],"study_design_scores_gemma":[0.000015933825,0.0002103862,0.000027815659,0.001660454,0.0013558383,0.000040354193,0.00041741287,0.0011941019,0.00005498879,0.05204499,0.9428307,0.00014702821],"about_ca_topic_score_codex":0.00016072004,"about_ca_topic_score_gemma":0.00018851954,"teacher_disagreement_score":0.99272126,"about_ca_system_score_codex":0.0001927342,"about_ca_system_score_gemma":0.00036769555,"threshold_uncertainty_score":0.7233812},"labels":[],"label_agreement":null},{"id":"W4400405364","doi":"10.1016/s2213-8587(24)00155-4","title":"Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Toronto General Hospital; University of Toronto","funders":"Sanofi; Medical Research Council; Ramaciotti Foundations; AstraZeneca; Defense Acquisition Program Administration; National Health and Medical Research Council; Pfizer","keywords":"Medicine; Meta-analysis; MEDLINE; Library science; Internal medicine; Pharmacology; Biochemistry","score_opus":0.07908310206695787,"score_gpt":0.3579486775459569,"score_spread":0.27886557547899904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400405364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050284397,0.9843319,0.0000025401105,0.00075902505,0.00016114154,0.008250226,0.0005037516,0.000064468484,0.00089851755],"genre_scores_gemma":[0.002774131,0.9928476,0.0003653683,0.0001597023,0.00014993054,0.0019906198,0.0003736004,0.000072652976,0.001266367],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940017,0.001926579,0.0021437085,0.0007602771,0.0003540337,0.00081372855],"domain_scores_gemma":[0.9923018,0.004548753,0.0019290039,0.00088549475,0.0002115977,0.00012330426],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0027452921,0.00087204226,0.026403781,0.0008011284,0.00007569945,0.00004828885,0.0002498749,0.00018387269,0.00012994684],"category_scores_gemma":[0.0008276517,0.00038039716,0.0023792516,0.0011946944,0.0007871512,0.00004735988,0.00022239993,0.00038892814,0.0000073724714],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009371342,0.00022945939,0.00030225478,0.007837633,0.9314799,0.000014275844,0.0002815613,0.000001964855,0.00002472503,0.00078166,0.0016969056,0.04797837],"study_design_scores_gemma":[0.045214973,0.00073489995,0.000032056316,0.0010972823,0.70561516,0.0000029693856,0.00007066708,0.0000065365725,0.000051594056,0.000021229549,0.24691014,0.00024250912],"about_ca_topic_score_codex":0.000021619277,"about_ca_topic_score_gemma":0.00003152239,"teacher_disagreement_score":0.24521324,"about_ca_system_score_codex":0.00006800222,"about_ca_system_score_gemma":0.00020446126,"threshold_uncertainty_score":0.9998648},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4400901124","doi":"10.1016/s2213-8587(24)00188-8","title":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Disease; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.03298948662715839,"score_gpt":0.2862749919852486,"score_spread":0.2532855053580902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400901124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64092964,0.17453992,3.2286042e-7,0.1822145,0.0010481781,0.0005984067,0.00025493407,0.00012781934,0.0002862661],"genre_scores_gemma":[0.45649397,0.20627448,0.00008083592,0.3147289,0.012828578,0.0008263557,0.0006489806,0.00034860187,0.0077693057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964589,0.000226036,0.0004325893,0.00080935814,0.0006801121,0.0013929976],"domain_scores_gemma":[0.9979181,0.00030074356,0.00030702617,0.001082689,0.00027279885,0.00011861806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006000045,0.00053281075,0.0020641428,0.00014452144,0.00008870475,0.00003942102,0.00023977204,0.00034131194,0.000018130442],"category_scores_gemma":[0.0003242205,0.0003510922,0.00022646111,0.0002687737,0.0005243933,0.000064018204,0.00031491928,0.0016689245,0.0000088509105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013753095,0.000022218905,0.43185028,0.0017680587,0.031145148,0.0002492197,0.00019071744,0.000003156382,0.00011390229,0.000039176804,0.53206605,0.002414575],"study_design_scores_gemma":[0.0015752218,0.0001635995,0.17792477,0.00046330693,0.022258043,0.00000878228,0.000019526628,0.00002568573,0.00009741493,0.0005262116,0.79657227,0.00036514824],"about_ca_topic_score_codex":0.0003322032,"about_ca_topic_score_gemma":0.00006114029,"teacher_disagreement_score":0.26450625,"about_ca_system_score_codex":0.0001830282,"about_ca_system_score_gemma":0.00023992013,"threshold_uncertainty_score":0.9998941},"labels":[],"label_agreement":null},{"id":"W4400901428","doi":"10.1016/s2213-8587(24)00190-6","title":"Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Population Health Research Institute","funders":"","keywords":"Medicine; Glycaemic index; Type 2 diabetes; Association (psychology); Index (typography); Diabetes mellitus; Internal medicine; Endocrinology; Glycemic index; Psychotherapist; World Wide Web","score_opus":0.01924760007878476,"score_gpt":0.2741374424820921,"score_spread":0.25488984240330737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400901428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6602379,0.009949303,4.7251568e-8,0.32725397,0.000664151,0.00086201786,0.000030210478,0.0000659133,0.00093651714],"genre_scores_gemma":[0.7985329,0.0017608202,0.0000145834065,0.19302392,0.0034520961,0.00029188202,0.0000688909,0.0000795326,0.002775388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965013,0.00048611936,0.00048754297,0.00057553936,0.00061270053,0.0013367647],"domain_scores_gemma":[0.99767256,0.00088090927,0.00035118684,0.0008698273,0.00019625538,0.000029252817],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001073212,0.00045379865,0.0016258786,0.00021948869,0.00009301798,0.00004333021,0.0004767705,0.00032536578,0.000020652486],"category_scores_gemma":[0.00048243435,0.00023418,0.000101316764,0.0005305195,0.0003441399,0.00004676285,0.00024830713,0.0027970874,0.000026619722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095097086,0.000065973014,0.4961428,0.00034793376,0.0010900992,0.0001374261,0.0017622513,4.1058436e-7,0.000111687,0.000030024044,0.4994287,0.000787611],"study_design_scores_gemma":[0.0028072374,0.0012568326,0.3283742,0.0003981264,0.0025644226,0.000017373519,0.0008898091,0.000012624589,0.0000935914,0.0011394728,0.66209185,0.00035441702],"about_ca_topic_score_codex":0.00008408361,"about_ca_topic_score_gemma":0.00016104833,"teacher_disagreement_score":0.16776857,"about_ca_system_score_codex":0.00012355122,"about_ca_system_score_gemma":0.00013347232,"threshold_uncertainty_score":0.9995035},"labels":[],"label_agreement":null},{"id":"W4401067215","doi":"10.1016/s2213-8587(24)00182-7","title":"Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; LMC Diabetes & Endocrinology (Canada)","funders":"Steno Diabetes Center Aarhus; Novo Nordisk","keywords":"Medicine; Semaglutide; Prediabetes; Placebo; Double blind; Physical therapy; Internal medicine; Diabetes mellitus; Type 2 diabetes; Alternative medicine; Endocrinology","score_opus":0.02610063540675881,"score_gpt":0.2991046831145682,"score_spread":0.2730040477078094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401067215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98109096,0.005409844,0.0000056728263,0.0024114975,0.00033541894,0.00794452,0.000034240762,0.0001544219,0.0026134162],"genre_scores_gemma":[0.99637836,0.00094478135,0.00026033277,0.00010987201,0.00033589694,0.000941839,0.000061034032,0.000043327313,0.0009245374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970788,0.0002616204,0.0005860357,0.00061427103,0.00026519608,0.0011941018],"domain_scores_gemma":[0.99635255,0.0027635193,0.00016907317,0.00051122793,0.00005373321,0.00014987646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006992774,0.00043469158,0.0017411968,0.00026484102,0.00009754107,0.0000617004,0.00019752697,0.00010764753,0.00009113256],"category_scores_gemma":[0.00021544422,0.00027154587,0.00013490333,0.00031162708,0.0003723849,0.000110141074,0.00019406286,0.00036604406,0.000018749235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9707719,0.00083640666,0.009095177,0.00049192796,0.002315425,0.00008097535,0.00059076474,0.000029095114,0.0003065887,0.00070951786,0.00057353184,0.014198656],"study_design_scores_gemma":[0.98390406,0.0036905666,0.0024883498,0.00034466165,0.0023688104,0.0000061798373,0.0002419271,0.0026717791,0.0008444218,0.00004313871,0.0031356246,0.00026048147],"about_ca_topic_score_codex":0.000055010383,"about_ca_topic_score_gemma":0.00024226193,"teacher_disagreement_score":0.015287411,"about_ca_system_score_codex":0.00009578718,"about_ca_system_score_gemma":0.00009255655,"threshold_uncertainty_score":0.99997365},"labels":[],"label_agreement":null},{"id":"W4401825270","doi":"10.1016/s2213-8587(24)00179-7","title":"Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Key Research and Development Program of China; European Regional Development Fund; Instituto de Salud Carlos III; Medical Research Council; Seventh Framework Programme; Kadoorie Charitable Foundation; Chinese Society of Clinical Oncology; NIHR Cambridge Biomedical Research Centre; Tehran University of Medical Sciences and Health Services; Ministry of Health, Labour and Welfare; National Institute on Aging; National Institute for Health and Care Research; Department of Health and Aged Care, Australian Government; European Commission; University of Oxford; British Heart Foundation; Wellcome Trust; Cancer Research UK; National Natural Science Foundation of China; Vetenskapsrådet; Australian Government; Consejo Nacional de Ciencia y Tecnología; National Cancer Center; Centre International de Recherche sur le Cancer; GlaxoSmithKline; FP7 Health; Cancer Council Victoria; Office of Research and Development; U.S. Department of Veterans Affairs; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute of Diabetes and Digestive and Kidney Diseases; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Science Foundation; American Diabetes Association; National Institutes of Health; Health Services Research and Development; Bloomberg Philanthropies","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Consumption (sociology); Environmental health; Diabetes mellitus; MEDLINE; Gerontology; Demography; Internal medicine; Endocrinology","score_opus":0.17913932926069784,"score_gpt":0.3716981970797779,"score_spread":0.19255886781908008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39203253,0.6055724,1.1885189e-7,0.0002721845,0.00007623783,0.0007454406,0.0012508341,0.000037416943,0.000012841025],"genre_scores_gemma":[0.15267642,0.8437261,0.0000379099,0.00044950983,0.00014442831,0.00044920217,0.0024449658,0.00003923882,0.00003220178],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963973,0.00046373633,0.00101778,0.00073733245,0.00045505684,0.00092876976],"domain_scores_gemma":[0.99748516,0.0011184422,0.0004994279,0.0005561847,0.00021742197,0.00012333588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004583685,0.00060226483,0.006425296,0.00053793803,0.00012382332,0.00007027935,0.00022106677,0.00020196395,0.00020790564],"category_scores_gemma":[0.00014908543,0.0003326147,0.0004809645,0.0007914474,0.00047870158,0.00007691221,0.00026050903,0.0005192277,0.000030881445],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010659503,0.0009184113,0.33329022,0.023872314,0.6144509,0.0013798794,0.0013286402,0.000033535136,0.000021380187,0.00047512908,0.005713931,0.01744975],"study_design_scores_gemma":[0.001570758,0.001297045,0.040193427,0.0038111233,0.81800866,0.00004964055,0.00026143427,0.00006230051,0.000065131026,0.00014888738,0.13389818,0.00063341117],"about_ca_topic_score_codex":0.0008661437,"about_ca_topic_score_gemma":0.0040524104,"teacher_disagreement_score":0.2930968,"about_ca_system_score_codex":0.00009721239,"about_ca_system_score_gemma":0.00012627045,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W4401825293","doi":"10.1016/s2213-8587(24)00240-7","title":"Closed-loop systems: a bridge to cell therapy for type 1 diabetes?","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Medicine; Type 2 diabetes; Closed loop; Bridge (graph theory); Diabetes mellitus; MEDLINE; Intensive care medicine; Internal medicine; Endocrinology; Control engineering; Biochemistry","score_opus":0.0619580491677977,"score_gpt":0.3238697753986138,"score_spread":0.2619117262308161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567026,0.024607074,0.000050881583,0.0089169545,0.0024966537,0.0014446791,0.00008205293,0.0005455126,0.005153583],"genre_scores_gemma":[0.981052,0.00070778787,0.00021191398,0.010319348,0.0019659435,0.0006667751,0.00007362475,0.0000762681,0.004926331],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735045,0.00011427031,0.00033676258,0.00049107784,0.00018453997,0.0015229245],"domain_scores_gemma":[0.9979673,0.000943396,0.00005500558,0.0007235585,0.00013555096,0.00017517045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041766788,0.00029779196,0.0008156222,0.00019036536,0.000114999115,0.00009139761,0.00028636688,0.000106283405,0.00016900233],"category_scores_gemma":[0.00024252746,0.00019341121,0.00017318224,0.0004362102,0.00011645689,0.00005701063,0.00007298682,0.00029752674,0.00081768626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082327035,0.0003832629,0.10052227,0.0021747053,0.0015594974,0.00006135702,0.0006960178,0.00007290782,0.24241099,0.0120862285,0.5867858,0.052423704],"study_design_scores_gemma":[0.0034281758,0.002357688,0.030461311,0.00032413713,0.000352263,0.000014680578,0.000096302225,0.0024748978,0.059787255,0.00076980295,0.899494,0.00043951356],"about_ca_topic_score_codex":0.000017356928,"about_ca_topic_score_gemma":0.0000011366361,"teacher_disagreement_score":0.31270817,"about_ca_system_score_codex":0.00007373741,"about_ca_system_score_gemma":0.000114789254,"threshold_uncertainty_score":0.9999603},"labels":[],"label_agreement":null},{"id":"W4401825468","doi":"10.1016/s2213-8587(24)00186-4","title":"Association of age with gaps in diabetes-related care and hospitalisations from childhood to young adulthood in Quebec, Canada: a cohort study","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; McGill University Health Centre","funders":"Diabetes Canada; Fonds de Recherche du Québec - Santé; Ministère de la Santé et des Services sociaux","keywords":"Medicine; Cohort; Cohort study; Diabetes mellitus; Young adult; Early adulthood; Demography; Association (psychology); Pediatrics; MEDLINE; Gerontology; Internal medicine","score_opus":0.0134316441151939,"score_gpt":0.2926620349015571,"score_spread":0.27923039078636325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7448264,0.0018752557,6.604511e-8,0.24840273,0.0007840324,0.0030242302,0.0007968021,0.000056713627,0.00023377089],"genre_scores_gemma":[0.92484295,0.00023303233,0.000015184571,0.070479654,0.0016376191,0.0009567658,0.0011442241,0.00008186442,0.0006087136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940772,0.0018142132,0.0010034593,0.00069558644,0.00045896127,0.001950597],"domain_scores_gemma":[0.99724406,0.0013931755,0.0004821975,0.0006293351,0.0001643182,0.0000869335],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004876281,0.00042599288,0.0014837184,0.0003523647,0.0001801884,0.000016780023,0.0004337168,0.0006349205,0.00005009637],"category_scores_gemma":[0.00032496967,0.00032289972,0.000050111394,0.00064104266,0.000052056173,0.000055451746,0.0002476908,0.0045328676,0.000018001825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008774522,0.000032306903,0.7995547,0.00045282292,0.00022070557,0.00012717851,0.014785463,0.0000031924494,8.02216e-7,0.000008353121,0.18462583,0.0001798543],"study_design_scores_gemma":[0.0015312579,0.00015085288,0.97137725,0.00070833013,0.00027960484,1.7996324e-7,0.004937989,0.0000034372035,0.0000014004654,0.00009285379,0.020604854,0.00031200674],"about_ca_topic_score_codex":0.7076447,"about_ca_topic_score_gemma":0.9850308,"teacher_disagreement_score":0.27738607,"about_ca_system_score_codex":0.0014316811,"about_ca_system_score_gemma":0.0013118772,"threshold_uncertainty_score":0.99992234},"labels":[],"label_agreement":null},{"id":"W4402289378","doi":"10.1016/s2213-8587(24)00219-5","title":"Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Public Health Scotland; National Heart, Lung, and Blood Institute; NIHR Nottingham Biomedical Research Centre; Medical Research Council; Swansea University; National Institutes of Health; Public Health England; National Institute for Health and Care Research; AstraZeneca; UK Research and Innovation; National Heart and Lung Institute; NIHR Oxford Biomedical Research Centre; Wellcome Trust; World Health Organization; Bill and Melinda Gates Foundation","keywords":"Medicine; Placebo; Coronavirus disease 2019 (COVID-19); Meta-analysis; Randomized controlled trial; MEDLINE; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Intensive care medicine; Pharmacology; Alternative medicine; Virology; Disease","score_opus":0.12741284742750297,"score_gpt":0.3928776897507555,"score_spread":0.2654648423232525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402289378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014464544,0.9736287,0.000023799039,0.00073561835,0.00027081152,0.020426493,0.0028031808,0.0001736103,0.00049131375],"genre_scores_gemma":[0.005034438,0.96279,0.00025986822,0.0010632202,0.00040685845,0.022940798,0.0067339134,0.00018892455,0.00058198255],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943916,0.0008295494,0.0018320194,0.0010396098,0.0005766823,0.0013304963],"domain_scores_gemma":[0.9943745,0.002399832,0.0014285542,0.0013244001,0.00024870937,0.0002240003],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0023976632,0.0010005386,0.016943641,0.0010101866,0.0000987729,0.00004908409,0.00050483714,0.00022475977,0.0003359714],"category_scores_gemma":[0.00064754294,0.00046375752,0.006846394,0.0011127988,0.00039783458,0.000060593367,0.00008877742,0.00038988597,0.000021656495],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017816118,0.00070470397,0.0020979117,0.017530497,0.91908956,0.000031654916,0.0002234139,0.000003822139,7.26994e-7,0.00072032824,0.0058521503,0.05196362],"study_design_scores_gemma":[0.018879877,0.0007113825,0.00010452134,0.00028168107,0.6582426,4.952282e-7,0.000016943717,0.0000037587904,0.00003211263,0.000176726,0.321252,0.00029794572],"about_ca_topic_score_codex":0.000019792415,"about_ca_topic_score_gemma":0.000022344502,"teacher_disagreement_score":0.31539983,"about_ca_system_score_codex":0.00031268655,"about_ca_system_score_gemma":0.00039486037,"threshold_uncertainty_score":0.9997814},"labels":[],"label_agreement":null},{"id":"W4402346997","doi":"10.1016/s2213-8587(24)00272-9","title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"","keywords":"Medicine; Skeletal muscle; MEDLINE; Weight loss; Physical medicine and rehabilitation; Internal medicine; Obesity; Biochemistry","score_opus":0.02436494382285738,"score_gpt":0.3125383633487066,"score_spread":0.28817341952584924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402346997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82240105,0.0024194808,0.0000074114873,0.17196234,0.0012235804,0.00039823382,0.000007743228,0.00016008361,0.0014200725],"genre_scores_gemma":[0.9648167,0.0008637941,0.00006659768,0.032823388,0.0011757732,0.000095685085,0.000009762806,0.00002715962,0.00012117672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981644,0.00020436353,0.00028101093,0.0002498531,0.00024667726,0.0008536855],"domain_scores_gemma":[0.99797094,0.0013352562,0.000059989674,0.0005119544,0.00003491043,0.00008695579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036627473,0.00015799343,0.00045420506,0.00010361272,0.000099341334,0.000014732048,0.00028607066,0.000075207456,0.00019957058],"category_scores_gemma":[0.00016528819,0.000084207684,0.00010885515,0.00020936174,0.00030879345,0.0000311491,0.00008610836,0.00069305714,0.00018840631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019240186,0.0007531312,0.015355863,0.010602492,0.00093172456,0.0011158371,0.0029784853,0.0000013878092,0.2387969,0.08073014,0.2010424,0.44749922],"study_design_scores_gemma":[0.004668662,0.0016083589,0.25239414,0.0025044351,0.00034113706,0.000110971916,0.00013529227,0.0002717561,0.047514133,0.008467445,0.6816705,0.00031319924],"about_ca_topic_score_codex":0.00001632248,"about_ca_topic_score_gemma":0.0000039553606,"teacher_disagreement_score":0.48062807,"about_ca_system_score_codex":0.000042597127,"about_ca_system_score_gemma":0.000058244168,"threshold_uncertainty_score":0.34338897},"labels":[],"label_agreement":null},{"id":"W4402737275","doi":"10.1016/s2213-8587(24)00200-6","title":"Aberrant hormone receptors regulate a wide spectrum of endocrine tumors","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal","keywords":"Medicine; Endocrine system; Somatostatin receptor; Endocrinology; Internal medicine; Pheochromocytoma; G protein-coupled receptor; Paraganglioma; Hormone; Receptor; Cancer research; Pathology","score_opus":0.03895178644335421,"score_gpt":0.3150462902382269,"score_spread":0.27609450379487266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402737275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040887967,0.9878814,7.229056e-7,0.0021234828,0.0008524581,0.0012060746,0.00017017983,0.00019987595,0.0034769985],"genre_scores_gemma":[0.0032036959,0.992707,0.00007127846,0.00027198804,0.0006989003,0.00025500453,0.0004050493,0.00012028242,0.002266759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616456,0.0002081126,0.0009183234,0.00067669887,0.00027285234,0.0017594453],"domain_scores_gemma":[0.99786687,0.00033184586,0.00037699577,0.0012474223,0.000034825363,0.00014205628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002047409,0.0007602757,0.0044324654,0.00034934562,0.000076973876,0.000018119514,0.00051376305,0.00016798069,0.00017131459],"category_scores_gemma":[0.000098443474,0.00041104856,0.000870338,0.0005126278,0.00037887634,0.000040030365,0.00029669647,0.0008577759,0.000433984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027926237,0.00074682495,0.0033378578,0.033794798,0.011011966,0.0021683944,0.00020843146,0.0000010249245,0.000020672875,0.0046939636,0.09684601,0.8468908],"study_design_scores_gemma":[0.0016295929,0.00071408524,0.00043906688,0.0054191737,0.0065543433,0.0004469647,0.000016630223,0.0000041372828,0.000042608655,0.0028009983,0.98156637,0.0003660102],"about_ca_topic_score_codex":0.000082476145,"about_ca_topic_score_gemma":0.00001922365,"teacher_disagreement_score":0.8847204,"about_ca_system_score_codex":0.000115977295,"about_ca_system_score_gemma":0.00021117127,"threshold_uncertainty_score":0.9998341},"labels":[],"label_agreement":null},{"id":"W4403115981","doi":"10.1016/s2213-8587(24)00221-3","title":"Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; Fundação para a Ciência e a Tecnologia; Esperion Therapeutics; Silence Therapeutics; Servier; Health Systems Research Institute; National Natural Science Foundation of China; HLS Therapeutics; Imperial College London; Amryt Pharma; Ultragenyx Pharmaceutical; Medpace; Alexion Pharmaceuticals; Javna Agencija za Raziskovalno Dejavnost RS; AstraZeneca; Amarin Corporation; Novo Nordisk; Abbott Laboratories; National Institute for Health and Care Research; Medical Research Council; Teva Pharmaceutical Industries; Sanofi; European Atherosclerosis Society; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; Chulalongkorn University; Universidad de Sevilla; Kowa Company; Regeneron Pharmaceuticals","keywords":"Medicine; Cross-sectional study; Type 2 diabetes; Diabetes mellitus; Medication adherence; Body mass index; Internal medicine; Pediatrics; Environmental health; Endocrinology; Pathology","score_opus":0.013872151055652185,"score_gpt":0.27606482593131165,"score_spread":0.26219267487565945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403115981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964905,0.0019902606,0.0000046792634,0.00049669767,0.00016019707,0.0007199349,0.000019751362,0.000046956186,0.000071017246],"genre_scores_gemma":[0.9988812,0.00043507316,0.00007317182,0.00011881586,0.0002707011,0.000114343246,0.000010582607,0.00002027832,0.00007583883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829966,0.00015035148,0.0003455527,0.00031842067,0.00039444145,0.0004915728],"domain_scores_gemma":[0.99909276,0.00022650542,0.0001199632,0.00038640728,0.00012837294,0.000045989425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085918384,0.00014324993,0.0005545552,0.00012695309,0.0000389549,0.000017150525,0.00013184705,0.00006803007,0.000010237401],"category_scores_gemma":[0.00014050143,0.000088895715,0.00004509813,0.0002885636,0.00018496913,0.00007872525,0.00006146586,0.00036986507,0.0000012781528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028839638,0.000103527236,0.99365616,0.0013356522,0.0004122583,0.000024868968,0.00057322124,0.000024643308,0.000882243,0.000020755724,0.00001584733,0.0026624426],"study_design_scores_gemma":[0.0024745301,0.0012645161,0.9940815,0.00047790087,0.00016441949,0.000020588433,0.00007951365,0.00009144793,0.001100077,0.00002503054,0.00013848691,0.00008198189],"about_ca_topic_score_codex":0.00012821771,"about_ca_topic_score_gemma":0.00029515754,"teacher_disagreement_score":0.0025804609,"about_ca_system_score_codex":0.00009006789,"about_ca_system_score_gemma":0.00008975294,"threshold_uncertainty_score":0.3625062},"labels":[],"label_agreement":null},{"id":"W4403460684","doi":"10.1016/s2213-8587(24)00277-8","title":"Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"Medicine; Familial hypercholesterolemia; MEDLINE; Intensive care medicine; Pediatrics; Internal medicine; Cholesterol","score_opus":0.028896982794405685,"score_gpt":0.2845322833172575,"score_spread":0.2556353005228518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403460684","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51688164,0.035051007,0.000006679509,0.4433909,0.00075193367,0.003249891,0.00038542252,0.000075474425,0.00020701905],"genre_scores_gemma":[0.24978457,0.029818118,0.00027902698,0.6675246,0.044380672,0.0047763647,0.001036124,0.00032793204,0.0020726412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712306,0.00021864109,0.00046131885,0.000497363,0.00027279812,0.0014268105],"domain_scores_gemma":[0.9977118,0.00052772247,0.00011774393,0.0015548554,0.00005145093,0.000036459656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039618602,0.00039252377,0.0016033055,0.000150082,0.00007023448,0.00001986998,0.00043272882,0.00037501738,0.0000147453975],"category_scores_gemma":[0.00005193548,0.00019461945,0.0006983653,0.00015348253,0.00028305012,0.00001730159,0.0000734279,0.0011509294,0.000030670773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033630177,0.0003082273,0.052517828,0.0017242831,0.008244372,0.00059376954,0.0007418262,0.000020085537,0.00021055863,0.00020518497,0.6625068,0.27259076],"study_design_scores_gemma":[0.0038798805,0.0012529484,0.04762488,0.000176554,0.0017043678,0.00033541836,0.000026037502,0.000030506302,0.00060118485,0.0005151861,0.9436339,0.00021909532],"about_ca_topic_score_codex":0.00053340057,"about_ca_topic_score_gemma":0.00005984458,"teacher_disagreement_score":0.28112713,"about_ca_system_score_codex":0.00021388041,"about_ca_system_score_gemma":0.00015170369,"threshold_uncertainty_score":0.7936351},"labels":[],"label_agreement":null},{"id":"W4403714936","doi":"10.1016/s2213-8587(24)00248-1","title":"Diabetes subtypes and patient-reported outcomes","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"HLS Therapeutics; Ultragenyx Pharmaceutical; Amgen","keywords":"Medicine; MEDLINE; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.032781906331710936,"score_gpt":0.2970231164502841,"score_spread":0.26424121011857316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403714936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3252638,0.008084255,1.4609263e-7,0.65692014,0.0010245425,0.00078226766,0.00004445766,0.00034439232,0.0075359987],"genre_scores_gemma":[0.07316237,0.00083988,0.00008538259,0.8910544,0.0043305503,0.00043470025,0.00046739553,0.00021904788,0.029406292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99489534,0.00022628272,0.00056173996,0.00087388896,0.0005872277,0.0028555163],"domain_scores_gemma":[0.997491,0.0007720434,0.0002019683,0.0013188816,0.000110724104,0.000105358275],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00036150162,0.0006240663,0.0016536482,0.00046493672,0.00014989909,0.00016284615,0.0005248098,0.0004713711,0.0003439806],"category_scores_gemma":[0.00029109063,0.00036710972,0.00029306332,0.00031732811,0.00074937707,0.00006878039,0.00082864787,0.0030390148,0.0007293727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012734118,0.00003151624,0.17352103,0.000986369,0.0020306217,0.0007519715,0.00004852323,1.705371e-7,0.0001118233,0.00015560543,0.80794936,0.014400261],"study_design_scores_gemma":[0.0008846431,0.00036165057,0.032275025,0.00025134775,0.0011000198,0.000011742878,0.000022997894,0.00004631052,0.0004247803,0.0027803306,0.9614431,0.00039802425],"about_ca_topic_score_codex":0.000011078392,"about_ca_topic_score_gemma":0.0000026870873,"teacher_disagreement_score":0.25210142,"about_ca_system_score_codex":0.00006278721,"about_ca_system_score_gemma":0.00006750318,"threshold_uncertainty_score":0.9998781},"labels":[],"label_agreement":null},{"id":"W4404404303","doi":"10.1016/s2213-8587(24)00287-0","title":"Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Sheba Medical Center","keywords":"Medicine; Overweight; Retrospective cohort study; Obesity; Young adult; Cohort; Pediatrics; Cohort study; MEDLINE; Adolescent Obesity; Environmental health; Demography; Gerontology; Internal medicine","score_opus":0.009798897785092991,"score_gpt":0.2640731411272716,"score_spread":0.25427424334217863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404404303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947445,0.0006794412,0.0000056437975,0.001150084,0.00026512754,0.0028087215,0.000070201524,0.0001169589,0.00015933704],"genre_scores_gemma":[0.99854493,0.0003461497,0.000021040614,0.0002247669,0.00041108002,0.000368302,0.0000064271744,0.000028748647,0.000048530957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787074,0.00039386543,0.00023666461,0.0005411524,0.0002353485,0.0007222518],"domain_scores_gemma":[0.99875593,0.00056756445,0.00009302158,0.0004331068,0.00008410788,0.000066271685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071902515,0.00023765392,0.0008019324,0.000085200954,0.00018723137,0.000071433824,0.00017980323,0.00006893759,0.0000037197497],"category_scores_gemma":[0.00041458386,0.00014275587,0.00008298716,0.00022560038,0.0005256878,0.00014531914,0.00025953236,0.00073719467,0.0000059980644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016321348,0.00079102174,0.9949484,0.0001279768,0.0003029048,0.000024180536,0.0009713508,7.5049695e-7,0.000043292977,0.0021343387,0.00010572514,0.00038683182],"study_design_scores_gemma":[0.0038100195,0.00042911703,0.98422134,0.000088554225,0.00040608502,0.000009392825,0.00015142266,0.0010636118,0.00021909291,0.009413121,0.000045787256,0.00014244409],"about_ca_topic_score_codex":0.0012725643,"about_ca_topic_score_gemma":0.00162906,"teacher_disagreement_score":0.010727061,"about_ca_system_score_codex":0.00010600704,"about_ca_system_score_gemma":0.000023672585,"threshold_uncertainty_score":0.5821416},"labels":[],"label_agreement":null},{"id":"W4404685978","doi":"10.1016/s2213-8587(24)00271-7","title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Meta-analysis; Glucagon-like peptide 1 receptor; Randomized controlled trial; MEDLINE; Semaglutide; Internal medicine; Type 2 diabetes; Disease; Diabetes mellitus; Intensive care medicine; Liraglutide; Agonist; Endocrinology; Receptor","score_opus":0.10556002575108235,"score_gpt":0.36492264539185565,"score_spread":0.2593626196407733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404685978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004925988,0.98907965,0.0000021599665,0.00085557206,0.00034736216,0.008255055,0.00050533895,0.000073382085,0.00038885084],"genre_scores_gemma":[0.0009893967,0.99240845,0.000045251105,0.0006554989,0.0001670276,0.004368864,0.00037484168,0.00006899449,0.0009216548],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993292,0.0027625675,0.0018148734,0.0007600868,0.00051375414,0.00085673144],"domain_scores_gemma":[0.9893219,0.0077230586,0.00097068003,0.0016666421,0.000081795646,0.00023593828],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0031075054,0.0008855163,0.03953955,0.0009210369,0.00004172102,0.000028584593,0.000377069,0.00015657936,0.00015563822],"category_scores_gemma":[0.0041626645,0.00037125053,0.021511866,0.00063792104,0.00028287104,0.000022825545,0.00020882713,0.00033807848,0.000034478107],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011306122,0.00023331297,0.00005293256,0.027686529,0.9059091,0.000060959355,0.000023391718,0.0000023952152,0.0000035016278,0.00068937923,0.0025786955,0.06162919],"study_design_scores_gemma":[0.023992516,0.00019774392,0.000027024318,0.0008659539,0.6852927,3.6727624e-7,0.0000024685917,0.0000056760923,0.000022781982,0.0000542821,0.28936478,0.00017368313],"about_ca_topic_score_codex":0.000014235085,"about_ca_topic_score_gemma":6.5456265e-7,"teacher_disagreement_score":0.28678608,"about_ca_system_score_codex":0.000056030807,"about_ca_system_score_gemma":0.0001367748,"threshold_uncertainty_score":0.99987394},"labels":[],"label_agreement":null},{"id":"W4405467041","doi":"10.1016/s2213-8587(24)00375-9","title":"Barriers to care for refugees and migrants with diabetes","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Refugee; Diabetes mellitus; MEDLINE; Gerontology; Family medicine; Nursing; Endocrinology","score_opus":0.01718669554345504,"score_gpt":0.3175438163189397,"score_spread":0.30035712077548465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405467041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720318,0.016661638,0.000027085698,0.008159006,0.00077438145,0.00078902,0.00018468105,0.00022005488,0.0011523726],"genre_scores_gemma":[0.9930858,0.000052902007,0.00030492703,0.004632533,0.0005994086,0.00085096044,0.000030669027,0.00003977705,0.0004030468],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774075,0.00012123533,0.00019739704,0.00045595647,0.000082512925,0.0014021649],"domain_scores_gemma":[0.99875927,0.0004974241,0.000033877397,0.00043654564,0.000053244883,0.00021963615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019811993,0.00020355466,0.00039046083,0.00011922407,0.00025054737,0.000052217772,0.00025352367,0.00007575073,0.00017158661],"category_scores_gemma":[0.000074311974,0.0001302709,0.000046614306,0.00018738421,0.0001608007,0.00005039779,0.00004028718,0.0002108944,0.0000963503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044924062,0.000033932272,0.6513044,0.0012938521,0.0008578739,0.00003725212,0.04723265,0.000014049036,0.0010504269,0.07971595,0.085045435,0.1329649],"study_design_scores_gemma":[0.0018092825,0.001392435,0.14391005,0.00015920837,0.00019207427,0.00001568448,0.004033695,0.00007220387,0.002116709,0.0031068241,0.84274775,0.00044405862],"about_ca_topic_score_codex":0.000047988324,"about_ca_topic_score_gemma":0.00066829746,"teacher_disagreement_score":0.75770235,"about_ca_system_score_codex":0.00002423792,"about_ca_system_score_gemma":0.000054286636,"threshold_uncertainty_score":0.5312293},"labels":[],"label_agreement":null},{"id":"W4406315151","doi":"10.1016/s2213-8587(24)00317-6","title":"Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Type 2 diabetes; MEDLINE; Diabetes mellitus; Heart failure; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.026868285444354927,"score_gpt":0.28785844414974193,"score_spread":0.260990158705387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406315151","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120954804,0.0038126071,0.000002945246,0.87262064,0.0006929722,0.0005915486,0.000088278066,0.00028123343,0.00095499645],"genre_scores_gemma":[0.059884753,0.00043857397,0.00030440826,0.91266555,0.002346821,0.00012149735,0.0036775123,0.00009145101,0.020469438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966898,0.0003076157,0.00049329334,0.0005580726,0.00039473776,0.0015565094],"domain_scores_gemma":[0.99773705,0.00086781377,0.00020781693,0.00089762016,0.00021649504,0.00007320257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024363612,0.0004910208,0.0016290668,0.00025082513,0.00016199623,0.00004422321,0.00037387272,0.0006347646,0.00044538247],"category_scores_gemma":[0.0005943527,0.00032644355,0.00029070687,0.00031283687,0.00021069625,0.000060624057,0.00019357249,0.0019616548,0.00032037418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020405758,0.00003903977,0.041610435,0.00016129429,0.00046877432,0.000035199308,0.000012599815,7.078256e-7,0.004684769,0.00004249234,0.9509863,0.0019379815],"study_design_scores_gemma":[0.00125398,0.00021386554,0.023908312,0.00024738745,0.0004349308,0.000013851023,0.00000849134,0.00009798557,0.0011027612,0.00034047966,0.97208977,0.00028819343],"about_ca_topic_score_codex":0.000016831125,"about_ca_topic_score_gemma":0.000010185681,"teacher_disagreement_score":0.06107005,"about_ca_system_score_codex":0.00009674886,"about_ca_system_score_gemma":0.00015734266,"threshold_uncertainty_score":0.99991876},"labels":[],"label_agreement":null},{"id":"W4406352689","doi":"10.1016/s2213-8587(24)00308-5","title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Ottawa","funders":"Agencia Nacional de Investigación y Desarrollo; Pontificia Universidad Católica de Chile; National Health and Medical Research Council; Hudson Institute of Medical Research; National Heart, Lung, and Blood Institute; State Government of Victoria; National Institute on Aging; Agenția Națională pentru Cercetare și Dezvoltare; Ministry of Health, Labour and Welfare; Deutsche Forschungsgemeinschaft; National Institute for Health and Care Research; Hudson Institute","keywords":"Medicine; Primary aldosteronism; Cohort; MEDLINE; Cohort study; Intensive care medicine; Internal medicine; Aldosterone","score_opus":0.03479493122060188,"score_gpt":0.3537968431540736,"score_spread":0.3190019119334717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406352689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770779,0.00019359193,0.000011586803,0.021853283,0.0001478924,0.0003620743,0.00009067625,0.00002094713,0.00024205493],"genre_scores_gemma":[0.996292,0.00030093972,0.0003969441,0.0022209676,0.000054082302,0.00016000493,0.00023761619,0.0000070784363,0.00033034713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988565,0.00015193086,0.0003006874,0.00025384495,0.00015723238,0.00027979503],"domain_scores_gemma":[0.9989403,0.000534795,0.00006168045,0.00030772123,0.00008964916,0.00006584348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028136585,0.00013292437,0.0006492658,0.00038470313,0.000026843862,0.000010369048,0.0001238892,0.000068007335,0.00008506916],"category_scores_gemma":[0.00014740802,0.000081540995,0.00010026254,0.0001148569,0.00016984907,0.00004099258,0.000044774133,0.000059370046,9.800502e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043039806,0.0002993338,0.9630079,0.000005117481,0.0019801534,0.00003824442,0.00015104927,0.000014071243,0.0013493741,0.00071968156,0.0000150310225,0.028116057],"study_design_scores_gemma":[0.004437312,0.000838179,0.9816341,0.000017371762,0.00074897567,0.000010876954,0.000042889373,0.005612033,0.00036838185,0.00009952865,0.006131573,0.000058813668],"about_ca_topic_score_codex":0.000054109372,"about_ca_topic_score_gemma":0.0002183335,"teacher_disagreement_score":0.028057244,"about_ca_system_score_codex":0.00024811024,"about_ca_system_score_gemma":0.00012697942,"threshold_uncertainty_score":0.33251452},"labels":[],"label_agreement":null},{"id":"W4406352787","doi":"10.1016/s2213-8587(24)00316-4","title":"Definition and diagnostic criteria of clinical obesity","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":1324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; World Health Organization","keywords":"Medicine; MEDLINE; Intensive care medicine; Obesity; Internal medicine","score_opus":0.30242526656903984,"score_gpt":0.5601540238261928,"score_spread":0.257728757257153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406352787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024922623,0.9807111,0.0000030438955,0.0017129194,0.0020993596,0.0015501791,0.00024859796,0.00008837814,0.011094175],"genre_scores_gemma":[0.00022648142,0.9949221,0.0003032901,0.0022204353,0.0014573181,0.0004582794,0.000095391784,0.000024464136,0.00029225764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98872614,0.007408857,0.0018436855,0.00046810674,0.00013057534,0.0014226261],"domain_scores_gemma":[0.93682146,0.060784373,0.0014100344,0.0007718711,0.00011656895,0.000095705],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033410282,0.00033741517,0.0039449907,0.0001547705,0.0006073811,0.00000906278,0.00058030133,0.0006809302,0.000515181],"category_scores_gemma":[0.009138197,0.00022476724,0.00025612582,0.0002217506,0.0004228665,0.00008499578,0.00064722315,0.0027006029,0.00045044045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029212342,0.00019456449,0.04449567,0.20890793,0.0003675601,0.000015020393,0.00020758723,1.1567532e-8,9.495061e-8,0.031436507,0.026242387,0.68810344],"study_design_scores_gemma":[0.00050158857,0.00011816642,0.013400671,0.019814324,0.0011669637,0.0000030377012,0.00005608027,6.674185e-7,1.3801215e-7,0.005918156,0.9588472,0.00017299423],"about_ca_topic_score_codex":0.00010274285,"about_ca_topic_score_gemma":0.00016901949,"teacher_disagreement_score":0.93260485,"about_ca_system_score_codex":0.000041245003,"about_ca_system_score_gemma":0.0007410625,"threshold_uncertainty_score":0.99960023},"labels":[],"label_agreement":null},{"id":"W4406606896","doi":"10.1016/s2213-8587(24)00304-8","title":"Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"American Regent; Vifor Pharma; Horizon Therapeutics; Impulse Dynamics; National Institutes of Health; Regeneron Pharmaceuticals; Dexcom; ReCor Medical; Astellas Pharma; Cytokinetics; Prothena; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Eli Lilly and Company; U.S. Department of Defense; Sanofi; HLS Therapeutics; LivaNova; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; Edwards Lifesciences; Amgen; Moderna; Pfizer; Tenax Therapeutics; Esperion Therapeutics; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Gilead Sciences","keywords":"Medicine; Heart failure; Heart failure with preserved ejection fraction; Ejection fraction; Internal medicine; Cardiology; Semaglutide; Obesity; Type 2 diabetes; Baseline (sea); Diabetes mellitus; Endocrinology","score_opus":0.017476821309334672,"score_gpt":0.2834660659037371,"score_spread":0.26598924459440243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406606896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857589,0.002963955,0.000021794925,0.0070811887,0.00015760734,0.0037451172,0.000059291164,0.00010270776,0.00010941587],"genre_scores_gemma":[0.997145,0.00017666431,0.0007701199,0.00062537176,0.000088588975,0.00061187934,0.0001118429,0.00002470255,0.00044582295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968207,0.00073739234,0.0007061423,0.0006025312,0.00023862248,0.0008946139],"domain_scores_gemma":[0.99656737,0.0023063445,0.00027113812,0.00064990536,0.00012380393,0.000081412225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009818844,0.00039867702,0.0028697185,0.0005382145,0.00013196332,0.00005815475,0.0001553117,0.0001635774,0.00011283827],"category_scores_gemma":[0.00062898925,0.0002563577,0.000249801,0.0009901739,0.00023587885,0.000136268,0.00016579677,0.00038746675,0.0000044039207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07927671,0.00038261779,0.9025173,0.00008809163,0.012302628,0.000005629561,0.00011801318,0.00011780198,0.0033417798,0.00012176935,0.0010690722,0.0006585371],"study_design_scores_gemma":[0.4022037,0.0004933306,0.5796964,0.00011010095,0.0075096064,5.5583496e-7,0.000261297,0.0022464236,0.0031757716,0.00018076034,0.0039109006,0.00021112352],"about_ca_topic_score_codex":0.00024912768,"about_ca_topic_score_gemma":0.0011420952,"teacher_disagreement_score":0.322927,"about_ca_system_score_codex":0.00005300082,"about_ca_system_score_gemma":0.0000478046,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W4406788773","doi":"10.1016/s2213-8587(24)00347-4","title":"Protein-binding therapy: a new approach to lower cholesterol","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cholesterol; MEDLINE; Internal medicine; Biochemistry","score_opus":0.040997041786902784,"score_gpt":0.2831626981905293,"score_spread":0.24216565640362653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788773","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047545366,0.0026601527,0.00015312903,0.92243564,0.0009366866,0.005231617,0.00007136212,0.00035346096,0.020612556],"genre_scores_gemma":[0.0043455795,0.0004441304,0.0010789046,0.9437542,0.02056246,0.0014223355,0.00028119131,0.0001326304,0.027978584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949474,0.0004112478,0.0004675438,0.0009748838,0.00059563,0.0026033064],"domain_scores_gemma":[0.9967323,0.000108747365,0.0001625679,0.0027301405,0.00009514639,0.00017112246],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00062307296,0.0006189925,0.0019829152,0.000313249,0.00017326346,0.00007592681,0.0009163265,0.0006320289,0.00011730023],"category_scores_gemma":[0.00012212755,0.0004037561,0.00058813934,0.0004276439,0.00013454344,0.000040471667,0.0003110606,0.0032657636,0.0003084518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009583242,0.00006710111,0.0003958852,0.0006314557,0.0012335747,0.00012578447,0.00011324199,0.0000020030363,0.00041390012,0.00013233317,0.9465995,0.050189376],"study_design_scores_gemma":[0.0024613284,0.00030834335,0.0009139259,0.00038771617,0.00026688934,0.00008397329,0.000012643216,0.0000051475313,0.0012994092,0.0001893142,0.9937092,0.00036209638],"about_ca_topic_score_codex":0.00021480033,"about_ca_topic_score_gemma":0.000004041034,"teacher_disagreement_score":0.04982728,"about_ca_system_score_codex":0.00018304124,"about_ca_system_score_gemma":0.00046769413,"threshold_uncertainty_score":0.99984145},"labels":[],"label_agreement":null},{"id":"W4407568618","doi":"10.1016/s2213-8587(24)00362-0","title":"Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health","keywords":"Medicine; Adverse effect; Randomized controlled trial; Internal medicine; MEDLINE; Intensive care medicine","score_opus":0.012227653886428429,"score_gpt":0.2715166031842844,"score_spread":0.25928894929785595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407568618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857062,0.001845154,0.000006647372,0.00084202096,0.00050238456,0.0028330428,0.0000360669,0.000042585318,0.008185868],"genre_scores_gemma":[0.99779904,0.00015038006,0.00001904848,0.00047608375,0.00011737367,0.00040998627,0.000034732577,0.0000139788735,0.0009793648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974745,0.00081854657,0.00046945963,0.00032513862,0.0002978027,0.0006145711],"domain_scores_gemma":[0.99722254,0.0010217781,0.00020755435,0.0014606641,0.000054293894,0.000033156186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095656316,0.0002435378,0.0018843486,0.00035126056,0.000066220666,0.000004246411,0.00043013654,0.000067028035,0.00011522491],"category_scores_gemma":[0.00035085174,0.00012657316,0.0014925633,0.0007916039,0.00022077232,0.000025370586,0.00019855422,0.00022257879,0.000007763354],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34668878,0.0016300754,0.19590105,0.0019181618,0.2966677,0.0000488176,0.0003989484,0.0013335295,0.0067665474,0.006198565,0.008892341,0.13355547],"study_design_scores_gemma":[0.6072986,0.0033229832,0.18154801,0.0003415337,0.074877515,6.3973044e-7,0.00006033846,0.00024619992,0.11658803,0.00040312408,0.015056848,0.00025616365],"about_ca_topic_score_codex":0.000027516593,"about_ca_topic_score_gemma":0.000009044484,"teacher_disagreement_score":0.26060984,"about_ca_system_score_codex":0.000059394482,"about_ca_system_score_gemma":0.000051209576,"threshold_uncertainty_score":0.51615036},"labels":[],"label_agreement":null},{"id":"W4407631637","doi":"10.1016/s2213-8587(24)00372-3","title":"Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Trillium Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; National Institutes of Health; Abbott Laboratories; Sanofi; National Institute of Diabetes and Digestive and Kidney Diseases; Dexcom","keywords":"Medicine; Deprescribing; Diabetes mellitus; Polypharmacy; Intensive care medicine; MEDLINE; Gerontology; Endocrinology","score_opus":0.04096049604617223,"score_gpt":0.3578353991457552,"score_spread":0.31687490309958294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407631637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00776646,0.97580093,0.000009387335,0.0020421816,0.00021168395,0.0031921463,0.000048184527,0.00018825843,0.010740748],"genre_scores_gemma":[0.0025216867,0.99104536,0.0002809037,0.0010202242,0.00044833453,0.0014419333,0.00026644973,0.00007716637,0.0028979601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952479,0.00051232305,0.00084126065,0.00093695754,0.0002932196,0.0021683562],"domain_scores_gemma":[0.9970858,0.0011897755,0.00024331789,0.0012346184,0.00010500992,0.00014145352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009963457,0.00057619106,0.0025834567,0.0008534318,0.00014390217,0.00014608135,0.00070752384,0.0002513727,0.00003212405],"category_scores_gemma":[0.000594277,0.0003910303,0.00021641974,0.0008922541,0.00022652351,0.0001178855,0.0007573254,0.0009027574,0.00007165497],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020507476,0.00008408889,0.0050724307,0.02561434,0.00040572105,0.00004167377,0.00019510892,0.0000023517232,0.000031724143,0.0029491775,0.0065096635,0.9590732],"study_design_scores_gemma":[0.0015289749,0.00023651795,0.0038549379,0.03965954,0.0007581972,0.0000039791375,0.00045717173,0.00005017701,0.000068541354,0.00049213704,0.9523491,0.0005406907],"about_ca_topic_score_codex":0.00003944909,"about_ca_topic_score_gemma":0.00003718416,"teacher_disagreement_score":0.9585325,"about_ca_system_score_codex":0.00016657187,"about_ca_system_score_gemma":0.00027698177,"threshold_uncertainty_score":0.99985415},"labels":[],"label_agreement":null},{"id":"W4407805683","doi":"10.1016/s2213-8587(24)00348-6","title":"Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; St. Michael's Hospital","funders":"National Center for Complementary and Integrative Health; Barts Charity","keywords":"Medicine; Meta-analysis; Intensive care medicine; MEDLINE; Vitamin D and neurology; Internal medicine","score_opus":0.16134388234045613,"score_gpt":0.44543376408052415,"score_spread":0.284089881740068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407805683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025372743,0.98772585,0.000008542064,0.002280751,0.000044677963,0.0068910783,0.0028749807,0.000041241678,0.00010752292],"genre_scores_gemma":[0.00003351349,0.9927524,0.00010664255,0.0014648647,0.000043284206,0.0037594286,0.00094730256,0.000024123568,0.000868496],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948379,0.0018232336,0.0014699958,0.00071356056,0.00036453243,0.00079081964],"domain_scores_gemma":[0.9940572,0.001936666,0.00077099,0.0029463375,0.0002024032,0.00008644297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019867641,0.00048156676,0.011884096,0.0007688855,0.00011107419,0.000025056166,0.0008969163,0.00009678496,0.00013083915],"category_scores_gemma":[0.0018779202,0.00026035766,0.0008852547,0.0016326733,0.00020752546,0.000068571455,0.0011998117,0.00046557665,0.000016787068],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016541253,0.000071919436,0.000013361658,0.66048586,0.33023557,0.000010286954,0.000021578604,2.4763884e-7,0.0000023856574,0.000105339735,0.0055869,0.0034649062],"study_design_scores_gemma":[0.0001863685,0.0002095101,0.000031838423,0.034963287,0.92477006,0.000007840887,0.00001901238,0.0000018347699,0.000014119055,0.000014499137,0.039609533,0.00017208119],"about_ca_topic_score_codex":0.000017582071,"about_ca_topic_score_gemma":0.00010153419,"teacher_disagreement_score":0.62552255,"about_ca_system_score_codex":0.00008801802,"about_ca_system_score_gemma":0.00021018794,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W4407931352","doi":"10.1016/s2213-8587(25)00029-4","title":"Type 1 diabetes screening: need for ethical, equity, and health systems perspective","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Direktion für Entwicklung und Zusammenarbeit","keywords":"Medicine; Perspective (graphical); Equity (law); Type 2 diabetes; MEDLINE; Diabetes mellitus; Health equity; Family medicine; Nursing; Endocrinology; Public health","score_opus":0.13289991826021094,"score_gpt":0.4174519800715645,"score_spread":0.2845520618113535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407931352","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016239366,0.017048083,0.00003351275,0.9673943,0.0011727039,0.002911153,0.00012986391,0.00025486777,0.009431586],"genre_scores_gemma":[0.011510515,0.0017651332,0.00035376343,0.9569839,0.008216618,0.00066835334,0.00062664074,0.00011543212,0.01975965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99418986,0.0005012985,0.0005131929,0.0008753058,0.00056876417,0.003351576],"domain_scores_gemma":[0.9964164,0.0016451192,0.00027612067,0.0010688894,0.0004558605,0.0001376406],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018829207,0.00054210634,0.0020510345,0.00048307996,0.00037251716,0.00020927397,0.0008965248,0.00083963195,0.000047747402],"category_scores_gemma":[0.00066126394,0.00037380785,0.00022553674,0.00042741996,0.0007435906,0.000044847267,0.001672669,0.004488028,0.000041171315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006314305,0.000034295776,0.005155771,0.0038450304,0.001364851,0.00002634667,0.000067058136,0.000002655085,0.00003352591,0.008115878,0.97499084,0.006300612],"study_design_scores_gemma":[0.0022081137,0.0012588879,0.0019779159,0.0008214387,0.0004947754,0.0000030337014,0.00019844303,0.00062473695,0.000047395362,0.005643282,0.9863565,0.0003655096],"about_ca_topic_score_codex":0.00010383906,"about_ca_topic_score_gemma":0.0000073279534,"teacher_disagreement_score":0.015282949,"about_ca_system_score_codex":0.0002316258,"about_ca_system_score_gemma":0.00033449326,"threshold_uncertainty_score":0.9998714},"labels":[],"label_agreement":null},{"id":"W4408830362","doi":"10.1016/s2213-8587(25)00028-2","title":"Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitis","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Diabetes Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Plasmapheresis; Heparin; Pancreatitis; Insulin; Acute pancreatitis; Internal medicine; Intensive care medicine; Endocrinology; Gastroenterology; Immunology","score_opus":0.06538229844568082,"score_gpt":0.35709232177869493,"score_spread":0.2917100233330141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408830362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37616998,0.6202148,1.6269685e-7,0.00021392708,0.00012203571,0.0017709172,0.00045825294,0.000024264586,0.0010256494],"genre_scores_gemma":[0.08374893,0.91399795,0.00013796038,0.00013994088,0.000111296205,0.0013427536,0.00033204677,0.000028650526,0.00016048363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99531955,0.0013385087,0.0013182937,0.0006161954,0.00022856388,0.0011789158],"domain_scores_gemma":[0.9950822,0.0027917984,0.0005795828,0.0014496507,0.00004778072,0.00004898441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047918278,0.0006654264,0.005473836,0.00047778638,0.000060017344,0.0000070199453,0.00068251434,0.0004793405,0.0000631563],"category_scores_gemma":[0.00023234099,0.00033108273,0.00047971474,0.0009465088,0.0003958485,0.000035884244,0.00012928767,0.00067728583,0.000016024453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005286197,0.0022130352,0.16565707,0.0068025785,0.0026720988,0.0011988026,0.000671563,6.141323e-7,0.000024634377,0.0005367937,0.00019132868,0.81950283],"study_design_scores_gemma":[0.03554826,0.011047861,0.3350699,0.031043295,0.024622548,0.001975162,0.000382947,0.000011282944,0.0028117336,0.0009304349,0.55510926,0.0014473273],"about_ca_topic_score_codex":0.00053576386,"about_ca_topic_score_gemma":0.0009450081,"teacher_disagreement_score":0.8180555,"about_ca_system_score_codex":0.00032097343,"about_ca_system_score_gemma":0.0006644488,"threshold_uncertainty_score":0.9999141},"labels":[],"label_agreement":null},{"id":"W4409656874","doi":"10.1016/s2213-8587(25)00089-0","title":"Compassionate care in obesity management: reclaiming humanity in health care","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Humanity; Health care; MEDLINE; Obesity; Nursing; Internal medicine; Economic growth","score_opus":0.05194853436021688,"score_gpt":0.4309319674851735,"score_spread":0.3789834331249566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409656874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8740186,0.013568446,0.0000056121603,0.032388613,0.0011319454,0.0016651732,0.000027944387,0.00015744365,0.07703623],"genre_scores_gemma":[0.97833955,0.0026454139,0.0002905509,0.017391933,0.00018785114,0.00035418474,0.000042093274,0.000015720703,0.00073268067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367714,0.0028041943,0.0007565868,0.00042619725,0.00014691008,0.002188999],"domain_scores_gemma":[0.9976429,0.0012686475,0.0003007967,0.0006426253,0.00007809993,0.000066983164],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0013190062,0.00020932789,0.0007650843,0.00036924338,0.0014767789,0.000011734202,0.00062470237,0.00015822645,0.00019944138],"category_scores_gemma":[0.00012324336,0.00017237542,0.000046551733,0.0004940668,0.00012050943,0.00013455715,0.00056431815,0.0020082071,0.00022603692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011860646,0.00010068106,0.89007825,0.0063847327,0.00003403913,0.00002695961,0.014048138,0.000033106866,0.000004828608,0.06616113,0.005978008,0.01703154],"study_design_scores_gemma":[0.0020034106,0.000061606406,0.72747636,0.0012051743,0.000014854004,2.574027e-7,0.024258276,0.00002563527,0.000015788306,0.003730448,0.24107258,0.00013562613],"about_ca_topic_score_codex":0.0023687962,"about_ca_topic_score_gemma":0.044490565,"teacher_disagreement_score":0.23509458,"about_ca_system_score_codex":0.00078723853,"about_ca_system_score_gemma":0.00029388917,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W4412647992","doi":"10.1016/s2213-8587(25)00405-x","title":"Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries","year":2025,"lang":"en","type":"preprint","venue":"The Lancet Diabetes & Endocrinology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Manchester Biomedical Research Centre; American Diabetes Association; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Novo Nordisk UK Research Foundation; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Polygenic risk score; Type 2 diabetes; Computational biology; Genetics; Demography; Diabetes mellitus; Medicine; Biology; Gerontology; Evolutionary biology; Gene; Endocrinology; Single-nucleotide polymorphism; Genotype; Sociology","score_opus":0.05627410835963777,"score_gpt":0.3163311507240522,"score_spread":0.26005704236441446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412647992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97845155,0.016817743,0.000373611,0.001758911,0.0005086509,0.00064795115,0.0013758648,0.000015031442,0.000050716648],"genre_scores_gemma":[0.9815666,0.0152670415,0.0017066837,0.00035799938,0.00025579103,0.0004106041,0.0003355304,0.000010718412,0.000089045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983583,0.00025967718,0.0003641474,0.00040141708,0.000048825783,0.000567632],"domain_scores_gemma":[0.99825317,0.0005772591,0.00035217786,0.00067445665,0.000120712146,0.000022234723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041129102,0.00019822048,0.00047011455,0.000058350615,0.00017035725,0.000012227872,0.0005134668,0.00024332754,0.0000025748857],"category_scores_gemma":[0.00073764217,0.00013737033,0.000097794786,0.000096942385,0.0005103919,0.0000023844195,0.00062649656,0.0003378698,7.762512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025553782,0.000036408746,0.98887104,0.0000839142,0.0003101549,5.5185613e-8,0.00007119594,0.0020709857,0.0030775454,0.0001627699,0.0019434901,0.0033469042],"study_design_scores_gemma":[0.00069607224,0.00013005939,0.98585963,0.000044736375,0.00019426893,4.7200876e-7,0.00013726878,0.0043220255,0.0019154566,0.002114978,0.004457358,0.00012767331],"about_ca_topic_score_codex":0.00011437275,"about_ca_topic_score_gemma":0.0002694923,"teacher_disagreement_score":0.003219231,"about_ca_system_score_codex":0.000016873028,"about_ca_system_score_gemma":0.00010470251,"threshold_uncertainty_score":0.56017995},"labels":[],"label_agreement":null},{"id":"W4413140592","doi":"10.1016/s2213-8587(25)00163-9","title":"The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prediabetes; Medicine; Gestational diabetes; Insulin resistance; Prospective cohort study; Internal medicine; Population; Diabetes mellitus; Homeostatic model assessment; Cohort; Cohort study; Glucose tolerance test; Pregnancy; Type 2 diabetes; Insulin; Obstetrics; Endocrinology; Gestation; Environmental health","score_opus":0.008158616106466414,"score_gpt":0.25239409147146075,"score_spread":0.24423547536499432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413140592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920485,0.0011387495,0.0000014791921,0.001103397,0.00009299003,0.0016965036,0.000017485609,0.0000044301974,0.003896451],"genre_scores_gemma":[0.99906445,0.00033931402,0.000012599414,0.00017113738,0.000022506765,0.00022799884,0.000010931756,0.0000052046303,0.00014583836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981428,0.00034495312,0.00039189748,0.00017425693,0.0003263976,0.0006196911],"domain_scores_gemma":[0.99842614,0.0008790816,0.00014040095,0.00042658212,0.00010620822,0.000021599602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070407405,0.00009981196,0.00041244336,0.00011029704,0.000038085134,0.000004110477,0.0003144202,0.000022230966,0.000011357977],"category_scores_gemma":[0.0003595866,0.00005301624,0.000042248816,0.0004159095,0.00012722674,0.000027205215,0.000109093126,0.0002521108,4.0270348e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032304486,0.00027838282,0.98904985,0.0001536442,0.0001593101,0.0000026735938,0.0002466362,0.00010522256,0.004560676,0.0007304409,0.00068639405,0.0037037455],"study_design_scores_gemma":[0.0014677924,0.0005165463,0.9819446,0.00007946707,0.000071363844,1.4905666e-7,0.003100579,0.00018233548,0.009595042,0.0024447101,0.0005610252,0.000036371377],"about_ca_topic_score_codex":0.05972953,"about_ca_topic_score_gemma":0.13214855,"teacher_disagreement_score":0.07241901,"about_ca_system_score_codex":0.00019026526,"about_ca_system_score_gemma":0.00045313698,"threshold_uncertainty_score":0.94653183},"labels":[],"label_agreement":null},{"id":"W4413547117","doi":"10.1016/s2213-8587(25)00227-x","title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Prolactin; Pathogenesis; MEDLINE; Intensive care medicine; Bioinformatics; Internal medicine; Hormone","score_opus":0.04254029183216959,"score_gpt":0.3269108296853808,"score_spread":0.2843705378532112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413547117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010670244,0.9913595,0.0000012044916,0.00077099394,0.00023014388,0.0020227896,0.00007934191,0.00011859007,0.004350428],"genre_scores_gemma":[0.00042336885,0.9953724,0.00017860274,0.0007545232,0.0002946534,0.0020617507,0.000262505,0.00004063701,0.0006115215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746627,0.00022323088,0.0004213865,0.0005799509,0.00013431399,0.0011748784],"domain_scores_gemma":[0.99846935,0.00049191853,0.000195159,0.00073339057,0.000023098248,0.00008709637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018571636,0.0004983012,0.002250027,0.0001952217,0.00016858541,0.000029407613,0.0002974322,0.00015825554,0.000042369673],"category_scores_gemma":[0.000067735935,0.00029431528,0.00027496796,0.00022901772,0.0001267258,0.00002845715,0.00036737128,0.00036426057,0.000048900438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003127084,0.000118629796,0.022685084,0.026531577,0.0013678734,0.00022839184,0.000016810467,2.8489241e-8,1.362768e-7,0.00075559266,0.0018333659,0.9464312],"study_design_scores_gemma":[0.0012355011,0.0001437588,0.0062586847,0.008003243,0.004820958,0.00007096416,0.000022756714,7.576305e-7,0.0000021944336,0.00027187422,0.9789201,0.00024923452],"about_ca_topic_score_codex":0.0000071559984,"about_ca_topic_score_gemma":0.000006744628,"teacher_disagreement_score":0.9770867,"about_ca_system_score_codex":0.00005919029,"about_ca_system_score_gemma":0.00007227113,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W4414189723","doi":"10.1016/s2213-8587(25)00225-6","title":"Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Type 2 diabetes; Obesity; Diabetes mellitus; Clinical trial; MEDLINE","score_opus":0.013636066117558401,"score_gpt":0.27955186139662896,"score_spread":0.26591579527907055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414189723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97732246,0.005087128,0.0000082839,0.0064446935,0.0005467171,0.0047181416,0.00001316561,0.00015102566,0.0057083615],"genre_scores_gemma":[0.9921375,0.0008758414,0.00021213331,0.0027549337,0.00030274034,0.00095891673,0.000050302016,0.000029230949,0.0026783934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969812,0.00030146982,0.00050451874,0.0005570967,0.00020251772,0.0014531646],"domain_scores_gemma":[0.99805206,0.0008992096,0.00017264271,0.0006780633,0.000091674796,0.00010637733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055748445,0.000408415,0.001798571,0.0002770881,0.00012619187,0.00004430272,0.00027178074,0.00009966438,0.00006835087],"category_scores_gemma":[0.00033931798,0.00024850862,0.00014073375,0.00041197528,0.00035991299,0.00007446489,0.0001854619,0.00036960052,0.00003067875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5750534,0.0025598763,0.32207948,0.00074439944,0.0038977864,0.00020320617,0.0004625016,0.000007393847,0.00093429,0.0053532314,0.012718687,0.0759858],"study_design_scores_gemma":[0.96113956,0.0037589248,0.017807664,0.00051321654,0.0013441168,0.0000029938335,0.00019930406,0.0008056932,0.0011464523,0.000688232,0.012291605,0.00030224977],"about_ca_topic_score_codex":0.000050492956,"about_ca_topic_score_gemma":0.00013119755,"teacher_disagreement_score":0.38608617,"about_ca_system_score_codex":0.00009578283,"about_ca_system_score_gemma":0.00009504287,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W4414189914","doi":"10.1016/s2213-8587(25)00226-8","title":"Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Obesity; German; MEDLINE; Diabetes mellitus; Clinical trial","score_opus":0.01465677988245434,"score_gpt":0.28648707511636473,"score_spread":0.2718302952339104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414189914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652044,0.0019897418,0.00004669143,0.00943438,0.00057861046,0.006013177,0.000014444803,0.00018578325,0.016532777],"genre_scores_gemma":[0.9881352,0.00038092776,0.00025064748,0.0035346714,0.00038558975,0.0018547085,0.000052450854,0.000027304286,0.0053784763],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996855,0.00032119214,0.00054989103,0.0005231314,0.00022954069,0.0015212379],"domain_scores_gemma":[0.99805224,0.000776201,0.00018229606,0.00082158885,0.000076503144,0.000091189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000566755,0.00038588356,0.0018286599,0.00028122097,0.00011408102,0.000032869913,0.0003567609,0.00008935512,0.00010502449],"category_scores_gemma":[0.00027119202,0.00022852053,0.00022723681,0.0003968106,0.0002770727,0.00006264644,0.00015540974,0.00039350262,0.000063309395],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8469782,0.003069741,0.060808796,0.00040903036,0.0031067613,0.0003589901,0.00037486808,0.000014871019,0.00037965772,0.007994459,0.015993314,0.0605113],"study_design_scores_gemma":[0.9709055,0.0024197854,0.00558165,0.0003956376,0.0011086743,0.000004586354,0.00020960781,0.0006003272,0.00083578855,0.0005718423,0.017133862,0.00023275205],"about_ca_topic_score_codex":0.000093954724,"about_ca_topic_score_gemma":0.00022552142,"teacher_disagreement_score":0.12392727,"about_ca_system_score_codex":0.00014232741,"about_ca_system_score_gemma":0.00011559364,"threshold_uncertainty_score":0.93187964},"labels":[],"label_agreement":null},{"id":"W4414708467","doi":"10.1016/s2213-8587(25)00216-5","title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inversago Pharma (Canada); Université Laval","funders":"National Institutes of Health; Novo Nordisk","keywords":"Obesity; MEDLINE; Phase (matter); Clinical trial; Diabetes mellitus","score_opus":0.01761303373829149,"score_gpt":0.31190151615145645,"score_spread":0.29428848241316496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414708467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763499,0.009089582,0.000004824328,0.008280127,0.000086971806,0.0054123793,0.000019382149,0.000030582487,0.00072626566],"genre_scores_gemma":[0.99610966,0.002043609,0.000026919603,0.00028486445,0.000097067685,0.0007952734,0.0000108274435,0.000015587397,0.0006161769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977303,0.00027492226,0.00049225095,0.00039300913,0.0002118808,0.0008976211],"domain_scores_gemma":[0.99888504,0.00031275413,0.00012944748,0.0004750385,0.000092119066,0.00010562554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008616779,0.0002381146,0.0017590451,0.00030485602,0.000091294125,0.000020439607,0.0001877301,0.000091348906,0.0000324325],"category_scores_gemma":[0.00024477247,0.00013895986,0.00009333133,0.00036674482,0.0005362621,0.000045474775,0.00015325217,0.00048469772,0.0000014647874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97846985,0.00056002144,0.00932466,0.00025597296,0.0005460162,0.00008680238,0.00023306356,0.0000046917075,0.0005523379,0.001627732,0.00037726457,0.007961572],"study_design_scores_gemma":[0.96700054,0.0014949219,0.026428489,0.00023590456,0.00039563366,0.000075002914,0.00011417228,0.00015064521,0.0018576401,0.00010561005,0.0020137937,0.00012761605],"about_ca_topic_score_codex":0.00015353668,"about_ca_topic_score_gemma":0.00010234522,"teacher_disagreement_score":0.01975979,"about_ca_system_score_codex":0.000028940494,"about_ca_system_score_gemma":0.00017799767,"threshold_uncertainty_score":0.5666619},"labels":[],"label_agreement":null},{"id":"W4415224168","doi":"10.1016/s2213-8587(25)00260-8","title":"Managing adults with screen-detected islet autoantibody positivity: a pragmatic framework","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Autoantibody; Islet; Type 1 diabetes; Diabetes mellitus; CLARITY; MEDLINE","score_opus":0.009093133503021069,"score_gpt":0.2767513570405053,"score_spread":0.26765822353748425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415224168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015531043,0.9927185,0.00016725072,0.0007897545,0.0002682767,0.0012403314,0.00035527835,0.00014700889,0.0027604643],"genre_scores_gemma":[0.0014750717,0.99416393,0.00046489356,0.001088003,0.0005422445,0.00041382533,0.0013018601,0.000106064566,0.00044411307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567956,0.0006729116,0.0005136449,0.00090294733,0.00020408985,0.0020268438],"domain_scores_gemma":[0.997498,0.00046522898,0.0004929278,0.0013712606,0.0000907808,0.00008182433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003345045,0.0007715337,0.0021059662,0.00017873623,0.00023266285,0.000097269396,0.0011641012,0.00052666815,0.00002775219],"category_scores_gemma":[0.00035515375,0.00051644054,0.00043680109,0.000522619,0.000287014,0.000006665488,0.0005767221,0.0009250828,0.00004592516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060246024,0.00013006429,0.00033766113,0.009045336,0.0027033284,0.000032211912,0.000036878046,0.000008363964,0.000060639988,0.0010730892,0.0037424266,0.9827697],"study_design_scores_gemma":[0.0010789199,0.00052581774,0.00008038337,0.016615495,0.0018282499,0.000021049558,0.000056320016,0.000025336589,0.0001516461,0.0008990208,0.97776496,0.0009527914],"about_ca_topic_score_codex":0.000024817567,"about_ca_topic_score_gemma":0.00003110284,"teacher_disagreement_score":0.98181695,"about_ca_system_score_codex":0.00004075325,"about_ca_system_score_gemma":0.00023463383,"threshold_uncertainty_score":0.99972874},"labels":[],"label_agreement":null},{"id":"W4415450658","doi":"10.1016/s2213-8587(25)00286-4","title":"Recent advances in research and care of familial hypercholesterolaemia","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidad de Sevilla","keywords":"Familial hypercholesterolemia; Risk stratification; Clinical Practice; Ldl cholesterol; Atherosclerotic cardiovascular disease; Cardiovascular health","score_opus":0.1133343352357879,"score_gpt":0.4203352713989604,"score_spread":0.3070009361631725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415450658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003784747,0.9913606,2.6542503e-7,0.00042954736,0.00021792062,0.0015245234,0.00006132319,0.000022933176,0.002598122],"genre_scores_gemma":[0.00039602726,0.9983918,0.0000449887,0.00013284983,0.00049041904,0.00037858722,0.000064541535,0.000024516656,0.00007624946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671125,0.00085000065,0.0005118368,0.00045292155,0.00033004853,0.0011439614],"domain_scores_gemma":[0.9980808,0.0005230058,0.00010651255,0.0010450748,0.00018013158,0.00006450279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011007168,0.00025561143,0.002897739,0.00035297865,0.000065152446,0.000009067666,0.00035321468,0.0002226427,0.000009259938],"category_scores_gemma":[0.00031918057,0.00015680277,0.00021409614,0.0005449144,0.00039391193,0.00003283702,0.00032349443,0.0013297205,0.000005403629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023700051,0.000025913672,0.0009572839,0.03627433,0.00011801825,0.000022326782,0.00008245149,1.0974148e-7,9.539744e-7,0.00028793656,0.000090989866,0.962116],"study_design_scores_gemma":[0.0008238851,0.0002567161,0.0007287978,0.01081647,0.00028274333,0.000032724205,0.00014588573,1.9621902e-7,0.0000134766415,0.00016159768,0.98663354,0.00010396023],"about_ca_topic_score_codex":0.000038753205,"about_ca_topic_score_gemma":0.000077262885,"teacher_disagreement_score":0.9865426,"about_ca_system_score_codex":0.00016048244,"about_ca_system_score_gemma":0.0004661285,"threshold_uncertainty_score":0.63942313},"labels":[],"label_agreement":null},{"id":"W4416021875","doi":"10.1016/s2213-8587(25)00265-7","title":"Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Canadian VIGOUR Centre; University of Alberta; Toronto General Hospital; University Health Network; Alberta Health Services; Institute for Clinical Evaluative Sciences","funders":"Centers for Disease Control and Prevention; Eli Lilly and Company; Science Foundation Ireland; Diabetes Australia; National Health and Medical Research Council; Australian Institute of Health and Welfare, Australian Government; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Fondation de France; Novo Nordisk; Sanofi; National Heart Foundation of Australia; Baker Heart and Diabetes Institute; Mylan; National Health Insurance Service; State Government of Victoria; Pfizer","keywords":"Heart failure; Diabetes mellitus; Disease; Government (linguistics); Atherosclerotic cardiovascular disease; MEDLINE; Heart disease","score_opus":0.02768364782512464,"score_gpt":0.3123284678318541,"score_spread":0.2846448200067294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416021875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948372,0.0010905422,0.000060940038,0.003029246,0.000031937325,0.000860466,0.000024465484,0.000049655726,0.00001550547],"genre_scores_gemma":[0.99864227,0.0000136403005,0.00019290338,0.0006571119,0.000047949132,0.0002912297,0.00010567918,0.00001425132,0.000034954202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975349,0.001041447,0.00026586474,0.0004150613,0.00026013464,0.00048259742],"domain_scores_gemma":[0.9992844,0.000099498146,0.000041012347,0.00044521253,0.00004772744,0.000082143226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012320793,0.00016906833,0.0007424315,0.00022448825,0.00007002832,0.000017305714,0.00007146152,0.000054158394,0.000028662258],"category_scores_gemma":[0.0001057078,0.00012580061,0.000105351035,0.0003541689,0.00007978496,0.000055672084,0.000048449318,0.00025815304,0.0000029714956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027398386,0.00023827667,0.99654317,0.00007967705,0.00045775675,0.000004384789,0.00011508274,0.00048730025,0.000041914045,0.00001564013,0.000011350237,0.001978041],"study_design_scores_gemma":[0.0068292585,0.000089823916,0.9857793,0.00013434576,0.00034094232,6.1624814e-7,0.000059850194,0.006416076,0.000012142841,0.0000975664,0.00013311992,0.00010696987],"about_ca_topic_score_codex":0.00050092203,"about_ca_topic_score_gemma":0.0011494954,"teacher_disagreement_score":0.01076389,"about_ca_system_score_codex":0.00009010264,"about_ca_system_score_gemma":0.000078603036,"threshold_uncertainty_score":0.513},"labels":[],"label_agreement":null},{"id":"W4417297764","doi":"10.1016/s2213-8587(25)00331-6","title":"Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University Health Centre","funders":"JDRF","keywords":"Diabetic ketoacidosis; Ketoacidosis; Medical diagnosis; Ketone; Anxiety; Diabetes mellitus","score_opus":0.01127745767893358,"score_gpt":0.27905649803717403,"score_spread":0.26777904035824046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417297764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492669,0.0009567835,0.0011879578,0.046781965,0.00030187547,0.0005119266,0.00004163917,0.000038903803,0.0009120512],"genre_scores_gemma":[0.99626535,0.00026920106,0.0006864117,0.0014216042,0.0002497842,0.0006126681,0.000090601905,0.000016019594,0.00038833512],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895895,0.000040051378,0.00018591808,0.00025204674,0.00006411883,0.0004989239],"domain_scores_gemma":[0.99914,0.00014749647,0.00014202375,0.00044793318,0.000104443876,0.000018052777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015005161,0.00013797956,0.00025833838,0.00007392076,0.000118695265,0.00001687345,0.0005460678,0.00008917987,0.0000071500704],"category_scores_gemma":[0.00016298775,0.00008844685,0.00006506427,0.00020092605,0.00012272249,0.000003940277,0.000118738724,0.00012317074,0.000002743234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001887679,0.00029065716,0.51800615,0.000036081165,0.0014386874,1.7473988e-7,0.0002674068,0.00012608165,0.23945639,0.024810504,0.043540936,0.17183821],"study_design_scores_gemma":[0.0026540512,0.0006496841,0.014171499,0.00010591808,0.00009755579,5.193675e-7,0.0013816087,0.00022906763,0.5156741,0.006013598,0.4587317,0.00029068344],"about_ca_topic_score_codex":0.0000141998935,"about_ca_topic_score_gemma":0.000031693846,"teacher_disagreement_score":0.5038346,"about_ca_system_score_codex":0.000017763003,"about_ca_system_score_gemma":0.00004557599,"threshold_uncertainty_score":0.3606758},"labels":[],"label_agreement":null},{"id":"W4417442786","doi":"10.1016/s2213-8587(25)00335-3","title":"Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lunenfeld-Tanenbaum Research Institute; University of Calgary","funders":"","keywords":"Gestational diabetes; Pregnancy; Type 2 diabetes; Type 1 diabetes; Diabetes mellitus; Insulin resistance; Randomized controlled trial; Blood Glucose Self-Monitoring; Insulin","score_opus":0.0241666148435305,"score_gpt":0.32585145716838154,"score_spread":0.30168484232485104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417442786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479437,0.00090678514,0.00008271731,0.0026200619,0.00011625525,0.0010572637,0.000071211274,0.00024847407,0.000102873026],"genre_scores_gemma":[0.99324244,0.0010893677,0.004573773,0.00017485843,0.000040908442,0.0005904535,0.00012733987,0.000013458725,0.0001474071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986359,0.000052513988,0.0002702848,0.00026364124,0.00018171508,0.0005959826],"domain_scores_gemma":[0.99862087,0.0004292391,0.00012572807,0.00028611414,0.00049588183,0.000042170683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002581269,0.00013801818,0.00033677276,0.00019232073,0.00007343161,0.0000223262,0.00021418156,0.00004598094,0.000008300787],"category_scores_gemma":[0.00034962926,0.00008974216,0.000014895093,0.0002470973,0.0002707538,0.000059106376,0.00012279762,0.00012275667,0.0000026230005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058676936,0.0007813098,0.5370231,0.0015893375,0.0026066843,0.000021700558,0.0005528063,0.0005664509,0.12390534,0.010315812,0.0019727047,0.31479704],"study_design_scores_gemma":[0.010238572,0.0066879825,0.8451449,0.0006342067,0.0002934216,0.000008176376,0.0034235585,0.024956418,0.07444496,0.005008714,0.028763006,0.00039607947],"about_ca_topic_score_codex":0.000011349308,"about_ca_topic_score_gemma":0.000005800236,"teacher_disagreement_score":0.31440097,"about_ca_system_score_codex":0.000101746555,"about_ca_system_score_gemma":0.00013466449,"threshold_uncertainty_score":0.36595795},"labels":[],"label_agreement":null},{"id":"W4417485603","doi":"10.1016/s2213-8587(25)00290-6","title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Université de Montréal; Université Laval","funders":"Arrowhead Pharmaceuticals","keywords":"RNA interference; Clinical trial; Phase (matter); MEDLINE; Hydroxymethylglutaryl-CoA Reductase Inhibitors","score_opus":0.040678481061447495,"score_gpt":0.3483097237388609,"score_spread":0.3076312426774134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417485603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910492,0.0009594974,0.00013457226,0.0010024572,0.00076766143,0.0047991686,0.00009217251,0.00017822387,0.0010170948],"genre_scores_gemma":[0.9903954,0.00009634109,0.0012761652,0.005457643,0.0010600357,0.0010185436,0.0004316562,0.0000662697,0.00019793834],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967057,0.00047294988,0.00054062094,0.00063672644,0.00020596637,0.0014379959],"domain_scores_gemma":[0.9981001,0.0004905523,0.00020784835,0.00086222694,0.00018930237,0.0001499495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067114015,0.00039643265,0.0012685299,0.00014169676,0.00041500703,0.00012775928,0.0007653104,0.00012369936,0.000029409612],"category_scores_gemma":[0.0003188296,0.0002476765,0.00008066679,0.00025724916,0.0002669675,0.0003625272,0.00014637376,0.00037308902,0.000005840127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55143356,0.008415702,0.08520129,0.00031467993,0.0013471993,0.000023912613,0.0017686217,0.000021457015,0.025087489,0.0017886466,0.0018148875,0.32278255],"study_design_scores_gemma":[0.9651803,0.0080091255,0.009850042,0.00008307205,0.0010716248,0.000005183853,0.0005005759,0.0004913525,0.003062609,0.00095897954,0.0103695495,0.00041759765],"about_ca_topic_score_codex":0.00007245692,"about_ca_topic_score_gemma":0.000033547054,"teacher_disagreement_score":0.41374674,"about_ca_system_score_codex":0.000043617227,"about_ca_system_score_gemma":0.00016621956,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null}]}